InChIKey,X1.x,accession.x,monisotopic_molecular_weight.x,iupac_name.x,name.x,chemical_formula.x,cas_registry_number.x,kegg.x,food,drugbank.x,drugbankmet,biocyc.x,pubchem.x,chemspider.x,smiles.x,metlin_id,kingdom.x,direct_parent.x,super_class.x,class.x,sub_class.x,molecular_framework.x,logpexp.x,X1.y,accession.y,origin,logpexp.y,carcinogenicity,lethaldose,classes,monisotopic_molecular_weight.y,iupac_name.y,name.y,chemical_formula.y,cas_registry_number.y,hmdb,drugbank.y,kegg.y,biocyc.y,pubchem.y,chemspider.y,smiles.y,kingdom.y,direct_parent.y,super_class.y,class.y,sub_class.y,molecular_framework.y,id,legacy_id,type,public_id,name,export,state,annotation_quality,description,cas_number,melting_point,protein_formula,protein_weight,experimental_solubility,experimental_logp,hydrophobicity,isoelectric_point,metabolism,kegg_compound_id,pubchem_compound_id,pubchem_substance_id,chebi_id,het_id,uniprot_id,uniprot_name,genbank_id,wikipedia_id,synthesis_citations,general_citations,comments,protein_structure_file_name,protein_structure_content_type,protein_structure_file_size,protein_structure_updated_at,msds_file_name,msds_content_type,msds_file_size,msds_updated_at,creator_id,updater_id,created_at,updated_at,phenolexplorer_id,dfc_id,hmdb_id,duke_id,drugbank_id,bigg_id,eafus_id,knapsack_id,boiling_point,boiling_point_reference,charge,charge_reference,density,density_reference,optical_rotation,optical_rotation_reference,percent_composition,percent_composition_reference,physical_description,physical_description_reference,refractive_index,refractive_index_reference,uv_index,uv_index_reference,experimental_pka,experimental_pka_reference,experimental_solubility_reference,experimental_logp_reference,hydrophobicity_reference,isoelectric_point_reference,melting_point_reference,moldb_alogps_logp,moldb_logp,moldb_alogps_logs,moldb_smiles,moldb_pka,moldb_formula,moldb_average_mass,moldb_inchi,moldb_mono_mass,moldb_inchikey,moldb_alogps_solubility,moldb_id,moldb_iupac,structure_source,duplicate_id,old_dfc_id,dfc_name,compound_source,flavornet_id,goodscent_id,superscent_id,phenolexplorer_metabolite_id,kingdom,superklass,klass,subklass,direct_parent,molecular_framework,chembl_id,chemspider_id,meta_cyc_id,foodcomex,phytohub_id,DrugBank ID,Accession Numbers,Common name,CAS,UNII,Synonyms,Standard InChI Key
AAOVKJBEBIDNHE-UHFFFAOYSA-N,9242,HMDB0014967,284.071640755,"7-chloro-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one",Diazepam,C16H13ClN2O,439-14-5,C06948,FDB007103,DB00829,NA,NA,3016,2908,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,NA,Organic compounds,"1,4-benzodiazepines",Organoheterocyclic compounds,Benzodiazepines,"1,4-benzodiazepines",Aromatic heteropolycyclic compounds,2.9,2332,T3D2903,Exogenous,2.82,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,284.071640755,"7-chloro-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one",Diazepam,C16H13ClN2O,439-14-5,HMDB14967,DB00829,C06948,NA,3016,2908,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,Organic compounds,"1,4-benzodiazepines",Organoheterocyclic compounds,Benzodiazepines,"1,4-benzodiazepines",Aromatic heteropolycyclic compounds,4118,12241,SmallMoleculeCompound,FDB004117,Lappaurin,TRUE,NA,low,NA,439-14-5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:06:05 UTC,2017-02-23 19:49:36 UTC,NA,NA,NA,LAPPAURIN,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,NA,C16H13ClN2O,284.74,"InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3",284.0716408,AAOVKJBEBIDNHE-UHFFFAOYSA-N,NA,NA,NA,NA,NA,NA,NA,DUKE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB00829,APRD00642 | DB07699,Diazepam,439-14-5,Q3JTX2Q7TU,"7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one | Diazepam | Methyl diazepinone",AAOVKJBEBIDNHE-UHFFFAOYSA-N
ADFCQWZHKCXPAJ-GFCCVEGCSA-N,1488,HMDB0002209,242.094294314,"(3S)-3-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-7-ol",Equol,C15H14O3,531-95-3,C14131,FDB021824,NA,NA,NA,91469,82594,OC1=CC=C(C=C1)[C@H]1COC2=CC(O)=CC=C2C1,NA,Organic compounds,Isoflavanols,Phenylpropanoids and polyketides,Isoflavonoids,Isoflavans,Aromatic heteropolycyclic compounds,NA,2988,T3D3962,Exogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,242.094294314,"(3S)-3-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-7-ol",Equol,C15H14O3,531-95-3,HMDB02209,NA,C14131,NA,91469,82594,[H][C@@]1(COC2=C(C1)C=CC(O)=C2)C1=CC=C(O)C=C1,Chemical entities,Isoflavanols,Organic compounds,Phenylpropanoids and polyketides,Isoflavonoids,Aromatic heteropolycyclic compounds,21982,NA,SmallMoleculeCompound,FDB021824,Equol,TRUE,Solid,low,"Equol is a metabolite of daidzein, a phytoestrogen common in the human diet and abundant in soy. Intestinal bacteria in humans can reduce daidzein to equol, and can be found in normal human urine. The clinical effectiveness of soy isoflavones may be a function of the ability to biotransform soy isoflavones to the more potent estrogenic metabolite, equol, which may enhance the actions of soy isoflavones, owing to its greater affinity for estrogen receptors, unique antiandrogenic properties, and superior antioxidant activity. However, not all individuals consuming daidzein produce equol. Only approximately one-third to one-half of the population is able to metabolize daidzein to equol. This high variability in equol production is presumably attributable to interindividual differences in the composition of the intestinal microflora, which may play an important role in the mechanisms of action of isoflavones. (PMID: 17579895, 17579894) [HMDB]",531-95-3,NA,NA,NA,NA,NA,NA,NA,NA,C14131,91469,NA,NA,NA,NA,NA,NA,Equol,NA,NA,NA,NA,NA,NA,NA,HMDB02209.pdf,application/pdf,51000,2015-02-28 18:07:16 UTC,NA,2,2011-04-11 17:01:49 UTC,2015-07-21 06:56:24 UTC,866,GZK56-X:FWN69-M,HMDB02209,NA,NA,NA,NA,C00009707,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2.91,3.191677877,-3.74,OC1=CC=C(C=C1)[C@H]1COC2=CC(O)=CC=C2C1,10.31068194,C15H14O3,242.2699,"InChI=1S/C15H14O3/c16-13-4-1-10(2-5-13)12-7-11-3-6-14(17)8-15(11)18-9-12/h1-6,8,12,16-17H,7,9H2/t12-/m1/s1",242.0942943,InChIKey=ADFCQWZHKCXPAJ-GFCCVEGCSA-N,4.45e-02 g/l,80979,"(3S)-3-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-7-ol",MANUAL,NA,NA,NA,HMDB,NA,NA,NA,866,Organic compounds,Phenylpropanoids and polyketides,Isoflavonoids,Isoflavans,Isoflavanols,Aromatic heteropolycyclic compounds,CHEMBL198877,82594,CPD-14115,NA,NA,DB11674,NA,Equol,531-95-3,2T6D2HPX7Q,S-equol,ADFCQWZHKCXPAJ-GFCCVEGCSA-N
AEMFNILZOJDQLW-QAGGRKNESA-N,37,HMDB0000053,286.193280076,"(1S,2R,10R,11S,15S)-2,15-dimethyltetracyclo[8.7.0.0\xc2\xb2,\xe2\x81\xb7.0\xc2\xb9\xc2\xb9,\xc2\xb9\xe2\x81\xb5]heptadec-6-ene-5,14-dione",Androstenedione,C19H26O2,63-05-8,C00280,FDB021807,NA,NA,ANDROST4ENE,6128,5898,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,2795,Organic compounds,Androgens and derivatives,Lipids and lipid-like molecules,Steroids and steroid derivatives,Androstane steroids,Aliphatic homopolycyclic compounds,2.75,3140,T3D4240,Endogenous,2.75,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,286.193280076,"(1S,2R,10R,11S,15S)-2,15-dimethyltetracyclo[8.7.0.0\xc2\xb2,\xe2\x81\xb7.0\xc2\xb9\xc2\xb9,\xc2\xb9\xe2\x81\xb5]heptadec-6-ene-5,14-dione",Androstenedione,C19H26O2,63-05-8,HMDB00053,DB01536,C00280,ANDROST4ENE,6128,5898,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,Chemical entities,Androgens and derivatives,Organic compounds,Lipids and lipid-like molecules,Steroids and steroid derivatives,Aliphatic homopolycyclic compounds,30841,NA,SmallMoleculeCompound,FDB030678,"androst-4-en-3,17-dione",TRUE,NA,NA,NA,1963-05-08,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2015-05-07 19:46:52 UTC,2017-03-11 23:04:08 UTC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,NA,C19H26O2,286.4085,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",286.1932801,AEMFNILZOJDQLW-QAGGRKNESA-N,NA,NA,NA,NA,NA,NA,NA,MANUAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB01536,EXPT00569 | DB07386,Androstenedione,63-05-8,409J2J96VR,"4-Androstene-3,17-dione | 4-Androstenedione",AEMFNILZOJDQLW-QAGGRKNESA-N
AEMRFAOFKBGASW-UHFFFAOYSA-N,73,HMDB0000115,76.016043994,2-hydroxyacetic acid,Glycolic acid,C2H4O3,79-14-1,C00160,FDB003298,DB03085,NA,GLYCOLLATE,757,737,OCC(O)=O,3219,Organic compounds,Alpha hydroxy acids and derivatives,Organic acids and derivatives,Hydroxy acids and derivatives,Alpha hydroxy acids and derivatives,Aliphatic acyclic compounds,-1.11,2695,T3D3660,Endogenous,-1.11,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,76.016043994,2-hydroxyacetic acid,Glycolic acid,C2H4O3,79-14-1,HMDB00115,DB03085,C00160,GLYCOLLATE,757,737,OCC(O)=O,Chemical entities,Alpha hydroxy acids and derivatives,Organic compounds,Organic acids and derivatives,Hydroxy acids and derivatives,Aliphatic acyclic compounds,3299,10201,SmallMoleculeCompound,FDB003298,Hydroxyacetic acid,TRUE,Solid,low,"Found in sugar cane (Saccharum officinarum)Glycolic acid (or hydroxyacetic acid) is the smallest alpha-hydroxy acid (AHA). This colorless, odorless, and hygroscopic crystalline solid is highly soluble in water. It is used in various skin-care products. Glycolic acid is found in some sugar-crops. (Wikipedia)",79-14-1,Mp 80å¡,NA,NA,NA,-1.11,NA,NA,NA,C03547,757,NA,17497,GOA,NA,NA,NA,Glycolic_acid,NA,NA,NA,NA,NA,NA,NA,HMDB00115.pdf,application/pdf,51572,2015-02-28 18:00:36 UTC,NA,2,2010-04-08 22:05:44 UTC,2015-10-09 22:28:10 UTC,NA,CVS61-P:CVS61-P,HMDB00115,GLYCOLLIC-ACID|GLYCOLIC-ACID,DB03085,34090,NA,C00007461,Bp 100å¡ dec.,DFC,NA,NA,NA,NA,NA,NA,C 31.59%; H 5.30%; O 63.11%,DFC,NA,NA,NA,NA,NA,NA,pKa 3.82,DFC,NA,"HANSCH,C ET AL. (1995)",NA,NA,DFC,-1.02,-1.04,0.9,OCC(O)=O,14.78,C2H4O3,76.0514,"InChI=1S/C2H4O3/c3-1-2(4)5/h3H,1H2,(H,4,5)",76.01604399,InChIKey=AEMRFAOFKBGASW-UHFFFAOYSA-N,6.08e+02 g/l,32029,2-hydroxyacetic acid,MANUAL,chebi:29805,NA,"Hydroxyacetic acid, 9CI",DFC,NA,NA,NA,NA,Organic compounds,Organic acids and derivatives,Hydroxy acids and derivatives,Alpha hydroxy acids and derivatives,Alpha hydroxy acids and derivatives,Aliphatic acyclic compounds,CHEMBL252557,737,GLYCOLLATE,TRUE,NA,DB03085,EXPT01629 | DB11307,Glycolic acid,79-14-1,0WT12SX38S,2-Hydroxyacetic acid | 2-Hydroxyethanoic acid | alpha-Hydroxyacetic acid | Glycollic acid | Hydroxyacetic Acid | Hydroxyethanoic Acid | Î±-hydroxyacetic acid,AEMRFAOFKBGASW-UHFFFAOYSA-N
AHCYMLUZIRLXAA-SHYZEUOFSA-N,924,HMDB0001191,467.973612734,"({[({[(2R,3S,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid",Deoxyuridine triphosphate,C9H15N2O14P3,1173-82-6,C00460,FDB022478,NA,NA,DUTP,65070,58580,O[C@H]1C[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O,6069,Organic compounds,Pyrimidine 2'-deoxyribonucleoside triphosphates,"Nucleosides, nucleotides, and analogues",Pyrimidine nucleotides,Pyrimidine deoxyribonucleotides,Aromatic heteromonocyclic compounds,NA,3223,T3D4430,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,467.973612734,"({[({[(2R,3S,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid",Deoxyuridine triphosphate,C9H15N2O14P3,1173-82-6,HMDB01191,DB02333,C00460,DUTP,65070,58580,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(O)=NC1=O,Chemical entities,Pyrimidine 2'-deoxyribonucleoside triphosphates,Organic compounds,"Nucleosides, nucleotides, and analogues",Pyrimidine nucleotides,Aromatic heteromonocyclic compounds,22641,NA,SmallMoleculeCompound,FDB022478,Deoxyuridine triphosphate,TRUE,Solid,low,"Deoxyuridine triphosphate is an intermediate in the metabolism of Pyrimidine. It is a substrate for Inosine triphosphate pyrophosphatase, Deoxyuridine 5'-triphosphate nucleotidohydrolase (mitochondrial), Uridine-cytidine kinase 1, Nucleoside diphosphate kinase 3, Nucleoside diphosphate kinase B, Nucleoside diphosphate kinase 6, Nucleoside diphosphate kinase (mitochondrial), Nucleoside diphosphate kinase homolog 5, Nucleoside diphosphate kinase A and Nucleoside diphosphate kinase 7. [HMDB]",1173-82-6,NA,NA,NA,NA,NA,NA,NA,NA,C00460,65070,NA,17625,DUT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2011-09-21 00:14:39 UTC,2015-07-21 06:57:14 UTC,NA,NA,HMDB01191,NA,NA,35037,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.12,-2.481767068,-1.73,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O[H])N1C([H])=C([H])C(=O)N([H])C1=O,2.51148134,C9H15N2O14P3,468.1417,"InChI=1S/C9H15N2O14P3/c12-5-3-8(11-2-1-7(13)10-9(11)14)23-6(5)4-22-27(18,19)25-28(20,21)24-26(15,16)17/h1-2,5-6,8,12H,3-4H2,(H,18,19)(H,20,21)(H,10,13,14)(H2,15,16,17)/t5-,6+,8+/m0/s1",467.9736127,InChIKey=AHCYMLUZIRLXAA-SHYZEUOFSA-N,8.63e+00 g/l,84054,"({[({[(2R,3S,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,"Nucleosides, nucleotides, and analogues",Pyrimidine nucleotides,Pyrimidine deoxyribonucleotides,Pyrimidine 2'-deoxyribonucleoside triphosphates,Aromatic heteromonocyclic compounds,CHEMBL374361,58580,DUTP,NA,NA,DB02333,EXPT01301,Deoxyuridine-5'-Triphosphate,NA,NA,NA,AHCYMLUZIRLXAA-SHYZEUOFSA-N
AHLPHDHHMVZTML-BYPYZUCNSA-N,140,HMDB0000214,132.089877638,"(2S)-2,5-diaminopentanoic acid",Ornithine,C5H12N2O2,3184-13-2,C00077,FDB003654,DB00129,NA,L-ORNITHINE,6262,6026,NCCC[C@H](N)C(O)=O,27,Organic compounds,L-alpha-amino acids,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,-4.22,3189,T3D4329,Endogenous,-4.22,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,132.089877638,"(2S)-2,5-diaminopentanoic acid",Ornithine,C5H12N2O2,70-26-8,HMDB00214,DB00129,C01602,L-ORNITHINE,6262,6026,[H][C@](N)(CCCN)C(O)=O,Organic compounds,L-alpha-amino acids,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,31132,NA,SmallMoleculeCompound,FDB030969,L-ornithine,TRUE,NA,NA,NA,70-26-8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2015-05-07 20:39:26 UTC,2017-03-11 23:05:40 UTC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NCCC[C@H](N)C(O)=O,NA,C5H12N2O2,132.161,"InChI=1S/C5H12N2O2/c6-3-1-2-4(7)5(8)9/h4H,1-3,6-7H2,(H,8,9)/t4-/m0/s1",132.0898776,AHLPHDHHMVZTML-BYPYZUCNSA-N,NA,NA,NA,NA,NA,NA,NA,MANUAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB00129,NUTR00043,Ornithine,70-26-8,E524N2IXA3,"(S)-2,5-Diaminopentanoate | (S)-2,5-Diaminopentanoic acid | (S)-2,5-diaminovaleric acid | (S)-alpha,delta-Diaminovaleric acid | (S)-ornithine | (S)-Î±,Î´-diaminovaleric acid | L-Ornithine | levo-ornithine",AHLPHDHHMVZTML-BYPYZUCNSA-N
AKPLHCDWDRPJGD-UHFFFAOYSA-N,40703,HMDB0060538,270.055990691,"7-chloro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one",Nordiazepam,C15H11ClN2O,1088-11-5,C07486,NA,NA,DBMET00113,NA,2997,NA,ClC1=CC=C2NC(=O)CN=C(C3=CC=CC=C3)C2=C1,NA,Organic compounds,"1,4-benzodiazepines",Organoheterocyclic compounds,Benzodiazepines,"1,4-benzodiazepines",Aromatic heteropolycyclic compounds,NA,3343,T3D4588,Exogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,270.055990691,"7-chloro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one",Nordiazepam,C15H11ClN2O,1088-11-5,HMDB60538,NA,C07486,NA,2997,2890,OC1=NC2=C(C=C(Cl)C=C2)C(=NC1)C1=CC=CC=C1,Organic compounds,"1,4-benzodiazepines",Organoheterocyclic compounds,Benzodiazepines,"1,4-benzodiazepines",Aromatic heteropolycyclic compounds,7125,17821,SmallMoleculeCompound,FDB007124,N-Demethyldiazepam,TRUE,NA,low,NA,1088-11-5,216.5 oC,NA,NA,NA,2.93,NA,NA,NA,C07486,2997,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:07:27 UTC,2017-03-01 02:05:16 UTC,NA,NA,NA,N-DEMETHYL-DIAZEPAM,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HANSCH,C ET AL. (1995)",NA,NA,NA,2.79,3.21,-4.09,ClC1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1,NA,C15H11ClN2O,270.714,"InChI=1S/C15H11ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)",270.0559907,InChIKey=AKPLHCDWDRPJGD-UHFFFAOYSA-N,2.19e-02 g/l,41303,"7-chloro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one",BIOSPIDER,NA,NA,NA,DUKE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB14028,NA,Nordazepam,1088-11-5,67220MCM01,Desmethyldiazepam | N-desmethyldiazepam | Nordazepam CIV | Nordazepamum | Nordiazepam,AKPLHCDWDRPJGD-UHFFFAOYSA-N
ALRHLSYJTWAHJZ-UHFFFAOYSA-N,550,HMDB0000700,90.031694058,3-hydroxypropanoic acid,Hydroxypropionic acid,C3H6O3,503-66-2,C01013,FDB022189,NA,NA,NA,68152,61460,OCCC(O)=O,5668,Organic compounds,Beta hydroxy acids and derivatives,Organic acids and derivatives,Hydroxy acids and derivatives,Beta hydroxy acids and derivatives,Aliphatic acyclic compounds,NA,3178,T3D4304,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,90.031694058,3-hydroxypropanoic acid,Hydroxypropionic acid,C3H6O3,503-66-2,HMDB00700,DB03688,C01013,NA,68152,61460,OCCC(O)=O,Chemical entities,Beta hydroxy acids and derivatives,Organic compounds,Organic acids and derivatives,Hydroxy acids and derivatives,Aliphatic acyclic compounds,22352,NA,SmallMoleculeCompound,FDB022189,Hydroxypropionic acid,TRUE,Liquid,low,3-Hydroxypropionic acid is a carboxylic acid. It is used in the production of various chemicals such as acrylates in industry. It can be produced by certain microbes . Its chemical structure is similar to L-serine. [HMDB],503-66-2,NA,NA,NA,NA,NA,NA,NA,NA,C01013,68152,NA,16510,3OH,NA,NA,NA,Hydroxypropionic acid,NA,NA,NA,NA,NA,NA,NA,HMDB00700.pdf,application/pdf,148449,2015-02-28 17:49:30 UTC,NA,NA,2011-09-21 00:09:50 UTC,2015-10-09 22:30:57 UTC,NA,NA,HMDB00700,NA,DB03688,53188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.95,-0.803581024,0.86,[H]OC(=O)C([H])([H])C([H])([H])O[H],16.02280713,C3H6O3,90.0779,"InChI=1S/C3H6O3/c4-2-1-3(5)6/h4H,1-2H2,(H,5,6)",90.03169406,InChIKey=ALRHLSYJTWAHJZ-UHFFFAOYSA-N,6.47e+02 g/l,81216,3-hydroxypropanoic acid,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organic acids and derivatives,Hydroxy acids and derivatives,Beta hydroxy acids and derivatives,Beta hydroxy acids and derivatives,Aliphatic acyclic compounds,CHEMBL1205969,61460,NA,TRUE,NA,DB03688,EXPT00183,3-Hydroxy-Propanoic Acid,NA,C4ZF6XLD2X,NA,ALRHLSYJTWAHJZ-UHFFFAOYSA-N
AQIXAKUUQRKLND-UHFFFAOYSA-N,8969,HMDB0014644,252.115715232,(Z)-1-cyano-2-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine,Cimetidine,C10H16N6S,51481-61-9,C06952,NA,DB00501,NA,NA,2756,2654,C\N=C(\NCCSCC1=C(C)NC=N1)NC#N,NA,Organic compounds,Imidazoles,Organoheterocyclic compounds,Azoles,Imidazoles,Aromatic heteromonocyclic compounds,1,2264,T3D2810,Exogenous,0.4,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,252.115715232,(Z)-1-cyano-2-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine,Cimetidine,C10H16N6S,51481-61-9,HMDB14644,DB00501,C06952,NA,2756,2654,CN=C(NCCSCC1=C(C)N=CN1)NC#N,Chemical entities,Imidazoles,Organic compounds,Organoheterocyclic compounds,Azoles,Aromatic heteromonocyclic compounds,10097,25041,SmallMoleculeCompound,FDB010095,Poly(divinylbenzene-co-trimethyl(vinylbenzyl)ammonium chloride),TRUE,NA,low,Used as a food additive [EAFUS],60177-39-1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:08:57 UTC,2015-07-20 22:31:37 UTC,NA,NA,NA,NA,NA,NA,3076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,C\N=C(\NCCSCC1=C(C)NC=N1)NC#N,NA,C10H16N6S,252.339,"InChI=1S/C10H16N6S/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14)",252.1157152,AQIXAKUUQRKLND-UHFFFAOYSA-N,NA,NA,NA,NA,NA,NA,NA,EAFUS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB00501,APRD00568,Cimetidine,51481-61-9,80061L1WGD,1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine | 2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine | Cimetag | Cimetidin | Cimetidina | CimÃ©tidine | Cimetidinum | N-Cyano-n'-methyl-n''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine | N''-cyano-N-methyl-n'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine | Tagamet hb 200 | Ulcerfen,AQIXAKUUQRKLND-UHFFFAOYSA-N
ATHGHQPFGPMSJY-UHFFFAOYSA-N,968,HMDB0001257,145.157897623,(4-aminobutyl)(3-aminopropyl)amine,Spermidine,C7H19N3,124-20-9,C00315,FDB012039,DB03566,NA,SPERMIDINE,1102,1071,NCCCCNCCCN,254,Organic compounds,Dialkylamines,Organic nitrogen compounds,Organonitrogen compounds,Amines,Aliphatic acyclic compounds,NA,3088,T3D4167,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,145.157897623,(4-aminobutyl)(3-aminopropyl)amine,Spermidine,C7H19N3,124-20-9,HMDB01257,DB03566,C00315,SPERMIDINE,1102,1071,NCCCCNCCCN,Chemical entities,Dialkylamines,Organic compounds,Organic nitrogen compounds,Organonitrogen compounds,Aliphatic acyclic compounds,8043,19376,SmallMoleculeCompound,FDB008042,Sperminidine,TRUE,NA,low,NA,124-20-9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:07:53 UTC,2017-03-11 22:53:08 UTC,NA,NA,NA,SPERMINIDINE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NCCCCNCCCN,NA,C7H19N3,145.2459,"InChI=1S/C7H19N3/c8-4-1-2-6-10-7-3-5-9/h10H,1-9H2",145.1578976,ATHGHQPFGPMSJY-UHFFFAOYSA-N,NA,NA,NA,NA,NA,NA,NA,DUKE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB03566,EXPT02942,Spermidine,124-20-9,U87FK77H25,"1,5,10-Triazadecane | 1,8-Diamino-4-azaoctane | 4-Azaoctane-1,8-diamine | N-(3-Aminopropyl)-1,4-butane-diamine | N-(3-Aminopropyl)-1,4-butanediamine | N-(3-Aminopropyl)-1,4-diaminobutane | N-(3-aminopropyl)butane-1,4-diamine | Spermidin",ATHGHQPFGPMSJY-UHFFFAOYSA-N
AUNGANRZJHBGPY-SCRDCRAPSA-N,165,HMDB0000244,376.138284392,"7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-2H,3H,4H,10H-benzo[g]pteridine-2,4-dione",Riboflavin,C17H20N4O6,83-88-5,C00255,FDB012160,DB00140,NA,RIBOFLAVIN,493570,431981,CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)CO)C3=NC(=O)NC(=O)C3=NC2=C1,5249,Organic compounds,Flavins,Organoheterocyclic compounds,Pteridines and derivatives,Alloxazines and isoalloxazines,Aromatic heteropolycyclic compounds,-1.46,3503,T3D4817,Endogenous,-1.46,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,376.138284392,"7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-2H,3H,4H,10H-benzo[g]pteridine-2,4-dione",Riboflavin,C17H20N4O6,83-88-5,HMDB00244,DB00140,C00255,RIBOFLAVIN,493570,6501,[H][C@@](O)(CO)[C@@]([H])(O)[C@@]([H])(O)CN1C2=C(C=C(C)C(C)=C2)N=C2C(O)=NC(=O)N=C12,Organic compounds,Flavins,Organoheterocyclic compounds,Pteridines and derivatives,Alloxazines and isoalloxazines,Aromatic heteropolycyclic compounds,12163,31462,SmallMoleculeCompound,FDB012160,Riboflavine,TRUE,Solid,low,"Colour additive in food, nutrient supplement. Vitamin cofactor.Riboflavin, also known as vitamin B2 or additive E101, is an easily absorbed micronutrient with a key role in maintaining health in humans and animals. It is the central component of the cofactors FAD and FMN, and is therefore required by all flavoproteins. As such, vitamin B2 is required for a wide variety of cellular processes. It plays a key role in energy metabolism, and for the metabolism of fats, ketone bodies, carbohydrates, and proteins. (Wikipedia)",83-88-5,Mp 280å¡ dec.,NA,NA,0.0847 mg/mL at 25 oC,-1.46,NA,NA,NA,C00255,493570,NA,17015,RBF,NA,NA,NA,Riboflavin,NA,NA,knapsack_id:C00001552,NA,NA,NA,NA,HMDB00244.pdf,application/pdf,48183,2015-02-28 17:58:45 UTC,NA,2,2010-04-08 22:10:01 UTC,2015-10-09 22:28:10 UTC,NA,HDV43-H:HDV43-H,HMDB00244,VITAMIN-B-2|VIT-B2|RIBOFLAVIN,DB00140,34409,3302,NA,NA,NA,NA,NA,NA,NA,[a]D -125 (20N NaOH),DFC,C 54.25%; H 5.36%; N 14.89%; O 25.51%,DFC,NA,NA,NA,NA,455 () (H2O),DFC,pKa2 10.2 (25å¡),DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,-1.05,-0.92,-2.76,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO)C1=NC(=O)NC(=O)C1=N2,12.85,C17H20N4O6,376.3639,"InChI=1S/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12+,14-/m0/s1",376.1382844,InChIKey=AUNGANRZJHBGPY-SCRDCRAPSA-N,6.57e-01 g/l,37818,"7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-2H,3H,4H,10H-benzo[g]pteridine-2,4-dione",MANUAL,NA,NA,"Riboflavine, 9CI, BAN, INN",DFC,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Pteridines and derivatives,Alloxazines and isoalloxazines,Flavins,Aromatic heteropolycyclic compounds,CHEMBL1534,431981,RIBOFLAVIN,TRUE,NA,DB00140,NUTR00010 | APRD00626 | EXPT02760 | DB09358,Riboflavin,83-88-5,TLM2976OFR,"1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol | 6,7-Dimethyl-9-D-ribitylisoalloxazine | 7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine | 7,8-Dimethyl-10-ribitylisoalloxazine | Lactoflavin | Lactoflavine | Riboflavina | Riboflavine | Riboflavinum | Vitamin B2 | Vitamin Bi | Vitamin G",AUNGANRZJHBGPY-SCRDCRAPSA-N
AYFVYJQAPQTCCC-GBXIJSLDSA-N,109,HMDB0000167,119.058243159,"(2S,3R)-2-amino-3-hydroxybutanoic acid",L-Threonine,C4H9NO3,72-19-5,C00188,FDB011999,DB00156,NA,THR,6288,6051,C[C@@H](O)[C@H](N)C(O)=O,32,Organic compounds,L-alpha-amino acids,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,-2.94,3210,T3D4368,Endogenous,-2.94,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,119.058243159,"(2S,3R)-2-amino-3-hydroxybutanoic acid",L-Threonine,C4H9NO3,72-19-5,HMDB00167,DB00156,C00188,THR,6288,6051,[H][C@](C)(O)[C@]([H])(N)C(O)=O,Chemical entities,L-alpha-amino acids,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Aliphatic acyclic compounds,12002,30806,SmallMoleculeCompound,FDB011999,L-Threonine,TRUE,Solid,low,"From wide variety of protein hydrolysates. Dietary supplement, nutrientThreonine (abbreviated as Thr or T) is an essential alpha-amino acid. (Wikipedia)",72-19-5,Mp 251-253å¡ dec.,NA,NA,97 mg/mL at 25 oC,-2.94,NA,NA,NA,C00188,6288,NA,16857,THR,NA,NA,NA,L-Threonine,NA,NA,NA,NA,NA,NA,NA,HMDB00167.pdf,application/pdf,48307,2015-02-28 17:52:51 UTC,NA,2,2010-04-08 22:09:56 UTC,2015-10-09 22:28:33 UTC,NA,HCL12-S:HCL15-V,HMDB00167,THREONINE|L-(-)-THREONINE,DB00156,34186,3669,C00001394,NA,NA,0,NA,NA,NA,[a]26D -33.9 (H2O),DFC,C 40.33%; H 7.62%; N 11.76%; O 40.29%,DFC,NA,NA,NA,NA,NA,NA,pKa2 9.62 (NH2),DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,-3.01,-3.61,0.6,C[C@@H](O)[C@H](N)C(O)=O,14.95,C4H9NO3,119.1192,"InChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1",119.0582432,InChIKey=AYFVYJQAPQTCCC-GBXIJSLDSA-N,4.77e+02 g/l,31394,"(2S,3R)-2-amino-3-hydroxybutanoic acid",MANUAL,NA,NA,"2-Amino-3-hydroxybutanoic acid; (2S,3R)-form",DFC,NA,NA,NA,NA,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Hydroxy fatty acids,Aliphatic acyclic compounds,CHEMBL291747,6051,THR,TRUE,NA,DB00156,NUTR00057,L-Threonine,72-19-5,2ZD004190S,"(2S,3R)-(-)-Threonine | (2S)-threonine | 2-Amino-3-hydroxybutyric acid | L-(-)-Threonine | L-2-Amino-3-hydroxybutyric acid | L-alpha-amino-beta-hydroxybutyric acid | L-Threonin | L-Î±-amino-Î²-hydroxybutyric acid | Thr | Threonine",AYFVYJQAPQTCCC-GBXIJSLDSA-N
BAVYZALUXZFZLV-UHFFFAOYSA-N,108,HMDB0000164,31.042199165,methanamine,Methylamine,CH5N,74-89-5,C00218,FDB003958,NA,NA,METHYLAMINE,6329,6089,CN,3767,Organic compounds,Monoalkylamines,Organic nitrogen compounds,Organonitrogen compounds,Amines,Aliphatic acyclic compounds,-0.57,3073,T3D4151,Endogenous,-0.57,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,31.042199165,methanamine,Methylamine,CH5N,74-89-5,HMDB00164,DB01828,C00218,CPD-4521,6329,6089,CN,Organic compounds,Monoalkylamines,Organic nitrogen compounds,Organonitrogen compounds,Amines,Aliphatic acyclic compounds,3959,11963,SmallMoleculeCompound,FDB003958,Methylamine,TRUE,gas,low,"Methylamine is a colourless gas derivative of ammonia, but with one H atom replaced by a methyl group. It is the simplest primary amine. It has a strong odor similar to fish. Methylamine is used as a building block for the synthesis of many other commercially available compounds. Hundreds of millions of kilograms are produced annually. (Wikipedia)",74-89-5,-93.4 oC,NA,NA,1080 mg/mL at 25 oC,-0.57,NA,NA,NA,C00218,6329,NA,NA,NA,NA,NA,NA,Methylamine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:06:01 UTC,2015-10-09 22:28:21 UTC,NA,NA,HMDB60291,METHYL-AMINE,DB01828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10.6,NA,"SCHWEIZER,AE et al. (1978)","HANSCH,C ET AL. (1995)",NA,NA,NA,-1.06,-0.63,1.07,CN,NA,CH5N,31.0571,"InChI=1S/CH5N/c1-2/h2H2,1H3",31.04219917,InChIKey=BAVYZALUXZFZLV-UHFFFAOYSA-N,3.67e+02 g/l,41467,methanamine,BIOSPIDER,NA,NA,NA,DUKE,NA,NA,NA,NA,Organic compounds,Organonitrogen compounds,Amines,Primary amines,Monoalkylamines,Aliphatic acyclic compounds,CHEMBL43280,6089,NA,TRUE,NA,DB01828,EXPT02363,Methylamine,74-89-5,BSF23SJ79E,NA,BAVYZALUXZFZLV-UHFFFAOYSA-N
BCGWQEUPMDMJNV-UHFFFAOYSA-N,1219,HMDB0001848,280.193948778,"(3-{2-azatricyclo[9.4.0.0\xc2\xb3,\xe2\x81\xb8]pentadeca-1(15),3,5,7,11,13-hexaen-2-yl}propyl)dimethylamine",Imipramine,C19H24N2,50-49-7,C07049,FDB022706,NA,NA,NA,3696,3568,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,500,Organic compounds,Dibenzazepines,Organoheterocyclic compounds,Benzazepines,Dibenzazepines,Aromatic heteropolycyclic compounds,4.8,2252,T3D2797,Exogenous,4.8,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,280.193948778,"(3-{2-azatricyclo[9.4.0.0\xc2\xb3,\xe2\x81\xb8]pentadeca-1(15),3,5,7,11,13-hexaen-2-yl}propyl)dimethylamine",Imipramine,C19H24N2,50-49-7,HMDB01848,DB00458,C07049,NA,3696,3568,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,Organic compounds,Dibenzazepines,Organoheterocyclic compounds,Benzazepines,Dibenzazepines,Aromatic heteropolycyclic compounds,22869,NA,SmallMoleculeCompound,FDB022706,Imipramine,TRUE,Solid,low,"The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. -- Pubchem; Imipramine (sold as Antideprin, Janimine, Tofranil) is an antidepressant medication, a tricyclic antidepressant of the dibenzazepine group, mainly used in the treatment of clinical depression and enuresis. -- Wikipedia [HMDB]",50-49-7,NA,NA,NA,NA,NA,NA,NA,NA,C07049,3696,NA,5881,IXX,NA,NA,NA,Imipramine,NA,NA,NA,NA,NA,NA,NA,HMDB01848.pdf,application/pdf,156431,2015-02-28 18:06:12 UTC,NA,NA,2011-09-21 00:18:15 UTC,2015-10-09 22:30:54 UTC,NA,NA,HMDB01848,NA,DB00458,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4.53,4.278568794,-3.63,[H]C1=C([H])C([H])=C2C(=C1[H])N(C1=C([H])C([H])=C([H])C([H])=C1C([H])([H])C2([H])[H])C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H],NA,C19H24N2,280.4073,"InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3",280.1939488,InChIKey=BCGWQEUPMDMJNV-UHFFFAOYSA-N,6.64e-02 g/l,83675,"(3-{2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-2-yl}propyl)dimethylamine",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Benzazepines,Dibenzazepines,Dibenzazepines,Aromatic heteropolycyclic compounds,CHEMBL11,3568,CPD-11438,TRUE,NA,DB00458,APRD00672 | DB08002,Imipramine,50-49-7,OGG85SX4E4,"10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine | 3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine | 5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine | Antideprin | Imipramin | Imipramine | Imipraminum | Imizine | Irmin | Melipramine | N-(gamma-Dimethylaminopropyl)iminodibenzyl | N-(Î³-dimethylaminopropyl)iminodibenzyl",BCGWQEUPMDMJNV-UHFFFAOYSA-N
BDJRBEYXGGNYIS-UHFFFAOYSA-N,622,HMDB0000784,188.104859,nonanedioic acid,Azelaic acid,C9H16O4,123-99-9,C08261,FDB012192,DB00548,NA,NA,2266,2179,OC(=O)CCCCCCCC(O)=O,5750,Organic compounds,Medium-chain fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,1.57,3485,T3D4799,Endogenous,1.57,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,188.104859,nonanedioic acid,Azelaic Acid,C9H16O4,123-99-9,HMDB00784,DB00548,C08261,NA,2266,2179,OC(=O)CCCCCCCC(O)=O,Organic compounds,Medium-chain fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,12195,31573,SmallMoleculeCompound,FDB012192,Azelaic acid,TRUE,Solid,low,"Occurs in rancid fats. Isol. from a few higher plantsAzelaic acid (AZA) is a naturally occurring saturated nine-carbon dicarboxylic acid (COOH (CH2)7-COOH). It possesses a variety of biological actions both in vitro and in vivo. Interest in the biological activity of AZA arose originally out of studies of skin surface lipids and the pathogenesis of hypochromia in pityriasis versicolor infection. Later, it was shown that Pityrosporum can oxidize unsaturated fatty acids to C8-C12 dicarboxylic acids that are cornpetitive inhibitors of tyrosinase in vitro. Azelaic acid was chosen for further investigation and development of a new topical drug for treating hyperpigmentary disorders for the following reasons: it possesses a middle-range of antityrosinase activity, is inexpensive, and more soluble to be incorporated into a base cream than other dicarboxylic acids.  Azelaic acid is another option for the topical treatment of mild to moderate inflammatory acne vulgaris. It offers effectiveness similar to that of other agents without the systemic side effects of oral antibiotics or the allergic sensitization of topical benzoyl peroxide and with less irritation than tretinoin. Azelaic acid is less expensive than certain other prescription acne preparations, but it is much more expensive than nonprescription benzoyl peroxide preparations. Whether it is safe and effective when used in combination with other agents is not known. (PMID: 7737781, 8961845); Azelaic acid is a saturated dicarboxylic acid found naturally in wheat, rye, and barley. It is a natural substance that is produced by <i>Malassezia furfur</i> (also known as <i>Pityrosporum ovale</i>), a yeast that lives on normal skin. It is effective against a number of skin conditions, such as mild to moderate acne, when applied topically in a cream formulation of 20%. It works in part by stopping the growth of skin bacteria that cause acne, and by keeping skin pores clear. Azelaic acid's antimicrobial action may be attributable to inhibition of microbial cellular protein synthesis.; Azelaic acid is a saturated dicarboxylic acid found naturally in wheat, rye, and barley. It is a natural substance that is produced by Malassezia furfur (also known as Pityrosporum ovale), a yeast that lives on normal skin. It is effective against a number of skin conditions, such as mild to moderate acne, when applied topically in a cream formulation of 20%. Azelaic acid may be useful as a hair growth stimulant.[citation needed]",123-99-9,Mp 106.5å¡,NA,NA,2.4 mg/mL at 20 oC,1.57,NA,NA,NA,C08261,2266,NA,48131,AZ1,NA,NA,NA,Nonanedioic acid,NA,NA,NA,NA,NA,NA,NA,HMDB00784.pdf,application/pdf,48767,2015-02-28 18:08:46 UTC,NA,NA,2010-04-08 22:10:02 UTC,2015-10-09 22:28:25 UTC,NA,HDZ47-F:HDZ47-F,HMDB00784,NONANEDIOIC-ACID|AZELAIC-ACID,DB00548,NA,NA,NA,Bp10 226å¡,DFC,NA,NA,NA,NA,NA,NA,C 57.43%; H 8.57%; O 34.00%,DFC,NA,NA,NA,NA,NA,NA,"pKa2 5.53 (25å¡, 0.1M KNO3)",DFC,"YALKOWSKY,SH & HE,Y (2003)","HANSCH,C ET AL. (1995)",NA,NA,DFC,1.37,1.82,-1.92,OC(=O)CCCCCCCC(O)=O,4.98,C9H16O4,188.2209,"InChI=1S/C9H16O4/c10-8(11)6-4-2-1-3-5-7-9(12)13/h1-7H2,(H,10,11)(H,12,13)",188.104859,InChIKey=BDJRBEYXGGNYIS-UHFFFAOYSA-N,2.28e+00 g/l,31794,nonanedioic acid,DFC,NA,NA,"Nonanedioic acid, 9CI",DFC,NA,NA,NA,NA,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Medium-chain fatty acids,Aliphatic acyclic compounds,CHEMBL1238,2179,NA,TRUE,NA,DB00548,APRD00812 | EXPT00598,Azelaic Acid,123-99-9,F2VW3D43YT,"1,7-Dicarboxyheptane | 1,7-Heptanedicarboxylic acid | 1,9-Nonanedioic acid | Acide azÃ©laÃ¯que | Ãcido azelaico | Acidum acelaicum | Acidum azelaicum | Anchoic acid | Azelaic acid | Azelainsaeure | AzelainsÃ¤ure | Lepargylic acid | N-Nonanedioic acid | Nonandisaeure | NonandisÃ¤ure | Nonanedioic acid | Skinoren",BDJRBEYXGGNYIS-UHFFFAOYSA-N
BEJNERDRQOWKJM-UHFFFAOYSA-N,13867,HMDB0032923,142.02660868,5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one,Kojic acid,C6H6O4,501-30-4,C14516,FDB010906,DB01759,NA,KOJIC-ACID,3840,3708,OCC1=CC(=O)C(O)=CO1,NA,Organic compounds,Pyranones and derivatives,Organoheterocyclic compounds,Pyrans,Pyranones and derivatives,Aromatic heteromonocyclic compounds,-0.64,2802,T3D3769,Exogenous,-0.64,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,142.02660868,5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one,Kojic acid,C6H6O4,501-30-4,HMDB32923,DB01759,C14516,NA,3840,3708,OCC1=CC(=O)C(O)=CO1,Chemical entities,Pyranones and derivatives,Organic compounds,Organoheterocyclic compounds,Pyrans,Aromatic heteromonocyclic compounds,10908,27117,SmallMoleculeCompound,FDB010906,Kojic acid,TRUE,NA,low,Synthetic intermed. for prodn. of food additives,501-30-4,Mp 161å¡ (152å¡),NA,NA,NA,-0.64,NA,NA,NA,C14516,3840,NA,34805,KOJ,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HMDB32923.pdf,application/pdf,48803,2015-02-28 17:54:09 UTC,NA,NA,2010-04-08 22:09:22 UTC,2015-07-20 22:36:23 UTC,NA,FTS56-K:FTS56-K,HMDB32923,NA,DB01759,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 50.71%; H 4.26%; O 45.03%,DFC,NA,NA,NA,NA,[base] lmax 319 (e 6020) (MeOH/NaOH) (Berdy),DFC,7.66,NA,NA,"KONTOGHIORGHES,GJ (1988)",NA,NA,DFC,-1.02,-0.500482047,-0.19,OCC1=CC(=O)C(O)=CO1,14.39808304,C6H6O4,142.1094,"InChI=1S/C6H6O4/c7-2-4-1-5(8)6(9)3-10-4/h1,3,7,9H,2H2",142.0266087,InChIKey=BEJNERDRQOWKJM-UHFFFAOYSA-N,9.23e+01 g/l,39311,5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one,HMDB_from_dfc,NA,NA,"5-Hydroxy-2-(hydroxymethyl)-4H-pyran-4-one, 9CI",DFC,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Pyrans,Pyranones and derivatives,Pyranones and derivatives,Aromatic heteromonocyclic compounds,CHEMBL287556,3708,NA,NA,NA,DB01759,EXPT01978,Kojic acid,501-30-4,6K23F1TT52,5-hydroxy-2-(hydroxymethyl)-4-pyrone | 5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one,BEJNERDRQOWKJM-UHFFFAOYSA-N
BGNXCDMCOKJUMV-UHFFFAOYSA-N,13115,HMDB0032062,166.099379692,"2-tert-butylbenzene-1,4-diol","2-tert-Butyl-1,4-benzenediol",C10H14O2,1948-33-0,NA,FDB008771,NA,NA,NA,16043,15235,CC(C)(C)C1=CC(O)=CC=C1O,NA,Organic compounds,Phenylpropanes,Benzenoids,Benzene and substituted derivatives,Phenylpropanes,Aromatic homomonocyclic compounds,NA,3542,T3D4859,Exogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,166.099379692,"2-tert-butylbenzene-1,4-diol","2-tert-Butyl-1,4-benzenediol",C10H14O2,1948-33-0,HMDB32062,NA,NA,NA,16043,15235,CC(C)(C)C1=C(O)C=CC(O)=C1,Chemical entities,Phenylpropanes,Organic compounds,Benzenoids,Benzene and substituted derivatives,Aromatic homomonocyclic compounds,8772,21795,SmallMoleculeCompound,FDB008771,"2-tert-Butyl-1,4-benzenediol",TRUE,NA,low,"Antioxidant used in food, e.g. oils and fats. Polym. inhibitor",1948-33-0,Mp 127-129å¡,NA,NA,NA,NA,NA,NA,NA,NA,16043,NA,NA,EYK,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:08:14 UTC,2015-07-20 22:25:59 UTC,NA,DWL34-S:DWL34-S,HMDB32062,NA,DB07726,NA,3619,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 72.26%; H 8.49%; O 19.25%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DFC,2.61,2.911171443,-1.78,CC(C)(C)C1=C(O)C=CC(O)=C1,11.96868486,C10H14O2,166.217,"InChI=1S/C10H14O2/c1-10(2,3)8-6-7(11)4-5-9(8)12/h4-6,11-12H,1-3H3",166.0993797,InChIKey=BGNXCDMCOKJUMV-UHFFFAOYSA-N,2.75e+00 g/l,37993,"2-tert-butylbenzene-1,4-diol",HMDB_from_dfc,NA,NA,"2-tert-Butyl-1,4-benzenediol, 8CI",DFC,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenylpropanes,Phenylpropanes,Aromatic homomonocyclic compounds,CHEMBL242080,15235,NA,NA,NA,DB07726,NA,"2-tert-butylbenzene-1,4-diol",NA,C12674942B,NA,BGNXCDMCOKJUMV-UHFFFAOYSA-N
BHQCQFFYRZLCQQ-OELDTZBJSA-N,479,HMDB0000619,408.28757439,"(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid",Cholic acid,C24H40O5,81-25-4,C00695,FDB012810,DB02659,NA,NA,221493,192176,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(O)=O,206,Organic compounds,"Trihydroxy bile acids, alcohols and derivatives",Lipids and lipid-like molecules,Steroids and steroid derivatives,"Bile acids, alcohols and derivatives",Aliphatic homopolycyclic compounds,2.02,3192,T3D4343,Endogenous,2.02,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,408.28757439,"(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0\xc2\xb2,\xe2\x81\xb7.0\xc2\xb9\xc2\xb9,\xc2\xb9\xe2\x81\xb5]heptadecan-14-yl]pentanoic acid",Cholic acid,C24H40O5,81-25-4,HMDB00619,DB02659,C00695,NA,221493,192176,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C,Organic compounds,"Trihydroxy bile acids, alcohols and derivatives",Lipids and lipid-like molecules,Steroids and steroid derivatives,"Bile acids, alcohols and derivatives",Aliphatic homopolycyclic compounds,30887,NA,SmallMoleculeCompound,FDB030724,cholate,TRUE,NA,NA,NA,81-25-4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2015-05-07 19:55:49 UTC,2017-03-11 23:04:24 UTC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C,NA,C24H40O5,408.5714,"InChI=1S/C24H40O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-20,22,25-27H,4-12H2,1-3H3,(H,28,29)/t13-,14+,15-,16-,17+,18+,19-,20+,22+,23+,24-/m1/s1",408.2875744,BHQCQFFYRZLCQQ-OELDTZBJSA-N,NA,NA,NA,NA,NA,NA,NA,MANUAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB02659,EXPT00906,Cholic Acid,81-25-4,G1JO7801AE,NA,BHQCQFFYRZLCQQ-OELDTZBJSA-N
BKAJNAXTPSGJCU-UHFFFAOYSA-N,545,HMDB0000695,130.062994186,4-methyl-2-oxopentanoic acid,Ketoleucine,C6H10O3,816-66-0,C00233,FDB012607,DB03229,NA,2K-4CH3-PENTANOATE,70,69,CC(C)CC(=O)C(O)=O,5663,Organic compounds,Short-chain keto acids and derivatives,Organic acids and derivatives,Keto acids and derivatives,Short-chain keto acids and derivatives,Aliphatic acyclic compounds,NA,3222,T3D4426,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,130.062994186,4-methyl-2-oxopentanoic acid,Ketoleucine,C6H10O3,816-66-0,HMDB00695,DB03229,C00233,2K-4CH3-PENTANOATE,70,69,CC(C)CC(=O)C(O)=O,Chemical entities,Short-chain keto acids and derivatives,Organic compounds,Organic acids and derivatives,Keto acids and derivatives,Aliphatic acyclic compounds,12610,32984,SmallMoleculeCompound,FDB012607,4-Methyl-2-oxopentanoic acid,TRUE,Liquid,low,"Found in bananas, asparagus, cheese, wine and cocoa. Constit. of Trigonella caerulea (sweet trefoil). Flavouring ingredientKetoleucine is a metabolite that accumulates in Maple Syrup Urine Disease (MSUD) and shown to compromise brain energy metabolism by blocking the respiratory chain; this is of relevance to the understanding of the pathophysiology of the neurological dysfunction of MSUD patients. (PMID 14636955)",816-66-0,Mp 10-11å¡ (-1.5å¡),NA,NA,NA,NA,NA,NA,NA,C00233,70,NA,48430,COI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HMDB00695.pdf,application/pdf,30016,2015-02-28 17:47:25 UTC,NA,NA,2010-04-08 22:10:16 UTC,2015-10-09 22:29:22 UTC,NA,HJH40-C:HJH40-C,HMDB00695,NA,DB03229,34334,2436,C00019677,Bp15 84-85å¡,DFC,NA,NA,NA,NA,NA,NA,C 55.37%; H 7.74%; O 36.88%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DFC,0.82,1.5,-1.28,CC(C)CC(=O)C(O)=O,NA,C6H10O3,130.1418,"InChI=1S/C6H10O3/c1-4(2)3-5(7)6(8)9/h4H,3H2,1-2H3,(H,8,9)",130.0629942,InChIKey=BKAJNAXTPSGJCU-UHFFFAOYSA-N,6.76e+00 g/l,35485,4-methyl-2-oxopentanoic acid,DFC,NA,NA,"4-Methyl-2-oxopentanoic acid, 9CI",DFC,NA,rw1047101,NA,NA,Organic compounds,Organic acids and derivatives,Keto acids and derivatives,Short-chain keto acids and derivatives,Short-chain keto acids and derivatives,Aliphatic acyclic compounds,CHEMBL445647,69,2K-4CH3-PENTANOATE,TRUE,NA,DB03229,EXPT00985,2-Oxo-4-Methylpentanoic Acid,NA,4GUJ8AH400,NA,BKAJNAXTPSGJCU-UHFFFAOYSA-N
BLFLLBZGZJTVJG-UHFFFAOYSA-N,2336,HMDB0004992,165.078978601,ethyl 4-aminobenzoate,Benzocaine,C9H11NO2,94-09-7,C07527,FDB023574,NA,NA,NA,2337,13854242,CCOC(=O)C1=CC=C(N)C=C1,3934,Organic compounds,Benzoic acid esters,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Aromatic homomonocyclic compounds,1.86,2393,T3D2980,Exogenous,1.86,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,165.078978601,ethyl 4-aminobenzoate,Benzocaine,C9H11NO2,94-09-7,HMDB04992,DB01086,C07527,NA,2337,13854242,CCOC(=O)C1=CC=C(N)C=C1,Chemical entities,Benzoic acid esters,Organic compounds,Benzenoids,Benzene and substituted derivatives,Aromatic homomonocyclic compounds,23737,NA,SmallMoleculeCompound,FDB023574,Benzocaine,TRUE,Solid,low,"A surface anesthetic that acts by preventing transmission of impulses along nerve fibers and at nerve endings.; Benzocaine is a local anesthetic commonly used as a topical pain reliever. It is the active ingredient in many over-the-counter analgesic ointments. Benzocaine is an ester, a compound made from the organic acid PABA (para-aminobenzoic acid) and ethanol. The process in which this ester is created is known as Fischer esterification. [HMDB]",1994-09-07,NA,NA,NA,NA,NA,NA,NA,NA,C07527,2337,NA,NA,NA,NA,NA,NA,Benzocaine,NA,NA,NA,NA,NA,NA,NA,HMDB04992.pdf,application/pdf,48612,2015-02-28 17:55:09 UTC,NA,NA,2011-09-21 00:31:49 UTC,2015-10-09 22:33:11 UTC,NA,NA,HMDB04992,NA,DB01086,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2.2,1.504604781,-1.76,[H]N([H])C1=C([H])C([H])=C(C([H])=C1[H])C(=O)OC([H])([H])C([H])([H])[H],NA,C9H11NO2,165.1891,"InChI=1S/C9H11NO2/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6H,2,10H2,1H3",165.0789786,InChIKey=BLFLLBZGZJTVJG-UHFFFAOYSA-N,2.85e+00 g/l,87513,ethyl 4-aminobenzoate,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Benzoic acid esters,Aromatic homomonocyclic compounds,CHEMBL278172,13854242,NA,TRUE,NA,DB01086,APRD00539,Benzocaine,94-09-7,U3RSY48JW5,4-aminobenzoic acid ethyl ester | Amben ethyl ester | Benzocaina | Benzocaine | Benzocainum | Ethyl Aminobenzoate | Ethyl p-Aminobenzoate | Ethyl p-Aminophenylcarboxylate | p-(Ethoxycarbonyl)aniline | p-Carbethoxyaniline | p-Ethoxycarboxylic Aniline,BLFLLBZGZJTVJG-UHFFFAOYSA-N
BPMFZUMJYQTVII-UHFFFAOYSA-N,83,HMDB0000128,117.053826483,2-carbamimidamidoacetic acid,Guanidoacetic acid,C3H7N3O2,352-97-6,C00581,FDB021898,NA,NA,GUANIDOACETIC_ACID,763,743,NC(=N)NCC(O)=O,5163,Organic compounds,Alpha amino acids and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,NA,3071,T3D4149,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,117.053826483,2-carbamimidamidoacetic acid,Guanidoacetic acid,C3H7N3O2,352-97-6,HMDB00128,DB02751,C00581,GUANIDOACETIC_ACID,763,743,NC(=N)NCC(O)=O,Organic compounds,Alpha amino acids and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,5418,14837,SmallMoleculeCompound,FDB005417,Guanidino acetic acid,TRUE,NA,low,NA,352-97-6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:06:40 UTC,2017-02-23 19:51:12 UTC,NA,NA,NA,GUANIDINOACETIC-ACID,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NC(=N)NCC(O)=O,NA,C3H7N3O2,117.1066,"InChI=1S/C3H7N3O2/c4-3(5)6-1-2(7)8/h1H2,(H,7,8)(H4,4,5,6)",117.0538265,BPMFZUMJYQTVII-UHFFFAOYSA-N,NA,NA,NA,NA,NA,NA,NA,DUKE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB02751,EXPT02364,Glycocyamine,352-97-6,GO52O1A04E,Amidinoglycine | Betacyamine | Guanidineacetic acid | Guanidoacetic acid | Guanyl glycine | N-(aminoiminomethyl)glycine | N-amidinoglycine,BPMFZUMJYQTVII-UHFFFAOYSA-N
BQJCRHHNABKAKU-KBQPJGBKSA-N,8799,HMDB0014440,285.136493479,"(1S,5R,13R,14S,17R)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0\xc2\xb9,\xc2\xb9\xc2\xb3.0\xe2\x81\xb5,\xc2\xb9\xe2\x81\xb7.0\xe2\x81\xb7,\xc2\xb9\xe2\x81\xb8]octadeca-7(18),8,10,15-tetraene-10,14-diol",Morphine,C17H19NO3,57-27-2,C01516,NA,DB00295,DBMET00313,NA,5288826,4450907,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,NA,Organic compounds,Morphinans,Alkaloids and derivatives,Morphinans,NA,Aromatic heteropolycyclic compounds,0.8,2215,T3D2740,Exogenous,0.89,No indication of carcinogenicity to humans (not listed by IARC).,Human lethal dose by ingestion is 120-250 mg of morphine sulfate.,SmallMolecule,285.136493479,"(1S,5R,13R,14S,17R)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0\xc2\xb9,\xc2\xb9\xc2\xb3.0\xe2\x81\xb5,\xc2\xb9\xe2\x81\xb7.0\xe2\x81\xb7,\xc2\xb9\xe2\x81\xb8]octadeca-7(18),8,10,15-tetraene-10,14-diol",Morphine,C17H19NO3,57-27-2,HMDB14440,DB00295,C01516,MORPHINE,5288826,4450907,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@]2([H])O,Organic compounds,Morphinans,Alkaloids and derivatives,Morphinans,NA,Aromatic heteropolycyclic compounds,31171,NA,SmallMoleculeCompound,FDB031008,morphine,TRUE,NA,NA,NA,57-27-2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2015-05-07 20:47:30 UTC,2017-03-11 23:05:56 UTC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,NA,C17H19NO3,285.3377,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1",285.1364935,BQJCRHHNABKAKU-KBQPJGBKSA-N,NA,NA,NA,NA,NA,NA,NA,MANUAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB00295,APRD00215 | DB05354,Morphine,57-27-2,76I7G6D29C,"(â)-morphine | (5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol | (5alpha,6alpha)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol | (5R,6S,9R,13S,14R)-4,5-epoxy-N-methyl-7-morphinen-3,6-diol | (5Î±,6Î±)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol | (5Î±,6Î±)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol | (7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol | anhydrous morphine | morfina | Morphia | Morphin | Morphinum | Morphium",BQJCRHHNABKAKU-KBQPJGBKSA-N
BSWWXRFVMJHFBN-UHFFFAOYSA-N,10777,HMDB0029642,327.773402659,"2,4,6-tribromophenol","2,4,6-Tribromophenol",C6H3Br3O,118-79-6,C14454,FDB000813,DB02417,NA,NA,1483,1438,OC1=C(Br)C=C(Br)C=C1Br,NA,Organic compounds,P-bromophenols,Benzenoids,Phenols,Halophenols,Aromatic homomonocyclic compounds,4.13,3490,T3D4804,Endogenous,4.13,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,327.773402659,"2,4,6-tribromophenol","2,4,6-Tribromophenol",C6H3Br3O,118-79-6,HMDB29642,DB02417,C14454,NA,1483,1438,OC1=C(Br)C=C(Br)C=C1Br,Chemical entities,P-bromophenols,Organic compounds,Benzenoids,Phenols,Aromatic homomonocyclic compounds,813,2260,SmallMoleculeCompound,FDB000813,"2,4,6-Tribromophenol",TRUE,NA,low,"Isol. from molluscs and crustaceans. Flavour component of seafood, imparts an intense shrimp-like flavour",118-79-6,Mp 87-89å¡,NA,NA,0.07 mg/mL at 15 oC,4.13,NA,NA,NA,C14454,1483,NA,NA,TBP,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:04:43 UTC,2015-07-20 21:34:43 UTC,NA,BJD51-Y:BJD51-Y,HMDB29642,NA,DB02417,NA,NA,C00033540,Subl. 95-96å¡,DFC,NA,NA,NA,NA,NA,NA,C 21.79%; H 0.91%; Br 72.46%; O 4.84%,DFC,NA,NA,NA,NA,297 () (EtOH) (Berdy),DFC,6.8,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,4.2,3.98,-3.78,OC1=C(Br)C=C(Br)C=C1Br,NA,C6H3Br3O,330.799,"InChI=1S/C6H3Br3O/c7-3-1-4(8)6(10)5(9)2-3/h1-2,10H",327.7734027,InChIKey=BSWWXRFVMJHFBN-UHFFFAOYSA-N,5.45e-02 g/l,38643,"2,4,6-tribromophenol",DFC,NA,NA,"2,4,6-Tribromophenol, 9CI, 8CI",DFC,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenols and derivatives,P-bromophenols,Aromatic homomonocyclic compounds,CHEMBL220087,1438,NA,NA,NA,DB02417,EXPT03018,"2,4,6-Tribromophenol",118-79-6,YS6K3EU393,NA,BSWWXRFVMJHFBN-UHFFFAOYSA-N
BSYNRYMUTXBXSQ-UHFFFAOYSA-N,1247,HMDB0001879,180.042258744,2-(acetyloxy)benzoic acid,Aspirin,C9H8O4,50-78-2,C01405,FDB000894,DB00945,NA,NA,2244,2157,CC(=O)OC1=CC=CC=C1C(O)=O,NA,Organic compounds,Acylsalicylic acids,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Aromatic homomonocyclic compounds,1.19,2358,T3D2936,Exogenous,1.19,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,180.042258744,2-(acetyloxy)benzoic acid,Aspirin,C9H8O4,50-78-2,HMDB01879,DB00945,C01405,CPD-524,2244,2157,CC(=O)OC1=CC=CC=C1C(O)=O,Organic compounds,Acylsalicylic acids,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Aromatic homomonocyclic compounds,894,2537,SmallMoleculeCompound,FDB000894,Acetylsalicylic acid,TRUE,Solid,low,Constit. of Glycyrrhiza glabra var. typica (licorice) roots,50-78-2,Fp 118å¡,NA,NA,4.6 mg/mL at 25 oC,1.19,NA,NA,NA,C01405,2244,NA,15365,AIN,NA,NA,NA,Aspirin,NA,NA,NA,NA,NA,NA,NA,HMDB01879.pdf,application/pdf,47316,2015-02-28 18:04:18 UTC,NA,2,2010-04-08 22:04:45 UTC,2015-10-09 22:32:01 UTC,NA,BLS47-M:BLS47-M,HMDB01879,NA,DB00945,45400,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 60.00%; H 4.48%; O 35.52%,DFC,NA,NA,NA,NA,NA,NA,"pKa 3.38 (25å¡, 1M KCl)",DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,1.43,1.24,-2.09,CC(=O)OC1=C(C=CC=C1)C(O)=O,NA,C9H8O4,180.1574,"InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)",180.0422587,InChIKey=BSYNRYMUTXBXSQ-UHFFFAOYSA-N,1.46e+00 g/l,35510,2-(acetyloxy)benzoic acid,MANUAL,NA,NA,2-Acetoxybenzoic acid,DFC,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenol esters,Phenol esters,Aromatic homomonocyclic compounds,CHEMBL25,2157,NA,TRUE,NA,DB00945,APRD00264 | EXPT00475,Acetylsalicylic acid,50-78-2,R16CO5Y76E,2-Acetoxybenzenecarboxylic acid | 2-Acetoxybenzoic acid | Acetylsalicylate | AcetylsalicylsÃ¤ure | acide 2-(acÃ©tyloxy)benzoÃ¯que | acide acÃ©tylsalicylique | Ã¡cido acetilsalicÃ­lico | Acidum acetylsalicylicum | ASA | Aspirin | AzetylsalizylsÃ¤ure | o-acetoxybenzoic acid | O-acetylsalicylic acid | o-carboxyphenyl acetate | Polopiryna | salicylic acid acetate,BSYNRYMUTXBXSQ-UHFFFAOYSA-N
BTCSSZJGUNDROE-UHFFFAOYSA-N,71,HMDB0000112,103.063328537,4-aminobutanoic acid,gamma-Aminobutyric acid,C4H9NO2,56-12-2,C00334,FDB008937,DB02530,NA,4-AMINO-BUTYRATE,119,116,NCCCC(O)=O,NA,Organic compounds,Gamma amino acids and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,-3.17,3146,T3D4250,Endogenous,-3.17,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,103.063328537,4-aminobutanoic acid,Gamma-Aminobutyric acid,C4H9NO2,56-12-2,HMDB00112,DB02530,C00334,4-AMINO-BUTYRATE,119,116,NCCCC(O)=O,Chemical entities,Gamma amino acids and derivatives,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Aliphatic acyclic compounds,8938,22321,SmallMoleculeCompound,FDB008937,4-Aminobutyric acid,TRUE,Solid,low,"gamma-Aminobutyric acid is the chief inhibitory neurotransmitter in the mammalian central nervous system. It plays a role in regulating neuronal excitability throughout the nervous system. In humans, GABA is also directly responsible for the regulation of muscle tone. [Wikipedia]",1956-12-02,203 oC,NA,NA,1300 mg/mL at 25 oC,-3.17,NA,NA,NA,C00334,119,NA,16865,ABU,NA,NA,NA,GABA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:08:19 UTC,2015-10-09 22:28:40 UTC,NA,NA,HMDB00112,GABA|GAMMA-AMINOBUTYRIC-ACID,DB02530,34652,165,C00001337,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4.05,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,NA,-2.99,-3.12,0.55,NCCCC(O)=O,NA,C4H9NO2,103.1198,"InChI=1S/C4H9NO2/c5-3-1-2-4(6)7/h1-3,5H2,(H,6,7)",103.0633285,InChIKey=BTCSSZJGUNDROE-UHFFFAOYSA-N,3.65e+02 g/l,40426,4-aminobutanoic acid,BIOSPIDER,NA,NA,NA,EAFUS,NA,rw1198861,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Gamma amino acids and derivatives,Aliphatic acyclic compounds,CHEMBL96,116,4-AMINO-BUTYRATE,TRUE,NA,DB02530,EXPT00402 | DB08850,gamma-Aminobutyric acid,56-12-2,2ACZ6IPC6I,4-aminobutanoic acid | 4-aminobutyric acid | 4Abu | GABA | gamma-Aminobutyric acid | piperidic acid | piperidinic acid | Î³-amino-n-butyric acid | Î³-aminobutanoic acid | Î³-AminobuttersÃ¤ure | Î³-aminobutyric acid | Ï-aminobutyric acid,BTCSSZJGUNDROE-UHFFFAOYSA-N
BTJIUGUIPKRLHP-UHFFFAOYSA-N,951,HMDB0001232,139.026943031,4-nitrophenol,4-Nitrophenol,C6H5NO3,100-02-7,C00870,FDB022503,NA,NA,P-NITROPHENOL,980,955,OC1=CC=C(C=C1)[N+]([O-])=O,4100,Organic compounds,Nitrophenols,Benzenoids,Phenols,Nitrophenols,Aromatic homomonocyclic compounds,1.91,206,T3D0257,Exogenous,1.91,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,139.026943031,4-nitrophenol,4-Nitrophenol,C6H5NO3,100-02-7,HMDB01232,DB04417,C00870,P-NITROPHENOL,980,955,OC1=CC=C(C=C1)N(=O)=O,Organic compounds,Nitrophenols,Benzenoids,Phenols,Nitrophenols,Aromatic homomonocyclic compounds,22666,NA,SmallMoleculeCompound,FDB022503,4-Nitrophenol,TRUE,Solid,low,"4-Nitrophenol is a phenolic metabolite of environmental chemicals present in samples from the general population. 4-Nitrophenol measurement in urine is used in biological monitoring for establishing the presence and magnitude of exposures to pesticides. (PMID 15899376) (Methods in Biotechnology, 2006,61-78) [HMDB]",100-02-7,NA,NA,NA,NA,NA,NA,NA,NA,C00870,980,NA,16836,NPO,NA,NA,NA,4-Nitrophenol,NA,NA,NA,NA,NA,NA,NA,HMDB01232.pdf,application/pdf,888279,2015-02-28 17:54:42 UTC,NA,NA,2011-09-21 00:15:01 UTC,2015-10-09 22:31:36 UTC,NA,NA,HMDB01232,NA,DB04417,36247,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.93,1.609664684,-1.59,[H]OC1=C([H])C([H])=C(C([H])=C1[H])[N+]([O-])=O,NA,C6H5NO3,139.1088,"InChI=1S/C6H5NO3/c8-6-3-1-5(2-4-6)7(9)10/h1-4,8H",139.026943,InChIKey=BTJIUGUIPKRLHP-UHFFFAOYSA-N,3.60e+00 g/l,88325,4-nitrophenol,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenols and derivatives,Nitrophenols and derivatives,Aromatic homomonocyclic compounds,CHEMBL14130,955,P-NITROPHENOL,TRUE,NA,DB04417,EXPT02385,P-Nitrophenol,100-02-7,Y92ZL45L4R,NA,BTJIUGUIPKRLHP-UHFFFAOYSA-N
BTJIUGUIPKRLHP-UHFFFAOYSA-N,42239,HMDB0062627,139.026943031,4-nitrophenol,4-nitrophenolate,C6H5NO3,NA,NA,NA,NA,NA,NA,644235,NA,OC1=CC=C(C=C1)[N+]([O-])=O,NA,Organic compounds,Nitrophenols,Benzenoids,Phenols,Nitrophenols,Aromatic homomonocyclic compounds,1.22,206,T3D0257,Exogenous,1.91,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,139.026943031,4-nitrophenol,4-Nitrophenol,C6H5NO3,100-02-7,HMDB01232,DB04417,C00870,P-NITROPHENOL,980,955,OC1=CC=C(C=C1)N(=O)=O,Organic compounds,Nitrophenols,Benzenoids,Phenols,Nitrophenols,Aromatic homomonocyclic compounds,22666,NA,SmallMoleculeCompound,FDB022503,4-Nitrophenol,TRUE,Solid,low,"4-Nitrophenol is a phenolic metabolite of environmental chemicals present in samples from the general population. 4-Nitrophenol measurement in urine is used in biological monitoring for establishing the presence and magnitude of exposures to pesticides. (PMID 15899376) (Methods in Biotechnology, 2006,61-78) [HMDB]",100-02-7,NA,NA,NA,NA,NA,NA,NA,NA,C00870,980,NA,16836,NPO,NA,NA,NA,4-Nitrophenol,NA,NA,NA,NA,NA,NA,NA,HMDB01232.pdf,application/pdf,888279,2015-02-28 17:54:42 UTC,NA,NA,2011-09-21 00:15:01 UTC,2015-10-09 22:31:36 UTC,NA,NA,HMDB01232,NA,DB04417,36247,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.93,1.609664684,-1.59,[H]OC1=C([H])C([H])=C(C([H])=C1[H])[N+]([O-])=O,NA,C6H5NO3,139.1088,"InChI=1S/C6H5NO3/c8-6-3-1-5(2-4-6)7(9)10/h1-4,8H",139.026943,InChIKey=BTJIUGUIPKRLHP-UHFFFAOYSA-N,3.60e+00 g/l,88325,4-nitrophenol,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenols and derivatives,Nitrophenols and derivatives,Aromatic homomonocyclic compounds,CHEMBL14130,955,P-NITROPHENOL,TRUE,NA,DB04417,EXPT02385,P-Nitrophenol,100-02-7,Y92ZL45L4R,NA,BTJIUGUIPKRLHP-UHFFFAOYSA-N
BXFFHSIDQOFMLE-UHFFFAOYSA-N,534,HMDB0000682,213.009578407,1H-indol-3-yloxidanesulfonic acid,Indoxyl sulfate,C8H7NO4S,487-94-5,NA,FDB022179,NA,NA,NA,10258,9840,OS(=O)(=O)OC1=CNC2=CC=CC=C12,524,Organic compounds,Arylsulfates,Organic acids and derivatives,Organic sulfuric acids and derivatives,Arylsulfates,Aromatic heteropolycyclic compounds,NA,3079,T3D4158,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,213.009578407,1H-indol-3-yloxidanesulfonic acid,Indoxyl sulfate,C8H7NO4S,487-94-5,HMDB00682,DB07992,NA,NA,10258,9840,OS(=O)(=O)OC1=CNC2=CC=CC=C12,Chemical entities,Arylsulfates,Organic compounds,Organic acids and derivatives,Organic sulfuric acids and derivatives,Aromatic heteropolycyclic compounds,22342,NA,SmallMoleculeCompound,FDB022179,Indoxyl sulfate,TRUE,Solid,low,"Indoxyl sulfate is a dietary protein metabolite, and also the metabolite of the common amino acid tryptophan. Indoxyl sulfate is a circulating uremic toxin stimulating glomerular sclerosis and interstitial fibrosis. Indoxyl sulfate is one of the well known substances of a group of protein-bound uremic retention solutes. Indoxyl sulfate increases the rate of progression of renal failure. In plasma, indoxyl sulfate is a protein-bound uremic solute that induces endothelial dysfunction by inhibiting endothelial proliferation and migration in vitro. Some studies suggest that indoxyl sulfate is also involved in oxidative stress. In hemodialyzed patients, serum levels of indoxyl sulfate are associated with levels of pentosidine, a marker of carbonyl and oxidative stress; in vitro, indoxyl sulfate increases reactive oxygen species (ROS) production in tubular cells, and increases NAD(P)H oxidase activity in endothelial cells. Indoxyl sulfate impairs osteoblst function and induces abnormalities of bone turnover. Indoxyl sulfate strongly decreases the levels of glutathione, one of the most active antioxidant systems of the cell. (PMID: 10681668, 14681860, 17471003, 17403109) [HMDB]",487-94-5,NA,NA,NA,NA,NA,NA,NA,NA,NA,10258,NA,16700,IOS,NA,NA,NA,Indican,NA,NA,NA,NA,NA,NA,NA,HMDB00682.pdf,application/pdf,130612,2015-02-28 17:59:56 UTC,NA,NA,2011-09-21 00:09:41 UTC,2015-10-09 22:30:37 UTC,NA,NA,HMDB00682,NA,DB07992,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.48,1.293129141,-2.43,[H]OS(=O)(=O)OC1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12,14.81369306,C8H7NO4S,213.21,"InChI=1S/C8H7NO4S/c10-14(11,12)13-8-5-9-7-4-2-1-3-6(7)8/h1-5,9H,(H,10,11,12)",213.0095784,InChIKey=BXFFHSIDQOFMLE-UHFFFAOYSA-N,7.87e-01 g/l,88664,1H-indol-3-yloxidanesulfonic acid,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Indoles and derivatives,Indoles,Indoles,Aromatic heteropolycyclic compounds,CHEMBL1233636,9840,NA,TRUE,NA,DB07992,NA,3-SULFOOXY-1H-INDOLE,NA,KT0QA88913,NA,BXFFHSIDQOFMLE-UHFFFAOYSA-N
BXWNKGSJHAJOGX-UHFFFAOYSA-N,1875,HMDB0003424,242.26096571,hexadecan-1-ol,1-Hexadecanol,C16H34O,36653-82-4,C00823,FDB003051,NA,NA,CPD-348,2682,2581,CCCCCCCCCCCCCCCCO,6927,Organic compounds,Long-chain fatty alcohols,Lipids and lipid-like molecules,Fatty Acyls,Fatty alcohols,Aliphatic acyclic compounds,NA,3546,T3D4863,Exogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,242.26096571,hexadecan-1-ol,1-Hexadecanol,C16H34O,36653-82-4,HMDB03424,NA,C00823,CPD-348,2682,2581,CCCCCCCCCCCCCCCCO,NA,NA,NA,NA,NA,NA,3052,9282,SmallMoleculeCompound,FDB003051,Cetyl alcohol,TRUE,Solid,low,Flavouring ingredient,36653-82-4,Mp 50å¡,NA,NA,4.12e-05 mg/mL at 25 oC,NA,NA,NA,NA,C00823,2682,NA,16125,PL3,NA,NA,NA,1-Hexadecanol,NA,NA,NA,NA,NA,NA,NA,HMDB03424.pdf,application/pdf,30118,2015-02-28 17:49:18 UTC,NA,2,2010-04-08 22:05:38 UTC,2015-10-09 22:32:13 UTC,NA,CQD42-E:CQD42-E,HMDB03424,HEXADECAN-1-OL|HEXADECANOL,NA,NA,594,NA,Bp12 178-182å¡,DFC,NA,NA,NA,NA,NA,NA,C 79.27%; H 14.13%; O 6.60%,DFC,NA,NA,NA,NA,NA,NA,16.2,NA,"YALKOWSKY,SH & HE,Y (2003)",NA,NA,NA,DFC,7.17,6.14,-6.13,CCCCCCCCCCCCCCCCO,NA,C16H34O,242.4406,"InChI=1S/C16H34O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17/h17H,2-16H2,1H3",242.2609657,InChIKey=BXWNKGSJHAJOGX-UHFFFAOYSA-N,1.81e-04 g/l,37230,hexadecan-1-ol,DFC,NA,NA,1-Hexadecanol,DFC,36653-82-4,rw1026181,NA,NA,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Fatty alcohols,Long-chain fatty alcohols,Aliphatic acyclic compounds,CHEMBL706,2581,CPD-348,TRUE,NA,DB09494,NA,Cetyl alcohol,36653-82-4,936JST6JCN,hexadecan-1-ol | palmityl alcohol,BXWNKGSJHAJOGX-UHFFFAOYSA-N
CEUORZQYGODEFX-UHFFFAOYSA-N,2371,HMDB0005042,447.148032537,"7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-1,2,3,4-tetrahydroquinolin-2-one",Aripiprazole,C23H27Cl2N3O2,129722-12-9,C12564,FDB004879,DB01238,NA,NA,60795,54790,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,NA,Organic compounds,Phenylpiperazines,Organoheterocyclic compounds,Diazinanes,Piperazines,Aromatic heteropolycyclic compounds,NA,2175,T3D2677,Exogenous,4.5,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,447.148032537,"7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-1,2,3,4-tetrahydroquinolin-2-one",Aripiprazole,C23H27Cl2N3O2,129722-12-9,HMDB05042,DB01238,C12564,NA,60795,54790,OC1=NC2=C(CC1)C=CC(OCCCCN1CCN(CC1)C1=CC=CC(Cl)=C1Cl)=C2,Organic compounds,Phenylpiperazines,Organoheterocyclic compounds,Diazinanes,Piperazines,Aromatic heteropolycyclic compounds,4880,13861,SmallMoleculeCompound,FDB004879,OPC,TRUE,Solid,low,"Aripiprazole is an atypical antipsychotic and antidepressant used in the treatment of schizophrenia, bipolar disorder, and clinical depression. (Wikipedia)",129722-12-9,139-139.5 oC,NA,NA,NA,NA,NA,NA,NA,C12564,60795,NA,31236,NA,NA,NA,NA,Aripiprazole,NA,NA,NA,NA,NA,NA,NA,HMDB05042.pdf,application/pdf,60080,2015-02-28 18:03:31 UTC,NA,2,2010-04-08 22:06:26 UTC,2015-07-20 22:02:13 UTC,NA,NA,HMDB05042,OPC,DB01238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5.21,4.9,-4.76,ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl,NA,C23H27Cl2N3O2,448.385,"InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)",447.1480325,InChIKey=CEUORZQYGODEFX-UHFFFAOYSA-N,7.77e-03 g/l,41188,"7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-1,2,3,4-tetrahydroquinolin-2-one",BIOSPIDER,NA,NA,NA,DUKE,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Diazinanes,Piperazines,Phenylpiperazines,Aromatic heteropolycyclic compounds,CHEMBL1112,54790,NA,NA,NA,DB01238,APRD00638,Aripiprazole,129722-12-9,82VFR53I78,Abilitat | Aripiprazol | Aripiprazole | Aripiprazolum | OPC 31,CEUORZQYGODEFX-UHFFFAOYSA-N
COLNVLDHVKWLRT-QMMMGPOBSA-N,104,HMDB0000159,165.078978601,(2S)-2-amino-3-phenylpropanoic acid,L-Phenylalanine,C9H11NO2,63-91-2,C00079,FDB014705,DB00120,NA,PHE,6140,5910,N[C@@H](CC1=CC=CC=C1)C(O)=O,28,Organic compounds,Phenylalanine and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aromatic homomonocyclic compounds,-1.38,3208,T3D4366,Endogenous,-1.38,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,165.078978601,(2S)-2-amino-3-phenylpropanoic acid,L-Phenylalanine,C9H11NO2,63-91-2,HMDB00159,DB00120,C00079,PHE,6140,5910,[H][C@](N)(CC1=CC=CC=C1)C(O)=O,Chemical entities,Phenylalanine and derivatives,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Aromatic homomonocyclic compounds,4941,13992,SmallMoleculeCompound,FDB004940,L-(-)-Phenylalanine,TRUE,NA,low,NA,63-91-2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:06:27 UTC,2017-02-23 19:50:41 UTC,NA,NA,NA,L-(-)-PHENYLALANINE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,N[C@@H](CC1=CC=CC=C1)C(O)=O,NA,C9H11NO2,165.1891,"InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1",165.0789786,COLNVLDHVKWLRT-QMMMGPOBSA-N,NA,NA,NA,NA,NA,NA,NA,DUKE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB00120,NUTR00044,L-Phenylalanine,63-91-2,47E5O17Y3R,(S)-2-Amino-3-phenylpropionic acid | (S)-alpha-Amino-beta-phenylpropionic acid | 3-phenyl-L-alanine | beta-Phenyl-L-alanine | F | Phe | Phenylalanine | Î²-phenyl-L-alanine,COLNVLDHVKWLRT-QMMMGPOBSA-N
CURLTUGMZLYLDI-UHFFFAOYSA-N,1311,HMDB0001967,43.989829244,methanedione,Carbon dioxide,CO2,124-38-9,C00011,FDB014084,NA,DBMET00423,NA,280,274,O=C=O,3199,Inorganic compounds,Other non-metal oxides,Homogeneous non-metal compounds,Other non-metal organides,Other non-metal oxides,NA,0.83,2088,T3D2563,Endogenous,0.83,No indication of carcinogenicity (not listed by IARC). (L135),NA,SmallMolecule,43.989829244,methanedione,Carbon dioxide,CO2,124-38-9,HMDB01967,NA,C00011,CARBON-MONOXIDE,280,274,O=C=O,Chemical entities,Other non-metal oxides,Inorganic compounds,Homogeneous non-metal compounds,Other non-metal organides,NA,14087,37360,SmallMoleculeCompound,FDB014084,Carbon dioxide,TRUE,Liquid,low,"Leavening agent, propellant, aerating agent, preservative. Solvent for supercritical extraction e.g. of caffeine in manufacture of caffeine-free instant coffee. Used in carbonation of beverages, in the frozen food industry and as a component of controlled atmosphere packaging (CAD) to inhibit bacterial growth. Esp. effective against Gram-negative spoilage bacteria, e.g. PseudomonasA colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals. Carbon dioxide is produced during respiration by all animals, fungi and microorganisms that depend on living and decaying plants for food, either directly or indirectly. It is, therefore, a major component of the carbon cycle.  Additionally, carbon dioxide is used by plants during photosynthesis to make sugars which may either be consumed again in respiration or used as the raw material to produce polysaccharides such as starch and cellulose, proteins and the wide variety of other organic compounds required for plant growth and development. When inhaled at concentrations much higher than usual atmospheric levels, it can produce a sour taste in the mouth and a stinging sensation in the nose and throat. These effects result from the gas dissolving in the mucous membranes and saliva, forming a weak solution of carbonic acid. Carbon dioxide is used by the food industry, the oil industry, and the chemical industry. Carbon dioxide is used to produce carbonated soft drinks and soda water. Traditionally, the carbonation in beer and sparkling wine comes about through natural fermentation, but some manufacturers carbonate these drinks artificially.; As of March 2009[update], carbon dioxide in the Earth's atmosphere is at a concentration of 387 ppm by volume. Atmospheric concentrations of carbon dioxide fluctuate slightly with the change of the seasons, driven primarily by seasonal plant growth in the Northern Hemisphere. Concentrations of carbon dioxide fall during the northern spring and summer as plants consume the gas, and rise during the northern autumn and winter as plants go dormant, die and decay. Carbon dioxide is a greenhouse gas as it transmits visible light but absorbs strongly in the infrared and near-infrared.; CO2 is an acidic oxide: an aqueous solution turns litmus from blue to pink. It is the anhydride of carbonic acid, an acid which is unstable and is known to exist only in aqueous solution.; Carbon dioxide (chemical formula: CO2) is a chemical compound composed of two oxygen atoms covalently bonded to a single carbon atom. It is a gas at standard temperature and pressure and exists in Earth's atmosphere in this state.; Carbon dioxide in earth's atmosphere is considered a trace gas currently occurring at an average concentration of about 385 parts per million by volume or 582 parts per million by mass. The total mass of atmospheric carbon dioxide is 3.0ÌÑ1015 kg (3,000 gigatonnes). Its concentration varies seasonally (see graph at right) and also considerably on a regional basis, especially near the ground. In urban areas concentrations are generally higher and indoors they can reach 10 times background levels. Carbon dioxide is a greenhouse gas.; Carbon dioxide is an end product in organisms that obtain energy from breaking down sugars, fats and amino acids with oxygen as part of their metabolism, in a process known as cellular respiration. This includes all plants, animals, many fungi and some bacteria. In higher animals, the carbon dioxide travels in the blood from the body's tissues to the lungs where it is exhaled. In plants using photosynthesis, carbon dioxide is absorbed from the atmosphere.; Carbon dioxide is one of the mediators of local autoregulation of blood supply. If its levels are high, the capillaries expand to allow a greater blood flow to that tissue.; Carbon dioxide is one of the most commonly used compressed gases for pneumatic (pressurized gas) systems in portable pressure tools and combat robots.; Carbon dioxide was one of the first gases to be described as a substance distinct from air. In the seventeenth century, the Flemish chemist Jan Baptist van Helmont observed that when he burned charcoal in a closed vessel, the mass of the resulting ash was much less than that of the original charcoal. His interpretation was that the rest of the charcoal had been transmuted into an invisible substance he termed a ""gas"" or ""wild spirit"" (spiritus sylvestre).; Liquid carbon dioxide is a good solvent for many lipophilic organic compounds, and is used to remove caffeine from coffee. First, the green coffee beans are soaked in water. The beans are placed in the top of a column seventy feet (21 m) high. Then supercritical carbon dioxide in fluid form at about 93 degrees Celsius enters at the bottom of the column. The caffeine diffuses out of the beans and into the carbon dioxide",124-38-9,Mp -57 under 5 atm.å¡,NA,NA,1.48 mg/mL at 25 oC,0.83,NA,NA,NA,C00011,280,NA,16526,CO2,NA,NA,NA,Carbon Dioxide,NA,NA,NA,NA,NA,NA,NA,HMDB01967.pdf,application/pdf,2125735,2015-02-28 18:08:43 UTC,NA,NA,2010-04-08 22:11:04 UTC,2015-07-20 23:04:45 UTC,NA,JNR87-R:JNR87-R,HMDB01967,NA,NA,33506,519,NA,Subl. -78.46å¡,DFC,NA,NA,d 1,DFC,NA,NA,C 27.29%; O 72.71%,DFC,NA,NA,NA,NA,NA,NA,"6.35, 10.33",NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,-0.63,-0.28,0.63,O=C=O,NA,CO2,44.0095,InChI=1S/CO2/c2-1-3,43.98982924,InChIKey=CURLTUGMZLYLDI-UHFFFAOYSA-N,1.86e+02 g/l,39272,methanedione,DFC,NA,NA,Carbon dioxide,DFC,NA,rw1227321,NA,NA,Organic compounds,Organooxygen compounds,NA,NA,Organooxygen compounds,Aliphatic acyclic compounds,CHEMBL1231871,274,CARBON-DIOXIDE,NA,NA,DB09157,NA,Carbon dioxide,124-38-9,142M471B3J,NA,CURLTUGMZLYLDI-UHFFFAOYSA-N
CVSVTCORWBXHQV-UHFFFAOYSA-N,46,HMDB0000064,131.069476547,2-(N-methylcarbamimidamido)acetic acid,Creatine,C4H9N3O2,57-00-1,C00300,FDB005403,DB00148,NA,CREATINE,586,566,CN(CC(O)=O)C(N)=N,7,Organic compounds,Alpha amino acids and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,NA,3170,T3D4290,Endogenous,-0.2,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,131.069476547,2-(1-methylcarbamimidamido)acetic acid,Creatine,C4H9N3O2,57-00-1,HMDB00064,DB00148,C00300,CREATINE,586,566,CN(CC(O)=O)C(N)=N,Chemical entities,Alpha amino acids and derivatives,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Aliphatic acyclic compounds,5404,14814,SmallMoleculeCompound,FDB005403,Creatine,TRUE,Solid,low,"Creatine is a essential, non-proteinaceous amino acid found in all animals and in some plants. Creatine is synthesized in the kidney, liver and pancreas from L-arginine, glycine and L-methionine.",57-00-1,303 oC,NA,NA,13.3 mg/mL at 18 oC,NA,NA,NA,NA,C00300,586,NA,16919,CRN,NA,NA,NA,Creatine,NA,NA,NA,NA,NA,NA,NA,HMDB00064.pdf,application/pdf,74471,2015-02-28 17:55:35 UTC,NA,2,2010-04-08 22:06:40 UTC,2015-10-09 22:27:18 UTC,NA,NA,HMDB00064,CREATINE,DB00148,34543,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)",NA,NA,NA,NA,-1.59,-3.1,-1.5,CN(CC(O)=O)C(N)=N,NA,C4H9N3O2,131.1332,"InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)",131.0694765,InChIKey=CVSVTCORWBXHQV-UHFFFAOYSA-N,4.11e+00 g/l,40367,2-(1-methylcarbamimidamido)acetic acid,BIOSPIDER,NA,NA,NA,DUKE,NA,NA,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Alpha amino acids and derivatives,Aliphatic acyclic compounds,CHEMBL283800,566,CREATINE,TRUE,NA,DB00148,NUTR00022,Creatine,57-00-1,MU72812GK0,((amino(Imino)methyl)(methyl)amino)acetic acid | (alpha-Methylguanido)acetic acid | (N-methylcarbamimidamido)acetic acid | (Î±-methylguanido)acetic acid | alpha-Methylguanidino acetic acid | Creatin | Kreatin | Methylglycocyamine | N-(aminoiminomethyl)-N-methylglycine | N-amidinosarcosine | N-carbamimidoyl-N-methylglycine | N-methyl-N-guanylglycine,CVSVTCORWBXHQV-UHFFFAOYSA-N
CXMXRPHRNRROMY-UHFFFAOYSA-N,630,HMDB0000792,202.120509064,decanedioic acid,Sebacic acid,C10H18O4,111-20-6,C08277,FDB022247,NA,NA,CPD-3623,5192,5004,OC(=O)CCCCCCCCC(O)=O,4240,Organic compounds,Medium-chain fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,NA,3566,T3D4883,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,202.120509064,decanedioic acid,Sebacic acid,C10H18O4,111-20-6,HMDB00792,NA,C08277,CPD-3623,5192,5004,OC(=O)CCCCCCCCC(O)=O,Organic compounds,Medium-chain fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,22410,NA,SmallMoleculeCompound,FDB022247,Sebacic acid,TRUE,Solid,low,"Sebacic acid is a saturated, straight-chain naturally occurring dicarboxylic acid with 10 carbon atoms. Sebacic acid is a normal urinary acid. In patients with multiple acyl-CoA-dehydrogenase deficiency (MADD) or glutaric aciduria type II (GAII) are a group of metabolic disorders due to deficiency of either electron transfer flavoprotein or electron transfer flavoprotein ubiquinone oxidoreductase, biochemical data shows an increase in urine sebacic acid excretion.Sebacic acid is a white flake or powdered crystal slightly soluble in water that has been proposed as an alternative energy substrate in total parenteral nutrition. Sebacic Acid was named from the Latin sebaceus (tallow candle) or sebum (tallow) in reference to its use in the manufacture of candles.  Sebacic Acid and its derivatives such as azelaic acid have a variety of industrial uses as plasticizers, lubricants, hydraulic fluids, cosmetics, candles, etc. It is used in the synthesis of polyamide and alkyd resins.  It is also used as an intermediate for aromatics, antiseptics and painting materials. (PMID: 10556649, 1738216, 8442769, 12706375) [HMDB]",111-20-6,NA,NA,NA,NA,NA,NA,NA,NA,C08277,5192,NA,9071,DEC,NA,NA,NA,Sebacic acid,NA,NA,NA,NA,NA,NA,NA,HMDB00792.pdf,application/pdf,48132,2015-02-28 17:48:15 UTC,NA,NA,2011-09-21 00:10:50 UTC,2015-10-09 22:28:13 UTC,NA,NA,HMDB00792,NA,DB07645,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.93,2.268929023,-2.35,[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)O[H],5.322146873,C10H18O4,202.2475,"InChI=1S/C10H18O4/c11-9(12)7-5-3-1-2-4-6-8-10(13)14/h1-8H2,(H,11,12)(H,13,14)",202.1205091,InChIKey=CXMXRPHRNRROMY-UHFFFAOYSA-N,9.12e-01 g/l,87879,decanedioic acid,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Medium-chain fatty acids,Aliphatic acyclic compounds,CHEMBL1232164,5004,CPD-3623,TRUE,NA,DB07645,NA,SEBACIC ACID,NA,97AN39ICTC,NA,CXMXRPHRNRROMY-UHFFFAOYSA-N
CYQFCXCEBYINGO-IAGOWNOFSA-N,8940,HMDB0014613,314.224580204,"(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6H,6aH,7H,8H,10aH-benzo[c]isochromen-1-ol",Tetrahydrocannabinol,C21H30O2,1972-08-3,C06972,FDB031310,DB00470,NA,CPD-7172,16078,15266,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21,NA,Organic compounds,"2,2-dimethyl-1-benzopyrans",Organoheterocyclic compounds,Benzopyrans,1-benzopyrans,Aromatic heteropolycyclic compounds,5.648,2255,T3D2801,Exogenous,5.648,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,314.224580204,"(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6H,6aH,7H,8H,10aH-benzo[c]isochromen-1-ol",delta9-Tetrahydrocannabinol,C21H30O2,1972-08-3,HMDB41865,DB00470,C06972,NA,2978,2872,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21,Organic compounds,"2,2-dimethyl-1-benzopyrans",Organoheterocyclic compounds,Benzopyrans,1-benzopyrans,Aromatic heteropolycyclic compounds,1065,3089,SmallMoleculeCompound,FDB001065,Maxepa,TRUE,NA,low,"Mixt. of fatty acid triglycerides (from marine fish) containing 18% 5,8,11,14,17-Eicosapentaenoic acid <ht>HDJ50-Z</ht> and 12% 4,7,10,13,16,19-Docosahexaenoic acid <ht>CPW70-V</ht>. Reduces plasma triglycerides; dietary supplement",1972-08-03,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:04:49 UTC,2017-02-15 22:26:40 UTC,NA,BRD35-A:BRD35-A,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1,NA,C21H30O2,314.4617,"InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1",314.2245802,CYQFCXCEBYINGO-IAGOWNOFSA-N,NA,NA,NA,NA,NA,NA,"Omega-3 Marine Triglycerides, BAN",DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB00470,APRD00571,Dronabinol,1972-08-3,7J8897W37S,"(-)-delta9-trans-Tetrahydrocannabinol | 1-trans-delta-9-Tetrahydrocannabinol | 3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol | 6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol | delta-9-tetrahydrocannabinol | delta-9-THC | delta(1)-Tetrahydrocannabinol | delta(9)-THC | delta9-Tetrahydrocannabinol | Dronabinol | Dronabinolum | Tetrahydrocannabinol | Î9-tetrahydrocannabinol",CYQFCXCEBYINGO-IAGOWNOFSA-N
CZWCKYRVOZZJNM-USOAJAOKSA-N,811,HMDB0001032,368.165744696,"[(1S,2R,5S,10R,11S,15S)-2,15-dimethyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl]oxidanesulfonic acid",Dehydroepiandrosterone sulfate,C19H28O5S,651-48-9,C04555,FDB022381,NA,DBMET00518,DEHYDRO-EPIANDROSTERONE-SULFATE,12594,12074,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@H](CC[C@]12C)OS(O)(=O)=O,4095,Organic compounds,Sulfated steroids,Lipids and lipid-like molecules,Steroids and steroid derivatives,Sulfated steroids,Aliphatic homopolycyclic compounds,NA,3141,T3D4242,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,368.165744696,"[(1S,2R,5S,10R,11S,15S)-2,15-dimethyl-14-oxotetracyclo[8.7.0.0\xc2\xb2,\xe2\x81\xb7.0\xc2\xb9\xc2\xb9,\xc2\xb9\xe2\x81\xb5]heptadec-7-en-5-yl]oxidanesulfonic acid",Dehydroepiandrosterone sulfate,C19H28O5S,651-48-9,HMDB01032,DB05804,C04555,DEHYDRO-EPIANDROSTERONE-SULFATE,12594,12074,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@]([H])(CC[C@]12C)OS(O)(=O)=O,Organic compounds,Sulfated steroids,Lipids and lipid-like molecules,Steroids and steroid derivatives,Sulfated steroids,Aliphatic homopolycyclic compounds,22544,NA,SmallMoleculeCompound,FDB022381,DHEA sulfate,TRUE,Solid,low,"DHEAS or Dehydroepiandrosterone sulfate is the sulfated form of DHEA.  This sulfation is reversibly catalyzed by sulfotransferase (SULT2A1) primarily in the adrenals, the liver, and small intestine. In the blood, most DHEA is found as DHEAS with levels that are about 300 times higher than those of free DHEA. Orally-ingested DHEA is converted to its sulfate when passing through intestines and liver. Whereas DHEA levels naturally reach their peak in the early morning hours, DHEAS levels show no diurnal variation. From a practical point of view, measurement of DHEAS is preferable to DHEA, as levels are more stable.  DHEA (from which DHEAS comes from) is a natural steroid prohormone produced from cholesterol by the adrenal glands, the gonads, adipose tissue, brain and in the skin (by an autocrine mechanism). DHEA is the precursor of androstenedione, which can undergo further conversion to produce the androgen testosterone and the estrogens estrone and estradiol. DHEA is also a potent sigma-1 agonist. DHEAS can serve as a precursor for testosterone; androstenedione; estradiol; and estrone. [HMDB]",651-48-9,NA,NA,NA,NA,NA,NA,NA,NA,C04555,12594,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2011-09-21 00:13:08 UTC,2015-07-21 06:57:10 UTC,NA,NA,HMDB01032,NA,DB05804,44038,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.49,3.416690823,-4.66,[H]OS(=O)(=O)O[C@]1([H])C([H])([H])C2=C([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])C(=O)[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@]3([H])[C@@]2(C([H])([H])[H])C([H])([H])C1([H])[H],19.95770586,C19H28O5S,368.488,"InChI=1S/C19H28O5S/c1-18-9-7-13(24-25(21,22)23)11-12(18)3-4-14-15-5-6-17(20)19(15,2)10-8-16(14)18/h3,13-16H,4-11H2,1-2H3,(H,21,22,23)/t13-,14-,15-,16-,18-,19-/m0/s1",368.1657447,InChIKey=CZWCKYRVOZZJNM-USOAJAOKSA-N,8.06e-03 g/l,81794,"[(1S,2R,5S,10R,11S,15S)-2,15-dimethyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl]oxidanesulfonic acid",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Lipids and lipid-like molecules,Steroids and steroid derivatives,Sulfated steroids,Sulfated steroids,Aliphatic homopolycyclic compounds,CHEMBL259898,12074,DEHYDRO-EPIANDROSTERONE-SULFATE,NA,NA,DB05804,NA,Prasterone sulfate,651-48-9,57B09Q7FJR,(3-beta)-3-(Sulfooxy)androst-5-en-17-one | 17-Ketoandrost-5-en-3beta-yl sulfate | 17-oxoandrost-5-en-3Î²-yl hydrogen sulphate | 3-O-Sulfodehydroepiandrosterone | 3beta-Hydroxyandrost-5-en-17-one 3-sulfate | Androst-5-en-17-on-3beta-yl sulfuric acid | Dehydroepiandrosterone 3-sulfate | Dehydroepiandrosterone monosulfate | Dehydroepiandrosterone sulfate | Dehydroepiandrosterone sulphate | Dehydroisoandrosterone sulfate | Dehydroisoandrosterone-3-sulfate | DHEA sulfate | DHEA sulphate | DHEA-S | Prasterone sulphate,CZWCKYRVOZZJNM-USOAJAOKSA-N
DBVJJBKOTRCVKF-UHFFFAOYSA-N,9449,HMDB0015210,205.974526594,(1-hydroxy-1-phosphonoethyl)phosphonic acid,Etidronic acid,C2H8O7P2,7414-83-7,C07736,FDB001018,DB01077,NA,NA,3305,3189,CC(O)(P(O)(O)=O)P(O)(O)=O,NA,Organic compounds,Bisphosphonates,Organic acids and derivatives,Organic phosphonic acids and derivatives,Bisphosphonates,Aliphatic acyclic compounds,-3.8,2569,T3D3483,Exogenous,-3.8,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,205.974525634,(1-hydroxy-1-phosphonoethyl)phosphonic acid,Etidronic acid,C2H8O7P2,7414-83-7,HMDB15210,DB01077,C07736,NA,3305,3189,CC(O)(P(O)(O)=O)P(O)(O)=O,Chemical entities,Bisphosphonates,Organic compounds,Organic acids and derivatives,Organic phosphonic acids and derivatives,Aliphatic acyclic compounds,1018,2967,SmallMoleculeCompound,FDB001018,Etidronic acid,TRUE,Solid,low,"Food contaminant arising from its use as a boiler water additive for prepn. of steam used in food processing. Component of antimicrobial washes for poultry carcasses and fruitEtidronic acid is a first generation (non-nitrogenous) bisphosphonate in the same family as clodronate and tiludronate. Etidronic acid affects calcium metabolism and inhibits bone resorption and soft tissue calcification. Of the etidronic acid that is resorbed (from oral preparation) or infused (for intravenous drugs), about 50% is excreted unchanged by the kidney. The remainder has a very high affinity for bone tissue, and is rapidly absorbed onto the bone surface. Etidronic acid has been shown to prevent or delay skeletal-related events and decrease bone pain as well as normalize calcium levels in the presence of hypercalcemia.",2809-21-4,Mp 105å¡,NA,NA,690 mg/mL at 20 oC,NA,NA,NA,NA,C07736,3305,NA,NA,911,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:04:48 UTC,2015-07-20 21:37:00 UTC,NA,BPC55-N:BPC55-N,HMDB15210,NA,DB01077,NA,1748,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 11.66%; H 3.91%; O 54.36%; P 30.07%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,MERCK INDEX (1996),NA,NA,NA,DFC,-0.77,-2.28,-1.25,CC(O)(P(O)(O)=O)P(O)(O)=O,1.46,C2H8O7P2,206.0282,"InChI=1S/C2H8O7P2/c1-2(3,10(4,5)6)11(7,8)9/h3H,1H3,(H2,4,5,6)(H2,7,8,9)",205.9745256,InChIKey=DBVJJBKOTRCVKF-UHFFFAOYSA-N,1.15e+01 g/l,36495,(1-hydroxy-1-phosphonoethyl)phosphonic acid,DFC,NA,NA,"1-Hydroxy-1,1-ethanediphosphonic acid",DFC,NA,NA,NA,NA,Organic compounds,Organophosphorus compounds,Organic phosphonic acids and derivatives,Bisphosphonates,Bisphosphonates,Aliphatic acyclic compounds,CHEMBL871,3189,NA,NA,NA,DB01077,APRD00964,Etidronic acid,2809-21-4,M2F465ROXU,"(1-hydroxy-ethylidene)diphosphonic acid | (1-Hydroxyethylene)diphosphonic acid | (1-Hydroxyethylidene)bis(phosphonic acid) | (1-Hydroxyethylidene)bisphosphonic acid | (1-Hydroxyethylidene)diphosphonic acid | (Hydroxyethylidene)diphosphonic acid | 1-Hydroxy-1,1-diphosphonoethane | 1-hydroxyethane 1,1-diphosphonic acid | 1-Hydroxyethane-1,1-bisphosphonic acid | 1-Hydroxyethane-1,1-diphosphonate | 1-Hydroxyethane-1,1-diphosphonic acid | 1-Hydroxyethanediphosphonic acid | 1-Hydroxyethylidene-1,1-bisphosphonate | 1-Hydroxyethylidene-1,1-diphosphonic acid | 1,1,1-Ethanetriol diphosphonate | Acetodiphosphonic acid | acide Ã©tidronique | Ã¡cido etidrÃ³nico | acidum etidronicum | EHDP | Ethane-1-hydroxy-1,1-bisphosphonic acid | Ethane-1-hydroxy-1,1-diphosphonate | Ethane-1-hydroxy-1,1-diphosphonic acid | Etidronate | EtidronsÃ¤ure | HEDP | Hydroxyethanediphosphonic acid | Oxyethylidenediphosphonic acid",DBVJJBKOTRCVKF-UHFFFAOYSA-N
DCXYFEDJOCDNAF-REOHCLBHSA-N,110,HMDB0000168,132.053492132,(2S)-2-amino-3-carbamoylpropanoic acid,L-Asparagine,C4H8N2O3,70-47-3,C00152,FDB000787,NA,NA,ASN,6267,6031,N[C@@H](CC(N)=O)C(O)=O,14,Organic compounds,Asparagine and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,-3.82,3204,T3D4362,Endogenous,-3.82,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,132.053492132,(2S)-2-amino-3-carbamoylpropanoic acid,L-Asparagine,C4H8N2O3,70-47-3,HMDB00168,DB00174,C00152,ASN,6267,6031,[H][C@](N)(CC(O)=N)C(O)=O,Chemical entities,Asparagine and derivatives,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Aliphatic acyclic compounds,787,2159,SmallMoleculeCompound,FDB000787,L-Asparagine,TRUE,Solid,low,"One of the nonessential amino acids. Dietary supplement, nutrient. Widely distributed in the plant kingdom. Isol. from asparagus, beetroot, peas, beans, etc.Asparagine (abbreviated as Asn or N; Asx or B represent either asparagine or aspartic acid) is one of the 20 most common natural amino acids on Earth. It has carboxamide as the side-chain's functional group. It is not an essential amino acid. Its codons are AAU and AAC. (Wikipedia)",70-47-3,Mp 226-227 dec. (slow heat),NA,NA,29.4 mg/mL at 25 oC,-3.82,NA,NA,NA,C00152,6267,NA,17196,ASN,NA,NA,NA,Asparagine,NA,NA,NA,NA,NA,NA,NA,HMDB00168.pdf,application/pdf,40736,2015-02-28 18:07:37 UTC,NA,2,2010-04-08 22:04:42 UTC,2015-10-09 22:28:06 UTC,NA,BCF96-C:BHH57-K,HMDB00168,L-ASPARAGINE|ASPARAGINE|ASPARAGIN,DB00174,34055,261,C00001341,NA,NA,NA,NA,NA,NA,[a]D +33.2 (3M HCl),DFC,C 36.36%; H 6.10%; N 21.20%; O 36.33%,DFC,NA,NA,NA,NA,NA,NA,pKa2 8.6 (NH2),DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","CHMELIK,J ET AL. (1991)",NA,NA,DFC,-3.36,-4.42,0.1,N[C@@H](CC(N)=O)C(O)=O,16.09,C4H8N2O3,132.1179,"InChI=1S/C4H8N2O3/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H2,6,7)(H,8,9)/t2-/m0/s1",132.0534921,InChIKey=DCXYFEDJOCDNAF-REOHCLBHSA-N,1.68e+02 g/l,32673,(2S)-2-amino-3-carbamoylpropanoic acid,MANUAL,NA,NA,"Asparagine, 9CI; (S)-form",DFC,NA,rw1039271,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",L-alpha-amino acids,Aliphatic acyclic compounds,CHEMBL58832,6031,ASN,TRUE,NA,DB00174,NUTR00015,L-Asparagine,70-47-3,5Z33R5TKO7,"(2S)-2-amino-3-carbamoylpropanoic acid | (2S)-2,4-diamino-4-oxobutanoic acid | (S)-2-amino-3-carbamoylpropanoic acid | (S)-Asparagine | 2-Aminosuccinamic acid | alpha-aminosuccinamic acid | Asn | Asparagine | Aspartamic acid | L-2-aminosuccinamic acid | L-Asparagin | L-Asparagine | L-aspartic acid beta-amide | L-aspartic acid Î²-amide | N | Î±-aminosuccinamic acid",DCXYFEDJOCDNAF-REOHCLBHSA-N
DFPAKSUCGFBDDF-UHFFFAOYSA-N,1082,HMDB0001406,122.048012824,pyridine-3-carboxamide,Niacinamide,C6H6N2O,98-92-0,C00153,FDB012485,DB02701,NA,NIACINAMIDE,936,911,NC(=O)C1=CC=CN=C1,1497,Organic compounds,Nicotinamides,Organoheterocyclic compounds,Pyridines and derivatives,Pyridinecarboxylic acids and derivatives,Aromatic heteromonocyclic compounds,-0.37,3089,T3D4168,Endogenous,-0.37,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,122.048012824,pyridine-3-carboxamide,Niacinamide,C6H6N2O,98-92-0,HMDB01406,DB02701,C00153,NIACINAMIDE,936,911,OC(=N)C1=CN=CC=C1,Organic compounds,Nicotinamides,Organoheterocyclic compounds,Pyridines and derivatives,Pyridinecarboxylic acids and derivatives,Aromatic heteromonocyclic compounds,12488,32439,SmallMoleculeCompound,FDB012485,Nicotinamide,TRUE,Solid,low,"Widespread in plants, e.g. rice, yeast and fungi. Dietary supplement, may be used in infant formulasNicotinamide, also known as niacinamide and nicotinic acid amide, is the amide of nicotinic acid (vitamin B3 / niacin). Nicotinamide is a water-soluble vitamin and is part of the vitamin B group. Nicotinic acid, also known as niacin, is converted to nicotinamide in vivo, and, though the two are identical in their vitamin functions, nicotinamide does not have the same pharmacologic and toxic effects of niacin, which occur incidental to niacin's conversion. (Wikipedia)",98-92-0,Mp 129-130å¡,NA,NA,500 mg/mL at 25 oC,-0.37,NA,NA,NA,C00153,936,NA,17154,NCA,NA,NA,NA,Niacinamide,NA,NA,NA,NA,NA,NA,NA,HMDB01406.pdf,application/pdf,56682,2015-02-28 17:53:28 UTC,NA,2,2010-04-08 22:10:12 UTC,2015-10-09 22:27:58 UTC,NA,HHJ27-Z:HHJ27-Z,HMDB01406,NICOTINIC-ACID-AMIDE|NICOTINAMIDE,DB02701,34058,2662,C00000209,Bp0.0005 150-160å¡,DFC,NA,NA,NA,NA,NA,NA,C 59.01%; H 4.95%; N 22.94%; O 13.10%,DFC,NA,NA,NA,NA,NA,NA,pKa 3.33 (20å¡),DFC,MERCK INDEX (1996),"HANSCH,C ET AL. (1995)",NA,NA,DFC,-0.45,-0.39,-0.39,NC(=O)C1=CC=CN=C1,NA,C6H6N2O,122.1246,"InChI=1S/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9)",122.0480128,InChIKey=DFPAKSUCGFBDDF-UHFFFAOYSA-N,5.01e+01 g/l,32904,pyridine-3-carboxamide,MANUAL,NA,NA,"3-Pyridinecarboxamide, 9CI",DFC,NA,rw1068911,NA,NA,Organic compounds,Organoheterocyclic compounds,Pyridines and derivatives,Pyridinecarboxylic acids and derivatives,Nicotinamides,Aromatic heteromonocyclic compounds,CHEMBL1140,911,NIACINAMIDE,TRUE,NA,DB02701,EXPT02307,Nicotinamide,98-92-0,25X51I8RD4,Niacinamide | Nicotinic amide,DFPAKSUCGFBDDF-UHFFFAOYSA-N
DHMQDGOQFOQNFH-UHFFFAOYSA-N,78,HMDB0000123,75.032028409,2-aminoacetic acid,Glycine,C2H5NO2,56-40-6,C00037,FDB000484,DB00145,NA,GLY,750,730,NCC(O)=O,20,Organic compounds,Alpha amino acids,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,-3.21,3182,T3D4318,Endogenous,-3.21,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,75.032028409,2-aminoacetic acid,Glycine,C2H5NO2,56-40-6,HMDB00123,DB00145,C00037,GLY,750,730,NCC(O)=O,Organic compounds,Alpha amino acids,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,484,1190,SmallMoleculeCompound,FDB000484,Glycine,TRUE,Solid,low,"Flavouring ingredient; dietary additive, nutrientGlycine (abbreviated as Gly or G) is the organic compound with the formula NH2CH2COOH. With only a hydrogen atom as its side chain, glycine is the smallest of the 20 amino acids commonly found in proteins. Glycine is unique among the proteinogenic amino acids in that it is not chiral. It can fit into hydrophilic or hydrophobic environment due to its single hydrogen atom side chain. It is coded by codons GGU, GGC, GGA and GGG. Most proteins incorporate only small quantities of glycine. A notable exception is collagen, which contains about 35% glycine. Glycine is a colourless, sweet-tasting crystalline solid.; Glycine is a simple, nonessential amino acid, although experimental animals show reduced growth on low-glycine diets. The average adult ingests 3 to 5 grams of glycine daily. Glycine is involved in the body's production of DNA, phospholipids and collagen, and in release of energy. Glycine levels are effectively measured in plasma in both normal patients and those with inborn errors of glycine metabolism. (http://www.dcnutrition.com/AminoAcids/) Nonketotic hyperglycinaemia (OMIM 606899) is an autosomal recessive condition caused by deficient enzyme activity of the glycine cleavage enzyme system (EC 2.1.1.10). The glycine cleavage enzyme system comprises four proteins: P-, T-, H- and L-proteins (EC 1.4.4.2, EC 2.1.2.10 and EC 1.8.1.4 for P-, T- and L-proteins). Mutations have been described in the GLDC (OMIM 238300), AMT (OMIM 238310), and GCSH (OMIM 238330) genes encoding the P-, T-, and H-proteins respectively. The glycine cleavage system catalyses the oxidative conversion of glycine into carbon dioxide and ammonia, with the remaining one-carbon unit transferred to folate as methylenetetrahydrofolate. It is the main catabolic pathway for glycine and it also contributes to one-carbon metabolism. Patients with a deficiency of this enzyme system have increased glycine in plasma, urine and cerebrospinal fluid (CSF) with an increased CSF: plasma glycine ratio. (PMID 16151895); Glycine is an inhibitory neurotransmitter in the central nervous system, especially in the spinal cord, brainstem, and retina. When glycine receptors are activated, chloride enters the neuron via ionotropic receptors, causing an Inhibitory postsynaptic potential (IPSP). Strychnine is a strong antagonist at ionotropic glycine receptors, whereas bicuculline is a weak one. Glycine is a required co-agonist along with glutamate for NMDA receptors. In contrast to the inhibitory role of glycine in the spinal cord, this behaviour is facilitated at the (NMDA) glutaminergic receptors which are excitatory.[citation needed] The LD50 of glycine is 7930 mg/kg in rats (oral), and it usually causes death by hyperexcitability.; Glycine is an intermediate in the synthesis of a variety of chemical products. It is used in the manufacture of the herbicide Glyphosate. Glyphosate (N-(phosphonomethyl) glycine) is a non-selective systemic herbicide used to kill weeds, especially perennials and broadcast or used in the cut-stump treatment as a forestry herbicide. Initially, Glyphosate was sold only by Monsanto under the Monsanto tradename Roundup, but is no longer under patent.; Helps trigger the release of oxygen to the energy requiring cell-making process",56-40-6,Mp 292 (262å¡)å¡ dec.,NA,NA,249 mg/mL at 25 oC,-3.21,NA,NA,NA,C00037,750,NA,NA,GLY,NA,NA,NA,Glycine,NA,NA,NA,NA,NA,NA,NA,HMDB00123.pdf,application/pdf,48988,2015-02-28 17:58:57 UTC,NA,2,2010-04-08 22:04:35 UTC,2015-10-09 22:28:32 UTC,1062,BCV25-I:BCV25-I,HMDB00123,GLYCINE|GYLCINE,DB00145,33610,1527,C00001361,NA,NA,0,NA,NA,NA,NA,NA,C 32.00%; H 6.71%; N 18.66%; O 42.63%,DFC,NA,NA,NA,NA,NA,NA,pKa2 9.78 (25å¡),DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,-3.34,-3.55,0.87,NCC(O)=O,NA,C2H5NO2,75.0666,"InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)",75.03202841,InChIKey=DHMQDGOQFOQNFH-UHFFFAOYSA-N,5.52e+02 g/l,32632,2-aminoacetic acid,DFC,NA,NA,Glycine,DFC,NA,rw1008481,NA,1062,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Alpha amino acids,Aliphatic acyclic compounds,CHEMBL773,730,GLY,TRUE,NA,DB00145,NUTR00028,Glycine,56-40-6,TE7660XO1C,Aminoacetic acid | AminoessigsÃ¤ure | Aminoethanoic acid | Gly | Glycin | Glycocoll | Glykokoll | Glyzin | Leimzucker,DHMQDGOQFOQNFH-UHFFFAOYSA-N
DLFVBJFMPXGRIB-UHFFFAOYSA-N,12709,HMDB0031645,59.037113787,acetamide,Acetamide,C2H5NO,60-35-5,C06244,FDB008298,DB02736,NA,NA,178,173,CC(N)=O,NA,Organic compounds,Carboximidic acids,Organic acids and derivatives,Carboximidic acids and derivatives,Carboximidic acids,Aliphatic acyclic compounds,-1.26,3127,T3D4209,Endogenous,-1.26,"2B, possibly carcinogenic to humans. (L135)",NA,SmallMolecule,59.037113787,acetamide,Acetamide,C2H5NO,60-35-5,HMDB31645,DB02736,C06244,NA,178,173,CC(O)=N,Chemical entities,Carboximidic acids,Organic compounds,Organic acids and derivatives,Carboximidic acids and derivatives,Aliphatic acyclic compounds,8299,20333,SmallMoleculeCompound,FDB008298,Acetamide,TRUE,NA,low,"Acetamide (or acetic acid amide or ethanamide), CH3CONH2, the amide of acetic acid, is a white crystalline solid in pure form. It is produced by dehydrating ammonium acetate:",60-35-5,Mp 82-83å¡,NA,NA,2250 mg/mL at 25 oC,-1.26,NA,NA,NA,C06244,178,NA,27856,ACM,NA,NA,NA,Acetamide,NA,NA,NA,NA,NA,NA,NA,HMDB31645.pdf,application/pdf,50425,2015-02-28 18:11:36 UTC,NA,NA,2010-04-08 22:08:01 UTC,2015-10-09 22:29:39 UTC,NA,DFR77-W:DFR77-W,HMDB31645,ACETAMIDE,DB02736,NA,16,NA,Bp5 92å¡,DFC,NA,NA,NA,NA,NA,NA,C 40.67%; H 8.53%; N 23.71%; O 27.09%,DFC,NA,NA,NA,NA,NA,NA,pKa1 ?1.4 (25å¡),DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,-1.1,-1.03,0.8,CC(N)=O,NA,C2H5NO,59.0672,"InChI=1S/C2H5NO/c1-2(3)4/h1H3,(H2,3,4)",59.03711379,InChIKey=DLFVBJFMPXGRIB-UHFFFAOYSA-N,3.69e+02 g/l,38767,acetamide,DFC,NA,NA,"Acetamide, 9CI",DFC,NA,rw1097381,NA,NA,Organic compounds,Organic acids and derivatives,Carboximidic acids and derivatives,Carboximidic acids,Carboximidic acids,Aliphatic acyclic compounds,CHEMBL16081,173,ACETAMIDE,TRUE,NA,DB02736,EXPT00414,Acetamide,60-35-5,8XOE1JSO29,NA,DLFVBJFMPXGRIB-UHFFFAOYSA-N
DLGOEMSEDOSKAD-UHFFFAOYSA-N,8772,HMDB0014407,213.007181961,"1,3-bis(2-chloroethyl)-3-nitrosourea",Carmustine,C5H9Cl2N3O2,154-93-8,C06873,FDB012974,DB00262,NA,NA,2578,2480,ClCCNC(=O)N(CCCl)N=O,NA,Organic compounds,Nitrosoureas,Organic acids and derivatives,Organic carbonic acids and derivatives,Ureas,Aliphatic acyclic compounds,1.5,3386,T3D4681,Exogenous,1.53,"2A, probably carcinogenic to humans. (L135)",NA,SmallMolecule,213.007181961,"1,3-bis(2-chloroethyl)-3-nitrosourea",Carmustine,C5H9Cl2N3O2,154-93-8,HMDB14407,DB00262,C06873,NA,2578,2480,OC(=NCCCl)N(CCCl)N=O,Organic compounds,Nitrosoureas,Organic acids and derivatives,Organic carbonic acids and derivatives,Ureas,Aliphatic acyclic compounds,12977,34263,SmallMoleculeCompound,FDB012974,Mercenene,TRUE,Solid,low,"Isol. from the common clam Mercenaria mercenaria and from Mercenaria campechiensisCarmustine is one of the nitrosoureas indicated as palliative therapy as a single agent or in established combination therapy with other approved chemotherapeutic agents in treatment of brain tumors, multiple myeloma, Hodgkin's disease, and non-Hodgkin's lymphomas. Although it is generally agreed that carmustine alkylates DNA and RNA, it is not cross resistant with other alkylators. As with other nitrosoureas, it may also inhibit several key enzymatic processes by carbamoylation of amino acids in proteins.",154-93-8,NA,NA,NA,NA,NA,NA,NA,NA,C06873,2578,NA,3423,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:10:27 UTC,2015-07-20 22:55:23 UTC,NA,HNQ43-A:HNQ43-A,HMDB14407,NA,DB00262,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,274 () (H2O) (Berdy),DFC,NA,NA,NA,NA,NA,NA,NA,1.24,1.02,-2.15,ClCCNC(=O)N(CCCl)N=O,NA,C5H9Cl2N3O2,214.05,"InChI=1S/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2,(H,8,11)",213.007182,InChIKey=DLGOEMSEDOSKAD-UHFFFAOYSA-N,1.53e+00 g/l,39577,"1,3-bis(2-chloroethyl)-3-nitrosourea",BIOSPIDER,NA,NA,Mercenene,DFC,NA,NA,NA,NA,Organic compounds,Organonitrogen compounds,Nitroso compounds,N-nitroso compounds,Organic nitrosamines,Aliphatic acyclic compounds,CHEMBL513,2480,NA,NA,NA,DB00262,APRD00006,Carmustine,154-93-8,U68WG3173Y,"BCNU | Bicnu (tn) | bis-chloroethylnitrosourea | Bischloroethyl nitrosourea | Carmustina | Carmustine | Carmustinum | N,N'-Bis(2-chloroethyl)-N-nitrosourea",DLGOEMSEDOSKAD-UHFFFAOYSA-N
DNXHEGUUPJUMQT-CBZIJGRNSA-N,94,HMDB0000145,270.161979948,"(1S,10R,11S,15S)-5-hydroxy-15-methyltetracyclo[8.7.0.0\xc2\xb2,\xe2\x81\xb7.0\xc2\xb9\xc2\xb9,\xc2\xb9\xe2\x81\xb5]heptadeca-2(7),3,5-trien-14-one",Estrone,C18H22O2,53-16-7,C00468,FDB012798,NA,DBMET00490,ESTRONE,5870,5660,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,264,Organic compounds,Estrogens and derivatives,Lipids and lipid-like molecules,Steroids and steroid derivatives,Estrane steroids,Aromatic homopolycyclic compounds,3.13,3433,T3D4746,Exogenous,3.13,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,270.161979948,"(1S,10R,11S,15S)-5-hydroxy-15-methyltetracyclo[8.7.0.0\xc2\xb2,\xe2\x81\xb7.0\xc2\xb9\xc2\xb9,\xc2\xb9\xe2\x81\xb5]heptadeca-2(7),3,5-trien-14-one",Estrone,C18H22O2,53-16-7,HMDB00145,DB00655,C00468,ESTRONE,5870,5660,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3CC[C@@]21[H],Organic compounds,Estrogens and derivatives,Lipids and lipid-like molecules,Steroids and steroid derivatives,Estrane steroids,Aromatic homopolycyclic compounds,12801,33793,SmallMoleculeCompound,FDB012798,Estrone,TRUE,Solid,low,"A trace constit. of plant tissues, e.g. seeds  of date (Phoenix dactylifera) and pomegranate (Punica granatum)",53-16-7,Mp 259å¡,NA,NA,0.03 mg/mL at 25 oC,3.13,NA,NA,NA,C00468,5870,NA,NA,J3Z,NA,NA,NA,Estrone,NA,NA,NA,NA,NA,NA,NA,HMDB00145.pdf,application/pdf,51287,2015-02-28 17:46:55 UTC,NA,2,2010-04-08 22:10:22 UTC,2015-10-09 22:30:10 UTC,NA,HLF43-J:HLF43-J,HMDB00145,ESTRONE,DB00655,35059,NA,C00003663,NA,NA,0,NA,NA,NA,[a]D +165 (CHCl3),DFC,C 79.96%; H 8.20%; O 11.84%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,MERCK INDEX (1996),"HANSCH,C ET AL. (1995)",NA,NA,DFC,4.03,4.31,-4.84,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,19.96,C18H22O2,270.3661,"InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1",270.1619799,InChIKey=DNXHEGUUPJUMQT-CBZIJGRNSA-N,3.94e-03 g/l,35002,"(1S,10R,11S,15S)-5-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-one",MANUAL,NA,NA,"Estrone, INN",DFC,NA,NA,NA,NA,Organic compounds,Lipids and lipid-like molecules,Steroids and steroid derivatives,Estrane steroids,Estrogens and derivatives,Aromatic homopolycyclic compounds,CHEMBL1405,5660,ESTRONE,TRUE,NA,DB00655,APRD00588,Estrone,53-16-7,2DI9HA706A,"3-Hydroxy-1,3,5(10)-estratrien-17-one | Estrona | Estrone | Estronum | follicular hormone | Folliculin | Oestrone",DNXHEGUUPJUMQT-CBZIJGRNSA-N
DOBMPNYZJYQDGZ-UHFFFAOYSA-N,8775,HMDB0014411,336.063388116,4-hydroxy-3-[(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]-2H-chromen-2-one,Dicumarol,C19H12O6,66-76-2,C00796,FDB012523,DB00266,NA,NA,54676038,10183330,OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=C1C=CC=C2,NA,Organic compounds,4-hydroxycoumarins,Phenylpropanoids and polyketides,Coumarins and derivatives,Hydroxycoumarins,Aromatic heteropolycyclic compounds,3.1,2770,T3D3735,Exogenous,2.07,No indication of carcinogenicity to humans (not listed by IARC).,"LD50: 233 mg/kg (Oral, Mouse) (A308)",SmallMolecule,336.063388116,4-hydroxy-3-[(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]-2H-chromen-2-one,Dicumarol,C19H12O6,66-76-2,HMDB14411,DB00266,C00796,NA,54676038,10183330,OC1=C(CC2=C(O)C3=CC=CC=C3OC2=O)C(=O)OC2=CC=CC=C12,Chemical entities,4-hydroxycoumarins,Organic compounds,Phenylpropanoids and polyketides,Coumarins and derivatives,Aromatic heteropolycyclic compounds,12526,32620,SmallMoleculeCompound,FDB012523,Dicoumarol,TRUE,Solid,low,"Isol. from Melilotus alba (white melilot)Dicoumarol (INN) or dicumarol (USAN) is an anticoagulant that functions as a Vitamin K antagonist (similar to warfarin). It is also used in biochemical experiments as an inhibitor of reductases.; Dicumarol is an coumarin-like compound found in sweet clover. It is used as an oral anticoagulant and acts by inhibiting the hepatic synthesis of vitamin K-dependent coagulation factors (prothrombin and factors VII, IX, and X). It is also used in biochemical experiments as an inhibitor of reductases.; It is a derivative of coumarin.; Mechanism of action : it is a competitive inhibitor of Vitamin K preventing the formation of prothrombin , Administration of Vitamin K is the antidote for dicumarol toxicity; also that Dicumarol is a chemical subsrance of plant origin given only orally and acts within two days",66-76-2,Mp 288-289å¡,NA,NA,NA,2.07,NA,NA,NA,C00796,54676038,NA,NA,NA,NA,NA,NA,Dicoumarol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:10:13 UTC,2015-07-20 22:51:21 UTC,NA,HHR78-D:HHR78-D,HMDB14411,NA,DB00266,NA,NA,C00002467,NA,NA,NA,NA,NA,NA,NA,NA,C 67.86%; H 3.60%; O 28.54%,DFC,NA,NA,NA,NA,325 (e 19320) (CHCl3) (Berdy),DFC,NA,NA,NA,"HANSCH,C ET AL. (1995)",NA,NA,DFC,1.54,1.94,-3.71,OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=C1C=CC=C2,6.42,C19H12O6,336.295,"InChI=1S/C19H12O6/c20-16-10-5-1-3-7-14(10)24-18(22)12(16)9-13-17(21)11-6-2-4-8-15(11)25-19(13)23/h1-8,20-21H,9H2",336.0633881,InChIKey=DOBMPNYZJYQDGZ-UHFFFAOYSA-N,6.62e-02 g/l,34138,4-hydroxy-3-[(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]-2H-chromen-2-one,DFC,NA,NA,"Dicoumarol, INN",DFC,NA,NA,NA,NA,Organic compounds,Phenylpropanoids and polyketides,Coumarins and derivatives,Hydroxycoumarins,4-hydroxycoumarins,Aromatic heteropolycyclic compounds,CHEMBL1466,10183330,DICOUMAROL,NA,NA,DB00266,APRD00761,Dicoumarol,66-76-2,7QID3E7BG7,"3,3'-Methylen-bis(4-hydroxy-cumarin) | 3,3'-Methylene-bis(4-hydroxycoumarine) | 3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone) | 3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one) | 3,3'-Methylenebis(4-hydroxycoumarin) | bis-3,3'-(4-hydroxycoumarinyl)methane | bis-hydroxycoumarin | Bis(4-hydroxycoumarin-3-yl)methane | di-(4-hydroxy-3-coumarinyl)methane | Dicoumarol | Dicoumarolum | Dicumarol",DOBMPNYZJYQDGZ-UHFFFAOYSA-N
DRLFMBDRBRZALE-UHFFFAOYSA-N,1070,HMDB0001389,232.121177766,N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide,Melatonin,C13H16N2O2,73-31-4,C01598,FDB004234,DB01065,NA,N-ACETYL-5-METHOXY-TRYPTAMINE,896,872,COC1=CC=C2NC=C(CCNC(C)=O)C2=C1,73,Organic compounds,3-alkylindoles,Organoheterocyclic compounds,Indoles and derivatives,Indoles,Aromatic heteropolycyclic compounds,NA,2385,T3D2972,Endogenous,1.6,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,232.121177766,N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide,Melatonin,C13H16N2O2,73-31-4,HMDB01389,DB01065,C01598,N-ACETYL-5-METHOXY-TRYPTAMINE,896,872,COC1=CC2=C(NC=C2CCN=C(C)O)C=C1,Organic compounds,3-alkylindoles,Organoheterocyclic compounds,Indoles and derivatives,Indoles,Aromatic heteropolycyclic compounds,4235,12486,SmallMoleculeCompound,FDB004234,Melatonin,TRUE,Solid,low,"Melatonin, also known chemically as N-acetyl-5-methoxytryptamine, is a naturally occurring compound found in animals, plants and microbes. In animals, circulating levels of the hormone melatonin vary in a daily cycle, thereby allowing the entrainment of the circadian rhythms of several biological functions. (Wikipedia)",73-31-4,117 oC,NA,NA,NA,NA,NA,NA,NA,C01598,896,NA,16796,ML1,NA,NA,NA,Melatonin,NA,NA,NA,NA,NA,NA,NA,HMDB01389.pdf,application/pdf,48072,2015-02-28 17:50:39 UTC,NA,2,2010-04-08 22:06:09 UTC,2015-10-09 22:31:52 UTC,NA,NA,HMDB01389,MELATONIN,DB01065,37965,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.42,1.15,-3.21,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,16.59,C13H16N2O2,232.2783,"InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)",232.1211778,InChIKey=DRLFMBDRBRZALE-UHFFFAOYSA-N,1.43e-01 g/l,40431,N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide,BIOSPIDER,NA,NA,NA,DUKE,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Indoles and derivatives,Tryptamines and derivatives,Serotonins,Aromatic heteropolycyclic compounds,CHEMBL45,872,N-ACETYL-5-METHOXY-TRYPTAMINE,TRUE,NA,DB01065,APRD00742 | DB08189,Melatonin,73-31-4,JL5DK93RCL,5-methoxy-N-acetyltryptamine | Melatonin | Melatonine | N-[2-(5-methoxyindol-3-yl)ethyl]acetamide | N-Acetyl-5-methoxytryptamine,DRLFMBDRBRZALE-UHFFFAOYSA-N
DTOSIQBPPRVQHS-PDBXOOCHSA-N,1069,HMDB0001388,278.224580204,"(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid",Alpha-Linolenic acid,C18H30O2,463-40-1,C06427,FDB012462,DB00132,NA,LINOLENIC_ACID,5280934,4444437,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,6208,Organic compounds,Lineolic acids and derivatives,Lipids and lipid-like molecules,Fatty Acyls,Lineolic acids and derivatives,Aliphatic acyclic compounds,6.46,3498,T3D4812,Endogenous,6.46,Not listed by IARC.,NA,SmallMolecule,278.224580204,"(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid",Alpha-Linolenic Acid,C18H30O2,463-40-1,HMDB01388,DB00132,C06427,LINOLENIC_ACID,5280934,4444437,[H]\C(CC)=C(/[H])C\C([H])=C(\[H])C\C([H])=C(\[H])CCCCCCCC(O)=O,Organic compounds,Lineolic acids and derivatives,Lipids and lipid-like molecules,Fatty Acyls,Lineolic acids and derivatives,Aliphatic acyclic compounds,12465,32370,SmallMoleculeCompound,FDB012462,alpha-Linolenic acid,TRUE,Liquid,low,"An essential fatty acidalpha-Linolenic acid (Not to be confused with linoleic acid) is an organic compound found in many common vegetable oils. In terms of its structure, it is named all-cis-9,12,15-octadecatrienoic acid. In physiological literature, it is given the name 18:3 (n?3). (Wikipedia)",463-40-1,Mp -11.3å¡,NA,NA,NA,6.46,NA,NA,NA,C06427,5280934,NA,27432,LNL,NA,NA,NA,Alpha-Linolenic_acid,NA,NA,NA,NA,NA,NA,NA,HMDB01388.pdf,application/pdf,3758895,2015-02-28 18:03:44 UTC,NA,2,2010-04-08 22:10:11 UTC,2015-10-09 22:31:49 UTC,NA,CPM16-L:HHB80-W,HMDB01388,CIS-LINOLEIC-ACID|ALPHA-LINOLENIC-ACID|LINOLENIC-ACID,DB00132,48237,NA,C00007247,Bp0.05 125å¡,DFC,NA,NA,d204<vs=1> 0.92,DFC,NA,NA,C 77.65%; H 10.86%; O 11.49%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,SANGSTER (1993),NA,NA,DFC,6.62,6.06,-6.02,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,NA,C18H30O2,278.4296,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9-",278.2245802,InChIKey=DTOSIQBPPRVQHS-PDBXOOCHSA-N,2.66e-04 g/l,31110,"(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid",MANUAL,NA,NA,"9,12,15-Octadecatrienoic acid, 9CI; (Z,Z,Z)-form",DFC,NA,rw1045911,NA,NA,Organic compounds,Lipids and lipid-like molecules,Lineolic acids and derivatives,NA,Lineolic acids and derivatives,Aliphatic acyclic compounds,CHEMBL8739,4444437,LINOLENIC_ACID,TRUE,NA,DB00132,NUTR00034,Alpha-Linolenic Acid,463-40-1,0RBV727H71,"(9,12,15)-linolenic acid | (9Z,12Z,15Z)-Octadecatrienoic acid | (Z,Z,Z)-9,12,15-octadecatrienoic acid | 9-cis,12-cis,15-cis-octadecatrienoic acid | 9,12,15-Octadecatrienoic acid | ALA | all-cis-9,12,15-Octadecatrienoic acid | alpha-Linolenic acid | cis-delta(9,12,15)-Octadecatrienoic acid | cis,cis,cis-9,12,15-Octadecatrienoic acid | Linolenic acid | Î±-linolenic acid",DTOSIQBPPRVQHS-PDBXOOCHSA-N
DTUQWGWMVIHBKE-UHFFFAOYSA-N,2664,HMDB0006236,120.057514878,2-phenylacetaldehyde,Phenylacetaldehyde,C8H8O,122-78-1,C00601,FDB012238,NA,NA,HYDRPHENYLAC-CPD,998,13876539,O=CCC1=CC=CC=C1,NA,Organic compounds,Phenylacetaldehydes,Benzenoids,Benzene and substituted derivatives,Phenylacetaldehydes,Aromatic homomonocyclic compounds,1.78,3491,T3D4805,Endogenous,1.78,Not listed by IARC.,NA,SmallMolecule,120.057514878,2-phenylacetaldehyde,Phenylacetaldehyde,C8H8O,122-78-1,HMDB06236,DB02178,C00601,HYDRPHENYLAC-CPD,998,13876539,O=CCC1=CC=CC=C1,Chemical entities,Phenylacetaldehydes,Organic compounds,Benzenoids,Benzene and substituted derivatives,Aromatic homomonocyclic compounds,12241,31696,SmallMoleculeCompound,FDB012238,Phenylacetaldehyde,TRUE,Solid,low,"Found in some essential oils, e.g. Citrus spp., Tagetes minuta (Mexican marigold) and in the mushroom Phallus impudicus (common stinkhorn). Flavouring ingredientPhenylacetaldehyde is one important oxidation-related aldehyde. Exposure to styrene gives phenylacetaldehyde as a secondary metabolite. Styrene has been implicated as reproductive toxicant, neurotoxicant, or carcinogen in vivo or in vitro. Phenylacetaldehyde could be formed by diverse thermal reactions during the cooking process together with C8 compounds is identified as a major aroma- active compound in cooked pine mushroom. Phenylacetaldehyde is readily oxidized to phenylacetic acid. Therefore will eventually be hydrolyzed and oxidized to yield phenylacetic acid that will be excreted primarily in the urine in conjugated form. (PMID: 16910727, 7818768, 15606130)",122-78-1,120.5-121.5 oC,NA,NA,NA,1.78,NA,NA,NA,C00601,998,NA,NA,HY1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HMDB06236.pdf,application/pdf,169668,2015-02-28 17:44:10 UTC,NA,2,2010-04-08 22:10:04 UTC,2015-10-09 22:33:21 UTC,NA,HFG98-S:HFG98-S,HMDB06236,2-PHENYLACETALDEHYDE|PHENYL-ACETALDEHYDE,DB02178,35469,2985,C00007535,Bp10 78å¡,DFC,0,NA,d19.64<vs=3> 1.03,DFC,NA,NA,C 79.97%; H 6.71%; O 13.32%,DFC,NA,NA,n20D<vs=1>  1.5290,DFC,NA,NA,NA,NA,NA,"HANSCH,C ET AL. (1995)",NA,NA,NA,1.75,1.45,-1.76,O=CCC1=CC=CC=C1,NA,C8H8O,120.1485,"InChI=1S/C8H8O/c9-7-6-8-4-2-1-3-5-8/h1-5,7H,6H2",120.0575149,InChIKey=DTUQWGWMVIHBKE-UHFFFAOYSA-N,2.08e+00 g/l,35306,2-phenylacetaldehyde,DFC,NA,NA,Phenylacetaldehyde,DFC,122-78-1,rw1009931,998,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenylacetaldehydes,Phenylacetaldehydes,Aromatic homomonocyclic compounds,CHEMBL1233464,13876539,HYDRPHENYLAC-CPD,TRUE,NA,DB02178,EXPT01801,Phenylacetaldehyde,122-78-1,U8J5PLW9MR,NA,DTUQWGWMVIHBKE-UHFFFAOYSA-N
DZGWFCGJZKJUFP-UHFFFAOYSA-N,210,HMDB0000306,137.084063979,4-(2-aminoethyl)phenol,Tyramine,C8H11NO,51-67-2,C00483,FDB000433,NA,NA,CPD-7650,5610,5408,NCCC1=CC=C(O)C=C1,60,Organic compounds,Phenethylamines,Benzenoids,Benzene and substituted derivatives,Phenethylamines,Aromatic homomonocyclic compounds,NA,3225,T3D4435,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,137.084063979,4-(2-aminoethyl)phenol,Tyramine,C8H11NO,51-67-2,HMDB00306,NA,C00483,CPD-7650,5610,5408,NCCC1=CC=C(O)C=C1,Organic compounds,Phenethylamines,Benzenoids,Benzene and substituted derivatives,Phenethylamines,Aromatic homomonocyclic compounds,433,933,SmallMoleculeCompound,FDB000433,Tyramine,TRUE,Solid,low,"Present in germinating barley, sawa millet seed hulls, Pisum sativum, Piper nigrum (pepper) and in putrefied animal tissues. Also isol. from commercial and household prepared sauerkraut",51-67-2,Mp 164-164.5å¡ (161å¡),NA,NA,10.4 mg/mL at 15 oC,NA,NA,NA,NA,C00483,5610,NA,15760,AEF,NA,NA,NA,Tyramine,NA,NA,NA,NA,NA,NA,NA,HMDB00306.pdf,application/pdf,49125,2015-02-28 18:04:23 UTC,NA,2,2010-04-08 22:04:34 UTC,2015-10-09 22:27:38 UTC,NA,BCB62-V:BCB62-V,HMDB00306,TYRAMINE,NA,35110,3788,C00001435,NA,NA,NA,NA,NA,NA,NA,NA,C 70.04%; H 8.08%; N 10.21%; O 11.66%,DFC,NA,NA,NA,NA,NA,NA,pKa2 10.9 (25å¡),DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)",NA,NA,NA,DFC,-0.14,0.66,-1.38,NCCC1=CC=C(O)C=C1,NA,C8H11NO,137.179,"InChI=1S/C8H11NO/c9-6-5-7-1-3-8(10)4-2-7/h1-4,10H,5-6,9H2",137.084064,InChIKey=DZGWFCGJZKJUFP-UHFFFAOYSA-N,5.72e+00 g/l,38007,4-(2-aminoethyl)phenol,DFC,NA,NA,4-Hydroxyphenethylamine,DFC,NA,rw1051461,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenethylamines,Phenethylamines,Aromatic homomonocyclic compounds,CHEMBL11608,5408,CPD-7650,TRUE,NA,DB08841,NA,Tyramine,51-67-2,X8ZC7V0OX3,NA,DZGWFCGJZKJUFP-UHFFFAOYSA-N
FDGQSTZJBFJUBT-UHFFFAOYSA-N,102,HMDB0000157,136.03851077,7H-purin-6-ol,Hypoxanthine,C5H4N4O,68-94-0,C00262,FDB003949,DB04076,DBMET00493,HYPOXANTHINE,790,768,OC1=NC=NC2=C1NC=N2,83,Organic compounds,Hypoxanthines,Organoheterocyclic compounds,Imidazopyrimidines,Purines and purine derivatives,Aromatic heteropolycyclic compounds,-1.11,3072,T3D4150,Endogenous,-1.11,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,136.03851077,7H-purin-6-ol,Hypoxanthine,C5H4N4O,68-94-0,HMDB00157,DB04076,C00262,HYPOXANTHINE,790,768,OC1=NC=NC2=C1N=CN2,Organic compounds,Hypoxanthines,Organoheterocyclic compounds,Imidazopyrimidines,Purines and purine derivatives,Aromatic heteropolycyclic compounds,3950,11935,SmallMoleculeCompound,FDB003949,Hypoxanthine,TRUE,Solid,low,Occurs widely in plant and animal tissue (CCD),68-94-0,Mp 360å¡,NA,NA,0.7 mg/mL at 23 oC,-1.11,NA,NA,NA,C00262,790,NA,17368,HPA,NA,NA,NA,Hypoxanthine,NA,NA,Many alternative tautomeric forms possible,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:06:01 UTC,2015-10-09 22:28:47 UTC,NA,BVX59-I:BVX59-I,HMDB00157,HYPOXANTHINE|HYPOXANTHIN,DB04076,34434,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 44.12%; H 2.96%; N 41.16%; O 11.75%,CCD,Needles,CCD,NA,NA,NA,NA,p Ka11.91 ( 20å¡ ) p Ka28.96 ( 20å¡ ) p Ka312.18 ( 20å¡ ),CCD,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,CCD,-1.11,-0.92,-1.81,O=C1NC=NC2=C1N=CN2,10.27,C5H4N4O,136.1115,"InChI=1S/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)",136.0385108,InChIKey=FDGQSTZJBFJUBT-UHFFFAOYSA-N,2.09e+00 g/l,41709,"6,9-dihydro-1H-purin-6-one",MANUAL,NA,NA,NA,DUKE,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Imidazopyrimidines,Purines and purine derivatives,Hypoxanthines,Aromatic heteropolycyclic compounds,CHEMBL1427,768,HYPOXANTHINE,TRUE,NA,DB04076,EXPT01767,Hypoxanthine,68-94-0,2TN51YD919,NA,FDGQSTZJBFJUBT-UHFFFAOYSA-N
FERIUCNNQQJTOY-UHFFFAOYSA-N,28,HMDB0000039,88.0524295,butanoic acid,Butyric acid,C4H8O2,107-92-6,C00246,FDB012062,DB03568,NA,NA,264,259,CCCC(O)=O,107,Organic compounds,Straight chain fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,0.79,3345,T3D4592,Endogenous,0.79,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,88.0524295,butanoic acid,Butyric acid,C4H8O2,107-92-6,HMDB00039,DB03568,C00246,NA,264,259,CCCC(O)=O,Chemical entities,Straight chain fatty acids,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Aliphatic acyclic compounds,12065,31046,SmallMoleculeCompound,FDB012062,Butanoic acid,TRUE,Liquid,low,"Found in fresh and cooked apples, banana, sour cherry, papaya, strawberries, wheat bread, cheeses, butter and coffee. Flavouring agentButyric acid (from Greek ???????? = butter), also known under the systematic name butanoic acid, is a carboxylic acid with the structural formula CH3CH2CH2-COOH. Salts and esters of butyric acid are known as butyrates or butanoates. Butyric acid is found in rancid butter, parmesan cheese, vomit, and body odor and has an unpleasant smell and acrid taste, with a sweetish aftertaste (similar to ether). It can be detected by mammals with good scent detection abilities (such as dogs) at 10 ppb, whereas humans can detect it in concentrations above 10 ppm.; Butyric acid is a fatty acid occurring in the form of esters in animal fats and plant oils. The triglyceride of butyric acid makes up 3% to 4% of butter. When butter goes rancid, butyric acid is liberated from the glyceride by hydrolysis leading to the unpleasant odor. It is an important member of the fatty acid sub-group called short chain fatty acids. Butyric acid is a weak acid with a pKa of 4.82, similar to acetic acid which has pKa 4.76. The similar strength of these acids results from their common -CH2COOH terminal structure. Pure butyric acid is 10.9 molar.; Butyric acid, a four-carbon fatty acid, is formed in the human colon by bacterial fermentation of carbohydrates (including dietary fiber), and putatively suppresses colorectal cancer (CRC).  Butyrate has diverse and apparently paradoxical effects on cellular proliferation, apoptosis and differentiation that may be either pro-neoplastic or anti-neoplastic, depending upon factors such as the level of exposure, availability of other metabolic substrate and the intracellular milieu.  In humans, the relationship between luminal butyrate exposure and CRC has been examined only indirectly in case-control studies, by measuring fecal butyrate concentrations, although this may not accurately reflect effective butyrate exposure during carcinogenesis.  Perhaps not surprisingly, results of these investigations have been mutually contradictory.  The direct effect of butyrate on tumorigenesis has been assessed in a no. of in vivo animal models, which have also yielded conflicting results.  In part, this may be explained by methodology: differences in the amount and route of butyrate administration, which are likely to significantly influence delivery of butyrate to the distal colon.  (PMID: 16460475) Butyric acid is a carboxylic acid found in rancid butter, parmesan cheese, and vomit, and has an unpleasant odor and acrid taste, with a sweetish aftertaste (similar to ether). Butyric acid is a fatty acid occurring in the form of esters in animal fats and plant oils. Interestingly, low-molecular-weight esters of butyric acid, such as methyl butyrate, have mostly pleasant aromas or tastes. As a consequence, they find use as food and perfume additives. Butyrate is produced as end-product of a fermentation process solely performed by obligate anaerobic bacteria.; The acid is an oily colorless liquid that is easily soluble in water, ethanol, and ether, and can be separated from an aqueous phase by saturation with salts such as calcium chloride. Potassium dichromate and sulfuric acid oxidize it to carbon dioxide and acetic acid, while alkaline potassium permanganate oxidizes it to carbon dioxide. The calcium salt, Ca(C4H7O2)2åáH2O, is less soluble in hot water than in cold.",107-92-6,Mp -8å¡,NA,NA,60 mg/mL at 25 oC,0.79,NA,NA,NA,C00246,264,NA,30772,BUA,NA,NA,NA,Butyric acid,NA,NA,NA,NA,NA,NA,NA,HMDB00039.pdf,application/pdf,49490,2015-02-28 17:51:55 UTC,NA,NA,2010-04-08 22:09:58 UTC,2015-10-09 22:27:23 UTC,NA,HCX15-D:HCX15-D,HMDB00039,1-BUTYRIC-ACID|BUTYRIC-ACID|BUTANOIC-ACID|N-BUTYRIC-ACID,DB03568,34376,438,C00001180,Bp 163.5å¡,DFC,NA,NA,d204<vs=1> 0.96,DFC,NA,NA,C 54.53%; H 9.15%; O 36.32%,DFC,NA,NA,NA,NA,NA,NA,pKa 4.82 (25å¡),DFC,"HEMPHILL,L & SWANSON,WS (1964)","HANSCH,C ET AL. (1995)",NA,NA,DFC,0.78,0.92,0.43,CCCC(O)=O,NA,C4H8O2,88.1051,"InChI=1S/C4H8O2/c1-2-3-4(5)6/h2-3H2,1H3,(H,5,6)",88.0524295,InChIKey=FERIUCNNQQJTOY-UHFFFAOYSA-N,2.39e+02 g/l,38655,butanoic acid,DFC,NA,NA,"Butanoic acid, 9CI",DFC,107-92-6,rw1003411,264,NA,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Straight chain fatty acids,Aliphatic acyclic compounds,CHEMBL14227,259,NA,TRUE,NA,DB03568,EXPT00774,Butyric Acid,107-92-6,40UIR9Q29H,1-propanecarboxylic acid | Butanoic acid | Butyrate | Butyricum acidum | Ethylacetic acid | N-butanoic acid | N-butyric acid | Propylformic acid,FERIUCNNQQJTOY-UHFFFAOYSA-N
FFEARJCKVFRZRR-BYPYZUCNSA-N,546,HMDB0000696,149.051049291,(2S)-2-amino-4-(methylsulfanyl)butanoic acid,L-Methionine,C5H11NO2S,63-68-3,C00073,FDB012683,DB00134,DBMET00506,MET,6137,5907,CSCC[C@H](N)C(O)=O,5664,Organic compounds,Methionine and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,-1.87,3188,T3D4328,Endogenous,-1.87,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,149.051049291,(2S)-2-amino-4-(methylsulfanyl)butanoic acid,L-Methionine,C5H11NO2S,63-68-3,HMDB00696,DB00134,C01733,MET,6137,5907,[H][C@](N)(CCSC)C(O)=O,Chemical entities,Methionine and derivatives,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Aliphatic acyclic compounds,12686,33262,SmallMoleculeCompound,FDB012683,L-Methionine,TRUE,Solid,low,"Dietary supplement and nutrientMethionine is an alpha-amino acid with the chemical formula HO2CCH(NH2)CH2CH2SCH3. This essential amino acid is classified as nonpolar. (Wikipedia)",63-68-3,Mp 283å¡ dec.,NA,NA,56.6 mg/mL at 25 oC,-1.87,NA,NA,NA,C00073,6137,NA,16643,MET,NA,NA,NA,Methionine,NA,NA,NA,NA,NA,NA,NA,HMDB00696.pdf,application/pdf,49100,2015-02-28 17:55:10 UTC,NA,2,2010-04-08 22:10:18 UTC,2015-10-09 22:27:14 UTC,NA,HJR27-B:HJR24-Y,HMDB00696,METHIONINE,DB00134,33753,2198,C00001379,NA,NA,NA,NA,NA,NA,[a]25D -14.9 (H2O); [a]D +34.6 (5M HCl),DFC,C 40.25%; H 7.43%; N 9.39%; O 21.44%; S 21.49%,DFC,NA,NA,NA,NA,NA,NA,"pKa2 9.2 (20å¡, 0.15M NaClO4)",DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,-1.85,-2.33,-0.8,CSCC[C@H](N)C(O)=O,NA,C5H11NO2S,149.211,"InChI=1S/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1",149.0510493,InChIKey=FFEARJCKVFRZRR-BYPYZUCNSA-N,2.39e+01 g/l,32965,(2S)-2-amino-4-(methylsulfanyl)butanoic acid,MANUAL,NA,NA,"Methionine, 9CI, INN; (S)-form",DFC,NA,NA,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",L-alpha-amino acids,Aliphatic acyclic compounds,CHEMBL42336,5907,MET,TRUE,NA,DB00134,NUTR00038,Methionine,63-68-3,AE28F7PNPL,(2S)-2-amino-4-(methylsulfanyl)butanoic acid | (S)-2-amino-4-(methylthio)butanoic acid | (S)-2-amino-4-(methylthio)butyric acid | (S)-methionine | L-(â)-methionine | L-a-Amino-g-methylthiobutyric acid | L-Methionin | L-Methionine | L-Î±-amino-Î³-methylmercaptobutyric acid | M | Met,FFEARJCKVFRZRR-BYPYZUCNSA-N
FPIPGXGPPPQFEQ-OVSJKPMPSA-N,209,HMDB0000305,286.229665582,"(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol",Vitamin A,C20H30O,68-26-8,C00473,FDB013828,NA,NA,RETINOL,445354,393012,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,NA,Organic compounds,Retinoids,Lipids and lipid-like molecules,Prenol lipids,Retinoids,Aliphatic homomonocyclic compounds,5.68,2184,T3D2699,Endogenous,5.68,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,286.229665582,"(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol",Vitamin A,C20H30O,68-26-8,HMDB00305,DB00162,C00473,RETINOL,445354,393012,[H]\C(CO)=C(\C)/C(/[H])=C(\[H])/C(/[H])=C(\C)/C(/[H])=C(\[H])C1=C(C)CCCC1(C)C,Organic compounds,Retinoids,Lipids and lipid-like molecules,Prenol lipids,Retinoids,Aliphatic homomonocyclic compounds,24003,NA,SmallMoleculeCompound,FDB023840,11-cis-Retinol,TRUE,Solid,low,"Cis-11-retinol is produce from vitamin A cycle  driven by interphotoreceptor retinoid binding protein(IRBP). cis-11-retinol is released from retinal pigment epithelium(RPE) membranes. (PMID: 10655150)  Retinoid metabolism of RPE cells freshly isolated by trypsinization showed no 11- cis -retinal and little 11- cis -retinol formation. Nondamaged cells cultured on thermally responsive surfaces detached in sheets upon temperature change. They showed metabolism similar to that of cells freshly isolated by nonenzymatic means. After trypsinization, confluent cultures dissociated into individual cells, but these cells showed poor retinoid metabolism, including no detectable retinyl esters or 11- cis -retinoid isomers. (PMID: 10375454) [HMDB]",22737-96-8,NA,NA,NA,NA,NA,NA,NA,NA,C00899,5280382,NA,16302,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2011-09-21 00:35:36 UTC,2015-07-21 06:57:54 UTC,NA,NA,HMDB06216,NA,NA,2265508,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6.38,4.694093173,-4.58,[H]OC([H])([H])C([H])=C(C([H])=C([H])C([H])=C(C([H])=C([H])C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H],NA,C20H30O,286.4516,"InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13+",286.2296656,InChIKey=FPIPGXGPPPQFEQ-OVSJKPMPSA-N,7.58e-03 g/l,84310,"3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Lipids and lipid-like molecules,Prenol lipids,Retinoids,Retinoids,Aliphatic homomonocyclic compounds,NA,4444073,CPD-882,NA,NA,DB00162,NUTR00007 | APRD00486,Vitamin A,68-26-8,G2SH0XKK91,"(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol | all-trans-retinol | all-trans-retinyl alcohol | all-trans-vitamin A alcohol | Retinol | Vitamin A1",FPIPGXGPPPQFEQ-OVSJKPMPSA-N
FSYKKLYZXJSNPZ-UHFFFAOYSA-N,185,HMDB0000271,89.047678473,2-(methylamino)acetic acid,Sarcosine,C3H7NO2,107-97-1,C00213,FDB021925,NA,NA,SARCOSINE,1088,1057,CNCC(O)=O,51,Organic compounds,Alpha amino acids,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,-2.78,3234,T3D4458,Endogenous,-2.78,Not listed by IARC. Has been implicated in oncogenesis (A15089).,NA,SmallMolecule,89.047678473,2-(methylamino)acetic acid,Sarcosine,C3H7NO2,107-97-1,HMDB00271,NA,C00213,SARCOSINE,1088,1057,CNCC(O)=O,Organic compounds,Alpha amino acids,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,4049,12135,SmallMoleculeCompound,FDB004048,Sarkosin,TRUE,NA,low,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:06:04 UTC,2015-07-20 21:58:40 UTC,NA,HCM00-S:HCM00-S,NA,SARKOSIN,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-3.06,-3.1863,0.54,CNCC(O)=O,NA,C3H7NO2,89.0932,"InChI=1S/C3H7NO2/c1-4-2-3(5)6/h4H,2H2,1H3,(H,5,6)",89.0477,InChIKey=FSYKKLYZXJSNPZ-UHFFFAOYSA-N,3.08e+02 g/l,80927,2-(methylamino)acetic acid,DFC,NA,NA,NA,DUKE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB12519,NA,Sarcosine,107-97-1,Z711V88R5F,NA,FSYKKLYZXJSNPZ-UHFFFAOYSA-N
GHMLBKRAJCXXBS-UHFFFAOYSA-N,13090,HMDB0032037,110.036779436,"benzene-1,3-diol","1,3-Benzenediol",C6H6O2,108-46-3,C01751,FDB008738,NA,NA,NA,5054,4878,OC1=CC(O)=CC=C1,NA,Organic compounds,Resorcinols,Benzenoids,Benzene and substituted derivatives,Phenols and derivatives,Aromatic homomonocyclic compounds,0.8,3336,T3D4580,Exogenous,0.8,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,110.036779436,"benzene-1,3-diol","1,3-Benzenediol",C6H6O2,108-46-3,HMDB32037,NA,C01751,NA,5054,4878,OC1=CC(O)=CC=C1,Organic compounds,Resorcinols,Benzenoids,Benzene and substituted derivatives,Phenols and derivatives,Aromatic homomonocyclic compounds,8739,21696,SmallMoleculeCompound,FDB008738,"1,3-Benzenediol",TRUE,NA,low,"Present in roasted barley, cane molasses, coffee, beer and wine. Flavouring ingredient",108-46-3,Mp 111å¡,NA,NA,717 mg/mL at 25 oC,0.8,NA,NA,NA,C01751,5054,NA,27810,RCO,NA,NA,NA,"1,3-Benzenediol",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:08:13 UTC,2015-07-20 22:25:29 UTC,663,DVK64-P:DVK64-P,HMDB32037,NA,NA,NA,3289,C00002671,Bp 280å¡,DFC,NA,NA,NA,NA,NA,NA,C 65.45%; H 5.49%; O 29.06%,DFC,NA,NA,NA,NA,NA,NA,pKa2 11.06 (20å¡),DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,0.7,1.37,-0.13,OC1=CC=CC(O)=C1,10.73,C6H6O2,110.1106,"InChI=1S/C6H6O2/c7-5-2-1-3-6(8)4-5/h1-4,7-8H",110.0367794,InChIKey=GHMLBKRAJCXXBS-UHFFFAOYSA-N,8.23e+01 g/l,37064,"benzene-1,3-diol",MANUAL,NA,NA,"1,3-Benzenediol, 9CI",DFC,NA,rw1009421,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenols and derivatives,Resorcinols,Aromatic homomonocyclic compounds,CHEMBL24147,4878,CPD-623,NA,NA,DB11085,NA,Resorcinol,108-46-3,YUL4LO94HK,"1,3-Benzenediol | 1,3-Dihydroxybenzene | 1,3-Dihydroxybenzol | m-Hydroquinone | m-hydroxyphenol | Resorzin",GHMLBKRAJCXXBS-UHFFFAOYSA-N
GHVNFZFCNZKVNT-UHFFFAOYSA-N,390,HMDB0000511,172.146329884,decanoic acid,Capric acid,C10H20O2,334-48-5,C01571,FDB012027,DB03600,NA,3-OXODODECANOATE,2969,2863,CCCCCCCCCC(O)=O,336,Organic compounds,Medium-chain fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,4.09,3460,T3D4773,Endogenous,4.09,No indication of carcinogenicity (not listed by IARC). (L135),NA,SmallMolecule,172.146329884,decanoic acid,Capric acid,C10H20O2,334-48-5,HMDB00511,DB03600,C01571,3-OXODODECANOATE,2969,2863,CCCCCCCCCC(O)=O,Organic compounds,Medium-chain fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,12030,30906,SmallMoleculeCompound,FDB012027,Decanoic acid,TRUE,Solid,low,"Widespread in plant oils and as glycerides in seed oils. Also present in apple, apricot, banana, morello cherry, citrus fruits, cheese, butter, white wine, Japanese whiskey, peated malt, wort and scallops. Used as a defoamer, lubricant and citrus fruit coating. Salts (Na, K, Mg, Ca, Al) used as binders, emulsifiers and anticaking agents in food manuf.",334-48-5,Mp 31.5å¡,NA,NA,0.0618 mg/mL at 25 oC,4.09,NA,NA,NA,C01571,2969,NA,30813,DKA,NA,NA,NA,Decanoic acid,NA,NA,NA,NA,NA,NA,NA,HMDB00511.pdf,application/pdf,14805,2015-02-28 18:12:28 UTC,NA,2,2010-04-08 22:09:57 UTC,2015-10-09 22:28:30 UTC,NA,HCQ58-J:HCQ58-J,HMDB00511,N-CAPRIC-ACID|CAPRIC-ACID|DECANOIC-ACID|CAPRINIC-ACID,DB03600,NA,834,C00001213,Bp11 148-150å¡,DFC,NA,NA,d440 0.89,DFC,NA,NA,C 69.72%; H 11.70%; O 18.58%,DFC,NA,NA,n40D<vs=1>  1.4288,DFC,NA,NA,4.9,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,3.93,3.59,-3.26,CCCCCCCCCC(O)=O,NA,C10H20O2,172.2646,"InChI=1S/C10H20O2/c1-2-3-4-5-6-7-8-9-10(11)12/h2-9H2,1H3,(H,11,12)",172.1463299,InChIKey=GHVNFZFCNZKVNT-UHFFFAOYSA-N,9.46e-02 g/l,35049,decanoic acid,MANUAL,NA,NA,Decanoic acid,DFC,334-48-5,rw1007741,NA,NA,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Medium-chain fatty acids,Aliphatic acyclic compounds,CHEMBL107498,2863,3-OXODODECANOATE,TRUE,NA,DB03600,EXPT01213 | DB03838,Capric acid,334-48-5,4G9EDB6V73,1-nonanecarboxylic acid | Decanoic acid | N-capric acid | N-decanoic acid,GHVNFZFCNZKVNT-UHFFFAOYSA-N
GLZPCOQZEFWAFX-JXMROGBWSA-N,15990,HMDB0035155,154.1357652,"(2E)-3,7-dimethylocta-2,6-dien-1-ol",beta-Geraniol,C10H18O,106-24-1,C01500,FDB013792,NA,NA,NA,637566,13849989,CC(C)=CCC\C(C)=C\CO,NA,Organic compounds,Acyclic monoterpenoids,Lipids and lipid-like molecules,Prenol lipids,Monoterpenoids,Aliphatic acyclic compounds,3.56,3522,T3D4838,Exogenous,3.56,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,154.135765198,"(2E)-3,7-dimethylocta-2,6-dien-1-ol",beta-Geraniol,C10H18O,106-24-1,HMDB35155,NA,C01500,NA,637566,13849989,[H]\C(CO)=C(\C)CCC=C(C)C,Organic compounds,Acyclic monoterpenoids,Lipids and lipid-like molecules,Prenol lipids,Monoterpenoids,Aliphatic acyclic compounds,13795,36581,SmallMoleculeCompound,FDB013792,Geraniol,TRUE,Liquid,low,"Found in free state and as esters in many essential oils including geranium oil. Most prolific natural source is palmarosa oil. Flavouring agentGeraniol is a monoterpenoid and an alcohol. It is the primary part of rose oil, palmarosa oil, and citronella oil (Java type). It also occurs in small quantities in geranium, lemon, and many other essential oils. It has a rose-like odor and is commonly used in perfumes. It is used in flavors such as peach, raspberry, grapefruit, red apple, plum, lime, orange, lemon, watermelon, pineapple, and blueberry. It is the isomer of nerol. (Wikipedia)",106-24-1,<-15 oC,NA,NA,0.1 mg/mL at 25 oC,3.56,NA,NA,NA,C01500,637566,NA,17447,NA,NA,NA,NA,Geraniol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:10:54 UTC,2015-10-09 22:33:30 UTC,NA,JVC33-F:JHG09-C,HMDB35155,GERANIOL,NA,NA,1460,C00000845,Bp 230å¡,DFC,NA,NA,NA,NA,NA,NA,C 77.87%; H 11.76%; O 10.37%,DFC,NA,NA,n30D<vs=1>  1.4777,DFC,[neutral] lmax 195 (e 19000) (MeOH) (Berdy),DFC,NA,NA,CHEMICALS INSPECTION AND TESTING INSTITU (1992),"GRIFFIN,S ET AL. (1999)",NA,NA,NA,2.89,2.5,-2.05,CC(C)=CCC\C(C)=C\CO,NA,C10H18O,154.2493,"InChI=1S/C10H18O/c1-9(2)5-4-6-10(3)7-8-11/h5,7,11H,4,6,8H2,1-3H3/b10-7+",154.1357652,InChIKey=GLZPCOQZEFWAFX-JXMROGBWSA-N,1.37e+00 g/l,36586,"(2E)-3,7-dimethylocta-2,6-dien-1-ol",MANUAL,NA,NA,"3,7-Dimethyl-2,6-octadien-1-ol; (E)-form",DFC,106-24-1,rw1006991,NA,NA,Organic compounds,Lipids and lipid-like molecules,Prenol lipids,Monoterpenoids,Acyclic monoterpenoids,Aliphatic acyclic compounds,CHEMBL25719,13849989,GERANIOL,TRUE,NA,DB14183,NA,Geraniol,106-24-1,NA,"(2E)-3,7-dimethylocta-2,6-dien-1-ol | (E)-3,7-Dimethyl-2,6-octadien-1-ol | (E)-Geraniol | (E)-Nerol | 2-trans-3,7-Dimethyl-2,6-octadien-1-ol | 2,6-Octadien-1-ol, 3,7-dimethyl-, (E)- | 2,6-Octadien-1-ol, 3,7-dimethyl-, trans- | 3,7-Dimethyl-2,6-octadien-1-ol, (E)- | 3,7-Dimethyl-trans-2,6-octadien-1-ol | geranyl alcohol | Lemonol | t-geraniol",GLZPCOQZEFWAFX-JXMROGBWSA-N
GSDSWSVVBLHKDQ-JTQLQIEISA-N,1283,HMDB0001929,361.143784348,"(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0\xe2\x81\xb5,\xc2\xb9\xc2\xb3]trideca-5(13),6,8,11-tetraene-11-carboxylic acid",Levofloxacin,C18H20FN3O4,100986-85-4,C07660,FDB022746,NA,NA,NA,149096,131410,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1,NA,Organic compounds,Quinoline carboxylic acids,Organoheterocyclic compounds,Quinolines and derivatives,Quinoline carboxylic acids,Aromatic heteropolycyclic compounds,NA,2009,T3D2478,Exogenous,2.1,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,361.143784348,"(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0\xe2\x81\xb5,\xc2\xb9\xc2\xb3]trideca-5(13),6,8,11-tetraene-11-carboxylic acid",Levofloxacin,C18H20FN3O4,100986-85-4,HMDB01929,DB01137,C07660,NA,149096,131410,[H][C@]1(C)COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1,Organic compounds,Quinoline carboxylic acids,Organoheterocyclic compounds,Quinolines and derivatives,Quinoline carboxylic acids,Aromatic heteropolycyclic compounds,22909,NA,SmallMoleculeCompound,FDB022746,Levofloxacin,TRUE,Solid,low,"Levofloxacin is a synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.  Levofloxacin is marketed by Ortho-McNeil under the trade name Levaquin. Chemically, levofloxacin is the S-enantiomer (L-isomer) of ofloxacin. -- Wikipedia [HMDB]",100986-85-4,NA,NA,NA,NA,NA,NA,NA,NA,C07660,149096,NA,NA,LFX,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HMDB01929.pdf,application/pdf,145798,2015-02-28 18:10:53 UTC,NA,NA,2011-09-21 00:18:59 UTC,2015-10-09 22:31:19 UTC,NA,NA,HMDB01929,NA,DB01137,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.02,0.654279753,-2.4,[H]OC(=O)C1=C([H])N2C3=C(C([H])=C(F)C(N4C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C4([H])[H])=C3OC([H])([H])[C@]2([H])C([H])([H])[H])C1=O,NA,C18H20FN3O4,361.3675,"InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)/t10-/m0/s1",361.1437843,InChIKey=GSDSWSVVBLHKDQ-JTQLQIEISA-N,1.44e+00 g/l,85908,"(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0^{5,13}]trideca-5(13),6,8,11-tetraene-11-carboxylic acid",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Quinolines and derivatives,Quinoline carboxylic acids,Quinoline carboxylic acids,Aromatic heteropolycyclic compounds,CHEMBL33,131410,NA,TRUE,NA,DB01137,APRD00477 | DB06085,Levofloxacin,100986-85-4,RIX4E89Y14,"(-)-Ofloxacin | (3S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid | (S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid | (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid | (S)-Ofloxacin | L-Ofloxacin | Levofloxacin anhydrous | Levofloxacine | Levofloxacino | Levofloxacinum | Ofloxacin S-(-)-form",GSDSWSVVBLHKDQ-JTQLQIEISA-N
GSEJCLTVZPLZKY-UHFFFAOYSA-N,13503,HMDB0032538,149.105193351,2-[bis(2-hydroxyethyl)amino]ethan-1-ol,Triethanolamine,C6H15NO3,102-71-6,C06771,FDB010410,NA,NA,NA,7618,13835630,OCCN(CCO)CCO,NA,Organic compounds,"1,2-aminoalcohols",Organonitrogen compounds,Amines,Alkanolamines,Aliphatic acyclic compounds,-1,3519,T3D4835,Exogenous,-1,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,149.105193351,2-[bis(2-hydroxyethyl)amino]ethan-1-ol,Triethanolamine,C6H15NO3,102-71-6,HMDB32538,NA,C06771,NA,7618,13835630,OCCN(CCO)CCO,Organic compounds,"1,2-aminoalcohols",Organonitrogen compounds,Amines,Alkanolamines,Aliphatic acyclic compounds,10412,25665,SmallMoleculeCompound,FDB010410,Triethanolamine,TRUE,Liquid,low,Used as a food additive [EAFUS],102-71-6,20.5 oC,NA,NA,1000 mg/mL,-1,NA,NA,NA,C06771,7618,NA,28621,211,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HMDB32538.pdf,application/pdf,51022,2015-02-28 17:50:52 UTC,NA,NA,2010-04-08 22:09:07 UTC,2015-07-20 22:32:32 UTC,NA,NA,HMDB32538,NA,NA,NA,3730,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7.76,NA,"RIDDICK,JA et al. (1986)","HANSCH,C ET AL. (1995)",NA,NA,NA,-1.38,-1.88013657,0.52,OCCN(CCO)CCO,15.59248844,C6H15NO3,149.1882,"InChI=1S/C6H15NO3/c8-4-1-7(2-5-9)3-6-10/h8-10H,1-6H2",149.1051934,InChIKey=GSEJCLTVZPLZKY-UHFFFAOYSA-N,4.97e+02 g/l,39692,2-[bis(2-hydroxyethyl)amino]ethan-1-ol,HMDB_from_biospider,NA,NA,NA,EAFUS,NA,NA,NA,NA,Organic compounds,Organonitrogen compounds,Amines,Alkanolamines,"1,2-aminoalcohols",Aliphatic acyclic compounds,CHEMBL446061,13835630,NA,NA,NA,DB13747,NA,Trolamine,102-71-6,9O3K93S3TK,"2,2',2''-nitrilotris(ethanol) | nitrilo-2,2',2''-triethanol | nitrilotriethanol | triethanolamine | tris(2-hydroxyethyl)amine | tris(Î²-hydroxyethyl)amine",GSEJCLTVZPLZKY-UHFFFAOYSA-N
GVJHHUAWPYXKBD-IEOSBIPESA-N,1257,HMDB0001893,430.381080844,"(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-1-benzopyran-6-ol",alpha-Tocopherol,C29H50O2,59-02-9,C02477,FDB000565,DB00163,NA,CPD-1125,14985,14265,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(O)=C(C)C(C)=C2O1,6376,Organic compounds,Tocopherols,Lipids and lipid-like molecules,Prenol lipids,Quinone and hydroquinone lipids,Aromatic heteropolycyclic compounds,NA,2185,T3D2700,Endogenous,10,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,430.381080844,"(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-1-benzopyran-6-ol",Alpha-Tocopherol,C29H50O2,59-02-9,HMDB01893,DB00163,C02477,CPD-1125,14985,14265,[H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@]1(C)CCC2=C(C)C(O)=C(C)C(C)=C2O1,Organic compounds,Tocopherols,Lipids and lipid-like molecules,Prenol lipids,Quinone and hydroquinone lipids,Aromatic heteropolycyclic compounds,565,1485,SmallMoleculeCompound,FDB000565,alpha-Tocopherol,TRUE,Liquid,low,"Constit. of many vegetable oils such as soya and sunflower oils. Dietary supplement and nutrient. Nutriceutical with anticancer and antioxidant props. Added to fats and oils to prevent rancidity. The naturally-occurring tocopherol is a single stereoisomer; synthetic forms are a mixt. of all eight possible isomersAlpha-tocopherol is traditionally recognized as the most active form of vitamin E in humans, and is a powerful biological antioxidant.",1959-02-09,Mp 2.5-3.5å¡,NA,NA,NA,NA,NA,NA,NA,C02477,14985,NA,NA,VIV,NA,NA,NA,Alpha-Tocopherol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:04:37 UTC,2015-10-09 22:31:09 UTC,NA,BDR14-R:BDR14-R,HMDB01893,ALPHA-TOCOPHEROL,DB00163,2296507,NA,C00007366,Bp0.03 140å¡,DFC,NA,NA,NA,NA,[a]25D +0.65 (EtOH),DFC,C 80.87%; H 11.70%; O 7.43%,DFC,NA,NA,NA,NA,[neutral] lmax 292 () (EtOH) (Berdy),DFC,NA,NA,NA,NA,NA,NA,DFC,8.84,10.51,-7.79,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(O)=C(C)C(C)=C2O1,NA,C29H50O2,430.7061,"InChI=1S/C29H50O2/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8)19-17-26-25(7)27(30)23(5)24(6)28(26)31-29/h20-22,30H,9-19H2,1-8H3/t21-,22-,29-/m1/s1",430.3810808,InChIKey=GVJHHUAWPYXKBD-IEOSBIPESA-N,7.04e-06 g/l,31918,"(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-1-benzopyran-6-ol",MANUAL,NA,NA,a-Tocopherol,DFC,NA,NA,NA,NA,Organic compounds,Lipids and lipid-like molecules,Prenol lipids,Quinone and hydroquinone lipids,Tocopherols,Aromatic heteropolycyclic compounds,CHEMBL47,14265,CPD-1125,TRUE,NA,DB00163,NUTR00061 | EXPT03227,Vitamin E,59-02-9,N9PR3490H9,"(+)-Î±-tocopherol | (2R,4'R,8'R)-Î±-tocopherol | (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL | (R,R,R)-Î±-tocopherol | 5,7,8-trimethyltocol | alpha-tocopherol | d-Î±-tocopherol",GVJHHUAWPYXKBD-IEOSBIPESA-N
HCAJQHYUCKICQH-VPENINKCSA-N,1833,HMDB0003333,283.091668551,"2-amino-8-hydroxy-9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one",8-Hydroxy-deoxyguanosine,C10H13N5O5,88847-89-6,NA,FDB023145,NA,NA,NA,73318,66049,NC1=NC2=C(N=C(O)N2[C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)N1,6890,Organic compounds,Purine 2'-deoxyribonucleosides,"Nucleosides, nucleotides, and analogues",Purine nucleosides,Purine 2'-deoxyribonucleosides,Aromatic heteropolycyclic compounds,NA,3096,T3D4175,Endogenous,NA,Not listed by IARC.,NA,SmallMolecule,283.091668551,"2-amino-8-hydroxy-9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one",8-Hydroxy-deoxyguanosine,C10H13N5O5,88847-89-6,HMDB03333,DB02502,NA,NA,73318,66049,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])CO)N1C(O)=NC2=C1NC(=N)N=C2O,Chemical entities,Purine 2'-deoxyribonucleosides,Organic compounds,"Nucleosides, nucleotides, and analogues",Purine nucleosides,Aromatic heteropolycyclic compounds,23308,NA,SmallMoleculeCompound,FDB023145,8-Hydroxy-deoxyguanosine,TRUE,Solid,low,"8-hydroxy-deoxyguanosine (8-OHdG) is a sensitive marker of the DNA damage due to hydroxyl radical attack at the C8 of guanine. This damage, if left unrepaired, has been proposed to contribute to mutagenicity and cancer promotion. [HMDB]",88847-89-6,NA,NA,NA,NA,NA,NA,NA,NA,NA,73318,NA,NA,8HG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HMDB03333.pdf,application/pdf,140878,2015-02-28 17:51:13 UTC,NA,NA,2011-09-21 00:25:19 UTC,2015-07-21 06:57:32 UTC,NA,NA,HMDB03333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-1.71,-1.42489545,-1.28,[H]OC1=NC2=C(N=C(N([H])[H])N([H])C2=O)N1[C@]1([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])C1([H])[H],12.30039046,C10H13N5O5,283.2407,"InChI=1S/C10H13N5O5/c11-9-13-7-6(8(18)14-9)12-10(19)15(7)5-1-3(17)4(2-16)20-5/h3-5,16-17H,1-2H2,(H,12,19)(H3,11,13,14,18)/t3-,4+,5+/m0/s1",283.0916686,InChIKey=HCAJQHYUCKICQH-VPENINKCSA-N,1.48e+01 g/l,87018,"2-amino-8-hydroxy-9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,"Nucleosides, nucleotides, and analogues",Purine nucleosides,Purine 3'-deoxyribonucleosides,Purine 3'-deoxyribonucleosides,Aromatic heteropolycyclic compounds,CHEMBL1230628,66049,CPD-12381,NA,NA,DB02502,EXPT00333,8-Hydroxy-2'-Deoxyguanosine,88847-89-6,NA,NA,HCAJQHYUCKICQH-VPENINKCSA-N
HCZHHEIFKROPDY-UHFFFAOYSA-N,564,HMDB0000715,189.042593095,"4-oxo-1,4-dihydroquinoline-2-carboxylic acid",Kynurenic acid,C10H7NO3,492-27-3,C01717,FDB022200,NA,NA,NA,3845,3712,OC(=O)C1=CC(=O)C2=CC=CC=C2N1,5683,Organic compounds,Quinoline carboxylic acids,Organoheterocyclic compounds,Quinolines and derivatives,Quinoline carboxylic acids,Aromatic heteropolycyclic compounds,NA,3081,T3D4160,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,189.042593095,"4-oxo-1,4-dihydroquinoline-2-carboxylic acid",Kynurenic acid,C10H7NO3,492-27-3,HMDB00715,NA,C01717,NA,3845,3712,OC(=O)C1=CC(=O)C2=CC=CC=C2N1,Chemical entities,Quinoline carboxylic acids,Organic compounds,Organoheterocyclic compounds,Quinolines and derivatives,Aromatic heteropolycyclic compounds,22363,NA,SmallMoleculeCompound,FDB022200,Kynurenic acid,TRUE,Solid,low,"Kynurenic acid (KYNA) is a well-known endogenous antagonist of the glutamate ionotropic excitatory amino acid receptors N-methyl-D-aspartate (NMDA), alphaamino-3-hydroxy-5-methylisoxazole-4-propionic acid and kainate receptors and of the nicotine cholinergic subtype alpha 7 receptors.  KYNA neuroprotective and anticonvulsive activities have been demonstrated in animal models of neurodegenerative diseases. Because of KYNA's neuromodulatory character, its involvement has been speculatively linked to the pathogenesis of a number of neurological conditions including those in the ageing process. Different patterns of abnormalities in various stages of KYNA metabolism in the CNS have been reported in Alzheimer's disease, Parkinson's disease and Huntington's disease. In HIV-1-infected patients and in patients with Lyme neuroborreliosis a marked rise of KYNA metabolism was seen. In the ageing process KYNA metabolism in the CNS of rats shows a characteristic pattern of changes throughout the life span. A marked increase of the KYNA content in the CNS occurs before the birth, followed by a dramatic decline on the day of birth. A low activity was seen during ontogenesis, and a slow and progressive enhancement occurs during maturation and ageing. This remarkable profile of KYNA metabolism alterations in the mammalian brain has been suggested to result from the development of the organisation of neuronal connections and synaptic plasticity, development of receptor recognition sites, maturation and ageing. There is significant evidence that KYNA can improve cognition and memory, but it has also been demonstrated that it interferes with working memory. Impairment of cognitive function in various neurodegenerative disorders is accompanied by profound reduction and/or elevation of KYNA metabolism. The view that enhancement of CNS KYNA levels could underlie cognitive decline is supported by the increased KYNA metabolism in Alzheimer's disease, by the increased KYNA metabolism in down's syndrome and the enhancement of KYNA function during the early stage of Huntington's disease. Kynurenic acid is the only endogenous N-methyl-D-aspartate (NMDA) receptor antagonist identified up to now, that mediates glutamatergic hypofunction. Schizophrenia is a disorder of dopaminergic neurotransmission, but modulation of the dopaminergic system by glutamatergic neurotransmission seems to play a key role. Despite the NMDA receptor antagonism, kynurenic acid also blocks, in lower doses, the nicotinergic acetycholine receptor, i.e., increased kynurenic acid  levels can explain psychotic symptoms and cognitive deterioration. Kynurenic acid levels are described to be higher in the cerebrospinal fluid (CSF) and in critical central nervous system (CNS) regions of schizophrenics as compared to controls. (PMID: 17062375, 16088227) [HMDB]",492-27-3,NA,NA,NA,NA,NA,NA,NA,NA,C01717,3845,NA,18344,KYA,NA,NA,NA,Kynurenic acid,NA,NA,NA,NA,NA,NA,NA,HMDB00715.pdf,application/pdf,46230,2015-02-28 18:06:50 UTC,NA,NA,2011-09-21 00:09:59 UTC,2015-10-09 22:28:01 UTC,NA,NA,HMDB00715,NA,NA,38234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.16,1.577556451,-2.3,[H]OC(=O)C1=C([H])C(=O)C2=C([H])C([H])=C([H])C([H])=C2N1[H],11.43045148,C10H7NO3,189.1675,"InChI=1S/C10H7NO3/c12-9-5-8(10(13)14)11-7-4-2-1-3-6(7)9/h1-5H,(H,11,12)(H,13,14)",189.0425931,InChIKey=HCZHHEIFKROPDY-UHFFFAOYSA-N,9.54e-01 g/l,83167,"4-oxo-1,4-dihydroquinoline-2-carboxylic acid",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Quinolines and derivatives,Quinoline carboxylic acids,Quinoline carboxylic acids,Aromatic heteropolycyclic compounds,CHEMBL299155,3712,NA,TRUE,NA,DB11937,NA,Kynurenic Acid,492-27-3,H030S2S85J,NA,HCZHHEIFKROPDY-UHFFFAOYSA-N
HJJPJSXJAXAIPN-UHFFFAOYSA-N,11465,HMDB0030353,155.094628665,"methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate",Arecoline,C8H13NO2,63-75-2,C10129,FDB002198,DB04365,NA,NA,2230,13872064,COC(=O)C1=CCCN(C)C1,NA,Organic compounds,Alkaloids and derivatives,Alkaloids and derivatives,NA,NA,Aliphatic heteromonocyclic compounds,NA,3383,T3D4675,Exogenous,0.35,Not listed by IARC.,NA,SmallMolecule,155.094628665,"methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate",Arecoline,C8H13NO2,63-75-2,HMDB30353,DB04365,C10129,NA,2230,13872064,COC(=O)C1=CCCN(C)C1,Chemical entities,Alkaloids and derivatives,Organic compounds,Alkaloids and derivatives,NA,Aliphatic heteromonocyclic compounds,2198,7042,SmallMoleculeCompound,FDB002198,Arecoline,TRUE,NA,low,"Isol. from betel nutsArecoline is an alkaloid natural product found in the areca nut, the fruit of the areca palm (Areca catechu). It is an oily liquid that is soluble in water, alcohols, and ether.; Owing to its muscarinic and nicotinic agonist properties, arecoline has shown improvement in the learning ability of healthy volunteers. Since one of the hallmarks of Alzheimer's disease is a cognitive decline, arecoline was suggested as a treatment to slow down this process and arecoline administered via i.v. route did indeed show modest verbal and spatial memory improvement in Alzheimer's patients, though due to arecoline's possible carcinogenic properties, it is not the first drug of choice for this degenerative disease.",63-75-2,NA,NA,NA,NA,NA,NA,NA,NA,C10129,2230,NA,NA,NA,NA,NA,NA,Arecoline,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:05:16 UTC,2015-07-20 21:43:55 UTC,NA,CGW37-F:CGW39-H,HMDB30353,NA,DB04365,NA,NA,C00002020,Bp7 74å¡,DFC,NA,NA,NA,NA,NA,NA,C 61.91%; H 8.44%; N 9.03%; O 20.62%,DFC,NA,NA,NA,NA,NA,NA,pKa 7.64 (25å¡),DFC,NA,NA,NA,NA,NA,0.55,0.648802661,0.46,COC(=O)C1=CCCN(C)C1,NA,C8H13NO2,155.1943,"InChI=1S/C8H13NO2/c1-9-5-3-4-7(6-9)8(10)11-2/h4H,3,5-6H2,1-2H3",155.0946287,InChIKey=HJJPJSXJAXAIPN-UHFFFAOYSA-N,4.46e+02 g/l,32641,"methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate",HMDB_from_dfc,NA,NA,"1,2,5,6-Tetrahydro-1-methyl-3-pyridinecarboxylic acid, 9CI; Me ester",DFC,NA,NA,NA,NA,Organic compounds,Alkaloids and derivatives,NA,NA,Alkaloids and derivatives,Aliphatic heteromonocyclic compounds,CHEMBL7303,13872064,NA,NA,NA,DB04365,EXPT03296,Arecoline,63-75-2,4ALN5933BH,NA,HJJPJSXJAXAIPN-UHFFFAOYSA-N
HVPFXCBJHIIJGS-LURJTMIESA-N,1834,HMDB0003334,202.14297584,"(2S)-2-amino-5-[(E)-2,3-dimethylcarbamimidamido]pentanoic acid",Symmetric dimethylarginine,C8H18N4O2,30344-00-4,NA,FDB000509,DB02302,NA,NA,169148,147942,CN\C(NCCC[C@H](N)C(O)=O)=N/C,6891,Organic compounds,Arginine and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,NA,3097,T3D4176,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,202.14297584,"(2S)-2-amino-5-[(E)-2,3-dimethylcarbamimidamido]pentanoic acid",Symmetric dimethylarginine,C8H18N4O2,30344-00-4,HMDB03334,DB02302,NA,NA,169148,147942,[H][C@](N)(CCCNC(NC)=NC)C(O)=O,Chemical entities,Arginine and derivatives,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Aliphatic acyclic compounds,509,1260,SmallMoleculeCompound,FDB000509,"NG,N'G-Dimethyl-L-arginine",TRUE,Solid,low,"Isol. from broad bean (Vicia faba) seed proteinsSymmetric dimethylarginine (SDMA) is an endogenously produced inhibitor of nitric oxide synthase (EC-Number 1.14.13.39). However, elevated levels of SDMA occur in patients with vascular disease, especially suffering end-stage renal disease. (PMID 12401860)",30344-00-4,Mp 237-239å¡ (diflavianate),NA,NA,NA,NA,NA,NA,NA,NA,169148,NA,25682,2MR,NA,NA,NA,SDMA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:04:36 UTC,2015-07-20 21:31:58 UTC,NA,BCZ76-S:BCZ77-T,HMDB03334,NA,DB02302,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 47.51%; H 8.97%; N 27.70%; O 15.82%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DFC,-2.94,-3.85,-2.11,CN\C(NCCC[C@H](N)C(O)=O)=N/C,NA,C8H18N4O2,202.2541,"InChI=1S/C8H18N4O2/c1-10-8(11-2)12-5-3-4-6(9)7(13)14/h6H,3-5,9H2,1-2H3,(H,13,14)(H2,10,11,12)/t6-/m0/s1",202.1429758,InChIKey=HVPFXCBJHIIJGS-LURJTMIESA-N,1.56e+00 g/l,33421,"(2S)-2-amino-5-[(E)-2,1-dimethylcarbamimidamido]pentanoic acid",MANUAL,NA,NA,"NG,N'G-Dimethylarginine; (S)-form",DFC,NA,NA,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",D-alpha-amino acids,Aliphatic acyclic compounds,NA,147942,NA,NA,NA,DB02302,EXPT00132,"N3, N4-Dimethylarginine",NA,49787G1ULV,NA,HVPFXCBJHIIJGS-LURJTMIESA-N
HZAXFHJVJLSVMW-UHFFFAOYSA-N,96,HMDB0000149,61.052763851,2-aminoethan-1-ol,Ethanolamine,C2H7NO,141-43-5,C00189,FDB000769,DB03994,NA,ETHANOL-AMINE,700,13835336,NCCO,3207,Organic compounds,"1,2-aminoalcohols",Organic nitrogen compounds,Organonitrogen compounds,Amines,Aliphatic acyclic compounds,-1.31,3456,T3D4769,Endogenous,-1.31,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,61.052763851,2-aminoethan-1-ol,Ethanolamine,C2H7NO,141-43-5,HMDB00149,DB03994,C00189,ETHANOL-AMINE,700,13835336,NCCO,Organic compounds,"1,2-aminoalcohols",Organic nitrogen compounds,Organonitrogen compounds,Amines,Aliphatic acyclic compounds,769,2090,SmallMoleculeCompound,FDB000769,2-Aminoethanol,TRUE,Liquid,low,"Used in flume water for washing sugar beets prior to the slicing operationEthanolamine is a toxic, flammable, corrosive, colorless, viscous liquid with an odor similar to that of ammonia.",141-43-5,Mp 10.5å¡,NA,NA,1000 mg/mL,-1.31,NA,NA,NA,C00189,700,NA,16000,ETA,NA,NA,NA,Ethanolamine,NA,NA,NA,NA,NA,NA,NA,HMDB00149.pdf,application/pdf,204394,2015-02-28 17:51:35 UTC,NA,2,2010-04-08 22:04:42 UTC,2015-10-09 22:28:46 UTC,NA,BGX64-F:BGX64-F,HMDB00149,COLAMINE|ETHANOLAMINE,DB03994,34189,2596,C00007279,Bp 171å¡,DFC,NA,NA,d254<vs=1> 1.01,DFC,NA,NA,C 39.33%; H 11.55%; N 22.93%; O 26.19%,DFC,NA,NA,n20D<vs=1>  1.4539,DFC,NA,NA,pKa 9.47,DFC,"RIDDICK,JA et al. (1986)","HANSCH,C ET AL. (1995)",NA,NA,DFC,-1.53,-1.32,1.14,NCCO,NA,C2H7NO,61.0831,"InChI=1S/C2H7NO/c3-1-2-4/h4H,1-3H2",61.05276385,InChIKey=HZAXFHJVJLSVMW-UHFFFAOYSA-N,8.49e+02 g/l,33209,2-aminoethan-1-ol,MANUAL,NA,NA,"2-Aminoethanol, 9CI",DFC,NA,NA,NA,NA,Organic compounds,Organonitrogen compounds,Amines,Alkanolamines,"1,2-aminoalcohols",Aliphatic acyclic compounds,CHEMBL104943,13835336,ETHANOL-AMINE,TRUE,NA,DB03994,EXPT01366,Ethanolamine,141-43-5,5KV86114PT,NA,HZAXFHJVJLSVMW-UHFFFAOYSA-N
IAZDPXIOMUYVGZ-UHFFFAOYSA-N,1442,HMDB0002151,78.013935504,methanesulfinylmethane,Dimethyl sulfoxide,C2H6OS,67-68-5,C11143,FDB000764,DB01093,NA,NA,679,659,CS(C)=O,3985,Organic compounds,Sulfoxides,Organosulfur compounds,Sulfoxides,NA,Aliphatic acyclic compounds,-1.35,2394,T3D2982,Exogenous,-1.35,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,78.013935504,methanesulfinylmethane,Dimethyl sulfoxide,C2H6OS,67-68-5,HMDB02151,DB01093,C11143,DMSO,679,659,CS(C)=O,Organic compounds,Sulfoxides,Organosulfur compounds,Sulfoxides,NA,Aliphatic acyclic compounds,764,2081,SmallMoleculeCompound,FDB000764,Dimethyl sulfoxide,TRUE,Liquid,low,"Found in broad bean Phaseolus vulgaris, alfalfa Medicago sativa and many other plants. Flavouring agentDimethyl sulfoxide (DMSO) is the organosulfur compound with the formula (CH3)2SO. This colorless liquid is an important polar aprotic solvent that dissolves both polar and nonpolar compounds and is miscible in a wide range of organic solvents as well as water. It penetrates the skin very readily, giving it the unusual property of being secreted onto the surface of the tongue after contact with the skin and causing a garlic-like taste in the mouth. (Wikipedia)",67-68-5,Mp 18.5å¡,NA,NA,1000 mg/mL,-1.35,NA,NA,NA,C11143,679,NA,28262,DMS,NA,NA,NA,Dimethyl_sulfoxide,NA,NA,NA,NA,NA,NA,NA,HMDB02151.pdf,application/pdf,51575,2015-02-28 18:10:57 UTC,NA,2,2010-04-08 22:04:42 UTC,2015-07-20 21:34:13 UTC,NA,BGW91-G:BGW91-G,HMDB02151,DIMETHYL-SULFOXIDE,DB01093,NA,1034,NA,Bp0.37 20å¡,DFC,NA,NA,d204<vs=1> 1.1,DFC,NA,NA,C 30.74%; H 7.74%; O 20.48%; S 41.04%,DFC,NA,NA,n25D<vs=1>  1.4790 ((1.4775)),DFC,NA,NA,35,NA,"DORIGAN,J et al. (1976A);@2ND","HANSCH,C ET AL. (1995)",NA,NA,DFC,-1.09,-1.41,-0.08,CS(C)=O,NA,C2H6OS,78.133,InChI=1S/C2H6OS/c1-4(2)3/h1-2H3,78.0139355,InChIKey=IAZDPXIOMUYVGZ-UHFFFAOYSA-N,6.57e+01 g/l,34773,methanesulfinylmethane,DFC,NA,NA,"Dimethyl sulfoxide, BAN, INN, USAN",DFC,67-68-5,rw1108491,NA,NA,Organic compounds,Organosulfur compounds,Sulfoxides,NA,Sulfoxides,Aliphatic acyclic compounds,CHEMBL504,659,DMSO,NA,NA,DB01093,APRD00925 | EXPT01231,Dimethyl sulfoxide,67-68-5,YOW8V9698H,(CH3)2SO | Dimethyl sulfoxide | Dimethyl sulfur oxide | Dimethyl sulphoxide | Dimethyli sulfoxidum | Dimethylsulfoxid | Dimethylsulfoxyde | Dimetil sulfoxido | DMSO | Methylsulfinylmethane | S(O)Me2 | Sulfinylbis(methane),IAZDPXIOMUYVGZ-UHFFFAOYSA-N
IGMNYECMUMZDDF-UHFFFAOYSA-N,84,HMDB0000130,168.042258744,"2-(2,5-dihydroxyphenyl)acetic acid",Homogentisic acid,C8H8O4,451-13-8,C00544,FDB021899,NA,NA,NA,780,759,OC(=O)CC1=C(O)C=CC(O)=C1,331,Organic compounds,2(hydroxyphenyl)acetic acids,Benzenoids,Benzene and substituted derivatives,Phenylacetic acids,Aromatic homomonocyclic compounds,0.86,3168,T3D4287,Endogenous,0.86,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,168.042258744,"2-(2,5-dihydroxyphenyl)acetic acid",Homogentisic acid,C8H8O4,451-13-8,HMDB00130,DB08327,C00544,NA,780,759,OC(=O)CC1=CC(O)=CC=C1O,Chemical entities,2(hydroxyphenyl)acetic acids,Organic compounds,Benzenoids,Benzene and substituted derivatives,Aromatic homomonocyclic compounds,22062,NA,SmallMoleculeCompound,FDB021899,Homogentisic acid,TRUE,Solid,low,"An intermediate of the metabolic breakdown of tyrosine and phenylalanine; it occurs in the urine in cases of alkaptonuria. (OMIN 203500)Homogentisic acid is the primary precursor of melanin synthesis in Vibrio cholerae. [HMDB]",451-13-8,NA,NA,NA,NA,NA,NA,NA,NA,C00544,780,NA,5755,OMD,NA,NA,NA,Homogentisic acid,NA,NA,NA,NA,NA,NA,NA,HMDB00130.pdf,application/pdf,132211,2015-02-28 17:50:19 UTC,NA,2,2011-09-21 00:04:50 UTC,2015-10-09 22:29:32 UTC,NA,NA,HMDB00130,HOMOGENTISINIC-ACID,DB08327,1485308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.81,1.003863462,-1.32,[H]OC(=O)C([H])([H])C1=C(O[H])C([H])=C([H])C(O[H])=C1[H],9.566007894,C8H8O4,168.1467,"InChI=1S/C8H8O4/c9-6-1-2-7(10)5(3-6)4-8(11)12/h1-3,9-10H,4H2,(H,11,12)",168.0422587,InChIKey=IGMNYECMUMZDDF-UHFFFAOYSA-N,8.10e+00 g/l,85998,"2-(2,5-dihydroxyphenyl)acetic acid",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenylacetic acid derivatives,Phenylacetic acid derivatives,Aromatic homomonocyclic compounds,NA,759,NA,TRUE,NA,DB08327,NA,"2-(3,6-DIHYDROXYPHENYL)ACETIC ACID",NA,NP8UE6VF08,NA,IGMNYECMUMZDDF-UHFFFAOYSA-N
IISBACLAFKSPIT-UHFFFAOYSA-N,13185,HMDB0032133,228.115029756,4-[2-(4-hydroxyphenyl)propan-2-yl]phenol,Bisphenol A,C15H16O2,80-05-7,C13624,FDB008856,NA,NA,NA,6623,6371,CC(C)(C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,NA,Organic compounds,Bisphenols,Benzenoids,Benzene and substituted derivatives,Diphenylmethanes,Aromatic homomonocyclic compounds,3.32,535,T3D0637,Exogenous,3.32,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,228.115029756,4-[2-(4-hydroxyphenyl)propan-2-yl]phenol,Bisphenol A,C15H16O2,1980-05-07,HMDB32133,DB06973,C13624,CPD-10489,6623,6371,CC(C)(C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,Chemical entities,Bisphenols,Organic compounds,Benzenoids,Benzene and substituted derivatives,Aromatic homomonocyclic compounds,8857,22042,SmallMoleculeCompound,FDB008856,"2,2'-Bis(4-hydroxyphenyl)propane",TRUE,NA,low,"Potential food contaminant arising from its use in reusable polycarbonate food containers such as water carboys, baby bottles and kitchen utensils",1980-05-07,Mp 156-157å¡,NA,NA,0.12 mg/mL at 25 oC,3.32,NA,NA,NA,C13624,6623,NA,33216,2OH,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:08:17 UTC,2015-07-20 22:26:40 UTC,NA,DZN19-W:DZN19-W,HMDB32133,NA,DB06973,NA,NA,NA,Bp13 250-252å¡,DFC,NA,NA,NA,NA,NA,NA,C 78.92%; H 7.06%; O 14.02%,DFC,NA,NA,NA,NA,NA,NA,10.1,NA,"DORN,PB et al. (1987)","HANSCH,C ET AL. (1995)",NA,NA,DFC,3.81,4.044975416,-3.42,CC(C)(C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,10.38764021,C15H16O2,228.2863,"InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3",228.1150298,InChIKey=IISBACLAFKSPIT-UHFFFAOYSA-N,8.65e-02 g/l,31357,4-[2-(4-hydroxyphenyl)propan-2-yl]phenol,HMDB_from_dfc,NA,NA,"2,2'-Bis(4-hydroxyphenyl)propane",DFC,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Diphenylmethanes,Bisphenols,Aromatic homomonocyclic compounds,CHEMBL418971,6371,NA,NA,NA,DB06973,NA,"4,4'-PROPANE-2,2-DIYLDIPHENOL",NA,MLT3645I99,NA,IISBACLAFKSPIT-UHFFFAOYSA-N
IPCSVZSSVZVIGE-UHFFFAOYSA-N,145,HMDB0000220,256.240230268,hexadecanoic acid,Palmitic acid,C16H32O2,57-10-3,C00249,FDB011679,NA,NA,CPD-8475,985,960,CCCCCCCCCCCCCCCC(O)=O,187,Organic compounds,Long-chain fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,7.17,3483,T3D4797,Endogenous,7.17,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,256.240230268,hexadecanoic acid,Palmitic acid,C16H32O2,57-10-3,HMDB00220,DB03796,C00249,CPD-8475,985,960,CCCCCCCCCCCCCCCC(O)=O,Organic compounds,Long-chain fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,11682,29586,SmallMoleculeCompound,FDB011679,Hexadecanoic acid,TRUE,Solid,low,"Occurs in the form of esters (glycerides) in oils and fats of vegetable and animal origin. Usually obt. from palm oil. Widely distributed in plants. Defoaming agent, lubricant and fruit coating constit.Palmitic acid is the first fatty acid produced during lipogenesis and from which longer fatty acids can be produced.; Palmitic acid, or hexadecanoic acid is one of the most common saturated fatty acids found in animals and plants.",1957-10-03,Mp 63-64å¡,NA,NA,4e-05 mg/mL at 25 oC,7.17,NA,NA,NA,C00249,985,NA,15756,PLM,NA,NA,NA,Palmitic_acid,NA,NA,NA,NA,NA,NA,NA,HMDB00220.pdf,application/pdf,48771,2015-02-28 17:46:45 UTC,NA,2,2010-04-08 22:09:46 UTC,2015-10-09 22:28:03 UTC,NA,GXZ18-W:GXZ18-W,HMDB00220,HEXADECANOIC-ACID|PALMITIC-ACID,DB03796,34386,2858,C00030479,Bp15 215å¡,DFC,NA,NA,NA,NA,NA,NA,C 74.94%; H 12.58%; O 12.48%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,"ROBB,ID (1966)",SANGSTER (1993),NA,NA,DFC,7.23,6.26,-5.8,CCCCCCCCCCCCCCCC(O)=O,NA,C16H32O2,256.4241,"InChI=1S/C16H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h2-15H2,1H3,(H,17,18)",256.2402303,InChIKey=IPCSVZSSVZVIGE-UHFFFAOYSA-N,4.07e-04 g/l,37120,hexadecanoic acid,DFC,NA,NA,Hexadecanoic acid,DFC,NA,rw1009101,NA,NA,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Long-chain fatty acids,Aliphatic acyclic compounds,CHEMBL82293,960,CPD-8475,TRUE,NA,DB03796,EXPT01393 | EXPT02607,Palmitic Acid,57-10-3,2V16EO95H1,1-Hexyldecanoic Acid | 1-Pentadecanecarboxylic acid | FAT | Hexadecanoate | Hexadecanoic acid | Hexadecoic acid | Hexadecylic acid | Hexaectylic acid | Palmitate | Palmitinic acid | Palmitinsaeure,IPCSVZSSVZVIGE-UHFFFAOYSA-N
ISWSIDIOOBJBQZ-UHFFFAOYSA-N,153,HMDB0000228,94.041864814,phenol,Phenol,C6H6O,108-95-2,C00146,FDB000893,NA,NA,24-DICHLOROPHENOL,996,971,OC1=CC=CC=C1,128,Organic compounds,1-hydroxy-4-unsubstituted benzenoids,Benzenoids,Phenols,1-hydroxy-4-unsubstituted benzenoids,Aromatic homomonocyclic compounds,1.46,156,T3D0182,Exogenous,1.46,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,94.041864814,phenol,Phenol,C6H6O,108-95-2,HMDB00228,DB03255,C00146,24-DICHLOROPHENOL,996,971,OC1=CC=CC=C1,Organic compounds,1-hydroxy-4-unsubstituted benzenoids,Benzenoids,Phenols,1-hydroxy-4-unsubstituted benzenoids,Aromatic homomonocyclic compounds,893,2534,SmallMoleculeCompound,FDB000893,Phenol,TRUE,Solid,low,"Used as a flavouring agent in a few foods, at maximum levels below 10 ppmPhenol, also known as carbolic acid, is an organic compound with the chemical formula C6H5OH. It is a white crystalline solid. The molecule consists of a phenyl (-C6H5), bonded to a hydroxyl (-OH) group. It is produced on a large scale (about 7 billion kg/year) as a precursor to many materials and useful compounds. (Wikipedia)",108-95-2,Fp 41å¡,NA,NA,82.8 mg/mL at 25 oC,1.46,NA,NA,NA,C15584,996,NA,15882,IPH,NA,NA,NA,Phenol,NA,NA,NA,NA,NA,NA,NA,HMDB00228.pdf,application/pdf,52795,2015-02-28 17:45:18 UTC,NA,2,2010-04-08 22:04:45 UTC,2015-10-09 22:31:57 UTC,657,BLS38-K:BLS38-K,HMDB00228,PHENOL,DB03255,NA,2977,C00002664,Bp25 90.2å¡,DFC,NA,NA,NA,NA,NA,NA,C 76.57%; H 6.43%; O 17.00%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,"SOUTHWORTH,GR & KELLER,JL (1986)","HANSCH,C ET AL. (1995)",NA,NA,DFC,1.39,1.67,-0.31,OC1=CC=CC=C1,NA,C6H6O,94.1112,"InChI=1S/C6H6O/c7-6-4-2-1-3-5-6/h1-5,7H",94.04186481,InChIKey=ISWSIDIOOBJBQZ-UHFFFAOYSA-N,4.66e+01 g/l,39100,phenol,MANUAL,NA,NA,Phenol,DFC,108-95-2,rw1009361,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenols and derivatives,Phenols and derivatives,Aromatic homomonocyclic compounds,CHEMBL14060,971,24-DICHLOROPHENOL,TRUE,NA,DB03255,EXPT01917,Phenol,108-95-2,339NCG44TV,Acide carbolique | Acide phenique | Benzenol | Carbolic acid | Carbolsaeure | Hydroxybenzene | Karbolsaeure | Monohydroxybenzene | Oxybenzene | Phenic Acid | Phenol | Phenyl alcohol | Phenyl hydroxide | Phenylic Acid | Phenylic alcohol | PHOH,ISWSIDIOOBJBQZ-UHFFFAOYSA-N
IWDCLRJOBJJRNH-UHFFFAOYSA-N,1228,HMDB0001858,108.057514878,4-methylphenol,p-Cresol,C7H8O,106-44-5,C01468,FDB008789,DB01688,NA,CPD-108,2879,13839082,CC1=CC=C(O)C=C1,4236,Organic compounds,Para cresols,Benzenoids,Phenols,Cresols,Aromatic homomonocyclic compounds,1.94,147,T3D0170,Endogenous,1.94,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,108.057514878,4-methylphenol,p-Cresol,C7H8O,106-44-5,HMDB01858,DB01688,C01468,CPD-108,2879,13839082,CC1=CC=C(O)C=C1,Chemical entities,Para cresols,Organic compounds,Benzenoids,Phenols,Aromatic homomonocyclic compounds,8790,21857,SmallMoleculeCompound,FDB008789,4-Methylphenol,TRUE,Solid,low,"Present in blackcurrant buds, asparagus, cooked cured pork, black tea, fermented tea, yellow passion fruit juice, malt, peated malt, kumazasa (Sasa albo-marginata), lamb's lettuce, squid and cuttlefish. Flavouring ingredient",106-44-5,Mp 36å¡,NA,NA,21.5 mg/mL at 25 oC,1.94,NA,NA,NA,C01468,2879,NA,17847,PCR,NA,NA,NA,P-Cresol,NA,NA,NA,NA,NA,NA,NA,HMDB01858.pdf,application/pdf,201653,2015-02-28 18:05:20 UTC,NA,2,2010-04-08 22:08:15 UTC,2015-10-09 22:32:26 UTC,NA,DXH45-J:DXH45-J,HMDB01858,CRESOL|P-CRESOL,DB01688,NA,772,C00002645,Bp11 90å¡,DFC,NA,NA,d204<vs=1> 1.03,DFC,NA,NA,C 77.75%; H 7.46%; O 14.80%,DFC,NA,NA,NA,NA,NA,NA,pKa 10.27 (25å¡),DFC,"YALKOWSKY,SH & HE,Y (2003)","HANSCH,C ET AL. (1995)",NA,NA,DFC,1.95,2.18,-0.67,CC1=CC=C(O)C=C1,NA,C7H8O,108.1378,"InChI=1S/C7H8O/c1-6-2-4-7(8)5-3-6/h2-5,8H,1H3",108.0575149,InChIKey=IWDCLRJOBJJRNH-UHFFFAOYSA-N,2.31e+01 g/l,38942,4-methylphenol,DFC,NA,NA,"4-Methylphenol, 9CI",DFC,106-44-5,rw1003851,2879,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Toluenes,Nitrotoluenes,Aromatic homomonocyclic compounds,CHEMBL16645,13839082,CPD-108,TRUE,NA,DB01688,EXPT02525,P-Cresol,106-44-5,1MXY2UM8NV,NA,IWDCLRJOBJJRNH-UHFFFAOYSA-N
IYRMWMYZSQPJKC-UHFFFAOYSA-N,2556,HMDB0005801,286.047738052,"3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one",Kaempferol,C15H10O6,520-18-3,C05903,FDB000633,NA,NA,CPD-8034,5280863,4444395,OC1=CC=C(C=C1)C1=C(O)C(=O)C2=C(O1)C=C(O)C=C2O,NA,Organic compounds,Flavonols,Phenylpropanoids and polyketides,Flavonoids,Flavones,Aromatic heteropolycyclic compounds,NA,3481,T3D4795,Exogenous,NA,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,286.047738052,"3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one",Kaempferol,C15H10O6,520-18-3,HMDB05801,DB01852,C05903,CPD-8034,5280863,4444395,OC1=CC=C(C=C1)C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1,Organic compounds,Flavonols,Phenylpropanoids and polyketides,Flavonoids,Flavones,Aromatic heteropolycyclic compounds,633,1703,SmallMoleculeCompound,FDB000633,Kaempferol,TRUE,Solid,low,"Very widespread in the plant world, e.g. in Brassicaceae, Apocynaceae, Dilleniaceae, Ranunculaceae, Leguminosae, etc. Found esp. in broccoli, capers, chives, kale, garden cress, fennel, lovage, dill weed and tarragon [CCD]Kaempferol is a natural flavonol, a type of flavonoid. Many glycosides of kaempferol, such as kaempferitrin and astragalin, have been isolated as natural products from plants. Kaempferol consumption in tea and broccoli has been associated with reduced risk of heart disease. [Wikipedia]",520-18-3,Mp 276-278å¡,NA,NA,NA,NA,NA,NA,NA,C05903,5280863,NA,NA,KMP,NA,NA,NA,Kaempferol,NA,NA,NA,NA,NA,NA,NA,HMDB05801.pdf,application/pdf,49130,2015-02-28 18:00:20 UTC,NA,2,2010-04-08 22:04:39 UTC,2015-10-09 22:32:31 UTC,290,BFG98-E:BFG98-E,HMDB05801,"3,5,7,4'-TETRAHYDROXYFLAVONE|KAEMPFEROL",DB01852,NA,NA,C00004565,NA,NA,NA,NA,NA,NA,NA,NA,C 62.94%; H 3.52%; O 33.54%,DFC,NA,NA,NA,NA,365 () (EtOH) (Berdy),DFC,NA,NA,NA,NA,NA,NA,DFC,1.99,2.4599,-3.21,OC1=CC=C(C=C1)C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1,7.8926,C15H10O6,286.23630000000003,"InChI=1S/C15H10O6/c16-8-3-1-7(2-4-8)15-14(20)13(19)12-10(18)5-9(17)6-11(12)21-15/h1-6,16-18,20H",286.0477,InChIKey=IYRMWMYZSQPJKC-UHFFFAOYSA-N,1.78e-01 g/l,36748,"3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one",MANUAL,NA,NA,"3,4',5,7-Tetrahydroxyflavone",DFC,NA,NA,NA,290,Organic compounds,Phenylpropanoids and polyketides,Flavonoids,Flavones,Flavonols,Aromatic heteropolycyclic compounds,CHEMBL150,4444395,CPD-8034,TRUE,NA,DB01852,EXPT01976,Kaempherol,520-18-3,731P2LE49E,NA,IYRMWMYZSQPJKC-UHFFFAOYSA-N
JCCNYMKQOSZNPW-UHFFFAOYSA-N,2340,HMDB0005000,382.144805697,"ethyl 4-{13-chloro-4-azatricyclo[9.4.0.0\xc2\xb3,\xe2\x81\xb8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene}piperidine-1-carboxylate",Loratadine,C22H23ClN2O2,79794-75-5,C06818,FDB023577,NA,NA,NA,3957,3820,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2,1021,Organic compounds,Benzocycloheptapyridines,Organoheterocyclic compounds,Benzocycloheptapyridines,NA,Aromatic heteropolycyclic compounds,5.2,2251,T3D2796,Exogenous,5.2,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,382.144805697,"ethyl 4-{13-chloro-4-azatricyclo[9.4.0.0\xc2\xb3,\xe2\x81\xb8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene}piperidine-1-carboxylate",Loratadine,C22H23ClN2O2,79794-75-5,HMDB05000,DB00455,C06818,NA,3957,3820,CCOC(=O)N1CCC(CC1)=C1C2=CC=C(Cl)C=C2CCC2=C1N=CC=C2,Organic compounds,Benzocycloheptapyridines,Organoheterocyclic compounds,Benzocycloheptapyridines,NA,Aromatic heteropolycyclic compounds,23740,NA,SmallMoleculeCompound,FDB023577,Loratadine,TRUE,Solid,low,"desloratadine is available off the shelf in Canada); Loratadine is a tricyclic antihistamine, which has a selective and peripheral H1-antagonist action. It has a long-lasting effect and does not normally cause drowsiness because it does not readily enter the central nervous system; An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake; Loratadine is a drug used to treat allergies. It is marketed by Schering-Plough under several trade names such as Claritin, Clarityn or Claratyne depending on the market, by Lek as Lomilan and by Wyeth as Alavert. It is also available as a generic; Loratadine is a drug used to treat allergies. It is marketed by Schering-Plough under several trade names such as Claritin, Clarityn or Claratyne depending on the market, by Lek as Lomilan and by Wyeth as Alavert. It is also available as a generic.Its active metabolite, desloratadine, is also on the market, though loratadine itself is the only drug of its class available over the counter (at least in the U.S. as of 2005. Loratadine is available off the shelf in the UK [HMDB]",79794-75-5,NA,NA,NA,NA,NA,NA,NA,NA,C06818,3957,NA,2618,NA,NA,NA,NA,Loratadine,NA,NA,NA,NA,NA,NA,NA,HMDB05000.pdf,application/pdf,650345,2015-02-28 17:47:08 UTC,NA,NA,2011-09-21 00:31:52 UTC,2015-10-09 22:33:18 UTC,NA,NA,HMDB05000,NA,DB00455,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4.21,4.554579307,-4.46,[H]C1=C([H])C([H])=C2C(=N1)C(C1=C(C([H])=C(Cl)C([H])=C1[H])C([H])([H])C2([H])[H])=C1C([H])([H])C([H])([H])N(C(=O)OC([H])([H])C([H])([H])[H])C([H])([H])C1([H])[H],NA,C22H23ClN2O2,382.883,"InChI=1S/C22H23ClN2O2/c1-2-27-22(26)25-12-9-15(10-13-25)20-19-8-7-18(23)14-17(19)6-5-16-4-3-11-24-21(16)20/h3-4,7-8,11,14H,2,5-6,9-10,12-13H2,1H3",382.1448057,InChIKey=JCCNYMKQOSZNPW-UHFFFAOYSA-N,1.34e-02 g/l,82796,"ethyl 4-{13-chloro-4-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-2-ylidene}piperidine-1-carboxylate",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Benzocycloheptapyridines,NA,Benzocycloheptapyridines,Aromatic heteropolycyclic compounds,CHEMBL998,3820,NA,TRUE,NA,DB00455,APRD00384,Loratadine,79794-75-5,7AJO3BO7QN,Loratadina | Loratadinum,JCCNYMKQOSZNPW-UHFFFAOYSA-N
JFCQEDHGNNZCLN-UHFFFAOYSA-N,516,HMDB0000661,132.042258744,pentanedioic acid,Glutaric acid,C5H8O4,110-94-1,C00489,FDB001477,DB03553,NA,NA,743,723,OC(=O)CCCC(O)=O,3254,Organic compounds,Dicarboxylic acids and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,Dicarboxylic acids and derivatives,Aliphatic acyclic compounds,-0.29,3202,T3D4359,Endogenous,-0.29,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,132.042258744,pentanedioic acid,Glutaric acid,C5H8O4,110-94-1,HMDB00661,DB03553,C00489,NA,743,723,OC(=O)CCCC(O)=O,Chemical entities,Dicarboxylic acids and derivatives,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Aliphatic acyclic compounds,1477,4525,SmallMoleculeCompound,FDB001477,Glutaric acid,TRUE,Solid,low,Isol. from basidiomycete fungi and fruits of Prunus cerasus (CCD),110-94-1,Mp 97  -  98å¡,NA,NA,"Sol. H2O, EtOH, Et2O, C6H6, CHCl3",-0.29,NA,NA,NA,C00489,743,NA,17859,GUA,NA,NA,NA,Glutaric acid,NA,NA,NA,NA,NA,NA,NA,HMDB00661.pdf,application/pdf,48675,2015-02-28 18:03:56 UTC,NA,2,2010-04-08 22:04:59 UTC,2015-10-09 22:28:20 UTC,NA,HKS12-F:HKS12-F,HMDB00661,GLUTARIC-ACID,DB03553,NA,NA,C00001184,Bp  302 - 304 å¡  Bp 20   200 å¡,CCD,NA,NA,NA,NA,NA,NA,C 45.46%; H 6.10%; O 48.44%,CCD,Needles or prisms (C6H6 or CHCl3),CCD,NA,NA,NA,NA,p Ka14.35 ( 25å¡ ) p Ka25.4 ( 25å¡ ),CCD,CCD,"HANSCH,C ET AL. (1995)",NA,NA,CCD,-0.25,0.05,-0.37,OC(=O)CCCC(O)=O,4.56,C5H8O4,132.1146,"InChI=1S/C5H8O4/c6-4(7)2-1-3-5(8)9/h1-3H2,(H,6,7)(H,8,9)",132.0422587,InChIKey=JFCQEDHGNNZCLN-UHFFFAOYSA-N,5.60e+01 g/l,39576,pentanedioic acid,MANUAL,NA,NA,NA,KNAPSACK,NA,rw1248291,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Dicarboxylic acids and derivatives,Dicarboxylic acids and derivatives,Aliphatic acyclic compounds,CHEMBL1162495,723,NA,TRUE,NA,DB03553,EXPT01668,Glutaric Acid,110-94-1,H849F7N00B,NA,JFCQEDHGNNZCLN-UHFFFAOYSA-N
JOYRKODLDBILNP-UHFFFAOYSA-N,12304,HMDB0031219,89.047678473,ethyl carbamate,Ethyl carbamate,C3H7NO2,51-79-6,C01537,FDB003243,DB04827,NA,NA,5641,5439,CCOC(N)=O,NA,Organic compounds,Carboximidic acids and derivatives,Organic acids and derivatives,Carboximidic acids and derivatives,NA,Aliphatic acyclic compounds,-0.15,3338,T3D4583,Endogenous,-0.15,"2A, probably carcinogenic to humans. (L135)",LD50 in rodents of 2g/kg (ingestion),SmallMolecule,89.047678473,ethyl carbamate,Ethyl carbamate,C3H7NO2,51-79-6,HMDB31219,DB04827,C01537,NA,5641,5439,CCOC(O)=N,Chemical entities,Carboximidic acids and derivatives,Organic compounds,Organic acids and derivatives,Carboximidic acids and derivatives,Aliphatic acyclic compounds,3244,9985,SmallMoleculeCompound,FDB003243,Ethyl carbamate,TRUE,NA,low,"Common contaminant of fermented beveragesEthyl carbamate (also called urethane) is a substance first prepared in the nineteenth century. Structurally it is an ester of carbamic acid, i. e., ethyl carbamate as shown. Urethane itself is: (NH2-COOC2H5) and is not a component of polyurethanes.; This ethyl ester is a white crystalline substance produced by the action of ammonia on ethyl chloroformate or by heating urea nitrate and ethyl alcohol.",51-79-6,Mp 48.5-50å¡,NA,NA,480 mg/mL at 15 oC,-0.15,NA,NA,NA,C01537,5641,NA,17967,NA,NA,NA,NA,Ethyl_carbamate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:05:43 UTC,2015-07-20 21:52:29 UTC,NA,CTW56-X:CTW56-X,HMDB31219,NA,DB04827,NA,NA,NA,Bp54 103å¡,DFC,NA,NA,NA,NA,NA,NA,C 40.44%; H 7.92%; N 15.72%; O 35.92%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,"SEIDELL,A (1941)","HANSCH,C ET AL. (1995)",NA,NA,DFC,-0.14,-0.05,0.62,CCOC(N)=O,NA,C3H7NO2,89.0932,"InChI=1S/C3H7NO2/c1-2-6-3(4)5/h2H2,1H3,(H2,4,5)",89.04767847,InChIKey=JOYRKODLDBILNP-UHFFFAOYSA-N,3.71e+02 g/l,35209,ethyl carbamate,DFC,NA,NA,"Ethyl carbamate, 9CI",DFC,NA,NA,NA,NA,Organic compounds,Organic acids and derivatives,Carboximidic acids and derivatives,NA,Carboximidic acids and derivatives,Aliphatic acyclic compounds,CHEMBL462547,5439,URETHAN,NA,NA,DB04827,NA,Ethyl carbamate,51-79-6,3IN71E75Z5,Aethylcarbamat | Aethylurethan | Carbamic acid ethyl ester | Carbamidsaeure-aethylester | Estane 5703 | Ethyl ester of carbamic acid | Ethyl urethan | Ethyl urethane | Ethylcarbamate | Ethylester kyseliny karbaminove | Ethylurethan | Ethylurethane | O-ethyl urethane | O-ethylurethane | Uretan | Uretan etylowy | Uretano | Urethan | Urethane | Urethanum,JOYRKODLDBILNP-UHFFFAOYSA-N
JVTAAEKCZFNVCJ-UWTATZPHSA-N,1006,HMDB0001311,90.031694058,(2R)-2-hydroxypropanoic acid,D-Lactic acid,C3H6O3,10326-41-7,C00256,FDB003293,DB03066,NA,D-LACTATE,61503,55423,C[C@@H](O)C(O)=O,6150,Organic compounds,Alpha hydroxy acids and derivatives,Organic acids and derivatives,Hydroxy acids and derivatives,Alpha hydroxy acids and derivatives,Aliphatic acyclic compounds,NA,3179,T3D4307,Endogenous,-0.72,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,90.031694058,(2R)-2-hydroxypropanoic acid,D-Lactic acid,C3H6O3,10326-41-7,HMDB01311,DB03066,C00256,D-LACTATE,61503,55423,[H][C@](C)(O)C(O)=O,Organic compounds,Alpha hydroxy acids and derivatives,Organic acids and derivatives,Hydroxy acids and derivatives,Alpha hydroxy acids and derivatives,Aliphatic acyclic compounds,3294,10156,SmallMoleculeCompound,FDB003293,D-Lactic acid,TRUE,Solid,low,"Widely distributed in nature - starch, molasses, potatoes etc.Lactic acid is chiral and has two optical isomers. One is known as L-(+)-lactic acid or (S)-lactic acid and the other, its mirror image, is D-(-)-lactic acid or (R)-lactic acid. L-(+)-Lactic acid is the biologically important isomer. (Wikipedia)",10326-41-7,Mp 53å¡,NA,NA,NA,NA,NA,NA,NA,C00256,61503,NA,341,LAC,NA,NA,NA,Lactic_acid,NA,NA,NA,NA,NA,NA,NA,HMDB01311.pdf,application/pdf,152848,2015-02-28 17:46:23 UTC,NA,2,2010-04-08 22:05:44 UTC,2015-10-09 22:31:39 UTC,NA,CVR18-C:CVR19-D,HMDB01311,NA,DB03066,34414,NA,C00019549,NA,NA,NA,NA,NA,NA,[a]D -2.26 (H2O),DFC,C 40.00%; H 6.71%; O 53.28%,DFC,NA,NA,NA,NA,NA,NA,pKa 3.83,DFC,NA,NA,NA,NA,DFC,-0.79,-0.47,0.79,C[C@@H](O)C(O)=O,14.59,C3H6O3,90.0779,"InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/t2-/m1/s1",90.03169406,InChIKey=JVTAAEKCZFNVCJ-UWTATZPHSA-N,5.62e+02 g/l,33572,(2R)-2-hydroxypropanoic acid,MANUAL,NA,NA,"2-Hydroxypropanoic acid, 9CI; (R)-form",DFC,NA,rw1447821,NA,NA,Organic compounds,Organic acids and derivatives,Hydroxy acids and derivatives,Alpha hydroxy acids and derivatives,Alpha hydroxy acids and derivatives,Aliphatic acyclic compounds,CHEMBL358850,55423,D-LACTATE,TRUE,NA,DB03066,EXPT01215,D-Lactic acid,10326-41-7,3Q6M5SET7W,(â)-lactic acid | (R)-(â)-lactic acid | (R)-lactic acid | D-2-Hydroxypropanoic acid | D-2-Hydroxypropionic acid | D-MilchsÃ¤ure,JVTAAEKCZFNVCJ-UWTATZPHSA-N
JWUBBDSIWDLEOM-DTOXIADCSA-N,1910,HMDB0003550,400.334130652,"(1S,3Z)-3-{2-[(1R,3aS,4E,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexan-1-ol",Calcidiol,C27H44O2,19356-17-3,C01561,FDB021782,DB00146,NA,CALCIDIOL,5283731,4446820,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,6949,Organic compounds,Vitamin D and derivatives,Lipids and lipid-like molecules,Steroids and steroid derivatives,Vitamin D and derivatives,Aliphatic homopolycyclic compounds,NA,2180,T3D2694,Endogenous,6,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,400.334130652,"(1S,3Z)-3-{2-[(1R,3aS,4E,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexan-1-ol",Calcidiol,C27H44O2,19356-17-3,HMDB03550,DB00146,C01561,CALCIDIOL,5283731,4446820,[H]\C(\C(\[H])=C1/CCC[C@@]2(C)[C@@]1([H])CC[C@]2([H])[C@]([H])(C)CCCC(C)(C)O)=C1/C[C@@]([H])(O)CCC1=C,Organic compounds,Vitamin D and derivatives,Lipids and lipid-like molecules,Steroids and steroid derivatives,Vitamin D and derivatives,Aliphatic homopolycyclic compounds,21939,NA,SmallMoleculeCompound,FDB021782,25-Hydroxycholecalciferol,TRUE,Solid,low,"Calfcifediol is a prehormone that is produced in the liver by hydroxylation of vitamin D3 (cholecalciferol) by the enzyme cholecalciferol 25-hydroxylase. Calcifediol is then converted in the kidneys into calcitriol (1,25-(OH)2D3), a secosteroid hormone that is the active form of vitamin D. It can also be converted into 24-hydroxycalcidiol in the kidneys via 24-hydroxylation. [Wikipedia]",19356-17-3,NA,NA,NA,NA,NA,NA,NA,NA,C01561,5283731,NA,17933,VDY,NA,NA,NA,Calcifediol,NA,"# Hollis BW, Roos BA, Draper HH, Lambert PW: Vitamin D and its metabolites in human and bovine milk. J Nutr. 1981 Jul;111(7):1240-8. ""Pubmed"":http://www.ncbi.nlm.nih.gov/pubmed/6788913 [Isolation]",NA,NA,NA,NA,NA,HMDB03550.pdf,application/pdf,158315,2015-02-28 17:48:31 UTC,2,2,2011-04-06 18:26:21 UTC,2015-07-21 06:56:06 UTC,NA,HLJ22-W:HMC07-T,HMDB03550,NA,DB00146,2289142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6.71,5.65,-5.26,[H][C@@]1(CC[C@]2([H])[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C)[C@H](C)CCCC(C)(C)O,18.53,C27H44O2,400.6371,"InChI=1S/C27H44O2/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23+,24-,25+,27-/m1/s1",400.3341307,InChIKey=JWUBBDSIWDLEOM-DTOXIADCSA-N,2.20e-03 g/l,70155,"(1S,3Z)-3-{2-[(1R,3aS,4E,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexan-1-ol",MANUAL,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Lipids and lipid-like molecules,Prenol lipids,Triterpenoids,Triterpenoids,Aliphatic homopolycyclic compounds,CHEMBL1040,4446820,CALCIDIOL,NA,NA,DB00146,NUTR00006 | APRD00428,Calcidiol,19356-17-3,T0WXW8F54E,"(3S,5Z,7E)-9,10-secocholesta-5,7,10-triene-3,25-diol | (3Î²,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol | (5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol | 25-hydroxycholecalciferol | 25-Hydroxyvitamin D3 | Calcidiol | CalcifÃ©diol | Calcifediol | Calcifediol anhydrous | Calcifediolum",JWUBBDSIWDLEOM-DTOXIADCSA-N
JZRWCGZRTZMZEH-UHFFFAOYSA-N,158,HMDB0000235,265.112306876,"3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium",Thiamine,C12H17N4OS,59-43-8,C00378,FDB008425,NA,NA,THIAMINE,1130,1098,CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N,5242,Organic compounds,Thiamines,Organoheterocyclic compounds,Diazines,Pyrimidines and pyrimidine derivatives,Aromatic heteromonocyclic compounds,NA,2181,T3D2696,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,265.111758296,"3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium",Thiamine,C12H17N4OS,59-43-8,HMDB00235,DB00152,C00378,THIAMINE,1130,1098,CC1=C(CCO)SC=[N+]1CC1=CN=C(C)NC1=N,Organic compounds,Thiamines,Organoheterocyclic compounds,Diazines,Pyrimidines and pyrimidine derivatives,Aromatic heteromonocyclic compounds,8425,20829,SmallMoleculeCompound,FDB008424,Thiamine,TRUE,NA,low,"Essential vitamin. Present in yeast, eggs, liver, milk, green vegetables, roots, tubers and cereals, esp. rice husks. Dietary supplement esp. in baked goods and grain products",70-16-6,248 oC,NA,NA,NA,NA,NA,NA,NA,NA,1130,NA,18385,NA,NA,NA,NA,Thiamine,NA,NA,A little confusing because some databases (e.g. KEGG and HMDB) give the CAS number for 'thiamine hydrochloride' (cas: 59-43-8 ) but show thiamine (cas: 70-16-6),NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:08:04 UTC,2015-10-09 22:28:44 UTC,NA,DKN09-S:DKN09-S,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 54.32%; H 6.46%; N 21.11%; O 6.03%; S 12.08%,DFC,NA,NA,NA,NA,NA,NA,pKa 5.17,DFC,NA,NA,NA,NA,NA,-2.11,-3.1,-4.29,CC1=C(CCO)SC=[N+]1CC1=C(N)N=C(C)N=C1,19.26,C12H17N4OS,265.355,"InChI=1S/C12H17N4OS/c1-8-11(3-4-17)18-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7,17H,3-4,6H2,1-2H3,(H2,13,14,15)/q+1",265.1123069,InChIKey=JZRWCGZRTZMZEH-UHFFFAOYSA-N,1.53e-02 g/l,31985,"3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium",DFC,NA,NA,"Thiamine, BAN, INN",DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,DB00152,NUTR00009 | APRD00552 | EXPT03222,Thiamine,70-16-6,4ABT0J945J,Aneurin | Antiberiberi factor | Thiamin | thiamine | thiamine(1+) | thiamine(1+) ion | thiaminium | tiamina | Vitamin B1,JZRWCGZRTZMZEH-UHFFFAOYSA-N
JZUFKLXOESDKRF-UHFFFAOYSA-N,1282,HMDB0001928,296.964474846,"6-chloro-1,1-dioxo-3,4-dihydro-2H-1\xce\xbb\xe2\x81\xb6,2,4-benzothiadiazine-7-sulfonamide",Hydrochlorothiazide,C7H8ClN3O4S2,58-93-5,C07041,FDB022745,DB00999,NA,12-DEHYDRORETICULINIUM,3639,3513,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,3169,Organic compounds,"1,2,4-benzothiadiazine-1,1-dioxides",Organoheterocyclic compounds,Thiadiazines,Benzothiadiazines,Aromatic heteropolycyclic compounds,-0.07,3468,T3D4781,Exogenous,-0.07,"2B, possibly carcinogenic to humans. (L135)",NA,SmallMolecule,296.964474846,"6-chloro-1,1-dioxo-3,4-dihydro-2H-1\xce\xbb\xe2\x81\xb6,2,4-benzothiadiazine-7-sulfonamide",Hydrochlorothiazide,C7H8ClN3O4S2,58-93-5,HMDB01928,DB00999,C07041,12-DEHYDRORETICULINIUM,3639,3513,NS(=O)(=O)C1=CC2=C(NCNS2(=O)=O)C=C1Cl,Organic compounds,"1,2,4-benzothiadiazine-1,1-dioxides",Organoheterocyclic compounds,Thiadiazines,Benzothiadiazines,Aromatic heteropolycyclic compounds,22908,NA,SmallMoleculeCompound,FDB022745,Hydrochlorothiazide,TRUE,Solid,low,"A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It has been used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism. -- PubchemHydrochlorothiazide (Apo-Hydro, Aquazide H, Microzide, Oretic), sometimes abbreviated HCT, HCTZ, or HZT is a popular diuretic drug that acts by inhibiting the kidney's ability to retain water. This reduces the volume of the blood, decreasing peripheral vascular resistance. Chlorothiazide, a carbonic anhydrase inhibitor. --Wikipedia [HMDB]",58-93-5,NA,NA,NA,NA,NA,NA,NA,NA,C07041,3639,NA,NA,HCZ,NA,NA,NA,Hydrochlorothiazide,NA,NA,NA,NA,NA,NA,NA,HMDB01928.pdf,application/pdf,48564,2015-02-28 18:01:56 UTC,NA,NA,2011-09-21 00:18:58 UTC,2015-10-09 22:31:18 UTC,NA,NA,HMDB01928,NA,DB00999,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.16,-0.575617776,-2.12,[H]N([H])S(=O)(=O)C1=C(Cl)C([H])=C2N([H])C([H])([H])N([H])S(=O)(=O)C2=C1[H],9.826927881,C7H8ClN3O4S2,297.739,"InChI=1S/C7H8ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-2,10-11H,3H2,(H2,9,12,13)",296.9644748,InChIKey=JZUFKLXOESDKRF-UHFFFAOYSA-N,2.24e+00 g/l,83178,"6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Thiadiazines,Benzothiadiazines,Benzothiadiazines,Aromatic heteropolycyclic compounds,CHEMBL435,3513,12-DEHYDRORETICULINIUM,TRUE,NA,DB00999,APRD00092,Hydrochlorothiazide,58-93-5,0J48LPH2TH,HCTZ,JZUFKLXOESDKRF-UHFFFAOYSA-N
KDXKERNSBIXSRK-YFKPBYRVSA-N,118,HMDB0000182,146.105527702,"(2S)-2,6-diaminohexanoic acid",L-Lysine,C6H14N2O2,56-87-1,C00047,FDB000474,NA,NA,LYS,5962,5747,NCCCC[C@H](N)C(O)=O,5200,Organic compounds,L-alpha-amino acids,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,-3.05,3145,T3D4248,Endogenous,-3.05,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,146.105527702,"(2S)-2,6-diaminohexanoic acid",L-Lysine,C6H14N2O2,56-87-1,HMDB00182,DB00123,C00047,LYS,5962,5747,[H][C@](N)(CCCCN)C(O)=O,Organic compounds,L-alpha-amino acids,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,474,1132,SmallMoleculeCompound,FDB000474,L-Lysine,TRUE,Solid,low,"Dietary supplement, nutrient. Found widely in protein hydrolysates, e.g. casein, egg albumen, fibrin, gelatin, beet molasses. Flavouring agent for a variety of foodsLysine (abbreviated as Lys or K) is an alpha-amino acid with the chemical formula HO2CCH(NH2)(CH2)4NH2. It is an essential amino acid, which means that the human body cannot synthesize it. Its codons are AAA and AAG. (Wikipedia)",56-87-1,Mp 224-225 dec. (darkens at 210å¡),NA,NA,1000 mg/mL at 20 oC,-3.05,NA,NA,NA,C00047,5962,NA,NA,1BBU,NA,NA,NA,Lysine,NA,NA,NA,NA,NA,NA,NA,HMDB00182.pdf,application/pdf,46364,2015-02-28 18:09:15 UTC,NA,2,2010-04-08 22:04:35 UTC,2015-10-09 22:29:18 UTC,NA,BCS45-Z:BCS47-B,HMDB00182,LYSINE,DB03252,33655,2071,C00001378,NA,NA,NA,NA,NA,NA,[a]D +37.9 (5M HCl),DFC,C 49.30%; H 9.65%; N 19.16%; O 21.89%,DFC,NA,NA,NA,NA,NA,NA,"pKa3 10.54 (25å¡, 0.1M NaClO4)",DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,-3.76,-3.76,-0.14,NCCCC[C@H](N)C(O)=O,NA,C6H14N2O2,146.1876,"InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/t5-/m0/s1",146.1055277,InChIKey=KDXKERNSBIXSRK-YFKPBYRVSA-N,1.05e+02 g/l,35312,"(2S)-2,6-diaminohexanoic acid",MANUAL,NA,NA,"Lysine, 9CI, INN, USAN; (S)-form",DFC,NA,rw1107871,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",L-alpha-amino acids,Aliphatic acyclic compounds,CHEMBL8085,5747,LYS,TRUE,NA,DB00123,NUTR00037 | DB11101,L-Lysine,56-87-1,K3Z4F929H6,"(S)-2,6-diaminohexanoic acid | (S)-lysine | (S)-Î±,Îµ-diaminocaproic acid | 6-ammonio-L-norleucine | L-2,6-Diaminocaproic acid | L-lys | L-Lysin | LYS | Lysina | Lysine | Lysine acid | Lysinum",KDXKERNSBIXSRK-YFKPBYRVSA-N
KDXKERNSBIXSRK-YFKPBYRVSA-N,1863,HMDB0003405,146.105527702,"(2S)-2,6-diaminohexanoic acid",D-Lysine,C6H14N2O2,923-27-3,C00739,FDB023163,NA,NA,CPD-219,57449,51793,NCCCC[C@H](N)C(O)=O,6919,Organic compounds,L-alpha-amino acids,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,NA,3145,T3D4248,Endogenous,-3.05,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,146.105527702,"(2S)-2,6-diaminohexanoic acid",L-Lysine,C6H14N2O2,56-87-1,HMDB00182,DB00123,C00047,LYS,5962,5747,[H][C@](N)(CCCCN)C(O)=O,Organic compounds,L-alpha-amino acids,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,474,1132,SmallMoleculeCompound,FDB000474,L-Lysine,TRUE,Solid,low,"Dietary supplement, nutrient. Found widely in protein hydrolysates, e.g. casein, egg albumen, fibrin, gelatin, beet molasses. Flavouring agent for a variety of foodsLysine (abbreviated as Lys or K) is an alpha-amino acid with the chemical formula HO2CCH(NH2)(CH2)4NH2. It is an essential amino acid, which means that the human body cannot synthesize it. Its codons are AAA and AAG. (Wikipedia)",56-87-1,Mp 224-225 dec. (darkens at 210å¡),NA,NA,1000 mg/mL at 20 oC,-3.05,NA,NA,NA,C00047,5962,NA,NA,1BBU,NA,NA,NA,Lysine,NA,NA,NA,NA,NA,NA,NA,HMDB00182.pdf,application/pdf,46364,2015-02-28 18:09:15 UTC,NA,2,2010-04-08 22:04:35 UTC,2015-10-09 22:29:18 UTC,NA,BCS45-Z:BCS47-B,HMDB00182,LYSINE,DB03252,33655,2071,C00001378,NA,NA,NA,NA,NA,NA,[a]D +37.9 (5M HCl),DFC,C 49.30%; H 9.65%; N 19.16%; O 21.89%,DFC,NA,NA,NA,NA,NA,NA,"pKa3 10.54 (25å¡, 0.1M NaClO4)",DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,-3.76,-3.76,-0.14,NCCCC[C@H](N)C(O)=O,NA,C6H14N2O2,146.1876,"InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/t5-/m0/s1",146.1055277,InChIKey=KDXKERNSBIXSRK-YFKPBYRVSA-N,1.05e+02 g/l,35312,"(2S)-2,6-diaminohexanoic acid",MANUAL,NA,NA,"Lysine, 9CI, INN, USAN; (S)-form",DFC,NA,rw1107871,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",L-alpha-amino acids,Aliphatic acyclic compounds,CHEMBL8085,5747,LYS,TRUE,NA,DB00123,NUTR00037 | DB11101,L-Lysine,56-87-1,K3Z4F929H6,"(S)-2,6-diaminohexanoic acid | (S)-lysine | (S)-Î±,Îµ-diaminocaproic acid | 6-ammonio-L-norleucine | L-2,6-Diaminocaproic acid | L-lys | L-Lysin | LYS | Lysina | Lysine | Lysine acid | Lysinum",KDXKERNSBIXSRK-YFKPBYRVSA-N
KDYFGRWQOYBRFD-UHFFFAOYSA-N,174,HMDB0000254,118.02660868,butanedioic acid,Succinic acid,C4H6O4,110-15-6,C00042,FDB001931,DB00139,NA,SUC,1110,1078,OC(=O)CCC(O)=O,114,Organic compounds,Dicarboxylic acids and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,Dicarboxylic acids and derivatives,Aliphatic acyclic compounds,-0.59,3230,T3D4453,Endogenous,-0.59,Not listed by IARC. Has been implicated in oncogenesis (A15088).,NA,SmallMolecule,118.02660868,butanedioic acid,Succinic acid,C4H6O4,110-15-6,HMDB00254,DB00139,C00042,SUC,1110,1078,OC(=O)CCC(O)=O,Organic compounds,Dicarboxylic acids and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,Dicarboxylic acids and derivatives,Aliphatic acyclic compounds,1931,6011,SmallMoleculeCompound,FDB001931,Succinic acid,TRUE,Solid,low,"Widely distributed in higher plants and prod. by microorganisms. Present in cheeses and fresh meats. Flavour enhancer, pH control agent [DFC]",110-15-6,Mp 184-185å¡,NA,NA,83.2 mg/mL at 25 oC,-0.59,NA,NA,NA,C00042,1110,NA,15741,SIN,NA,NA,NA,Succinic acid,NA,NA,NA,NA,NA,NA,NA,HMDB00254.pdf,application/pdf,48289,2015-02-28 18:05:05 UTC,NA,2,2010-04-08 22:05:10 UTC,2015-10-09 22:28:31 UTC,NA,CBG32-P:CBG32-P,HMDB00254,SUCCINIC-ACID,DB00139,33633,3557,C00001205,Bp 235å¡ dec.,DFC,NA,NA,NA,NA,NA,NA,C 40.68%; H 5.12%; O 54.19%,DFC,NA,NA,NA,NA,NA,NA,"pKa2 5.7 (25å¡, H2O)",DFC,"YALKOWSKY,SH & HE,Y (2003)","HANSCH,C ET AL. (1995)",NA,NA,DFC,-0.53,-0.4,0.25,OC(=O)CCC(O)=O,5.69,C4H6O4,118.088,"InChI=1S/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8)",118.0266087,InChIKey=KDYFGRWQOYBRFD-UHFFFAOYSA-N,2.11e+02 g/l,37237,butanedioic acid,DFC,NA,NA,"Succinic acid, 8CI",DFC,NA,rw1040431,1110,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Dicarboxylic acids and derivatives,Dicarboxylic acids and derivatives,Aliphatic acyclic compounds,CHEMBL576,1078,SUC,TRUE,NA,DB00139,NUTR00054,Succinic acid,110-15-6,AB6MNQ6J6L,"1,2-Ethanedicarboxylic acid | Acide butanedioique | Acide succinique | Acidum succinicum | Amber acid | Asuccin | Bernsteinsaeure | Bernsteinsaure | Butandisaeure | Butanedioic acid | Butanedionic acid | Dihydrofumaric acid | e363 | Ethylenesuccinic acid | HOOC-CH2-CH2-COOH | Spirit of amber | Succinate | Succinic acid",KDYFGRWQOYBRFD-UHFFFAOYSA-N
KFZMGEQAYNKOFK-UHFFFAOYSA-N,685,HMDB0000863,60.057514878,propan-2-ol,Isopropyl alcohol,C3H8O,67-63-0,C01845,FDB008282,DB02325,NA,NA,3776,3644,CC(C)O,4192,Organic compounds,Secondary alcohols,Organic oxygen compounds,Organooxygen compounds,Alcohols and polyols,Aliphatic acyclic compounds,0.05,3397,T3D4699,Exogenous,0.05,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,60.057514878,propan-2-ol,Isopropyl alcohol,C3H8O,67-63-0,HMDB00863,DB02325,C01845,NA,3776,3644,CC(C)O,Organic compounds,Secondary alcohols,Organic oxygen compounds,Organooxygen compounds,Alcohols and polyols,Aliphatic acyclic compounds,8283,20276,SmallMoleculeCompound,FDB008282,2-Propanol,TRUE,Liquid,low,"Present in fruit aromas, e.g. papaya (Carica papaya). Used as an extraction solvent in food preparationIsopropyl alcohol is a colorless, flammable chemical compound with a strong odor. It is the simplest example of a secondary alcohol, where the alcohol carbon is attached to two other carbons sometimes shown as (CH3)2CHOH. It is a structural isomer of propanol.",67-63-0,Mp -88.5å¡,NA,NA,1000 mg/mL at 25 oC,0.05,NA,NA,NA,C01845,3776,NA,17824,IOH,NA,NA,NA,Isopropyl_alcohol,NA,NA,NA,NA,NA,NA,NA,HMDB00863.pdf,application/pdf,52999,2015-02-28 17:49:58 UTC,NA,2,2010-04-08 22:08:00 UTC,2015-10-09 22:30:18 UTC,NA,DFP10-N:DFP10-N,HMDB00863,ISOPROPYL-ALCOHOL,DB02325,NA,1909,NA,Bp 82.5å¡,DFC,NA,NA,d204<vs=1> 0.79,DFC,NA,NA,C 59.96%; H 13.42%; O 26.62%,DFC,NA,NA,n20D<vs=1>  1.3776,DFC,NA,NA,pKa -4.7 (base),DFC,"RIDDICK,JA et al. (1986)","HANSCH,C ET AL. (1995)",NA,NA,DFC,0.04,0.25,0.8,CC(C)O,NA,C3H8O,60.095,"InChI=1S/C3H8O/c1-3(2)4/h3-4H,1-2H3",60.05751488,InChIKey=KFZMGEQAYNKOFK-UHFFFAOYSA-N,3.78e+02 g/l,35552,propan-2-ol,DFC,NA,NA,"2-Propanol, 9CI",DFC,NA,rw1007401,NA,NA,Organic compounds,Organooxygen compounds,Alcohols and polyols,Secondary alcohols,Secondary alcohols,Aliphatic acyclic compounds,CHEMBL582,3644,ISO-PROPANOL,TRUE,NA,DB02325,EXPT01912 | DB04402,Isopropyl Alcohol,67-63-0,ND2M416302,Isopropanol,KFZMGEQAYNKOFK-UHFFFAOYSA-N
KGBXLFKZBHKPEV-UHFFFAOYSA-N,16553,HMDB0035731,62.017524428,boric acid,Boric acid (H3BO3),BH3O3,10043-35-3,C12486,FDB014459,NA,NA,NA,7628,7346,OB(O)O,NA,Inorganic compounds,Miscellaneous borates,Mixed metal/non-metal compounds,Miscellaneous mixed metal/non-metals,Miscellaneous metallic oxoanionic compounds,Acyclic compounds,0.18,2828,T3D3799,Exogenous,0.18,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,62.017524428,boric acid,Boric acid (H3BO3),BH3O3,10043-35-3,HMDB35731,NA,C12486,NA,7628,7346,OB(O)O,Inorganic compounds,Miscellaneous borates,Mixed metal/non-metal compounds,Miscellaneous mixed metal/non-metals,Miscellaneous metallic oxoanionic compounds,Acyclic compounds,14462,38258,SmallMoleculeCompound,FDB014459,Boric acid (H3BO3),TRUE,NA,low,Food contaminant deriving from paper and paperboard in contact with food. V. limited use as an antibacterial agent in caviar,11113-50-1,Mp 171å¡,NA,NA,50 mg/mL at 25 oC,0.18,NA,NA,NA,C12486,7628,NA,33118,BO3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:11:17 UTC,2015-07-20 23:08:09 UTC,NA,JQX55-F:JQX55-F,HMDB35731,BORIC-ACID,NA,NA,354,NA,NA,NA,NA,NA,NA,NA,NA,NA,B 17.48%; H 4.89%; O 77.63%,DFC,NA,NA,NA,NA,NA,NA,9.24,NA,"SHIU,WY et al. (1990)",WHO EHC 204 Boron,NA,NA,DFC,NA,-0.51,NA,OB(O)O,12.11,BH3O3,61.833,InChI=1S/BH3O3/c2-1(3)4/h2-4H,62.01752443,InChIKey=KGBXLFKZBHKPEV-UHFFFAOYSA-N,NA,36342,boric acid,DFC,NA,NA,"Boric acid (H3BO3), 9CI, 8CI, INN, JAN, USAN",DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CHEMBL42403,7346,BORATE,NA,NA,DB11326,NA,Boric acid,10043-35-3,R57ZHV85D4,boracic acid | hydrogen borate | orthoboric acid,KGBXLFKZBHKPEV-UHFFFAOYSA-N
KIDHWZJUCRJVML-UHFFFAOYSA-N,1088,HMDB0001414,88.100048394,"butane-1,4-diamine",Putrescine,C4H12N2,110-60-1,C00134,FDB001494,DB01917,NA,PUTRESCINE,1045,13837702,NCCCCN,3226,Organic compounds,Monoalkylamines,Organic nitrogen compounds,Organonitrogen compounds,Amines,Aliphatic acyclic compounds,-0.7,3090,T3D4169,Endogenous,-0.7,Not listed by IARC.,NA,SmallMolecule,88.100048394,"butane-1,4-diamine",Putrescine,C4H12N2,110-60-1,HMDB01414,DB01917,C00134,PUTRESCINE,1045,13837702,NCCCCN,Organic compounds,Monoalkylamines,Organic nitrogen compounds,Organonitrogen compounds,Amines,Aliphatic acyclic compounds,1494,4592,SmallMoleculeCompound,FDB001494,Putrescine,TRUE,Solid,low,"Putrescine is an organic chemical compound related to cadaverine; both are produced by the breakdown of amino acids in living and dead organisms and both are toxic in large doses. The two compounds are largely responsible for the foul odor of putrefying flesh, but also contribute to the odor of such processes as bad breath and bacterial vaginosis. They are also found in semen and some microalgae, together with related molecules like spermine and spermidine.",110-60-1,27.5 oC,NA,NA,NA,-0.7,NA,NA,NA,C02896,1045,NA,17148,PUT,NA,NA,NA,Putrescine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:04:59 UTC,2015-10-09 22:29:25 UTC,NA,NA,HMDB01414,PUTRESCINE,DB01917,33980,NA,C00001428,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10.8,NA,NA,SANGSTER (1994),NA,NA,NA,-0.98,-0.85,0.43,NCCCCN,NA,C4H12N2,88.1515,InChI=1S/C4H12N2/c5-3-1-2-4-6/h1-6H2,88.10004839,InChIKey=KIDHWZJUCRJVML-UHFFFAOYSA-N,2.36e+02 g/l,39835,"butane-1,4-diamine",BIOSPIDER,NA,NA,NA,KNAPSACK,NA,NA,NA,NA,Organic compounds,Organonitrogen compounds,Amines,Primary amines,Monoalkylamines,Aliphatic acyclic compounds,CHEMBL46257,13837702,PUTRESCINE,TRUE,NA,DB01917,EXPT02702,Putrescine,110-60-1,V10TVZ52E4,NA,KIDHWZJUCRJVML-UHFFFAOYSA-N
KJADKKWYZYXHBB-XBWDGYHZSA-N,2364,HMDB0005034,339.098787343,"[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0\xc2\xb2,\xe2\x81\xb6]dodecan-6-yl]methyl sulfamate",Topiramate,C12H21NO8S,97240-79-4,C07502,FDB023601,NA,NA,NA,5284627,4447672,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,NA,Organic compounds,Dioxolopyrans,Organoheterocyclic compounds,Dioxolopyrans,NA,Aliphatic heteropolycyclic compounds,NA,2210,T3D2733,Exogenous,-0.7,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,339.098787343,"[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0\xc2\xb2,\xe2\x81\xb6]dodecan-6-yl]methyl sulfamate",Topiramate,C12H21NO8S,97240-79-4,HMDB05034,DB00273,C07502,NA,5284627,4447672,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,Organic compounds,Dioxolopyrans,Organoheterocyclic compounds,Dioxolopyrans,NA,Aliphatic heteropolycyclic compounds,23764,NA,SmallMoleculeCompound,FDB023601,Topiramate,TRUE,Solid,low,"Topiramate is an anticonvulsant drug used to treat epilepsy in both children and adults. In children it is also indicated for treatment of Lennox-Gastaut syndrome (a disorder that causes seizures and developmental delays). It is also Food and Drug Administration (FDA) approved, and now most frequently prescribed for, the prevention of migraines. It has been used by psychiatrists to treat bipolar disorder, although it is not FDA approved for this purpose and such use is somewhat controversial. This drug has been investigated for use in treatment of obesity, especially to aid in the reduction of binge eating, and also as a possible treatment for alcoholism. However, these uses are not actively promoted by the manufacturer, and like its use for bipolar disorder, are 'off-label' uses. The drug is also used in clinical trials to treat Post Traumatic Stress Disorder. A pilot study suggests that Topiramate is possibly effective against infantile spasm; Chemically, topiramate is a sulfamate-substituted monosaccharide, related to fructose, a rather unusual chemical structure for an anticonvulsant. Topiramate is quickly absorbed after oral use. Most of the drug (70%) is excreted in the urine as unchanged drug. The remainder is extensively metabolized by hydroxylation, hydrolysis, and glucuronidation. Six metabolites have been identified in humans, none of which constitutes more than 5% of an administered dose. Topiramate enhances GABA-activated chloride channels. In addition, topiramate inhibits excitatory neurotransmission, through actions on kainate and AMPA receptors. There is evidence that topiramate has a specific effect on GluR5 kainate receptors. It is also an inhibitor of carbonic anhydrase, particularly subtypes II and IV, but this action is weak and unlikely to be related to its anticonvulsant actions, but may account for the bad taste and the development of renal stones seen during treatment. Its possible effect as a mood stabilizer seems to occur before anticonvulsant qualities at lower dosages. Topiramate inhibits maximal electroshock and pentylenetetrazol-induced seizures as well as partial and secondarily generalized tonic-clonic seizures in the kindling model, findings predictive of a broad spectrum of antiseizure activities clinically; Johnson. It is used to treat epilepsy in both children and adults. In children it is also indicated for treatment of Lennox-Gastaut syndrome (a disorder that causes seizures and developmental delays). It is also Food and Drug Administration (FDA) approved for, and now most frequently prescribed for, the prevention of migraines. It has been used by psychiatrists to treat bipolar disorder, although it is not FDA approved for this purpose and such use is somewhat controversial. This drug has been investigated for use in treatment of obesity, especially to aid in the reduction of binge eating, and also as a possible treatment for alcoholism. However, these uses are not actively promoted by the manufacturer, and like its use for bipolar disorder, are 'off-label' uses. The drug is also used in clinical trials to treat Post Traumatic Stress Disorder. A pilot study suggests that Topiramate is possibly effective against infantile spasm. In May 2006 the U.S. National Institutes of Health web site clinicaltrials.gov listed several studies sponsored by Ortho-McNeil which propose to examine the use of topiramate on migraine, cluster, and severe headaches within various demographics; Topiramate (brand name: Topamax) is an anticonvulsant drug produced by Ortho-McNeil, a division of Johnson & Topiramate (brand name: Topamax) is an anticonvulsant drug produced by Ortho-McNeil, a division of Johnson & Johnson. It is used to treat epilepsy in both children and adults. In children it is also indicated for treatment of Lennox-Gastaut syndrome (a disorder that causes seizures and developmental delays). It is also Food and Drug Administration (FDA) approved for, and now most frequently prescribed for, the prevention of migraines. It has been used by psychiatrists to treat bipolar disorder, although it is not FDA approved for this purpose and such use is somewhat controversial. This drug has been investigated for use in treatment of obesity, especially to aid in the reduction of binge eating, and also as a possible treatment for alcoholism. However, these uses are not actively promoted by the manufacturer, and like its use for bipolar disorder, are 'off-label' uses. The drug is also used in clinical trials to treat Post Traumatic Stress Disorder. A pilot study suggests that Topiramate is possibly effective against infantile spasm. In May 2006 the U.S. National Institutes of Health web site clinicaltrials.gov listed several studies sponsored by Ortho-McNeil which propose to examine the use of topiramate on migraine, cluster, and severe headaches within various demographics. [HMDB]",97240-79-4,NA,NA,NA,NA,NA,NA,NA,NA,C07502,5284627,NA,NA,TOR,NA,NA,NA,Topiramate,NA,NA,NA,NA,NA,NA,NA,HMDB05034.pdf,application/pdf,58751,2015-02-28 18:10:17 UTC,NA,NA,2011-09-21 00:32:15 UTC,2015-07-21 06:57:47 UTC,NA,NA,HMDB05034,NA,DB00273,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.29,0.126959734,-1.7,[H]N([H])S(=O)(=O)OC([H])([H])[C@]12OC(O[C@@]1([H])[C@]1([H])OC(O[C@]1([H])C([H])([H])O2)(C([H])([H])[H])C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H],NA,C12H21NO8S,339.362,"InChI=1S/C12H21NO8S/c1-10(2)18-7-5-16-12(6-17-22(13,14)15)9(8(7)19-10)20-11(3,4)21-12/h7-9H,5-6H2,1-4H3,(H2,13,14,15)/t7-,8-,9+,12+/m1/s1",339.0987873,InChIKey=KJADKKWYZYXHBB-XBWDGYHZSA-N,6.80e+00 g/l,81760,"[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0^{2,6}]dodecan-6-yl]methyl sulfamate",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Dioxolopyrans,NA,Dioxolopyrans,Aliphatic heteropolycyclic compounds,CHEMBL220492,4447672,NA,NA,NA,DB00273,APRD00237,Topiramate,97240-79-4,0H73WJJ391,"2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate | 2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate | McN-4853 | RWJ-17021 | Tipiramate | Tipiramato | Topiramate | Topiramato | Topiramatum | TPM",KJADKKWYZYXHBB-XBWDGYHZSA-N
KJPRLNWUNMBNBZ-QPJJXVBHSA-N,1879,HMDB0003441,132.057514878,(2E)-3-phenylprop-2-enal,Cinnamaldehyde,C9H8O,104-55-2,C00903,FDB008781,NA,NA,CINNAMALDEHYDE,637511,553117,[H]C(=O)\C=C\C1=CC=CC=C1,6931,Organic compounds,Cinnamaldehydes,Phenylpropanoids and polyketides,Cinnamaldehydes,NA,Aromatic homomonocyclic compounds,1.9,3658,T3D4985,Exogenous,1.9,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,132.057514878,(2E)-3-phenylprop-2-enal,Cinnamaldehyde,C9H8O,104-55-2,HMDB03441,NA,C00903,CINNAMALDEHYDE,637511,553117,[H]\C(C=O)=C(\[H])C1=CC=CC=C1,NA,NA,NA,NA,NA,NA,8783,21834,SmallMoleculeCompound,FDB008782,(E)-3-Phenyl-2-propenal,TRUE,liquid,low,"Constit. of cinnamon and cassia oils. Used in perfumery and flavour industriesCinnamaldehyde is the organic compound that gives cinnamon its flavor and odor. This pale yellow viscous liquid occurs naturally in the bark of cinnamon trees and other species of the genus Cinnamomum. The essential oil of cinnamon bark is about 90% cinnamaldehyde. (Wikipedia)",14371-10-9,Fp -7.5å¡,NA,NA,NA,1.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Cinnamaldehyde,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:08:15 UTC,2015-07-20 22:26:06 UTC,NA,DXH04-W:DXH05-X,NA,(E)-CINNAMALDEHYDE|TRANS-CINNAMALDEHYDE,NA,NA,NA,C00035187,Bp20 130å¡,DFC,NA,NA,d204<vs=1> 1.05,DFC,NA,NA,C 81.79%; H 6.10%; O 12.11%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HANSCH,C ET AL. (1995)",NA,NA,DFC,2,1.98,-2.51,O=C\C=C\C1=CC=CC=C1,NA,C9H8O,132.1592,InChI=1S/C9H8O/c10-8-4-7-9-5-2-1-3-6-9/h1-8H/b7-4+,132.0575149,InChIKey=KJPRLNWUNMBNBZ-QPJJXVBHSA-N,4.09e-01 g/l,32719,(2E)-3-phenylprop-2-enal,MANUAL,NA,NA,"3-Phenyl-2-propenal, 9CI; (E)-form",DFC,14371-10-9,rw1092691,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB14184,NA,Cinnamaldehyde,14371-10-9,NA,(3E)-3-phenylprop-2-enal | (E)-3-Phenyl-2-propenal | (E)-3-Phenyl-propenal | (E)-3-Phenylpropenal | 3-phenylacrylaldehyde | Cinnamal | trans-Cinnamaldehyde | trans-Cinnamic aldehyde | Zimtaldehyde,KJPRLNWUNMBNBZ-QPJJXVBHSA-N
KQKPFRSPSRPDEB-UHFFFAOYSA-N,2367,HMDB0005037,295.135447621,1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide,Sumatriptan,C14H21N3O2S,103628-46-2,C07319,FDB023604,NA,NA,NA,5358,5165,CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1,2612,Organic compounds,Tryptamines and derivatives,Organoheterocyclic compounds,Indoles and derivatives,Tryptamines and derivatives,Aromatic heteropolycyclic compounds,0.93,2295,T3D2856,Exogenous,0.93,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,295.135447621,1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide,Sumatriptan,C14H21N3O2S,103628-46-2,HMDB05037,DB00669,C07319,NA,5358,5165,CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1,Chemical entities,Tryptamines and derivatives,Organic compounds,Organoheterocyclic compounds,Indoles and derivatives,Aromatic heteropolycyclic compounds,23767,NA,SmallMoleculeCompound,FDB023604,Sumatriptan,TRUE,Solid,low,"Oftentimes, serotonin levels in the brain become extremely erratic before the onset of a migraine. In an attempt to stabilize this, sumatriptan is administered to help aid in leveling the serotonin levels in the brain. Sumatriptan is structurally similar to serotonin, and is a 5-HT (5-HT1D) agonist, which is one of the receptors that serotonin binds to. The specific receptor subtype it activates is present in the cranial and basilar arteries. Activation of these receptors causes vasoconstriction of those dilated arteries. Sumatriptan is also shown to decrease the activity of the trigeminal nerve.; Sumatriptan is a triptan drug including a sulfonamide group structurally similar to serotonin, and is a 5-HT (5-HT1D) agonist, which is one of the receptors that serotonin binds to. Oftentimes, serotonin levels in the brain become extremely erratic before the onset of a migraine. In an attempt to stabilize this, sumatriptan is administered to help aid in leveling the serotonin levels in the brain.; A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of migraines.; Sumatriptan (Imitrex, Imigran,Imigran Recovery ) is a triptan drug including a sulfonamide group which was originally developed by Glaxo for the treatment of migraine headaches. [HMDB]",103628-46-2,NA,NA,NA,NA,NA,NA,NA,NA,C07319,5358,NA,10650,NA,NA,NA,NA,Sumatriptan,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2011-09-21 00:32:17 UTC,2015-07-21 06:57:47 UTC,NA,NA,HMDB05037,NA,DB00669,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.17,0.741928861,-3.37,[H]N(C([H])([H])[H])S(=O)(=O)C([H])([H])C1=C([H])C2=C(N([H])C([H])=C2C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])C([H])=C1[H],17.14019572,C14H21N3O2S,295.4,"InChI=1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3",295.1354476,InChIKey=KQKPFRSPSRPDEB-UHFFFAOYSA-N,1.27e-01 g/l,81651,1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Indoles and derivatives,Tryptamines and derivatives,Tryptamines and derivatives,Aromatic heteropolycyclic compounds,CHEMBL128,5165,NA,NA,NA,DB00669,APRD00379,Sumatriptan,103628-46-2,8R78F6L9VO,(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide | 1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide | 3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide | 3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide | NP101 | Sumatran | Sumatriptan | SumatriptÃ¡n | Sumatriptan Succinate | Sumatriptanum | Sumax | triptan,KQKPFRSPSRPDEB-UHFFFAOYSA-N
KRHYYFGTRYWZRS-UHFFFAOYSA-M,517,HMDB0000662,18.998403205,fluoride,Fluoride,F,7782-41-4,C00742,FDB003770,NA,DBMET00504,NA,28179,26214,[F-],NA,Inorganic compounds,Homogeneous halogens,Homogeneous non-metal compounds,Homogeneous halogens,NA,NA,NA,172,T3D0211,Exogenous,NA,Inorganic fluorides used in drinking-water are not classifiable as to their carcinogenicity to humans (Group 3). (L135),25 ppm over 5 minutes for an adult human. (L138),SmallMolecule,18.998951785,fluoride,Fluorine,F,7782-41-4,HMDB00662,NA,C00742,NA,28179,26214,[F-],Chemical entities,Homogeneous halogens,Inorganic compounds,Homogeneous non-metal compounds,Homogeneous halogens,NA,3771,11455,SmallMoleculeCompound,FDB003770,Fluorine,TRUE,Gas,low,"Fluorine is the chemical element with atomic number 9, represented by the symbol F. It is the lightest halogen. Under normal conditions, elemental fluorine is a yellow-green gas consisting of diatomic molecules, F2. (Wikipedia)",16984-48-8,-219.61 oC,NA,NA,0.00169 mg/mL at 25 oC,NA,NA,NA,NA,C00742,28179,NA,30236,F,NA,NA,NA,Fluorine,NA,NA,CAS number given for difluorine.,NA,NA,NA,NA,HMDB00662.pdf,application/pdf,75183,2015-02-28 18:01:49 UTC,NA,2,2010-04-08 22:05:57 UTC,2015-07-20 21:57:07 UTC,NA,NA,HMDB00662,FLUORINE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MCCRADY,JK et al. (1985)",NA,NA,NA,NA,NA,0.14883864,NA,[F-],NA,F,18.9984032,InChI=1S/FH/h1H/p-1,18.99840321,InChIKey=KRHYYFGTRYWZRS-UHFFFAOYSA-M,NA,89495,fluoride,HMDB,NA,NA,NA,DUKE,NA,NA,NA,NA,Inorganic compounds,Homogeneous non-metal compounds,Homogeneous halogens,NA,Homogeneous halogens,Acyclic compounds,CHEMBL1362,26214,F-,NA,NA,DB11257,NA,Fluoride ion,16984-48-8,Q80VPU408O,NA,KRHYYFGTRYWZRS-UHFFFAOYSA-M
KSFOVUSSGSKXFI-UJJXFSCMSA-N,163,HMDB0000241,562.258005596,"3-[20-(2-carboxyethyl)-9,14-diethenyl-5,10,15,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1\xc2\xb3,\xe2\x81\xb6.1\xe2\x81\xb8,\xc2\xb9\xc2\xb9.1\xc2\xb9\xc2\xb3,\xc2\xb9\xe2\x81\xb6]tetracosa-1(21),2,4,6,8(23),9,11,13,15,17,19-undecaen-4-yl]propanoic acid",Protoporphyrin IX,C34H34N4O4,553-12-8,C02191,FDB004277,DB02285,NA,PROTOPORPHYRIN_IX,NA,10469486,CC1=C(CCC(O)=O)/C2=C/C3=N/C(=C\C4=C(C)C(C=C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C=C)=C4C)/C(C)=C3CCC(O)=O,4158,Organic compounds,Porphyrins,Organoheterocyclic compounds,Tetrapyrroles and derivatives,Porphyrins,Aromatic heteropolycyclic compounds,NA,3227,T3D4440,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,562.258005596,"3-[20-(2-carboxyethyl)-9,14-diethenyl-5,10,15,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1\xc2\xb3,\xe2\x81\xb6.1\xe2\x81\xb8,\xc2\xb9\xc2\xb9.1\xc2\xb9\xc2\xb3,\xc2\xb9\xe2\x81\xb6]tetracosa-1(21),2,4,6,8(23),9,11,13,15,17,19-undecaen-4-yl]propanoic acid",Protoporphyrin IX,C34H34N4O4,553-12-8,HMDB00241,DB02285,C02191,PROTOPORPHYRIN_IX,NA,10469486,[H]\C-1=C2\N\C(=C([H])/C3=N/C(=C([H])\C4=C(C)C(CCC(O)=O)=C(N4)\C([H])=C4/N=C-1C(C)=C4CCC(O)=O)/C(C=C)=C3C)C(C=C)=C2C,NA,NA,NA,NA,NA,NA,4278,12577,SmallMoleculeCompound,FDB004277,Protoporphyrin,TRUE,Solid,low,"Obt. by demetallation of Haemin, occurs in small amounts in faeces. Brown pigment (Ooporphyrin) of birds' eggs. Isol. from Atolla wyvillei (CCD)",553-12-8,Mp 300å¡,NA,NA,0.169 mg/mL at 25 oC,NA,NA,NA,NA,C02191,4971,NA,15430,1HBG,NA,NA,NA,Protoporphyrin IX,NA,NA,NA,NA,NA,NA,NA,HMDB00241.pdf,application/pdf,39932,2015-02-28 18:03:05 UTC,NA,2,2010-04-08 22:06:10 UTC,2015-10-09 22:29:40 UTC,NA,HDX23-L:HDX23-L,HMDB00241,PROTOPORPHYRIN,DB02285,39293,NA,C00007370,NA,NA,NA,NA,NA,NA,NA,NA,C 72.58%; H 6.09%; N 9.96%; O 11.37%,CCD,Reddish-purple cryst.,CCD,NA,NA,"[neutral]?max557;582;602 ( dication, aq. HCl)",CCD,NA,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)",NA,NA,NA,CCD,4.4,6.75,-4.41,CC1=C2NC(\C=C3/N=C(/C=C4NC(=C\C5=N\C(=C/2)\C(C)=C5CCC(O)=O)/C(CCC(O)=O)=C\4C)C(C=C)=C/3C)=C1C=C,4.13,C34H34N4O4,562.6582,"InChI=1S/C34H34N4O4/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25/h7-8,13-16,35,38H,1-2,9-12H2,3-6H3,(H,39,40)(H,41,42)/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-",562.2580056,InChIKey=KSFOVUSSGSKXFI-UJJXFSCMSA-N,2.17e-02 g/l,39739,"3-[20-(2-carboxyethyl)-10,15-diethenyl-5,9,14,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1,3(24),4,6,8,10,12,14,16(22),17,19-undecaen-4-yl]propanoic acid",MANUAL,NA,NA,NA,DUKE,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Tetrapyrroles and derivatives,Porphyrins,Porphyrins,Aromatic heteropolycyclic compounds,CHEMBL1325592,10469486,PROTOPORPHYRIN_IX,TRUE,NA,DB02285,EXPT02636,Protoporphyrin,553-12-8,C2K325S808,Protoporphyrin IX,KSFOVUSSGSKXFI-UJJXFSCMSA-N
KVWDHTXUZHCGIO-UHFFFAOYSA-N,2348,HMDB0005012,312.14086735,"5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0\xc2\xb3,\xe2\x81\xb7]tetradeca-1(14),3(7),5,8,10,12-hexaene",Olanzapine,C17H20N4S,132539-06-1,C07322,FDB023585,NA,NA,NA,NA,10442212,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,NA,Organic compounds,Benzodiazepines,Organoheterocyclic compounds,Benzodiazepines,NA,Aromatic heteropolycyclic compounds,NA,2226,T3D2754,Exogenous,2,Not listed by IARC.,"Death has been reported after an acute overdose of 0.45 g, but also survival after an acute overdose of 1500 g. (A308)",SmallMolecule,312.14086735,"5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0\xc2\xb3,\xe2\x81\xb7]tetradeca-1(14),3(7),5,8,10,12-hexaene",Olanzapine,C17H20N4S,132539-06-1,HMDB05012,DB00334,C07322,NA,4585,10442212,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Chemical entities,Benzodiazepines,Organic compounds,Organoheterocyclic compounds,Benzodiazepines,Aromatic heteropolycyclic compounds,23748,NA,SmallMoleculeCompound,FDB023585,Olanzapine,TRUE,Solid,low,"Olanzapine was the third atypical antipsychotic to gain approval by the Food and Drug Administration (FDA) and has become one of the most commonly used atypical antipsychotics. Olanzapine has been approved by the FDA for the treatment of schizophrenia, acute mania in bipolar disorder, agitation associated with schizophrenia and bipolar disorder, and as maintenance treatment in bipolar disorder and psychotic depression.It has also been established in treating depression off-label because of its mood-stabilizing properties and its ability to increase the efficacy of antidepressants. Olanzapine is manufactured and marketed by the pharmaceutical company Eli Lilly and Company. It is available as a pill that comes in the strengths of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, and 20 mg and as as Zydis orally disintegrating tablets in the strengths of 5 mg, 10 mg, 15 mg, and 20 mg. It is also available as a rapid-acting intramuscular injection for short term acute use.; Olanzapine (oh-LAN-za-peen, sold as Zyprexa, Zydis, or in combination with fluoxetine, as Symbyax) was the third atypical antipsychotic to gain approval by the Food and Drug Administration (FDA) and has become one of the most commonly used atypical antipsychotics. Olanzapine has been approved by the FDA for the treatment of schizophrenia, acute mania in bipolar disorder, agitation associated with schizophrenia and bipolar disorder, and as maintenance treatment in bipolar disorder and psychotic depression. [HMDB]",132539-06-1,NA,NA,NA,NA,NA,NA,NA,NA,C07322,4585,NA,NA,NA,NA,NA,NA,Olanzapine,NA,NA,NA,NA,NA,NA,NA,HMDB05012.pdf,application/pdf,60926,2015-02-28 17:47:28 UTC,NA,NA,2011-09-21 00:31:59 UTC,2015-07-21 06:57:46 UTC,NA,NA,HMDB05012,NA,DB00334,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3.61,3.388495082,-3.52,[H]N1C2=C(C([H])=C(S2)C([H])([H])[H])C(=NC2=C([H])C([H])=C([H])C([H])=C12)N1C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C1([H])[H],NA,C17H20N4S,312.432,"InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3",312.1408674,InChIKey=KVWDHTXUZHCGIO-UHFFFAOYSA-N,9.42e-02 g/l,85982,"5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(14),3(7),5,8,10,12-hexaene",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Benzodiazepines,NA,Benzodiazepines,Aromatic heteropolycyclic compounds,CHEMBL715,10442212,NA,NA,NA,DB00334,APRD00138,Olanzapine,132539-06-1,N7U69T4SZR,"2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine | Olanzapin | Olanzapina | Olanzapine | Olanzapinum",KVWDHTXUZHCGIO-UHFFFAOYSA-N
KWGRBVOPPLSCSI-WCBMZHEXSA-N,1297,HMDB0001943,165.115364107,"(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol",Pseudoephedrine,C10H15NO,90-82-4,C02765,FDB022758,NA,NA,NA,7028,6761,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1,2189,Organic compounds,Phenylpropanes,Benzenoids,Benzene and substituted derivatives,Phenylpropanes,Aromatic homomonocyclic compounds,0.89,3314,T3D4555,Exogenous,0.89,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,165.115364107,"(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol",Pseudoephedrine,C10H15NO,90-82-4,NA,DB00852,C02765,NA,7028,6761,[H][C@@](C)(NC)[C@@]([H])(O)C1=CC=CC=C1,Chemical entities,Phenylpropanes,Organic compounds,Benzenoids,Benzene and substituted derivatives,Aromatic homomonocyclic compounds,22921,NA,SmallMoleculeCompound,FDB022758,Pseudoephedrine,TRUE,Solid,low,"Pseudoephedrine (commonly abbreviated as PSE) is a sympathomimetic amine commonly used as a decongestant. The salts pseudoephedrine hydrochloride and pseudoephedrine sulfate are found in many over-the-counter preparations either as single ingredient preparations, or more commonly in combination with antihistamines, paracetamol and/or ibuprofen. Consumers often refer to it by a product which contains pseudoephedrine, such as Sudafed, the trademark for a common brand of pseudoephedrine hydrochloride in North America; Pseudoephedrine is a phenethylamine, and an isomer of ephedrine. Pseudoephedrine is the International Nonproprietary Name (INN) of the (1S,2S)- diastereomer of ephedrine (which has 1R,2S- configuration). Other names are (+)-pseudoephedrine and D-pseudoephedrine. (Reynolds, 1989) (-)-(1R,2R)-Pseudoephedrine is not used clinically, since it is associated with greater central nervous system (CNS) stimulatory effects. (+)-(1S,2S)-Pseudoephedrine is a less-potent CNS stimulant, yet it retains its efficacy as a decongestant. -- Wikipedia; Pseudoephedrine is a sympathomimetic amine - that is, its principal mechanism of action relies on its indirect action on the adrenergic receptor system. While it may have weak agonist activity at adrenergic receptors, the principal mechanism is to displace noradrenaline from storage vesicles in presynaptic neurons. The displaced noradrenaline is released into the neuronal synapse where it is free to activate the aforementioned postsynaptic adrenergic receptors. -- Wikipedia; Pseudoephedrine is a phenethylamine, and an isomer of ephedrine. Pseudoephedrine is the International Nonproprietary Name (INN) of the (1S,2S)- diastereomer of ephedrine (which has 1R,2S- configuration). Other names are (+)-pseudoephedrine and D-pseudoephedrine (Reynolds, 1989). The enantiomer (-)-(1R,2R)-Pseudoephedrine has fewer side-effects, fewer central nervous system (CNS) stimulatory effects, does not reduce to d-methamphetamine, yet retains its efficacy as a decongestant.[citation needed] However, the patent holder for (-)-Pseudoephedrine (Pfizer/Warner-Lambert) has not yet sought or received government approval for its sale to the public.(US Patent 6,495,529); Treatment for urinary incontinence is an unlabeled use for these medications. Unlabeled use means doctors can use the medication to treat a condition other than that for which it was first approved by the U.S. Food and Drug Administration (FDA). These medications are approved by the FDA for the treatment of nasal congestion caused by colds or allergies. However it has also been succesful in treating stress incontinence by increasing the pressure (tension) exerted by the muscles of the bladder neck and the urethra, which helps retain the urine within the bladder; An alpha and beta adrenergic agonist that may also enhance release of norepinephrine. It has been used in the treatment of several disorders including asthma, heart failure, rhinitis, and urinary incontinence, and for its central nervous system stimulatory effects in the treatment of narcolepsy and depression. It has become less extensively used with the advent of more selective agonists; Pseudoephedrine is a sympathomimetic amine commonly used as a decongestant. The salts pseudoephedrine hydrochloride and pseudoephedrine sulfate are found in many over-the-counter preparations either as single-ingredient preparations, or more commonly in combination with antihistamines, paracetamol and/or ibuprofen. It is often referred to by consumers as Sudafed, which is the trademark for a common brand of pseudoephedrine hydrochloride. -- Wikipedia; Pseudoephedrine is a sympathomimetic amine - that is, its principal mechanism of action relies on its indirect action on the adrenergic receptor system. While it may have weak agonist activity at alpha and beta adrenergic receptors, the principal mechanism is to displace noradrenaline from storage vesicles in presynaptic neurons. The displaced noradrenaline is released into the neuronal synapse where it is free to activate the aforementioned postsynaptic adrenergic receptors. [HMDB]",90-82-4,NA,NA,NA,NA,NA,NA,NA,NA,C02765,7028,NA,NA,NA,NA,NA,NA,Pseudoephedrine,NA,NA,NA,NA,NA,NA,NA,HMDB01943.pdf,application/pdf,139955,2015-02-28 18:10:14 UTC,NA,NA,2011-09-21 00:19:09 UTC,2015-10-09 22:31:18 UTC,NA,NA,HMDB01943,NA,DB00852,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1.317834728,-1.3,[H]O[C@@]([H])(C1=C([H])C([H])=C([H])C([H])=C1[H])[C@@]([H])(N([H])C([H])([H])[H])C([H])([H])[H],NA,C10H15NO,165.2322,"InChI=1S/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10+/m0/s1",165.1153641,InChIKey=KWGRBVOPPLSCSI-WCBMZHEXSA-N,8.26e+00 g/l,86216,"(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenylpropanes,Phenylpropanes,Aromatic homomonocyclic compounds,CHEMBL1590,6761,CPD-9954,TRUE,NA,DB00852,APRD00634,Pseudoephedrine,90-82-4,7CUC9DDI9F,"(+) threo-2-(methylamino)-1-phenyl-1-propanol | (+)-(1S,2S)-Pseudoephedrine | (+)-Pseudoephedrine | (+)-psi-Ephedrine | (+)-threo-Ephedrine | d-Isoephedrine | d-Pseudoephedrine | d-psi-2-Methylamino-1-phenyl-1-propanol | d-psi-Ephedrine | Isoephedrine | L-(+)-Pseudoephedrine | L(+)-psi-Ephedrine | Pseudoefedrina | pseudoÃ©phÃ©drine | Pseudoephedrine D-form | Pseudoephedrinum | Psi-ephedrin | Psi-ephedrine | trans-Ephedrine | Ï-ephedrine",KWGRBVOPPLSCSI-WCBMZHEXSA-N
KXDHJXZQYSOELW-UHFFFAOYSA-N,1911,HMDB0003551,61.016378345,carbamic acid,Carbamic acid,CH3NO2,463-77-4,C01563,FDB023195,NA,NA,NA,277,271,NC(O)=O,6950,Organic compounds,Organic carbonic acids and derivatives,Organic acids and derivatives,Organic carbonic acids and derivatives,NA,Aliphatic acyclic compounds,NA,3123,T3D4202,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,61.016378345,carbamic acid,Carbamic acid,CH3NO2,463-77-4,HMDB03551,DB04261,C01563,NA,277,271,NC(O)=O,Chemical entities,Carbamic acids,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Aliphatic acyclic compounds,23358,NA,SmallMoleculeCompound,FDB023195,Carbamic acid,TRUE,Solid,low,"Carbamic acid is occasionally found as carbamate in workers exposed to pesticides. Carbamates, particularly carbofuran, seem to be more associated with exuberant and diversified symptomatology of pesticide exposure than organophosphates.  Neurological symptoms occur among farmers occupationally exposed to acetylcholinesterase-inhibiting insecticides such as carbamates. Carbamic acid products of several amines, such as beta-N-methylamino-L-alanine (BMAA), ethylenediamine, and L-cysteine have been implicated in toxicity. Studies suggested that a significant portion of amino-compounds in biological samples (that naturally contain CO2/bicarbonate) can be present as a carbamic acid. The formation of carbamate glucuronide metabolites has been described for numerous pharmaceuticals and they have been identified in all of the species commonly used in drug metabolism studies (rat, dog, mouse, rabbit, guinea pig, and human). There has been no obvious species specificity for their formation and no preference for 1 or 2 degree amines. Many biological reactions have also been described in the literature that involve the reaction of CO2 with amino groups of biomolecules. For example, CO2 generated from cellular respiration is expired in part through the reversible formation of a carbamate between CO2 and the -amino groups of the alpha and beta-chains of hemoglobin. Glucuronidation is an important mechanism used by mammalian systems to clear and eliminate both endogenous and foreign chemicals. Many functional groups are susceptible to conjugation with glucuronic acid, including hydroxyls, phenols, carboxyls, activated carbons, thiols, amines, and selenium. Primary and secondary amines can also react with carbon dioxide (CO2) via a reversible reaction to form a carbamic acid. The carbamic acid is also a substrate for glucuronidation and results in a stable carbamate glucuronide metabolite. The detection and characterization of these products has been facilitated greatly by the advent of soft ionization mass spectrometry techniques and high field NMR instrumentation. (PMID: 16268118, 17168688, 12929145) [HMDB]",463-77-4,NA,NA,NA,NA,NA,NA,NA,NA,C01563,277,NA,28616,OUT,NA,NA,NA,Carbamic acid,NA,NA,NA,NA,NA,NA,NA,HMDB03551.pdf,application/pdf,74745,2015-02-28 17:51:11 UTC,NA,NA,2011-09-21 00:26:07 UTC,2015-07-21 06:57:35 UTC,NA,NA,HMDB03551,NA,DB04261,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-1.1,-0.556891248,0.79,[H]OC(=O)N([H])[H],NA,CH3NO2,61.04,"InChI=1S/CH3NO2/c2-1(3)4/h2H2,(H,3,4)",61.01637835,InChIKey=KXDHJXZQYSOELW-UHFFFAOYSA-N,3.79e+02 g/l,83699,carbamic acid,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Carbamic acids,Aliphatic acyclic compounds,CHEMBL125278,271,NA,NA,NA,DB04261,EXPT02453,Carbamic Acid,463-77-4,O0UC6XOS4H,NA,KXDHJXZQYSOELW-UHFFFAOYSA-N
KZNIFHPLKGYRTM-UHFFFAOYSA-N,1424,HMDB0002124,270.05282343,"5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one",Apigenin,C15H10O5,520-36-5,C01477,FDB002798,NA,NA,CPD-431,5280443,4444100,OC1=CC=C(C=C1)C1=CC(=O)C2=C(O)C=C(O)C=C2O1,3397,Organic compounds,Flavones,Phenylpropanoids and polyketides,Flavonoids,Flavones,Aromatic heteropolycyclic compounds,3.02,3571,T3D4888,Exogenous,3.02,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,270.05282343,"5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one",Apigenin,C15H10O5,520-36-5,HMDB02124,DB07352,C01477,CPD-431,5280443,4444100,OC1=CC=C(C=C1)C1=CC(=O)C2=C(O)C=C(O)C=C2O1,Organic compounds,Flavones,Phenylpropanoids and polyketides,Flavonoids,Flavones,Aromatic heteropolycyclic compounds,2798,8629,SmallMoleculeCompound,FDB002798,Apigenin,TRUE,Solid,low,"Flavone found in a wide variety of foodstuffs; buckwheat, cabbage, celeriac, celery, lettuce, oregano, parsley, peppermint, perilla, pummelo juice, thyme, sweet potatoes, green tea and wild carrot [DFC]",520-36-5,Mp 352å¡,NA,NA,NA,3.02,NA,NA,NA,C01477,5280443,NA,NA,AGI,NA,NA,NA,Apigenin,NA,NA,NA,NA,NA,NA,NA,HMDB02124.pdf,application/pdf,179646,2015-02-28 18:00:51 UTC,NA,2,2010-04-08 22:05:31 UTC,2015-07-20 21:48:28 UTC,228,CNR54-G:CNR54-G,HMDB02124,APIGENIN,DB07352,NA,NA,C00003817,NA,NA,NA,NA,NA,NA,NA,NA,C 66.67%; H 3.73%; O 29.60%,DFC,NA,NA,NA,NA,340 (e 20900) (MeOH) (Berdy),DFC,NA,NA,NA,"PERRISSOUD,D & TESTA,B (1986)",NA,NA,DFC,3.07,2.71,-3.36,OC1=CC=C(C=C1)C1=CC(=O)C2=C(O1)C=C(O)C=C2O,8.63,C15H10O5,270.2369,"InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-7,16-18H",270.0528234,InChIKey=KZNIFHPLKGYRTM-UHFFFAOYSA-N,1.18e-01 g/l,35770,"5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one",DFC,NA,NA,"4',5,7-Trihydroxyflavone",DFC,NA,NA,NA,NA,Organic compounds,Phenylpropanoids and polyketides,Flavonoids,Flavones,Flavones,Aromatic heteropolycyclic compounds,CHEMBL28,4444100,CPD-431,NA,NA,DB07352,NA,Apigenin,520-36-5,7V515PI7F6,NA,KZNIFHPLKGYRTM-UHFFFAOYSA-N
KZSNJWFQEVHDMF-BYPYZUCNSA-N,702,HMDB0000883,117.078978601,(2S)-2-amino-3-methylbutanoic acid,L-Valine,C5H11NO2,72-18-4,C00183,FDB000465,DB00161,NA,VAL,6287,6050,CC(C)[C@H](N)C(O)=O,5842,Organic compounds,Valine and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,-2.26,3212,T3D4370,Endogenous,-2.26,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,117.078978601,(2S)-2-amino-3-methylbutanoic acid,L-Valine,C5H11NO2,72-18-4,HMDB00883,DB00161,C00183,VAL,6287,6050,[H][C@](N)(C(C)C)C(O)=O,Organic compounds,Valine and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,4906,13939,SmallMoleculeCompound,FDB004905,(+)-Valine,TRUE,NA,low,NA,72-18-4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:06:27 UTC,2017-02-23 19:50:38 UTC,NA,NA,NA,(+)-VALINE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CC(C)[C@H](N)C(O)=O,NA,C5H11NO2,117.1463,"InChI=1S/C5H11NO2/c1-3(2)4(6)5(7)8/h3-4H,6H2,1-2H3,(H,7,8)/t4-/m0/s1",117.0789786,KZSNJWFQEVHDMF-BYPYZUCNSA-N,NA,NA,NA,NA,NA,NA,NA,DUKE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB00161,NUTR00060,L-Valine,72-18-4,HG18B9YRS7,(2S)-2-Amino-3-methylbutanoic acid | (S)-Valine | 2-Amino-3-methylbutyric acid | L-(+)-alpha-Aminoisovaleric acid | L-alpha-Amino-beta-methylbutyric acid | Val | Valine,KZSNJWFQEVHDMF-BYPYZUCNSA-N
LCTONWCANYUPML-UHFFFAOYSA-N,164,HMDB0000243,88.016043994,2-oxopropanoic acid,Pyruvic acid,C3H4O3,127-17-3,C00022,FDB008293,DB00119,NA,PYRUVATE,1060,1031,CC(=O)C(O)=O,117,Organic compounds,Alpha-keto acids and derivatives,Organic acids and derivatives,Keto acids and derivatives,Alpha-keto acids and derivatives,Aliphatic acyclic compounds,NA,3187,T3D4325,Endogenous,-0.5,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,88.016043994,2-oxopropanoic acid,Pyruvic acid,C3H4O3,127-17-3,HMDB00243,DB00119,C00022,PYRUVATE,1060,1031,CC(=O)C(O)=O,Organic compounds,Alpha-keto acids and derivatives,Organic acids and derivatives,Keto acids and derivatives,Alpha-keto acids and derivatives,Aliphatic acyclic compounds,31304,NA,SmallMoleculeCompound,FDB031141,pyruvate,TRUE,NA,NA,NA,127-17-3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2015-05-07 21:08:21 UTC,2017-03-11 23:06:41 UTC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CC(=O)C(O)=O,NA,C3H4O3,88.0621,"InChI=1S/C3H4O3/c1-2(4)3(5)6/h1H3,(H,5,6)",88.01604399,LCTONWCANYUPML-UHFFFAOYSA-N,NA,NA,NA,NA,NA,NA,NA,MANUAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB00119,NUTR00050 | DB11194,Pyruvic acid,127-17-3,8558G7RUTR,2-ketopropionic acid | 2-oxopropanoic acid | 2-OxopropansÃ¤ure | 2-OxopropionsÃ¤ure | a-Ketopropionic acid | Acetylformic acid | acide pyruvique | alpha-ketopropionic acid | BrenztraubensÃ¤ure | BTS | Pyroracemic acid | Î±-ketopropionic acid | Î±-OxopropionsÃ¤ure,LCTONWCANYUPML-UHFFFAOYSA-N
LFQSCWFLJHTTHZ-UHFFFAOYSA-N,70,HMDB0000108,46.041864814,ethanol,Ethanol,C2H6O,64-17-5,C00469,FDB000753,DB00898,NA,ETOH,702,682,CCO,3203,Organic compounds,Primary alcohols,Organic oxygen compounds,Organooxygen compounds,Alcohols and polyols,Aliphatic acyclic compounds,-0.31,662,T3D0770,Endogenous,-0.31,Ethanol in alcoholic beverages is carcinogenic to humans (Group 1). (L135),"The fatal dose of ethanol is 300-400 mL of pure ethanol (600-800 mL of 50% spirits), for the average adult if consumed in less than one hour. More specifically, the lethal dose of alcohol is 5-8g/kg (3g/kg for children).",SmallMolecule,46.041864814,ethanol,Ethanol,C2H6O,64-17-5,HMDB00108,DB00898,C00469,ETOH,702,682,CCO,Organic compounds,Primary alcohols,Organic oxygen compounds,Organooxygen compounds,Alcohols and polyols,Aliphatic acyclic compounds,753,2050,SmallMoleculeCompound,FDB000753,Ethanol,TRUE,Liquid,low,"Intoxicating constit. of all alcoholic beverages. Used as a solvent and vehicle for food dressings and flavourings. Antimicrobial agent, e.g for pizza crusts prior to baking. extraction solvent for foodstuffs. Widely distributed in fruits and other foodsEthanol is a volatile, flammable, colorless liquid. It is a powerful psychoactive drug and one of the oldest recreational drugs. Best known as the type of alcohol found in alcoholic beverages, it is also used in thermometers, as a solvent, and as a fuel. In common usage, it is often referred to simply as alcohol or spirits. (Wikipedia)",64-17-5,Fp -117.3å¡ (-112.3å¡),NA,NA,1000 mg/mL at 25 oC,-0.31,NA,NA,NA,C00469,702,NA,16236,EOH,NA,NA,NA,Ethanol,NA,NA,NA,NA,NA,NA,NA,HMDB00108.pdf,application/pdf,47704,2015-02-28 17:48:04 UTC,NA,2,2010-04-08 22:04:42 UTC,2015-10-09 22:29:01 UTC,NA,BGT97-X:BGT97-X,HMDB00108,ETHANOL|ETHYL-ALCOHOL,DB00898,35062,1148,C00019560,Bp16 4å¡,DFC,0,NA,d204<vs=1> 0.79,DFC,NA,NA,C 52.14%; H 13.13%; O 34.73%,DFC,NA,NA,n20.5D<vs=3>  1.3610,DFC,NA,NA,pKa 15.93 (25å¡),DFC,"RIDDICK,JA et al. (1986)","HANSCH,C ET AL. (1995)",NA,NA,DFC,-0.4,-0.16,1.1,CCO,NA,C2H6O,46.0684,"InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3",46.04186481,InChIKey=LFQSCWFLJHTTHZ-UHFFFAOYSA-N,5.79e+02 g/l,37466,ethanol,DFC,NA,NA,"Ethanol, 9CI",DFC,64-17-5,rw1000511,NA,NA,Organic compounds,Organooxygen compounds,Alcohols and polyols,Primary alcohols,Primary alcohols,Aliphatic acyclic compounds,CHEMBL545,682,ETOH,TRUE,NA,DB00898,APRD00738,Ethanol,64-17-5,3K9958V90M,"1-Hydroxyethane | Alcohol | Alcohol (ethyl) | Alcohol anhydrous | Alcohol denatured | Alcohol etÃ­lico | Alcohol, denatured | Alcool Ã©thylique | Alkohol | Ãthanol | Ãthylalkohol | Dehydrated ethanol | etanol | Ã©thanol | Ethyl Alcohol | Grain alcohol | Hydroxyethane | Methylcarbinol | Spiritus vini",LFQSCWFLJHTTHZ-UHFFFAOYSA-N
LHGVFZTZFXWLCP-UHFFFAOYSA-N,1077,HMDB0001398,124.052429498,2-methoxyphenol,Guaiacol,C7H8O2,90-05-1,C01502,FDB011885,NA,NA,CPD-400,460,447,COC1=C(O)C=CC=C1,6217,Organic compounds,Methoxyphenols,Benzenoids,Phenols,Methoxyphenols,Aromatic homomonocyclic compounds,1.32,3333,T3D4576,Exogenous,1.32,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,124.0524295,2-methoxyphenol,Guaiacol,C7H8O2,1990-05-01,HMDB01398,NA,C01502,CPD-400,460,447,COC1=CC=CC=C1O,Chemical entities,Methoxyphenols,Organic compounds,Benzenoids,Phenols,Aromatic homomonocyclic compounds,9012,22444,SmallMoleculeCompound,FDB009011,"Beechwood, creosote (fagus spp.)",TRUE,liquid,low,A complex combination of phenols obtained as a distillate from wood tar (SciFinder),8021-39-4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:08:22 UTC,2015-07-20 22:27:13 UTC,NA,NA,NA,NA,NA,NA,292,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,COC1=CC=CC=C1O,NA,C7H8O2,124.13720000000001,"InChI=1S/C7H8O2/c1-9-7-5-3-2-4-6(7)8/h2-5,8H,1H3",124.0524295,LHGVFZTZFXWLCP-UHFFFAOYSA-N,NA,NA,NA,NA,NA,NA,NA,EAFUS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB11359,NA,Guaiacol,90-05-1,6JKA7MAH9C,1-hydroxy-2-methoxybenzene | 2-methoxyl-4-vinylphenol | 2-methoxyphenol | o-guaiacol | o-hydroxyanisole | o-Methoxyphenol | Pyrocatechol monomethyl ether | Pyroguaiac acid,LHGVFZTZFXWLCP-UHFFFAOYSA-N
LNEPOXFFQSENCJ-UHFFFAOYSA-N,8970,HMDB0014645,375.140134897,4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one,Haloperidol,C21H23ClFNO2,52-86-8,C01814,NA,DB00502,NA,NA,3559,3438,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,NA,Organic compounds,Alkyl-phenylketones,Organic oxygen compounds,Organooxygen compounds,Carbonyl compounds,Aromatic heteromonocyclic compounds,4,2098,T3D2576,Exogenous,4.3,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,375.140134897,4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one,Haloperidol,C21H23ClFNO2,52-86-8,HMDB14645,DB00502,C01814,NA,3559,3438,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Chemical entities,Alkyl-phenylketones,Organic compounds,Organic oxygen compounds,Organooxygen compounds,Aromatic heteromonocyclic compounds,9771,24167,SmallMoleculeCompound,FDB009770,Mastic gum,TRUE,NA,low,Used as a food additive [EAFUS],61789-92-2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:08:47 UTC,2015-07-20 22:30:08 UTC,NA,NA,NA,NA,NA,NA,2125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,NA,C21H23ClFNO2,375.864,"InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2",375.1401349,LNEPOXFFQSENCJ-UHFFFAOYSA-N,NA,NA,NA,NA,NA,NA,NA,EAFUS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB00502,APRD00538,Haloperidol,52-86-8,J6292F8L3D,1-(3-p-fluorobenzoylpropyl)-4-p-chlorophenyl-4-hydroxypiperidine | 4-(4-(para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone | 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one | 4'-fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone | 4'-fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone | Haloperidolum | Î³-(4-(p-chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone,LNEPOXFFQSENCJ-UHFFFAOYSA-N
LOUPRKONTZGTKE-WZBLMQSHSA-N,8938,HMDB0014611,324.183778022,"(R)-[(1S,2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol",Quinine,C20H24N2O2,130-95-0,C06526,FDB002087,DB00468,NA,NA,3034034,84989,[H][C@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@H](O)C1=CC=NC2=CC=C(OC)C=C12,NA,Organic compounds,Cinchona alkaloids,Alkaloids and derivatives,Cinchona alkaloids,NA,Aromatic heteropolycyclic compounds,2.6,2254,T3D2800,Exogenous,3.44,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,324.183778022,"(R)-[(1S,2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol",Quinine,C20H24N2O2,130-95-0,HMDB14611,DB00468,C06526,3-HYDROXYQUININE,3034034,84989,[H][C@@](O)(C1=C2C=C(OC)C=CC2=NC=C1)[C@]1([H])C[C@]2([H])CCN1C[C@]2([H])C=C,Chemical entities,Cinchona alkaloids,Organic compounds,Alkaloids and derivatives,Cinchona alkaloids,Aromatic heteropolycyclic compounds,2087,6602,SmallMoleculeCompound,FDB002087,Quinine,TRUE,Solid,low,"Used in tonics and bitter drinksQuinine is a natural white crystalline alkaloid having antipyretic, antimalarial, analgesic, anti-inflammatory properties and a bitter taste. It is a stereoisomer of quinidine which, unlike quinine, is an anti-arrhythmic. Though it has been synthesized in the lab, the bark of the cinchona tree is the only known natural source of quinine. Quinine was the first effective treatment for malaria caused by Plasmodium falciparum, appearing in therapeutics in the 17th century. It remained the antimalarial drug of choice until the 1940s, when other drugs replaced it. (Wikipedia)",130-95-0,Mp 177å¡ (anhyd.),NA,NA,0.5 mg/mL at 15 oC,3.44,NA,NA,NA,C06526,3034034,NA,15854,NA,NA,NA,NA,Quinine,NA,NA,NA,NA,NA,NA,NA,HMDB14611.pdf,application/pdf,47774,2015-02-28 18:04:05 UTC,NA,2,2010-04-08 22:05:14 UTC,2015-07-20 21:43:08 UTC,NA,CFC28-A:CFC28-A,HMDB14611,NA,DB00468,NA,NA,C00002193,NA,NA,NA,NA,NA,NA,[a]D -158 (-145) (EtOH),DFC,C 74.05%; H 7.46%; N 8.63%; O 9.86%,DFC,NA,NA,NA,NA,NA,NA,pKa2 4.21 (20å¡),DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,2.82,2.51,-2.99,[H][C@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@H](O)C1=CC=NC2=C1C=C(OC)C=C2,NA,C20H24N2O2,324.4168,"InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19-,20+/m0/s1",324.183778,InChIKey=LOUPRKONTZGTKE-WZBLMQSHSA-N,3.34e-01 g/l,35339,"(R)-[(1S,2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol",MANUAL,NA,NA,"Quinine, BAN",DFC,NA,NA,NA,NA,Organic compounds,Alkaloids and derivatives,Cinchona alkaloids,NA,Cinchona alkaloids,Aromatic heteropolycyclic compounds,CHEMBL170,84989,NA,NA,NA,DB00468,APRD00563,Quinine,130-95-0,A7V27PHC7A,"(-)-Quinine | (8S,9R)-Quinine | (R)-(-)-Quinine | (R)-(6-Methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol | 6'-Methoxycinchonidine | Chinin | Chinine | Chininum | Quinina | Quinine",LOUPRKONTZGTKE-WZBLMQSHSA-N
LXMSZDCAJNLERA-ZHYRCANASA-N,8900,HMDB0014565,416.202130202,"b""(1'S,2R,2'R,9'R,10'R,11'S,15'S)-9'-(acetylsulfanyl)-2',15'-dimethylspiro[oxolane-2,14'-tetracyclo[8.7.0.0\xc2\xb2,\xe2\x81\xb7.0\xc2\xb9\xc2\xb9,\xc2\xb9\xe2\x81\xb5]heptadecan]-6'-ene-5,5'-dione""",Spironolactone,C24H32O4S,52-01-7,C07310,NA,DB00421,NA,NA,5833,5628,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,NA,Organic compounds,Spironolactones and derivatives,Lipids and lipid-like molecules,Steroids and steroid derivatives,Steroid lactones,Aliphatic heteropolycyclic compounds,3.4,3440,T3D4753,Exogenous,2.78,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,416.202130202,"b""(1'S,2R,2'R,9'R,10'R,11'S,15'S)-9'-(acetylsulfanyl)-2',15'-dimethylspiro[oxolane-2,14'-tetracyclo[8.7.0.0\xc2\xb2,\xe2\x81\xb7.0\xc2\xb9\xc2\xb9,\xc2\xb9\xe2\x81\xb5]heptadecan]-6'-ene-5,5'-dione""",Spironolactone,C24H32O4S,52-01-7,HMDB14565,DB00421,C07310,NA,5833,5628,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,Organic compounds,Spironolactones and derivatives,Lipids and lipid-like molecules,Steroids and steroid derivatives,Steroid lactones,Aliphatic heteropolycyclic compounds,6239,16314,SmallMoleculeCompound,FDB006238,Latex,TRUE,NA,low,"Latex as found in nature is a milky fluid found in 10% of all flowering plants (angiosperms). It is a complex emulsion consisting of proteins, alkaloids, starches, sugars, oils, tannins, resins, and gums that coagulates on exposure to air. It is usually exuded after tissue injury. In most plants, latex is white, but some have yellow, orange, or scarlet latex. Since the 17th century, latex has been used as a term for the fluid substance in plants. It serves mainly as defense against herbivorous insects. Many people are allergic to latex. [Wikipedia]",1952-01-07,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Latex,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:07:03 UTC,2017-03-01 02:04:26 UTC,NA,NA,NA,LATEX,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,NA,C24H32O4S,416.573,"InChI=1S/C24H32O4S/c1-14(25)29-19-13-15-12-16(26)4-8-22(15,2)17-5-9-23(3)18(21(17)19)6-10-24(23)11-7-20(27)28-24/h12,17-19,21H,4-11,13H2,1-3H3/t17-,18-,19+,21+,22-,23-,24+/m0/s1",416.2021302,LXMSZDCAJNLERA-ZHYRCANASA-N,NA,NA,NA,NA,NA,NA,NA,DUKE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB00421,APRD01234,Spironolactone,52-01-7,27O7W4T232,Espironolactona | Spironolactone | Spironolactonum | Spironolattone,LXMSZDCAJNLERA-ZHYRCANASA-N
LXNHXLLTXMVWPM-UHFFFAOYSA-N,161,HMDB0000239,169.073893223,"4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol",Pyridoxine,C8H11NO3,65-23-6,C00314,FDB000574,NA,NA,CPD-455,1054,1025,CC1=C(O)C(CO)=C(CO)C=N1,5245,Organic compounds,Pyridoxines,Organoheterocyclic compounds,Pyridines and derivatives,Pyridoxines,Aromatic heteromonocyclic compounds,-0.77,2186,T3D2701,Endogenous,-0.77,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,169.073893223,"4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol",Pyridoxine,C8H11NO3,65-23-6,HMDB00239,DB00165,C00314,CPD-455,1054,1025,CC1=C(O)C(CO)=C(CO)C=N1,Organic compounds,Pyridoxines,Organoheterocyclic compounds,Pyridines and derivatives,Pyridoxines,Aromatic heteromonocyclic compounds,574,1553,SmallMoleculeCompound,FDB000574,Pyridoxine,TRUE,Solid,low,"Found in rice husks, cane molasses, yeast, wheat germ and cod liver oils. Vitamin, dietary supplement, nutrientPyridoxine is one of the compounds that can be called vitamin B6, along with pyridoxal and pyridoxamine. It differs from pyridoxamine by the substituent at the '4' position. It is often used as 'pyridoxine hydrochloride'. (Wikipedia)",65-23-6,Mp 160å¡,NA,NA,NA,-0.77,NA,NA,NA,C00314,1054,NA,16709,NA,NA,NA,NA,Pyridoxine,NA,NA,knapsack_id:C00001551,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:04:37 UTC,2015-10-09 22:27:24 UTC,NA,BDV40-Q:BDV40-Q,HMDB00239,VITAMIN-B-6|VIT-B-6|PYRIDOXINE,DB00165,34590,3262,NA,NA,NA,0,NA,NA,NA,NA,NA,C 56.80%; H 6.55%; N 8.28%; O 28.37%,DFC,NA,NA,NA,NA,NA,NA,"pKa2 8.96 (25å¡, 0.15M NaCl)",DFC,NA,SANGSTER (1993),NA,NA,DFC,-0.57,-0.95,-1.02,CC1=C(O)C(CO)=C(CO)C=N1,14.53,C8H11NO3,169.1778,"InChI=1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3",169.0738932,InChIKey=LXNHXLLTXMVWPM-UHFFFAOYSA-N,1.61e+01 g/l,34730,"4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol",MANUAL,NA,NA,"Pyridoxine, BAN, INN",DFC,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Pyridines and derivatives,Pyridoxines,Pyridoxines,Aromatic heteromonocyclic compounds,CHEMBL1364,1025,CPD-455,TRUE,NA,DB00165,NUTR00002 | APRD00204,Pyridoxine,65-23-6,KV2JZ1BI6Z,"2-Methyl-3-hydroxy-4,5-dihydroxymethylpyridine | 3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine | 3-Hydroxy-4,5-dimethylol-alpha-picoline | 5-Hydroxy-6-methyl-3,4-pyridinedimethanol | Pyridoxine | Pyridoxol | Vitamin B6",LXNHXLLTXMVWPM-UHFFFAOYSA-N
MECHNRXZTMCUDQ-RKHKHRCZSA-N,717,HMDB0000900,396.33921603,"(1S,3Z)-3-{2-[(1R,3aS,4E,7aR)-1-[(2R,3E,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexan-1-ol",Ergocalciferol,C28H44O,50-14-6,C05441,FDB012811,DB00153,NA,VITAMIN_D_{2},5280793,4444351,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,5856,Organic compounds,Vitamin D and derivatives,Lipids and lipid-like molecules,Steroids and steroid derivatives,Vitamin D and derivatives,Aliphatic homopolycyclic compounds,NA,2182,T3D2697,Endogenous,7.3,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,396.33921603,"(1S,3Z)-3-{2-[(1R,3aS,4E,7aR)-1-[(2R,3E,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexan-1-ol",Ergocalciferol,C28H44O,50-14-6,HMDB00900,DB00153,C05441,VITAMIN_D_{2},5280793,4444351,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C)[C@H](C)\C=C\[C@H](C)C(C)C,Organic compounds,Vitamin D and derivatives,Lipids and lipid-like molecules,Steroids and steroid derivatives,Vitamin D and derivatives,Aliphatic homopolycyclic compounds,12814,33854,SmallMoleculeCompound,FDB012811,Ergocalciferol,TRUE,Solid,low,"Antirachitic vitaminErgocalciferol is a form of vitamin D, also called vitamin D2. (Wikipedia)",50-14-6,Mp 114.5-117å¡,NA,NA,0.05 mg/mL,NA,NA,NA,NA,C05441,5280793,NA,28934,D2V,NA,NA,NA,Ergocalciferol,NA,NA,NA,NA,NA,NA,NA,HMDB00900.pdf,application/pdf,48855,2015-02-28 18:05:54 UTC,NA,2,2010-04-08 22:10:22 UTC,2015-10-09 22:32:38 UTC,NA,HGL83-Q:HLJ17-Y,HMDB00900,VITAMIN-D,DB00153,2289183,3857,NA,NA,NA,NA,NA,NA,NA,[a]20D +102.5 (EtOH),DFC,C 84.79%; H 11.18%; O 4.03%,DFC,NA,NA,NA,NA,[neutral] lmax 265 () (EtOH),DFC,NA,NA,"TOMLIN,C (1994)",NA,NA,NA,DFC,7.59,7.05,-5.96,[H][C@@]12CC[C@H]([C@H](C)\C=C\[C@H](C)C(C)C)[C@@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C,NA,C28H44O,396.6484,"InChI=1S/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-20,22,25-27,29H,4,7-8,11,14-18H2,1-3,5-6H3/b10-9+,23-12+,24-13-/t20-,22+,25-,26+,27-,28+/m0/s1",396.339216,InChIKey=MECHNRXZTMCUDQ-RKHKHRCZSA-N,4.33e-04 g/l,35373,"(1S,3Z)-3-{2-[(1R,3aS,4E,7aR)-1-[(2R,3E,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexan-1-ol",MANUAL,NA,NA,"9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol, 9CI; (3S,5Z,7E,22E)-form",DFC,NA,NA,NA,NA,Organic compounds,Lipids and lipid-like molecules,Prenol lipids,Triterpenoids,Triterpenoids,Aliphatic homopolycyclic compounds,CHEMBL1536,4444351,VITAMIN_D_{2},TRUE,NA,DB00153,NUTR00005 | APRD00426,Ergocalciferol,50-14-6,VS041H42XC,"(3Î²,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol | (5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol | (5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol | Activated ergosterol | Ercalciol | ErgocalcifÃ©rol | Ergocalciferol | Ergocalciferolum | Oleovitamin D2 | Viosterol | Vitamin D2 | Vitamina D2",MECHNRXZTMCUDQ-RKHKHRCZSA-N
MFDFERRIHVXMIY-UHFFFAOYSA-N,9152,HMDB0014859,236.152477894,2-(diethylamino)ethyl 4-aminobenzoate,Procaine,C13H20N2O2,59-46-1,C07375,NA,DB00721,NA,NA,4914,4745,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1,NA,Organic compounds,Benzoic acid esters,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Aromatic homomonocyclic compounds,1.8,2308,T3D2869,Exogenous,2.14,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,236.152477894,2-(diethylamino)ethyl 4-aminobenzoate,Procaine,C13H20N2O2,59-46-1,HMDB14859,DB00721,C07375,NA,4914,4745,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1,Chemical entities,Benzoic acid esters,Organic compounds,Benzenoids,Benzene and substituted derivatives,Aromatic homomonocyclic compounds,29534,NA,SmallMoleculeCompound,FDB029371,Procaine,TRUE,NA,low,"Procaine is a local anesthetic drug of the amino ester group. It is used primarily to reduce the pain of intramuscular injection of penicillin, and it is also used in dentistry. Owing to the ubiquity of the trade name Novocain, procaine is sometimes referred to generically as novocaine. It acts mainly by being a sodium channel blocker.Procaine was first synthesized in 1898[2] and was the first injectable man-made local anesthetic. It was created by the German chemist Alfred Einhorn (1856?1917) who gave the chemical the trade name Novocaine, from the Latin nov- (meaning new) and -caine, a common ending for alkaloids used as anesthetics. It was introduced into medical use by surgeon Heinrich Braun (1862?1934).Novocain application before removal of a decayed toothProcaine is used less frequently today since more effective (and hypoallergenic) alternatives such as lidocaine (Xylocaine) exist. Prior to the discovery of procaine, cocaine was the most commonly used local anesthetic. Like other local anesthetics (with the exception of cocaine), mepivacaine, and prilocaine, procaine is a vasodilator, and is often coadministered with epinephrine for the purpose of vasoconstriction. Vasoconstriction helps to reduce bleeding and prevents the drug from reaching systemic circulation in large amounts. Also unlike cocaine, procaine does not have the euphoric and addictive qualities that put it at risk for abuse.Procaine, an ester anesthetic, is metabolized in the plasma by the enzyme pseudocholinesterase through hydrolysis into para-amino benzoic acid (PABA), which is then excreted by the kidneys into the urine. Allergic reactions to procaine are usually not in response to procaine itself, but to PABA. About 1 in 3000 people have an atypical form of pseudocholinesterase, which does not hydrolyze ester anesthetics such as procaine, resulting in a prolonged period of high levels of the anesthetic in the blood and increased toxicity.Procaine is the primary ingredient in the controversial preparation Gerovital H3 by Ana Aslan (Romania), which is claimed by its advocates to remedy many effects of aging. The mainstream medical view is that these claims were seriously studied and discredited in the 1960s.Procaine is occasionally added as an additive in illicit street drugs such as cocaine. (from wiki) [HMDB]",59-46-1,NA,NA,NA,NA,NA,NA,NA,NA,C07375,4914,NA,8430,NA,NA,NA,NA,Procaine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2011-09-21 01:54:46 UTC,2015-07-21 06:59:42 UTC,NA,NA,HMDB13304,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2.1,1.880057258,-1.54,[H]N([H])C1=C([H])C([H])=C(C([H])=C1[H])C(=O)OC([H])([H])C([H])([H])N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H],NA,C13H20N2O2,236.3101,"InChI=1S/C13H20N2O2/c1-3-15(4-2)9-10-17-13(16)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3",236.1524779,InChIKey=MFDFERRIHVXMIY-UHFFFAOYSA-N,6.81e+00 g/l,89824,2-(diethylamino)ethyl 4-aminobenzoate,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB00721,APRD00650 | DB05342,Procaine,59-46-1,4Z8Y51M438,2-Diethylaminoethyl p-aminobenzoate | 4-aminobenzoic acid 2-diethylaminoethyl ester | Novocaine | p-Aminobenzoic acid 2-diethylaminoethyl ester | Procaina | Procainum | Vitamin H3 | Î²-(diethylamino)ethyl 4-aminobenzoate | Î²-(diethylamino)ethyl p-aminobenzoate,MFDFERRIHVXMIY-UHFFFAOYSA-N
MJVAVZPDRWSRRC-UHFFFAOYSA-N,1256,HMDB0001892,172.0524295,"2-methyl-1,4-dihydronaphthalene-1,4-dione",Menadione,C11H8O2,58-27-5,C05377,FDB000953,DB00170,NA,CPD-3766,4055,3915,CC1=CC(=O)C2=CC=CC=C2C1=O,3910,Organic compounds,Naphthoquinones,Benzenoids,Naphthalenes,Naphthoquinones,Aromatic homopolycyclic compounds,2.2,2189,T3D2704,Exogenous,2.2,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,172.0524295,"2-methyl-1,4-dihydronaphthalene-1,4-dione",Menadione,C11H8O2,58-27-5,HMDB01892,DB00170,C05377,CPD-3766,4055,3915,CC1=CC(=O)C2=CC=CC=C2C1=O,Organic compounds,Naphthoquinones,Benzenoids,Naphthalenes,Naphthoquinones,Aromatic homopolycyclic compounds,953,2714,SmallMoleculeCompound,FDB000953,Menadione,TRUE,Solid,low,"Prothrombogenic vitamin (synthetic)A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo. -- Pubchem; Despite the fact that it can serve as a precursor to various types of vitamin K, menadione is generally not used as a nutritional supplement. Large doses of menadione have been reported to cause adverse outcomes including hemolytic anemia due to G6PD deficiency, neonatal brain or liver damage, or neonatal death in some cases. Moreover, menadione supplements have been banned by the FDA because of their high toxicity.; It is sometimes called vitamin K3, although derivatives of naphthoquinone without the sidechain in the 3-position cannot exert all the functions of the K vitamins. Menadione is a vitamin precursor of K2 which utilizes alkylation in the liver to yield menaquinones (MK-n, n=1-13; It is also known as ""menaphthone"".; It is sometimes called vitamin K3, although derivatives of naphthoquinone without the side chain in the 3-position cannot exert all the functions of the K vitamins. Menadione is a vitamin precursor of K2 which utilizes alkylation to yield menaquinones (MK-n, n=1-13; K2 vitamers), and hence, is better classified as a provitamin.; K2 vitamers), and hence, is better classified as a provitamin. -- Wikipedia; Menadione (Vitamin K3) is a fat-soluble vitamin precursor that is converted into menaquinone in the liver. Vitamin K1 and K2 are the naturally occurring types of vitamin K. The former, which is also known as phylloquinone, is synthesized by plants and can be found in such foods as spinach, broccoli, lettuce, and soybeans. The latter, sometimes alternatively referred to as menaquinone, is primarily produced by bacteria in the anterior part of the gut and the intestines. Vitamin K3, on the other hand, is one of the many manmade versions of vitamin K. Also called menadione, this yellowish, synthetic crystalline substance is converted into the active form of the K2 vitamin inside of the animal body. While a vitamin K deficiency can be dangerous, especially to infants that may easily suffer from extensive hemorrhaging, an overdose can be as equally detrimental. Newborns that are administered too great a dosage of vitamin K3 can suffer from kernicterus, a form of severe brain damage that may produce decreased movement, loss of appetite, seizures, deafness, mental retardation, and even death. This condition is associated with an abnormally high concentration of bilirubin, a bile pigment, in the tissues of the brain, which can be caused by the presence of K3. For this reason, K3 is less often utilized medically than it was in former times.; Menadione is a polycyclic aromatic ketone, based on 1,4-naphthoquinone, with a 2-methyl substituent.",58-27-5,Mp 104-105å¡,NA,NA,0.16 mg/mL at 30 oC,2.2,NA,NA,NA,C05377,4055,NA,28869,VK3,NA,NA,NA,Menadione,NA,NA,NA,NA,NA,NA,NA,HMDB01892.pdf,application/pdf,48727,2015-02-28 18:03:24 UTC,NA,NA,2010-04-08 22:04:46 UTC,2015-10-09 22:31:08 UTC,NA,BNK27-G:BNK27-G,HMDB01892,NA,DB00170,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 76.73%; H 4.68%; O 18.58%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,1.91,1.89,-2.53,CC1=CC(=O)C2=C(C=CC=C2)C1=O,NA,C11H8O2,172.18,"InChI=1S/C11H8O2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6H,1H3",172.0524295,InChIKey=MJVAVZPDRWSRRC-UHFFFAOYSA-N,5.04e-01 g/l,37622,"2-methyl-1,4-dihydronaphthalene-1,4-dione",DFC,NA,NA,"2-Methyl-1,4-naphthoquinone",DFC,NA,NA,NA,NA,Organic compounds,Benzenoids,Naphthalenes,Naphthoquinones,Naphthoquinones,Aromatic homopolycyclic compounds,CHEMBL590,3915,CPD-3766,TRUE,NA,DB00170,NUTR00062,Menadione,58-27-5,723JX6CXY5,"2-Methyl-1,4-Naphthalenedione | 2-Methyl-1,4-naphthochinon | 2-Methyl-1,4-naphthoquinone | Menadione | Vitamin K3",MJVAVZPDRWSRRC-UHFFFAOYSA-N
MNWFXJYAOYHMED-UHFFFAOYSA-N,521,HMDB0000666,130.099379692,heptanoic acid,Heptanoic acid,C7H14O2,111-14-8,C17714,FDB008051,DB02938,NA,NA,8094,7803,CCCCCCC(O)=O,5636,Organic compounds,Medium-chain fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,2.42,3349,T3D4597,Endogenous,2.42,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,130.099379692,heptanoic acid,Heptanoic acid,C7H14O2,111-14-8,HMDB00666,DB02938,C17714,NA,8094,7803,CCCCCCC(O)=O,Chemical entities,Medium-chain fatty acids,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Aliphatic acyclic compounds,8052,19401,SmallMoleculeCompound,FDB008051,Heptanoic acid,TRUE,Liquid,low,"Present in essential oils, e.g. violet leaf oil, palm oil. Also present in apple, feijoa fruit, strawberry jam, clove bud, ginger, black tea, morello cherry, grapes, rice bran and other foodstuffs. Flavouring ingredient. Used as one of the components in washing solns. used to assist lye peeling of fruit and vegetablesHeptanoic acid, also called enanthic acid, is an organic compound composed of a seven-carbon chain terminating in a carboxylic acid. It is an oily liquid with an unpleasant, rancid odor. It contributes to the odor of some rancid oils. It is slightly soluble in water, but very soluble in ethanol and ether.; Heptanoic acid, also called enanthic acid, is an organic compound composed of a seven-carbon chain terminating in a carboxylic acid. It is an oily liquid with an unpleasant, rancid odor. It contributes to the odor of some rancid oils. It is slightly soluble in water, but well soluble in ethanol and ether.; It is also one of many additives in cigarettes.",111-14-8,Mp -9å¡,NA,NA,2.82 mg/mL at 25 oC,2.42,NA,NA,NA,C17714,8094,NA,45571,SHV,NA,NA,NA,Heptanoic acid,NA,NA,NA,NA,NA,NA,NA,HMDB00666.pdf,application/pdf,50429,2015-02-28 17:46:30 UTC,NA,NA,2010-04-08 22:07:54 UTC,2015-10-09 22:28:16 UTC,NA,DBM10-W:DBM10-W,HMDB00666,ENANTHIC-ACID|HEPTANOIC-ACID,DB02938,NA,1577,NA,Bp11 115-116å¡,DFC,NA,NA,d204<vs=1> 0.92,DFC,NA,NA,C 64.58%; H 10.84%; O 24.58%,DFC,NA,NA,n20D<vs=1>  1.4216,DFC,NA,NA,4.8,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)",SANGSTER (1994),NA,NA,DFC,2.41,2.26,-1.64,CCCCCCC(O)=O,NA,C7H14O2,130.1849,"InChI=1S/C7H14O2/c1-2-3-4-5-6-7(8)9/h2-6H2,1H3,(H,8,9)",130.0993797,InChIKey=MNWFXJYAOYHMED-UHFFFAOYSA-N,2.98e+00 g/l,37895,heptanoic acid,DFC,NA,NA,"Heptanoic acid, 9CI, 8CI",DFC,NA,rw1008501,8094,NA,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Medium-chain fatty acids,Aliphatic acyclic compounds,CHEMBL320358,7803,NA,TRUE,NA,DB02938,EXPT02907,Heptanoic Acid,NA,THE3YNP39D,NA,MNWFXJYAOYHMED-UHFFFAOYSA-N
MUBZPKHOEPUJKR-UHFFFAOYSA-N,1562,HMDB0002329,89.995308552,oxalic acid,Oxalic acid,C2H2O4,144-62-7,C00209,FDB003357,DB03902,DBMET00552,CUPRIZONE,971,946,OC(=O)C(O)=O,113,Organic compounds,Dicarboxylic acids and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,Dicarboxylic acids and derivatives,Aliphatic acyclic compounds,NA,710,T3D0856,Endogenous,NA,No indication of carcinogenicity (not listed by IARC). (L135),Oral LDLo (lowest published lethal dose) of 600 mg/kg. It has been reported that the lethal oral dose is 15 to 30 grams.,SmallMolecule,89.995308552,oxalic acid,Oxalic acid,C2H2O4,144-62-7,HMDB02329,DB03902,C00209,CUPRIZONE,971,946,OC(=O)C(O)=O,Organic compounds,Dicarboxylic acids and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,Dicarboxylic acids and derivatives,Aliphatic acyclic compounds,3358,10351,SmallMoleculeCompound,FDB003357,Oxalic acid,TRUE,Solid,low,"Present in many plants and vegetables. Toxin from rhubarb, esp. the leaves but also present in the stemsA strong dicarboxylic acid occurring in many plants and vegetables. It is produced in the body by metabolism of glyoxylic acid or ascorbic acid. It is not metabolized but excreted in the urine. It is used as an analytical reagent and general reducing agent. -- Pubchem; Bodily oxalic acid may also be synthesized via the metabolism of either glyoxylic acid or unused ascorbic acid (vitamin C), which is a serious health consideration for long term megadosers of vitamin C supplements. 80% of kidney stones are formed from calcium oxalate. Some Aspergillus species produce oxalic acid, which reacts with blood or tissue calcium to precipitate calcium oxalate. There is some preliminary evidence that the administration of probiotics can affect oxalic acid excretion rates (and presumably oxalic acid levels as well.) -- Wikipedia; Oxalate, the conjugate base of oxalic acid, is an excellent ligand for metal ions. It usually binds as a bidentate ligand forming a 5-membered MO2C2 ring. An illustrative complex is potassium ferrioxalate, K3[Fe(C2O4)3]. The drug Oxaliplatin exhibits improved water solubility relative to older platinum-based drugs, avoiding the dose-limiting side-effect of nephrotoxicity. Oxalic acid and oxalates can be oxidized by permanganate in an autocatalytic reaction.; Oxalic acid (IUPAC name: ethanedioic acid, formula H2C2O4) is a dicarboxylic acid with structure (HOOC)-(COOH). Because of the joining of two carboxyl groups, this is one of the strongest organic acids. It is also a reducing agent. The anions of oxalic acid as well as its salts and esters are known as oxalates. -- Wikipedia; Oxalic acid is an important reagent in lanthanide chemistry. Hydrated lanthanide oxalates form readily in strongly acid solution in a densely crystalline easily filtered form, largely free from contamination by non-lanthanide elements. Lanthanide oxalates figure importantly in commercial processing of lanthanides, and are used to recover lanthanides from solution after separation. Upon ignition, lanthanide oxalates are converted to the oxides, which are the most common form in which the lanthanides are marketed.; Oxalic acid is the chemical compound with the formula H2C2O4. This dicarboxylic acid is better described with the formula HOOCCOOH. It is a relatively strong organic acid, being about 3,000 times as strong as acetic acid. The di-anion, known as oxalate, is also a reducing agent as well as a ligand in coordination chemistry. Many metal ions form insoluble precipitates with oxalate, a prominent example being calcium oxalate, which is the primary constituent of the most common kind of kidney stones.",144-62-7,Mp 101.5å¡ (dihydrate),NA,NA,220 mg/mL at 25 oC,NA,NA,NA,NA,C00209,971,NA,NA,OXD,NA,NA,NA,Oxalic acid,NA,NA,NA,NA,NA,NA,NA,HMDB02329.pdf,application/pdf,75649,2015-02-28 17:55:00 UTC,NA,NA,2010-04-08 22:05:46 UTC,2015-10-09 22:32:01 UTC,NA,CWF22-Y:CWF22-Y,HMDB02329,OXALATE|12-DICARBONIC-ACID|OXALIC-ACID,DB03902,34265,NA,C00001198,NA,NA,NA,NA,d18.54<vs=3> 1.65,DFC,NA,NA,C 26.68%; H 2.24%; O 71.08%,DFC,NA,NA,NA,NA,NA,NA,"pKa2 3.85 (25å¡,H2O)",DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)",NA,NA,NA,DFC,-0.51,-0.26,-0.14,OC(=O)C(O)=O,4.11,C2H2O4,90.0349,"InChI=1S/C2H2O4/c3-1(4)2(5)6/h(H,3,4)(H,5,6)",89.99530855,InChIKey=MUBZPKHOEPUJKR-UHFFFAOYSA-N,6.57e+01 g/l,33705,oxalic acid,DFC,NA,NA,"Oxalic acid, 8CI",DFC,NA,NA,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Dicarboxylic acids and derivatives,Dicarboxylic acids and derivatives,Aliphatic acyclic compounds,CHEMBL146755,946,CUPRIZONE,TRUE,NA,DB03902,EXPT02457 | DB02737,Oxalic Acid,144-62-7,9E7R5L6H31,NA,MUBZPKHOEPUJKR-UHFFFAOYSA-N
MWFMGBPGAXYFAR-UHFFFAOYSA-N,40593,HMDB0060427,85.052763851,2-hydroxy-2-methylpropanenitrile,Acetone cyanohydrin,C4H7NO,NA,NA,NA,NA,NA,2-HYDROXY-2-METHYLPROPANENITRILE,0,NA,CC(C)(O)C#N,NA,Organic compounds,Tertiary alcohols,Organic oxygen compounds,Organooxygen compounds,Alcohols and polyols,Aliphatic acyclic compounds,NA,1391,T3D1678,Exogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,200 to 300 milligrams for an adult human (cyanide salts). (T86),SmallMolecule,85.052763851,2-hydroxy-2-methylpropanenitrile,Acetone cyanohydrin,C4H7NO,75-86-5,HMDB60427,DB02203,C02659,2-HYDROXY-2-METHYLPROPANENITRILE,6406,6166,CC(C)(O)C#N,Chemical entities,Tertiary alcohols,Organic compounds,Organic oxygen compounds,Organooxygen compounds,Aliphatic acyclic compounds,30810,NA,SmallMoleculeCompound,FDB030647,acetone cyanohydrin,TRUE,NA,NA,NA,75-86-5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2015-05-07 19:41:51 UTC,2017-03-11 23:03:54 UTC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CC(C)(O)C#N,NA,C4H7NO,85.1045,"InChI=1S/C4H7NO/c1-4(2,6)3-5/h6H,1-2H3",85.05276385,MWFMGBPGAXYFAR-UHFFFAOYSA-N,NA,NA,NA,NA,NA,NA,NA,MANUAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB02203,EXPT00968,Acetone Cyanohydrin,75-86-5,CO1YOV1KFI,NA,MWFMGBPGAXYFAR-UHFFFAOYSA-N
NBIIXXVUZAFLBC-UHFFFAOYSA-N,1411,HMDB0002105,97.976895096,phosphoric acid,Dihydrogen phosphate,H3O4P,14066-20-7,NA,FDB022848,NA,NA,CPD-16459,1003,978,OP(O)(O)=O,NA,Inorganic compounds,Non-metal phosphates,Homogeneous non-metal compounds,Non-metal oxoanionic compounds,Non-metal phosphates,NA,NA,3579,T3D4896,Endogenous,-1.436,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,97.976895096,phosphoric acid,Phosphoric acid,H3O4P,7664-38-2,HMDB02142,NA,C00009,NA,1004,979,OP(O)(O)=O,Chemical entities,Non-metal phosphates,Inorganic compounds,Homogeneous non-metal compounds,Non-metal oxoanionic compounds,NA,13383,35481,SmallMoleculeCompound,FDB013380,Phosphoric acid,TRUE,Solid,low,"Found in fruit juices. Used in foods as an acidulant for drinks and candies, pH control agent, buffering agent, flavour enhancer, flavouring agent, sequestrant, stabiliser and thickener, and synergistPhosphoric acid, also known as orthophosphoric acid or phosphoric(V) acid, is a mineral (inorganic) acid having the chemical formula H3PO4. Orthophosphoric acid molecules can combine with themselves to form a variety of compounds which are also referred to as phosphoric acids, but in a more general way. The term phosphoric acid can also refer to a chemical or reagent consisting of phosphoric acids, usually orthophosphoric acid. (Wikipedia)",7664-38-2,Mp 42.3å¡,NA,NA,NA,-1.436,NA,NA,NA,C00009,1004,NA,26078,NA,NA,NA,NA,Phosphoric_acid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:10:41 UTC,2015-10-09 22:32:53 UTC,NA,HTV82-A:HTV82-A,HMDB02142,PHOSPHORIC-ACID,NA,NA,3033,NA,NA,NA,NA,NA,d 1.86,DFC,NA,NA,H 3.09%; O 65.31%; P 31.61%,DFC,NA,NA,n20D<vs=1>  1.4503,DFC,NA,NA,pKa3 12.4 (H2O),DFC,NA,NA,NA,NA,DFC,NA,-1.02,NA,OP(O)(O)=O,6.95,H3O4P,97.9952,"InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)",97.9768951,InChIKey=NBIIXXVUZAFLBC-UHFFFAOYSA-N,NA,38363,phosphoric acid,MANUAL,NA,NA,"Phosphoric acid, 9CI, 8CI, USAN",DFC,NA,rw1033561,NA,NA,Inorganic compounds,Homogeneous non-metal compounds,Non-metal oxoanionic compounds,Non-metal phosphates,Non-metal phosphates,Acyclic compounds,CHEMBL1187,979,NA,TRUE,NA,DB09394,NA,Phosphoric acid,NA,E4GA8884NN,NA,NBIIXXVUZAFLBC-UHFFFAOYSA-N
NBIIXXVUZAFLBC-UHFFFAOYSA-N,1100,HMDB0001429,97.976895096,phosphoric acid,Phosphate,H3O4P,14265-44-2,C00009,FDB022617,NA,DBMET00532,CPD-8587,1061,1032,OP(O)(O)=O,3231,Inorganic compounds,Non-metal phosphates,Homogeneous non-metal compounds,Non-metal oxoanionic compounds,Non-metal phosphates,NA,NA,3579,T3D4896,Endogenous,-1.436,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,97.976895096,phosphoric acid,Phosphoric acid,H3O4P,7664-38-2,HMDB02142,NA,C00009,NA,1004,979,OP(O)(O)=O,Chemical entities,Non-metal phosphates,Inorganic compounds,Homogeneous non-metal compounds,Non-metal oxoanionic compounds,NA,13383,35481,SmallMoleculeCompound,FDB013380,Phosphoric acid,TRUE,Solid,low,"Found in fruit juices. Used in foods as an acidulant for drinks and candies, pH control agent, buffering agent, flavour enhancer, flavouring agent, sequestrant, stabiliser and thickener, and synergistPhosphoric acid, also known as orthophosphoric acid or phosphoric(V) acid, is a mineral (inorganic) acid having the chemical formula H3PO4. Orthophosphoric acid molecules can combine with themselves to form a variety of compounds which are also referred to as phosphoric acids, but in a more general way. The term phosphoric acid can also refer to a chemical or reagent consisting of phosphoric acids, usually orthophosphoric acid. (Wikipedia)",7664-38-2,Mp 42.3å¡,NA,NA,NA,-1.436,NA,NA,NA,C00009,1004,NA,26078,NA,NA,NA,NA,Phosphoric_acid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:10:41 UTC,2015-10-09 22:32:53 UTC,NA,HTV82-A:HTV82-A,HMDB02142,PHOSPHORIC-ACID,NA,NA,3033,NA,NA,NA,NA,NA,d 1.86,DFC,NA,NA,H 3.09%; O 65.31%; P 31.61%,DFC,NA,NA,n20D<vs=1>  1.4503,DFC,NA,NA,pKa3 12.4 (H2O),DFC,NA,NA,NA,NA,DFC,NA,-1.02,NA,OP(O)(O)=O,6.95,H3O4P,97.9952,"InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)",97.9768951,InChIKey=NBIIXXVUZAFLBC-UHFFFAOYSA-N,NA,38363,phosphoric acid,MANUAL,NA,NA,"Phosphoric acid, 9CI, 8CI, USAN",DFC,NA,rw1033561,NA,NA,Inorganic compounds,Homogeneous non-metal compounds,Non-metal oxoanionic compounds,Non-metal phosphates,Non-metal phosphates,Acyclic compounds,CHEMBL1187,979,NA,TRUE,NA,DB09394,NA,Phosphoric acid,NA,E4GA8884NN,NA,NBIIXXVUZAFLBC-UHFFFAOYSA-N
NBIIXXVUZAFLBC-UHFFFAOYSA-N,1436,HMDB0002142,97.976895096,phosphoric acid,Phosphoric acid,H3O4P,7664-38-2,C00009,FDB013380,NA,NA,NA,1004,979,OP(O)(O)=O,NA,Inorganic compounds,Non-metal phosphates,Homogeneous non-metal compounds,Non-metal oxoanionic compounds,Non-metal phosphates,NA,-1.436,3579,T3D4896,Endogenous,-1.436,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,97.976895096,phosphoric acid,Phosphoric acid,H3O4P,7664-38-2,HMDB02142,NA,C00009,NA,1004,979,OP(O)(O)=O,Chemical entities,Non-metal phosphates,Inorganic compounds,Homogeneous non-metal compounds,Non-metal oxoanionic compounds,NA,13383,35481,SmallMoleculeCompound,FDB013380,Phosphoric acid,TRUE,Solid,low,"Found in fruit juices. Used in foods as an acidulant for drinks and candies, pH control agent, buffering agent, flavour enhancer, flavouring agent, sequestrant, stabiliser and thickener, and synergistPhosphoric acid, also known as orthophosphoric acid or phosphoric(V) acid, is a mineral (inorganic) acid having the chemical formula H3PO4. Orthophosphoric acid molecules can combine with themselves to form a variety of compounds which are also referred to as phosphoric acids, but in a more general way. The term phosphoric acid can also refer to a chemical or reagent consisting of phosphoric acids, usually orthophosphoric acid. (Wikipedia)",7664-38-2,Mp 42.3å¡,NA,NA,NA,-1.436,NA,NA,NA,C00009,1004,NA,26078,NA,NA,NA,NA,Phosphoric_acid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:10:41 UTC,2015-10-09 22:32:53 UTC,NA,HTV82-A:HTV82-A,HMDB02142,PHOSPHORIC-ACID,NA,NA,3033,NA,NA,NA,NA,NA,d 1.86,DFC,NA,NA,H 3.09%; O 65.31%; P 31.61%,DFC,NA,NA,n20D<vs=1>  1.4503,DFC,NA,NA,pKa3 12.4 (H2O),DFC,NA,NA,NA,NA,DFC,NA,-1.02,NA,OP(O)(O)=O,6.95,H3O4P,97.9952,"InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)",97.9768951,InChIKey=NBIIXXVUZAFLBC-UHFFFAOYSA-N,NA,38363,phosphoric acid,MANUAL,NA,NA,"Phosphoric acid, 9CI, 8CI, USAN",DFC,NA,rw1033561,NA,NA,Inorganic compounds,Homogeneous non-metal compounds,Non-metal oxoanionic compounds,Non-metal phosphates,Non-metal phosphates,Acyclic compounds,CHEMBL1187,979,NA,TRUE,NA,DB09394,NA,Phosphoric acid,NA,E4GA8884NN,NA,NBIIXXVUZAFLBC-UHFFFAOYSA-N
NBIIXXVUZAFLBC-UHFFFAOYSA-N,772,HMDB0000973,97.976895096,phosphoric acid,Hydrogen phosphate,H3O4P,14066-19-4,C01293,FDB022346,NA,NA,NA,57424078,2913859,OP(O)(O)=O,NA,Inorganic compounds,Non-metal phosphates,Homogeneous non-metal compounds,Non-metal oxoanionic compounds,Non-metal phosphates,NA,NA,3579,T3D4896,Endogenous,-1.436,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,97.976895096,phosphoric acid,Phosphoric acid,H3O4P,7664-38-2,HMDB02142,NA,C00009,NA,1004,979,OP(O)(O)=O,Chemical entities,Non-metal phosphates,Inorganic compounds,Homogeneous non-metal compounds,Non-metal oxoanionic compounds,NA,13383,35481,SmallMoleculeCompound,FDB013380,Phosphoric acid,TRUE,Solid,low,"Found in fruit juices. Used in foods as an acidulant for drinks and candies, pH control agent, buffering agent, flavour enhancer, flavouring agent, sequestrant, stabiliser and thickener, and synergistPhosphoric acid, also known as orthophosphoric acid or phosphoric(V) acid, is a mineral (inorganic) acid having the chemical formula H3PO4. Orthophosphoric acid molecules can combine with themselves to form a variety of compounds which are also referred to as phosphoric acids, but in a more general way. The term phosphoric acid can also refer to a chemical or reagent consisting of phosphoric acids, usually orthophosphoric acid. (Wikipedia)",7664-38-2,Mp 42.3å¡,NA,NA,NA,-1.436,NA,NA,NA,C00009,1004,NA,26078,NA,NA,NA,NA,Phosphoric_acid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:10:41 UTC,2015-10-09 22:32:53 UTC,NA,HTV82-A:HTV82-A,HMDB02142,PHOSPHORIC-ACID,NA,NA,3033,NA,NA,NA,NA,NA,d 1.86,DFC,NA,NA,H 3.09%; O 65.31%; P 31.61%,DFC,NA,NA,n20D<vs=1>  1.4503,DFC,NA,NA,pKa3 12.4 (H2O),DFC,NA,NA,NA,NA,DFC,NA,-1.02,NA,OP(O)(O)=O,6.95,H3O4P,97.9952,"InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)",97.9768951,InChIKey=NBIIXXVUZAFLBC-UHFFFAOYSA-N,NA,38363,phosphoric acid,MANUAL,NA,NA,"Phosphoric acid, 9CI, 8CI, USAN",DFC,NA,rw1033561,NA,NA,Inorganic compounds,Homogeneous non-metal compounds,Non-metal oxoanionic compounds,Non-metal phosphates,Non-metal phosphates,Acyclic compounds,CHEMBL1187,979,NA,TRUE,NA,DB09394,NA,Phosphoric acid,NA,E4GA8884NN,NA,NBIIXXVUZAFLBC-UHFFFAOYSA-N
NIJJYAXOARWZEE-UHFFFAOYSA-N,1245,HMDB0001877,144.115029756,2-propylpentanoic acid,Valproic acid,C8H16O2,99-66-1,C07185,FDB022722,NA,NA,NA,3121,3009,CCCC(CCC)C(O)=O,2986,Organic compounds,Methyl-branched fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,2.75,2084,T3D2558,Exogenous,2.75,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,144.115029756,2-propylpentanoic acid,Valproic acid,C8H16O2,99-66-1,HMDB01877,DB00313,C07185,NA,3121,3009,CCCC(CCC)C(O)=O,Chemical entities,Methyl-branched fatty acids,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Aliphatic acyclic compounds,22885,NA,SmallMoleculeCompound,FDB022722,Valproic acid,TRUE,Solid,low,"Valproic acid (VPA) is considered to be a drug of first choice and one of the most frequently-prescribed antiepileptic drugs worldwide for the therapy of generalized and focal epilepsies, including special epileptic. It is a broad-spectrum antiepileptic drug and is usually well tolerated. Rarely, serious complications may occur in some patients, including hemorrhagic pancreatitis, coagulopathies, bone marrow suppression, VPA-induced hepatotoxicity and encephalopathy, but there is still a lack of knowledge about the incidence and occurrence of these special side effects. VPA has been approved for stabilization of manic episodes in patients with bipolar disorder. It is also used to treat migraine headaches and schizophrenia. As the use of VPA increases, the number of both accidental and intentional exposures increases. This is paralleled by more reports of VPA-induced toxicity. VPA is relatively contraindicated in pregnancy due to its teratogenicity. It is a known folate antagonist, which can cause neural tube defects. Thus, folic acid supplements may alleviate teratogenic problems. Women who become pregnant whilst taking valproate should be counselled as to its risks. VPA is an inhibitor of the enzyme histone deacetylase 1 (HDAC1). HDAC1 is needed for HIV to remain in infected cells. Patients treated with valproic acid in addition to highly active antiretroviral therapy (HAART) showed a median 75% reduction in latent HIV infection. VPA is believed to affect the function of the neurotransmitter GABA (as a GABA transaminase inhibitor) in the human brain. Valproic Acid dissociates to the valproate ion in the gastrointestinal tract. (PMID: 18201150, 17496767) [HMDB]",99-66-1,NA,NA,NA,NA,NA,NA,NA,NA,C07185,3121,NA,39867,2PP,NA,NA,NA,Valproic acid,NA,NA,NA,NA,NA,NA,NA,HMDB01877.pdf,application/pdf,3070784,2015-02-28 17:44:36 UTC,NA,NA,2011-09-21 00:18:28 UTC,2015-10-09 22:31:14 UTC,NA,NA,HMDB01877,NA,DB00313,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2.54,2.798451071,-1.79,[H]OC(=O)C([H])(C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[H],NA,C8H16O2,144.2114,"InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)",144.1150298,InChIKey=NIJJYAXOARWZEE-UHFFFAOYSA-N,2.36e+00 g/l,86497,2-propylpentanoic acid,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Methyl-branched fatty acids,Aliphatic acyclic compounds,CHEMBL109,3009,NA,TRUE,NA,DB00313,APRD00256 | DB00510 | APRD00066,Valproic Acid,99-66-1,614OI1Z5WI,2-n-propyl-n-valeric acid | 2-propyl-pentanoic acid | 2-Propylpentanoic Acid | 2-Propylvaleric Acid | 4-heptanecarboxylic acid | acide valproÃ¯que | Ã¡cido valproico | acidum valproicum | di-n-propylacetic acid | Di-n-propylessigsÃ¤ure | Dipropylacetic acid | DPA | n-DPA | Valproate | ValproinsÃ¤ure | VPA,NIJJYAXOARWZEE-UHFFFAOYSA-N
NIUVHXTXUXOFEB-UHFFFAOYSA-N,971,HMDB0001261,660.315914404,"3-[9,14,20-tris(2-carboxyethyl)-5,10,15,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1(20),3,5,8,10,13,15,18-octaen-4-yl]propanoic acid",Coproporphyrinogen III,C36H44N4O8,2624-63-7,C03263,FDB022518,NA,NA,COPROPORPHYRINOGEN_III,321,315,CC1=C2CC3=C(C)C(CCC(O)=O)=C(CC4=C(CCC(O)=O)C(C)=C(CC5=C(CCC(O)=O)C(C)=C(CC(N2)=C1CCC(O)=O)N5)N4)N3,6116,Organic compounds,Porphyrins,Organoheterocyclic compounds,Tetrapyrroles and derivatives,Porphyrins,Aromatic heteropolycyclic compounds,NA,3226,T3D4438,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,660.315914404,"3-[10,14,19-tris(2-carboxyethyl)-5,9,15,20-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1\xc2\xb3,\xe2\x81\xb6.1\xe2\x81\xb8,\xc2\xb9\xc2\xb9.1\xc2\xb9\xc2\xb3,\xc2\xb9\xe2\x81\xb6]tetracosa-1(20),3,5,8,10,13,15,18-octaen-4-yl]propanoic acid",Coproporphyrinogen III,C36H44N4O8,2624-63-7,HMDB01261,DB04461,C03263,COPROPORPHYRINOGEN_III,321,315,CC1=C2CC3=C(C)C(CCC(O)=O)=C(CC4=C(CCC(O)=O)C(C)=C(CC5=C(CCC(O)=O)C(C)=C(CC(N2)=C1CCC(O)=O)N5)N4)N3,Chemical entities,Porphyrins,Organic compounds,Organoheterocyclic compounds,Tetrapyrroles and derivatives,Aromatic heteropolycyclic compounds,22681,NA,SmallMoleculeCompound,FDB022518,Coproporphyrinogen III,TRUE,Solid,low,Coproporphyrinogen III oxidase is deficient in hereditary coproporphyria. These persons usually have enhanced excretion even in a subclinical state of the disease.(PubMed ID 14605502 ) [HMDB],2624-63-7,NA,NA,NA,NA,NA,NA,NA,NA,C03263,321,NA,15439,CP3,NA,NA,NA,Coproporphyrinogen III,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2011-09-21 00:15:13 UTC,2015-07-21 06:57:15 UTC,NA,NA,HMDB01261,NA,NA,41515,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.96,4.891239219,-4.77,[H]OC(=O)C([H])([H])C([H])([H])C1=C2N([H])C(=C1C([H])([H])[H])C([H])([H])C1=C(C(=C(N1[H])C([H])([H])C1=C(C(=C(N1[H])C([H])([H])C1=C(C(=C(N1[H])C2([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C(=O)O[H])C([H])([H])[H])C([H])([H])C([H])([H])C(=O)O[H])C([H])([H])C([H])([H])C(=O)O[H])C([H])([H])[H],4.229360781,C36H44N4O8,660.7566,"InChI=1S/C36H44N4O8/c1-17-21(5-9-33(41)42)29-14-27-19(3)22(6-10-34(43)44)30(39-27)15-28-20(4)24(8-12-36(47)48)32(40-28)16-31-23(7-11-35(45)46)18(2)26(38-31)13-25(17)37-29/h37-40H,5-16H2,1-4H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48)",660.3159144,InChIKey=NIUVHXTXUXOFEB-UHFFFAOYSA-N,1.12e-02 g/l,88285,"3-[10,14,19-tris(2-carboxyethyl)-5,9,15,20-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1(20),3,5,8,10,13,15,18-octaen-4-yl]propanoic acid",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Tetrapyrroles and derivatives,Porphyrins,Porphyrins,Aromatic heteropolycyclic compounds,CHEMBL1231891,315,COPROPORPHYRINOGEN_III,NA,NA,DB04461,EXPT00993,Coproporphyrinogen III,2624-63-7,NA,"3,8,13,17-tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,18-tetrapropionic acid | 5,10,15,20,22,24-hexahydro-3,8,13,17-tetramethyl-21H,23H-porphine-2,7,12,18-tetrapropanoic acid",NIUVHXTXUXOFEB-UHFFFAOYSA-N
NOOLISFMXDJSKH-KXUCPTDWSA-N,1843,HMDB0003352,156.151415264,"(1R,2S,5R)-5-methyl-2-(propan-2-yl)cyclohexan-1-ol",Menthol,C10H20O,2216-51-5,C00400,FDB014499,DB00825,NA,CPD-4944,16666,15803,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O,NA,Organic compounds,Menthane monoterpenoids,Lipids and lipid-like molecules,Prenol lipids,Monoterpenoids,Aliphatic homomonocyclic compounds,3.4,2513,T3D3224,Exogenous,3.4,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,156.151415262,"(1R,2S,5R)-5-methyl-2-(propan-2-yl)cyclohexan-1-ol",Menthol,C10H20O,2216-51-5,HMDB03352,DB00825,C00400,CPD-4944,16666,15803,[H][C@@]1(C)CC[C@@]([H])(C(C)C)[C@]([H])(O)C1,Organic compounds,Menthane monoterpenoids,Lipids and lipid-like molecules,Prenol lipids,Monoterpenoids,Aliphatic homomonocyclic compounds,14502,38350,SmallMoleculeCompound,FDB014499,(-)-Menthol,TRUE,Solid,low,"Present in large amts. in peppermint oil (Mentha piperita), also in other Mentha spp.. Used in confectionery and perfumery. Flavouring agent(-)-menthol is the major occuring menthol stereoisomer in nature. (Wikipedia)",2216-51-5,Mp 42.5-43å¡,NA,NA,0.49 mg/mL at 25 oC,3.4,NA,NA,NA,C00400,16666,NA,15409,NA,NA,NA,NA,Menthol,NA,NA,NA,NA,NA,NA,NA,HMDB03352.pdf,application/pdf,2449769,2015-02-28 18:02:53 UTC,NA,2,2010-04-08 22:11:18 UTC,2015-10-09 22:32:11 UTC,NA,JRL74-J:JRL66-I,HMDB03352,L-MENTHOL|MENTHOL|(-)-MENTHOL,DB00825,NA,2144,C00000810,Bp 216å¡,DFC,NA,NA,NA,NA,"[a]20D -50 (c, 2 in CHCl3)",DFC,C 76.86%; H 12.90%; O 10.24%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,CHEMICALS INSPECTION AND TESTING INSTITU (1992),"GRIFFIN,S ET AL. (1999)",NA,NA,DFC,2.68,2.66,-2.45,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O,NA,C10H20O,156.2652,"InChI=1S/C10H20O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-11H,4-6H2,1-3H3/t8-,9+,10-/m1/s1",156.1514153,InChIKey=NOOLISFMXDJSKH-KXUCPTDWSA-N,5.58e-01 g/l,34277,"(1R,2S,5R)-5-methyl-2-(propan-2-yl)cyclohexan-1-ol",MANUAL,NA,NA,"p-Menthan-3-ol; (1R,3R,4S)-form",DFC,2216-51-5,rw1030471,16666,NA,NA,NA,NA,NA,NA,NA,CHEMBL470670,15803,CPD-4944,TRUE,NA,DB00825,APRD01604,Menthol,2216-51-5,BZ1R15MTK7,"(-)-(1R,3R,4S)-Menthol | (-)-menthol | (1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol | (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol | (1R,3R,4S)-(-)-Menthol | (r)-(-)-menthol | L-(-)-menthol | L-menthol | Levomenthol | Levomentholum | Levomentol",NOOLISFMXDJSKH-KXUCPTDWSA-N
NPOAOTPXWNWTSH-UHFFFAOYSA-N,256,HMDB0000355,162.05282343,3-hydroxy-3-methylpentanedioic acid,3-Hydroxymethylglutaric acid,C6H10O5,503-49-1,C03761,FDB005950,NA,NA,NA,1662,1600,CC(O)(CC(O)=O)CC(O)=O,5344,Organic compounds,Hydroxy fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,NA,3152,T3D4262,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,162.05282343,3-hydroxy-3-methylpentanedioic acid,3-Hydroxymethylglutaric acid,C6H10O5,503-49-1,HMDB00355,DB04377,C03761,NA,1662,1600,CC(O)(CC(O)=O)CC(O)=O,Chemical entities,Hydroxy fatty acids,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Aliphatic acyclic compounds,4208,12438,SmallMoleculeCompound,FDB004207,beta-Hydroxy-beta-methylglutaric acid,TRUE,NA,low,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:06:08 UTC,2015-07-20 21:59:33 UTC,NA,NA,NA,BETA-HYDROXY-BETA-METHYL-GLUTARIC-ACID,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CC(O)(CC(O)=O)CC(O)=O,NA,C6H10O5,162.1406,"InChI=1S/C6H10O5/c1-6(11,2-4(7)8)3-5(9)10/h11H,2-3H2,1H3,(H,7,8)(H,9,10)",162.0528234,NPOAOTPXWNWTSH-UHFFFAOYSA-N,NA,NA,NA,NA,NA,NA,NA,DUKE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB04377,EXPT02109,3-Hydroxy-3-Methyl-Glutaric Acid,NA,CLA99KCD53,NA,NPOAOTPXWNWTSH-UHFFFAOYSA-N
NPOAOTPXWNWTSH-UHFFFAOYSA-N,39959,HMDB0059737,162.05282343,3-hydroxy-3-methylpentanedioic acid,3-Methyl-3-hydroxypentanedioate,C6H10O5,NA,NA,NA,NA,NA,CPD-547,5459993,4573695,CC(O)(CC(O)=O)CC(O)=O,NA,Organic compounds,Hydroxy fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,NA,3152,T3D4262,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,162.05282343,3-hydroxy-3-methylpentanedioic acid,3-Hydroxymethylglutaric acid,C6H10O5,503-49-1,HMDB00355,DB04377,C03761,NA,1662,1600,CC(O)(CC(O)=O)CC(O)=O,Chemical entities,Hydroxy fatty acids,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Aliphatic acyclic compounds,4208,12438,SmallMoleculeCompound,FDB004207,beta-Hydroxy-beta-methylglutaric acid,TRUE,NA,low,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:06:08 UTC,2015-07-20 21:59:33 UTC,NA,NA,NA,BETA-HYDROXY-BETA-METHYL-GLUTARIC-ACID,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CC(O)(CC(O)=O)CC(O)=O,NA,C6H10O5,162.1406,"InChI=1S/C6H10O5/c1-6(11,2-4(7)8)3-5(9)10/h11H,2-3H2,1H3,(H,7,8)(H,9,10)",162.0528234,NPOAOTPXWNWTSH-UHFFFAOYSA-N,NA,NA,NA,NA,NA,NA,NA,DUKE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB04377,EXPT02109,3-Hydroxy-3-Methyl-Glutaric Acid,NA,CLA99KCD53,NA,NPOAOTPXWNWTSH-UHFFFAOYSA-N
NPYPAHLBTDXSSS-UHFFFAOYSA-N,456,HMDB0000586,38.963706861,potassium(1+) ion,Potassium,K,7440-09-7,C00238,FDB003521,DB01345,NA,K%2b,NA,NA,[K+],3197,Inorganic compounds,Homogeneous alkali metal compounds,Homogeneous metal compounds,Homogeneous alkali metal compounds,NA,NA,NA,3193,T3D4344,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,38.963158281,potassium(1+) ion,Potassium,K,7440-09-7,HMDB00586,DB01345,C00238,K%2b,NA,NA,[K+],Chemical entities,Homogeneous alkali metal compounds,Inorganic compounds,Homogeneous metal compounds,Homogeneous alkali metal compounds,NA,3522,10945,SmallMoleculeCompound,FDB003521,Potassium,TRUE,Solid,low,"Potassium is an essential electrolyte. Potassium balance is crucial for regulating the excitability of nerves and muscles and so critical for regulating contractility of cardiac muscle. Although the most important changes seen in the presence of deranged potassium are cardiac, smooth muscle is also affected with increasing muscle weakness, a feature of both hyperkalaemia and hypokalaemia. Physiologically, it exists as an ion in the body. Potassium (K+) is a positively charged electrolyte, cation, which is present throughout the body in both intracellular and extracellular fluids. The majority of body potassium, >90%, are intracellular. It moves freely from intracellular fluid (ICF) to extracellular fluid (ECF) and vice versa when adenosine triphosphate increases the permeability of the cell membrane. It is mainly replaced inside or outside the cells by another cation, sodium (Na+). The movement of potassium into or out of the cells is linked to certain body hormones and also to certain physiological states. Standard laboratory tests measure ECF potassium. Potassium enters the body rapidly during food ingestion. Insulin is produced when a meal is eaten; this causes the temporary movement of potassium from ECF to ICF. Over the ensuing hours, the kidneys excrete the ingested potassium and homeostasis is returned. In the critically ill patient, suffering from hyperkalaemia, this mechanism can be manipulated beneficially by administering high concentration (50%) intravenous glucose. Insulin can be added to the glucose, but glucose alone will stimulate insulin production and cause movement of potassium from ECF to ICF. The stimulation of alpha receptors causes increased movement of potassium from ICF to ECF. A noradrenaline infusion can elevate serum potassium levels. An adrenaline infusion, or elevated adrenaline levels, can lower serum potassium levels. Metabolic acidosis causes a rise in extracellular potassium levels. In this situation, excess of hydrogen ions (H+) are exchanged for intracellular potassium ions, probably as a result of the cellular response to a falling blood pH. Metabolic alkalosis causes the opposite effect, with potassium moving into the cells. (PMID: 17883675) [HMDB]",24203-36-9,63.2 oC,NA,NA,NA,NA,NA,NA,NA,C00238,813,NA,29103,NA,NA,NA,NA,Potassium,NA,NA,CAS number for potassium atom: 7440-09-7,NA,NA,NA,NA,HMDB00586.pdf,application/pdf,51341,2015-02-28 18:06:09 UTC,NA,2,2010-04-08 22:05:50 UTC,2015-07-20 21:56:01 UTC,NA,NA,HMDB00586,POTASSIUM,DB01345,34349,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2,NA,[K+],NA,K,39.0983,InChI=1S/K/q+1,38.96370686,InChIKey=NPYPAHLBTDXSSS-UHFFFAOYSA-N,NA,41309,potassium,BIOSPIDER,NA,NA,NA,DUKE,NA,NA,NA,NA,Inorganic compounds,Homogeneous metal compounds,Homogeneous alkali metal compounds,NA,Homogeneous alkali metal compounds,Acyclic compounds,NA,791,K%2b,NA,NA,DB01345,NA,Potassium,24203-36-9,295O53K152,Potassium (ion) | Potassium cation | Potassium ion | potassium(1+) | potassium(1+) ion | potassium(I) cation,NPYPAHLBTDXSSS-UHFFFAOYSA-N
NUFNQYOELLVIPL-UHFFFAOYSA-N,17853,HMDB0037112,360.996484661,5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid,Acifluorfen,C14H7ClF3NO5,50594-66-6,NA,FDB016105,NA,NA,ACIFLUORFEN,44073,40113,OC(=O)C1=CC(OC2=CC=C(C=C2Cl)C(F)(F)F)=CC=C1[N+]([O-])=O,NA,Organic compounds,Diphenylethers,Benzenoids,Benzene and substituted derivatives,Diphenylethers,Aromatic homomonocyclic compounds,3.7,2819,T3D3790,Exogenous,3.7,Not listed by IARC.,NA,SmallMolecule,360.996484661,5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid,Acifluorfen,C14H7ClF3NO5,50594-66-6,HMDB37112,DB07338,NA,NA,44073,40113,OC(=O)C1=C(C=CC(OC2=C(Cl)C=C(C=C2)C(F)(F)F)=C1)N(=O)=O,Chemical entities,Diphenylethers,Organic compounds,Benzenoids,Benzene and substituted derivatives,Aromatic homomonocyclic compounds,16112,42427,SmallMoleculeCompound,FDB016105,Acifluorfen,TRUE,NA,low,Selective pre- and post-emergence herbicide. Used on soybeans and peanuts,50594-66-6,Mp 240å¡,NA,NA,0.12 mg/mL at 25 oC,3.7,NA,NA,NA,NA,44073,NA,NA,ACJ,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:12:14 UTC,2015-07-20 23:25:31 UTC,NA,KNP09-W:KNP09-W,HMDB37112,NA,DB07338,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 46.49%; H 1.95%; Cl 9.80%; F 15.76%; N 3.87%; O 22.12%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,"TOMLIN,C (1994)",NANDIHALLI UB ET AL. (1992),NA,NA,DFC,3.87,4.552993254,-5.63,OC(=O)C1=C(C=CC(OC2=C(Cl)C=C(C=C2)C(F)(F)F)=C1)N(=O)=O,NA,C14H7ClF3NO5,361.657,"InChI=1S/C14H7ClF3NO5/c15-10-5-7(14(16,17)18)1-4-12(10)24-8-2-3-11(19(22)23)9(6-8)13(20)21/h1-6H,(H,20,21)",360.9964847,InChIKey=NUFNQYOELLVIPL-UHFFFAOYSA-N,8.52e-04 g/l,31764,5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid,HMDB_from_dfc,NA,NA,"Acifluorfen, ANSI, BSI, ISO, WSSA",DFC,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Diphenylethers,Diphenylethers,Aromatic homomonocyclic compounds,CHEMBL222440,40113,NA,NA,NA,DB07338,NA,5-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENOXY]-2-NITROBENZOIC ACID,NA,OI60IB203A,NA,NUFNQYOELLVIPL-UHFFFAOYSA-N
NVKAWKQGWWIWPM-ABEVXSGRSA-N,1738,HMDB0002961,290.224580204,"(1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0\xc2\xb2,\xe2\x81\xb7.0\xc2\xb9\xc2\xb9,\xc2\xb9\xe2\x81\xb5]heptadecan-5-one",Dihydrotestosterone,C19H30O2,521-18-6,C03917,FDB023086,NA,DBMET00558,17-BETA-HYDROXY-5ALPHA-ANDROSTAN-3-O,10635,10189,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C,2789,Organic compounds,Androgens and derivatives,Lipids and lipid-like molecules,Steroids and steroid derivatives,Androstane steroids,Aliphatic homopolycyclic compounds,3.55,3438,T3D4751,Endogenous,3.55,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,290.224580204,"(1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0\xc2\xb2,\xe2\x81\xb7.0\xc2\xb9\xc2\xb9,\xc2\xb9\xe2\x81\xb5]heptadecan-5-one",Dihydrotestosterone,C19H30O2,521-18-6,HMDB02961,DB02901,C03917,17-BETA-HYDROXY-5ALPHA-ANDROSTAN-3-O,10635,14,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C,Organic compounds,Androgens and derivatives,Lipids and lipid-like molecules,Steroids and steroid derivatives,Androstane steroids,Aliphatic homopolycyclic compounds,23249,NA,SmallMoleculeCompound,FDB023086,Dihydrotestosterone,TRUE,Solid,low,"A potent androgenic metabolite of testosterone. Dihydrotestosterone (DHT) is generated by a 5-alpha reduction of testosterone. Unlike testosterone, DHT cannot be aromatized to estradiol therefore DHT is considered a pure androgenic steroid. -- Pubchem; Dihydrotestosterone (DHT) (INN: androstanolone) is a biologically active metabolite of the hormone testosterone, formed primarily in the prostate gland, testes, hair follicles, and adrenal glands by the enzyme 5-alpha-reductase by means of reducing the alpha 4,5 double-bond. Dihydrotestosterone belongs to the class of compounds called androgens, also commonly called androgenic hormones or testoids. DHT is thought to be approximately 30 times more potent than testosterone because of increased affinity to the androgen receptor. -- Wikipedia [HMDB]",521-18-6,NA,NA,NA,NA,NA,NA,NA,NA,C03917,10635,NA,16330,DHT,NA,NA,NA,Dihydrotestosterone,NA,NA,NA,NA,NA,NA,NA,HMDB02961.pdf,application/pdf,164363,2015-02-28 17:49:40 UTC,NA,NA,2011-09-21 00:24:28 UTC,2015-07-21 06:57:30 UTC,NA,NA,HMDB02961,NA,NA,42776,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3.37,3.411257633,-4.46,[H]O[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])[C@@]4([H])C([H])([H])C(=O)C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H],NA,C19H30O2,290.4403,"InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1",290.2245802,InChIKey=NVKAWKQGWWIWPM-ABEVXSGRSA-N,9.98e-03 g/l,83343,"(1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-5-one",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Lipids and lipid-like molecules,Steroids and steroid derivatives,Androstane steroids,Androgens and derivatives,Aliphatic homopolycyclic compounds,CHEMBL27769,10189,17-BETA-HYDROXY-5ALPHA-ANDROSTAN-3-O,NA,NA,DB02901,EXPT01199,Stanolone,521-18-6,08J2K08A3Y,17beta-Hydroxy-5alpha-androstan-3-one | 17beta-Hydroxy-5alpha-androstane-3-one | 17beta-Hydroxyandrostan-3-one | 17Î²-hydroxy-3-oxo-5Î±-androstanone | 17Î²-hydroxy-5Î±-androstan-3-one | 4-Dihydrotestosterone | 5alpha-Dihydrotestosterone | 5Î±-DHT | Androstanolone | DHT | Dihydrotestosteron | DihydrotestostÃ©rone | Dihydrotestosterone,NVKAWKQGWWIWPM-ABEVXSGRSA-N
ODHCTXKNWHHXJC-VKHMYHEASA-N,182,HMDB0000267,129.042593095,(2S)-5-oxopyrrolidine-2-carboxylic acid,Pyroglutamic acid,C5H7NO3,98-79-3,C01879,FDB014506,DB03088,NA,CPD-589,7405,7127,OC(=O)[C@@H]1CCC(=O)N1,3251,Organic compounds,Alpha amino acids and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic heteromonocyclic compounds,NA,3156,T3D4270,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,129.042593095,(2S)-5-oxopyrrolidine-2-carboxylic acid,Pyroglutamic acid,C5H7NO3,98-79-3,HMDB00267,DB03088,C01879,CPD-589,7405,7127,[H][C@]1(CCC(O)=N1)C(O)=O,Chemical entities,Alpha amino acids and derivatives,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Aliphatic heteromonocyclic compounds,6739,17188,SmallMoleculeCompound,FDB006738,Psidiolic acid,TRUE,NA,low,NA,98-79-3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:07:17 UTC,2017-03-01 02:04:52 UTC,NA,NA,NA,PSIDIOLIC-ACID,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,OC(=O)[C@@H]1CCC(=O)N1,NA,C5H7NO3,129.114,"InChI=1S/C5H7NO3/c7-4-2-1-3(6-4)5(8)9/h3H,1-2H2,(H,6,7)(H,8,9)/t3-/m0/s1",129.0425931,ODHCTXKNWHHXJC-VKHMYHEASA-N,NA,NA,NA,NA,NA,NA,NA,DUKE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB03088,EXPT00247,Pidolic Acid,98-79-3,SZB83O1W42,(â)-2-pyrrolidone-5-carboxylic acid | (S)-(â)-2-pyrrolidone-5-carboxylic acid | (S)-pyroglutamic acid | 5-L-oxoproline | 5-oxo-2-pyrrolidinecarboxylic acid | 5-oxo-L-proline | 5-Pyrrolidone-2-carboxylic acid | Glutimic acid | L-5-Pyrrolidone-2-carboxylic acid | L-pyroglutamic acid | L-pyrrolidone carboxylic acid | PCA | Pyroglutamic Acid,ODHCTXKNWHHXJC-VKHMYHEASA-N
ODKSFYDXXFIFQN-BYPYZUCNSA-N,395,HMDB0000517,174.111675712,(2S)-2-amino-5-carbamimidamidopentanoic acid,L-Arginine,C6H14N4O2,74-79-3,C00062,FDB002257,NA,DBMET00502,ARG,6322,6082,N[C@@H](CCCNC(N)=N)C(O)=O,5502,Organic compounds,L-alpha-amino acids,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,-4.2,3169,T3D4289,Endogenous,-4.2,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,174.111675712,(2S)-2-amino-5-carbamimidamidopentanoic acid,L-Arginine,C6H14N4O2,74-79-3,HMDB00517,DB00125,C00062,ARG,6322,6082,[H][C@](N)(CCCNC(N)=N)C(O)=O,Organic compounds,L-alpha-amino acids,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,2257,7256,SmallMoleculeCompound,FDB002257,Arginine,TRUE,Solid,low,"Dietary supplement, nutrientArginine (abbreviated as Arg or R) is an alpha-amino acid. The L-form is one of the 20 most common natural amino acids. (Wikipedia)",74-79-3,Mp 244 dec. (anhyd. 105å¡),NA,NA,182 mg/mL at 25 oC,-4.2,NA,NA,NA,C00062,6322,NA,16467,1FOL,NA,NA,NA,Arginine,NA,NA,NA,NA,NA,NA,NA,HMDB00517.pdf,application/pdf,49045,2015-02-28 18:00:17 UTC,NA,2,2010-04-08 22:05:18 UTC,2015-10-09 22:29:17 UTC,NA,CHQ98-B:CHQ90-T,HMDB00517,L-ARGININE|ARGININE,DB00125,33707,248,C00001340,NA,NA,NA,NA,NA,NA,"[a]25D +48.1 (c, 1 in 5M HCl)",DFC,C 41.37%; H 8.10%; N 32.16%; O 18.37%,DFC,NA,NA,NA,NA,NA,NA,pKa3 12.48 (guanido),DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,-3.49,-4.35,-1.88,N[C@@H](CCCNC(N)=N)C(O)=O,NA,C6H14N4O2,174.201,"InChI=1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s1",174.1116757,InChIKey=ODKSFYDXXFIFQN-BYPYZUCNSA-N,2.28e+00 g/l,33268,(2S)-2-amino-5-carbamimidamidopentanoic acid,MANUAL,NA,NA,"Arginine, INN, USAN; (S)-form",DFC,NA,rw1068131,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",L-alpha-amino acids,Aliphatic acyclic compounds,CHEMBL1485,6082,ARG,TRUE,NA,DB00125,NUTR00014,L-Arginine,74-79-3,94ZLA3W45F,(2S)-2-amino-5-(carbamimidamido)pentanoic acid | (2S)-2-amino-5-guanidinopentanoic acid | (S)-2-amino-5-guanidinopentanoic acid | (S)-2-Amino-5-guanidinovaleric acid | Arg | Arginine | L-(+)-Arginine | L-Arg | L-Arginin | R,ODKSFYDXXFIFQN-BYPYZUCNSA-N
OGSPWJRAVKPPFI-UHFFFAOYSA-N,1271,HMDB0001915,249.016724799,(4-amino-1-hydroxy-1-phosphonobutyl)phosphonic acid,Alendronic acid,C4H13NO7P2,66376-36-1,C07752,FDB022734,NA,NA,ALENDRONATE,2088,2004,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,818,Organic compounds,Bisphosphonates,Organic acids and derivatives,Organic phosphonic acids and derivatives,Bisphosphonates,Aliphatic acyclic compounds,NA,2164,T3D2666,Exogenous,-4.3,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,249.016724799,(4-amino-1-hydroxy-1-phosphonobutyl)phosphonic acid,Alendronic acid,C4H13NO7P2,66376-36-1,HMDB01915,DB00630,C07752,ALENDRONATE,2088,2004,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,Chemical entities,Bisphosphonates,Organic compounds,Organic acids and derivatives,Organic phosphonic acids and derivatives,Aliphatic acyclic compounds,22897,NA,SmallMoleculeCompound,FDB022734,Alendronic acid,TRUE,Solid,low,"Alendronate (Fosamax, Merck) is a bisphosphonate drug used for osteoporosis and several other bone diseases. It is marketed alone as well as in combination with vitamin D (2,800 U, under the name Fosavance). [HMDB]",66376-36-1,NA,NA,NA,NA,NA,NA,NA,NA,C07752,2088,NA,NA,NA,NA,NA,NA,Alendronic acid,NA,NA,NA,NA,NA,NA,NA,HMDB01915.pdf,application/pdf,142242,2015-02-28 18:07:30 UTC,NA,NA,2011-09-21 00:18:46 UTC,2015-10-09 22:31:19 UTC,NA,NA,HMDB01915,NA,DB00630,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-1.34,-4.190998027,-1.17,[H]OC(C([H])([H])C([H])([H])C([H])([H])N([H])[H])(P(=O)(O[H])O[H])P(=O)(O[H])O[H],1.453334585,C4H13NO7P2,249.096,"InChI=1S/C4H13NO7P2/c5-3-1-2-4(6,13(7,8)9)14(10,11)12/h6H,1-3,5H2,(H2,7,8,9)(H2,10,11,12)",249.0167248,InChIKey=OGSPWJRAVKPPFI-UHFFFAOYSA-N,1.69e+01 g/l,88280,(4-amino-1-hydroxy-1-phosphonobutyl)phosphonic acid,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organophosphorus compounds,Organic phosphonic acids and derivatives,Bisphosphonates,Bisphosphonates,Aliphatic acyclic compounds,CHEMBL870,2004,ALENDRONATE,TRUE,NA,DB00630,APRD00561,Alendronic acid,66376-36-1,X1J18R4W8P,"(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid) | (4-amino-1-hydroxybutylidene)bisphosphonic acid | 4-amino-1-hydroxybutane-1,1-diphosphonic acid | ABDP | Acide Alendronique | Acido Alendronico | Acidum Alendronicum | Alendronate",OGSPWJRAVKPPFI-UHFFFAOYSA-N
OIRDTQYFTABQOQ-KQYNXXCUSA-N,34,HMDB0000050,267.096753929,"(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol",Adenosine,C10H13N5O4,58-61-7,C00212,FDB003554,DB00640,NA,ADENOSINE,60961,54923,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,86,Organic compounds,Purine nucleosides,"Nucleosides, nucleotides, and analogues",Purine nucleosides,NA,Aromatic heteropolycyclic compounds,-1.05,3159,T3D4275,Endogenous,-1.05,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,267.096753929,"(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol",Adenosine,C10H13N5O4,58-61-7,HMDB00050,DB00640,C00212,ADENOSINE,60961,54923,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,Organic compounds,Purine nucleosides,"Nucleosides, nucleotides, and analogues",Purine nucleosides,NA,Aromatic heteropolycyclic compounds,3555,11001,SmallMoleculeCompound,FDB003554,Adenosine,TRUE,Solid,low,Adenosine is a nucleoside composed of a molecule of adenine attached to a ribose sugar molecule (ribofuranose) moiety via a beta-N9-glycosidic bond. [Wikipedia],58-61-7,235.5 oC,NA,NA,NA,-1.05,NA,NA,NA,C00212,60961,NA,16335,ADN,NA,NA,NA,Adenosine,NA,NA,NA,NA,NA,NA,NA,HMDB00050.pdf,application/pdf,48022,2015-02-28 17:59:06 UTC,NA,2,2010-04-08 22:05:51 UTC,2015-10-09 22:27:32 UTC,NA,NA,HMDB00050,ADENOSINE,DB00640,34273,NA,C00007444,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HANSCH,C ET AL. (1995)",NA,NA,NA,-1.21,-2.09,-1.28,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,13.89,C10H13N5O4,267.2413,"InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",267.0967539,InChIKey=OIRDTQYFTABQOQ-KQYNXXCUSA-N,1.40e+01 g/l,40207,"(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol",BIOSPIDER,NA,NA,NA,DUKE,NA,NA,NA,NA,Organic compounds,"Nucleosides, nucleotides, and analogues",Purine nucleosides,NA,Purine nucleosides,Aromatic heteropolycyclic compounds,CHEMBL477,54923,ADENOSINE,TRUE,NA,DB00640,APRD00132 | DB06639,Adenosine,58-61-7,K72T3FS567,"(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol | 6-Amino-9-beta-D-ribofuranosyl-9H-purine | 9-beta-D-Ribofuranosidoadenine | 9-beta-D-Ribofuranosyl-9H-purin-6-amine | 9-Î²-D-ribofuranosyl-9H-purin-6-amine | Ade-Rib | Adenin riboside | Adenine Deoxyribonucleoside | Adenogesic | Adenosin | Adenosina | AdÃ©nosine | Adenosinum | Ado | beta-D-Adenosine",OIRDTQYFTABQOQ-KQYNXXCUSA-N
ONIBWKKTOPOVIA-BYPYZUCNSA-N,106,HMDB0000162,115.063328537,(2S)-pyrrolidine-2-carboxylic acid,L-Proline,C5H9NO2,147-85-3,C00148,FDB000570,DB00172,DBMET00494,PRO,145742,128566,OC(=O)[C@@H]1CCCN1,29,Organic compounds,Proline and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic heteromonocyclic compounds,-2.54,3218,T3D4411,Endogenous,-2.54,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,115.063328537,(2S)-pyrrolidine-2-carboxylic acid,L-Proline,C5H9NO2,147-85-3,HMDB00162,DB00172,C00148,PRO,145742,128566,[H][C@]1(CCCN1)C(O)=O,Organic compounds,Proline and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic heteromonocyclic compounds,570,1519,SmallMoleculeCompound,FDB000570,L-Proline,TRUE,Solid,low,"Flavouring ingredient; dietary supplementProline (abbreviated as Pro or P) is an alpha-amino acid, one of the twenty DNA-encoded amino acids. Its codons are CCU, CCC, CCA, and CCG. It is not an essential amino acid, which means that the human body can synthesize it. It is unique among the 20 protein-forming amino acids in that the alpha-amino group is secondary. The more common L form has S stereochemistry. (Wikipedia)",147-85-3,Mp 220-222å¡ dec.,NA,NA,162 mg/mL at 25 oC,-2.54,NA,NA,NA,C00148,145742,NA,17203,PRO,NA,NA,NA,Proline,NA,NA,NA,NA,NA,NA,NA,HMDB00162.pdf,application/pdf,48194,2015-02-28 17:49:02 UTC,NA,2,2010-04-08 22:04:37 UTC,2015-10-09 22:28:04 UTC,NA,BDS30-Y:BDS36-E,HMDB00162,PROLINE,DB02853,34042,3165,C00001388,NA,NA,NA,NA,NA,NA,"[a]D -60.4 (c, 1 in 5M HCl)",DFC,C 52.16%; H 7.88%; N 12.17%; O 27.79%,DFC,NA,NA,NA,NA,NA,NA,pKa2 10.6 (NH2),DFC,MERCK INDEX (1996),"HANSCH,C ET AL. (1995)",NA,NA,DFC,-2.71,-2.71,0.5,OC(=O)[C@@H]1CCCN1,NA,C5H9NO2,115.1305,"InChI=1S/C5H9NO2/c7-5(8)4-2-1-3-6-4/h4,6H,1-3H2,(H,7,8)/t4-/m0/s1",115.0633285,InChIKey=ONIBWKKTOPOVIA-BYPYZUCNSA-N,3.65e+02 g/l,36812,(2S)-pyrrolidine-2-carboxylic acid,MANUAL,NA,NA,"Proline, 9CI; (S)-form",DFC,NA,rw1035851,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",L-alpha-amino acids,Aliphatic heteromonocyclic compounds,CHEMBL54922,128566,PRO,TRUE,NA,DB00172,NUTR00047,L-Proline,147-85-3,9DLQ4CIU6V,(-)-2-Pyrrolidinecarboxylic acid | (â)-(S)-proline | (â)-2-pyrrolidinecarboxylic acid | (â)-proline | (2S)-pyrrolidine-2-carboxylic acid | (S)-2-Carboxypyrrolidine | (S)-2-Pyrrolidinecarboxylic acid | (S)-pyrrolidine-2-carboxylic acid | 2-Pyrrolidinecarboxylic acid | L-(â)-proline | L-alpha-pyrrolidinecarboxylic acid | L-Prolin | L-pyrrolidine-2-carboxylic acid | L-Î±-pyrrolidinecarboxylic acid | P | Prolina | Proline | Prolinum,ONIBWKKTOPOVIA-BYPYZUCNSA-N
OROGSEYTTFOCAN-DNJOTXNNSA-N,2337,HMDB0004995,299.152143543,"(1S,5R,13R,14S,17R)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0\xc2\xb9,\xc2\xb9\xc2\xb3.0\xe2\x81\xb5,\xc2\xb9\xe2\x81\xb7.0\xe2\x81\xb7,\xc2\xb9\xe2\x81\xb8]octadeca-7(18),8,10,15-tetraen-14-ol",Codeine,C18H21NO3,76-57-3,C06174,FDB012162,DB00318,NA,NA,5284371,4447447,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,498,Organic compounds,Morphinans,Alkaloids and derivatives,Morphinans,NA,Aromatic heteropolycyclic compounds,1.19,2221,T3D2749,Exogenous,1.19,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,299.152143543,"(1S,5R,13R,14S,17R)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0\xc2\xb9,\xc2\xb9\xc2\xb3.0\xe2\x81\xb5,\xc2\xb9\xe2\x81\xb7.0\xe2\x81\xb7,\xc2\xb9\xe2\x81\xb8]octadeca-7(18),8,10,15-tetraen-14-ol",Codeine,C18H21NO3,76-57-3,HMDB04995,DB00318,C06174,CODEINE,5284371,4447447,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@]2([H])O,Organic compounds,Morphinans,Alkaloids and derivatives,Morphinans,NA,Aromatic heteropolycyclic compounds,12165,31466,SmallMoleculeCompound,FDB012162,Codeine,TRUE,Solid,low,"Opium alkaloid (Papaver somniferum) (content ca. 1%)An opioid analgesic related to morphine but with less potent analgesic properties and mild sedative effects. It also acts centrally to suppress cough.; Codeine (INN) or methylmorphine is an opiate used for its analgesic, antitussive and antidiarrheal properties.",76-57-3,Mp 155å¡,NA,NA,9 mg/mL at 20 oC,1.19,NA,NA,NA,C06174,163159,NA,16714,NA,NA,NA,NA,Codeine,NA,NA,NA,NA,NA,NA,NA,HMDB04995.pdf,application/pdf,48673,2015-02-28 17:51:15 UTC,NA,2,2010-04-08 22:10:01 UTC,2015-07-20 22:47:38 UTC,NA,HDV94-X:HDV94-X,HMDB04995,NA,DB00318,NA,NA,C00001837,NA,NA,NA,NA,NA,NA,[a]D -137.8 (EtOH),DFC,C 72.22%; H 7.07%; N 4.68%; O 16.03%,DFC,NA,NA,NA,NA,NA,NA,8.21,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","AVDEEF,A ET AL. (1996)",NA,NA,DFC,1.2,1.34,-2.72,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C,NA,C18H21NO3,299.3642,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1",299.1521435,InChIKey=OROGSEYTTFOCAN-DNJOTXNNSA-N,5.77e-01 g/l,41127,"(1S,5R,13R,14S,17R)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7,9,11(18),15-tetraen-14-ol",BIOSPIDER,NA,NA,"Codeine, BAN, USAN",DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4447447,NA,NA,NA,DB00318,APRD00120 | DB09471,Codeine,76-57-3,UX6OWY2V7J,"(â)-Codeine | (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol | (5Î±,6Î±)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol | 3-Methylmorphin | 3-methylmorphine | 7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol | 7,8-didehydro-4,5Î±-epoxy-3-methoxy-17-methylmorphinan-6Î±-ol | Codein | CodeÃ­na | CodÃ©ine | Codeine anhydrous | Codeine polistirex | Codeinum | L-Codeine | Methylmorphine | morphine 3-methyl ether | Morphine monomethyl ether | morphine monomethyl ether | morphine-3-methyl ether | O(3)-methylmorphine",OROGSEYTTFOCAN-DNJOTXNNSA-N
OSWPMRLSEDHDFF-UHFFFAOYSA-N,15087,HMDB0034172,152.047344122,methyl 2-hydroxybenzoate,Methyl 2-hydroxybenzoate,C8H8O3,119-36-8,C12305,FDB012459,NA,NA,NA,4133,13848808,COC(=O)C1=CC=CC=C1O,NA,Organic compounds,o-Hydroxybenzoic acid esters,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Aromatic homomonocyclic compounds,2.55,3532,T3D4848,Exogenous,2.55,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,152.047344122,methyl 2-hydroxybenzoate,Methyl 2-hydroxybenzoate,C8H8O3,119-36-8,HMDB34172,NA,C12305,NA,4133,13848808,COC(=O)C1=CC=CC=C1O,Chemical entities,o-Hydroxybenzoic acid esters,Organic compounds,Benzenoids,Benzene and substituted derivatives,Aromatic homomonocyclic compounds,12462,32360,SmallMoleculeCompound,FDB012459,Methyl salicylate,TRUE,Liquid,low,"Present in white wine, tea, porcini mushroom Boletus edulis, Bourbon vanilla, clary sage, red sage and fruits incl. cherry, apple, raspberry, papaya and plum. Found in leaves of Gaultheria procumbens (wintergreen). Flavouring agent",119-36-8,Mp -8.6å¡,NA,NA,0.7 mg/mL at 30 oC,2.55,NA,NA,NA,C12305,4133,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:10:11 UTC,2015-07-20 22:50:42 UTC,NA,HHB30-H:HHB30-H,HMDB34172,METHYL-SALICYLATE|SALICYLIC-ACID-METHYL-ESTER,NA,NA,2495,C00030767,Bp12 101å¡,DFC,NA,NA,d18.54<vs=3> 1.85,DFC,NA,NA,C 63.15%; H 5.30%; O 31.55%,DFC,NA,NA,NA,NA,NA,NA,"pKa 9.87 (20å¡, 0.1M NaClO4)",DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)",SANGSTER (1994),NA,NA,DFC,2.07,2.323157458,-1.42,COC(=O)C1=CC=CC=C1O,NA,C8H8O3,152.1473,"InChI=1S/C8H8O3/c1-11-8(10)6-4-2-3-5-7(6)9/h2-5,9H,1H3",152.0473441,InChIKey=OSWPMRLSEDHDFF-UHFFFAOYSA-N,5.73e+00 g/l,32529,methyl 2-hydroxybenzoate,HMDB_from_dfc,NA,NA,"Methyl 2-hydroxybenzoate, 9CI",DFC,119-36-8,rw1008471,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Benzoic acid esters,Aromatic homomonocyclic compounds,CHEMBL108545,13848808,CPD-6442,NA,NA,DB09543,NA,Methyl salicylate,119-36-8,LAV5U5022Y,2-(Methoxycarbonyl)phenol | 2-Carbomethoxyphenol | 2-Hydroxybenzoic acid methyl ester | Betula oil | Gaultheria oil | Methyl 2-hydroxybenzoate | Methyl o-hydroxybenzoate | Natural wintergreen oil | Oil of wintergreen | Spicewood Oil | Sweet birch oil | Teaberry oil,OSWPMRLSEDHDFF-UHFFFAOYSA-N
OVBPIULPVIDEAO-LBPRGKRZSA-N,76,HMDB0000121,441.139681375,"(2S)-2-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid",Folic acid,C19H19N7O6,59-30-3,C00504,FDB014504,DB00158,NA,FOLATE,6037,5815,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,246,Organic compounds,Glutamic acid and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aromatic heteropolycyclic compounds,NA,2183,T3D2698,Endogenous,-2.5,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,441.139681375,"(2S)-2-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid",Folic acid,C19H19N7O6,59-30-3,HMDB00121,DB00158,C00504,FOLATE,6037,5815,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(NCC2=NC3=C(NC(=N)N=C3O)N=C2)C=C1)C(O)=O,Chemical entities,Glutamic acid and derivatives,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Aromatic heteropolycyclic compounds,14507,38367,SmallMoleculeCompound,FDB014504,Folic acid,TRUE,Solid,low,"Dietary supplementFolic acid (also known as vitamin B9, vitamin Bc or folacin) and folate (the naturally occurring form), as well as pteroyl-L-glutamic acid, pteroyl-L-glutamate, and pteroylmonoglutamic acid are forms of the water-soluble vitamin B9. [Wikipedia]",59-30-3,250 oC,NA,NA,0.0016 mg/mL at 25 oC,NA,NA,NA,NA,C00504,6037,NA,27470,FOL,NA,NA,NA,Folic acid,NA,NA,NA,NA,NA,NA,NA,HMDB00121.pdf,application/pdf,48657,2015-02-28 17:44:26 UTC,NA,2,2010-04-08 22:11:18 UTC,2015-10-09 22:27:35 UTC,NA,JRL93-O:JRL93-O,HMDB00121,FOLIC-ACID|FOLACIN|FOLATE,DB00158,35180,1396,C00001539,NA,NA,NA,NA,NA,NA,"[a]25D +23 (c, 0.5 in 1M NaOH)",DFC,C 51.70%; H 4.34%; N 22.21%; O 21.75%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,MERCK INDEX (1983),NA,NA,NA,NA,0.35,-0.42,-3.58,NC1=NC(O)=C2N=C(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=NC2=N1,4.18,C19H19N7O6,441.3975,"InChI=1S/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s1",441.1396814,InChIKey=OVBPIULPVIDEAO-LBPRGKRZSA-N,1.16e-01 g/l,34950,(2S)-2-[(4-{[(2-amino-4-hydroxypteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid,MANUAL,NA,NA,Pteroylglutamic acid,DFC,NA,rw1098971,NA,NA,NA,NA,NA,NA,NA,NA,CHEMBL1622,5815,FOLATE,TRUE,NA,DB00158,NUTR00025,Folic Acid,59-30-3,935E97BOY8,"Folacin | Folate | Folic acid | Folsaeure | N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid | N-Pteroyl-L-glutamic acid | PGA | PteGlu | Pteroyl-L-glutamate | Pteroyl-L-glutamic acid | Pteroyl-L-monoglutamic acid | Pteroylglutamic acid | Vitamin B9 | Vitamin Bc | Vitamin M",OVBPIULPVIDEAO-LBPRGKRZSA-N
OYHQOLUKZRVURQ-HZJYTTRNSA-N,528,HMDB0000673,280.240230268,"(9Z,12Z)-octadeca-9,12-dienoic acid",Linoleic acid,C18H32O2,60-33-3,C01595,FDB012760,NA,NA,NA,5280450,4444105,CCCCC\C=C/C\C=C/CCCCCCCC(O)=O,191,Organic compounds,Lineolic acids and derivatives,Lipids and lipid-like molecules,Fatty Acyls,Lineolic acids and derivatives,Aliphatic acyclic compounds,7.05,3610,T3D4928,Endogenous,7.05,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,280.240230268,"(9Z,12Z)-octadeca-9,12-dienoic acid",Linoleic acid,C18H32O2,60-33-3,HMDB00673,NA,C01595,NA,5280450,4444105,[H]\C(CCCCC)=C(/[H])C\C([H])=C(\[H])CCCCCCCC(O)=O,NA,NA,NA,NA,NA,NA,6288,16393,SmallMoleculeCompound,FDB006287,alpha-Linoleic acid,TRUE,NA,low,NA,60-33-3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:07:04 UTC,2017-03-01 02:04:28 UTC,NA,NA,NA,ALPHA-LINOLEIC-ACID,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CCCCC\C=C/C\C=C/CCCCCCCC(O)=O,NA,C18H32O2,280.4455,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",280.2402303,OYHQOLUKZRVURQ-HZJYTTRNSA-N,NA,NA,NA,NA,NA,NA,NA,DUKE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB14104,NA,Linoleic acid,60-33-3,9KJL21T0QJ,"(9Z,12Z)-Octadecadienoic acid | (Z,Z)-9,12-octadecadienoic acid | 9-cis,12-cis-Octadecadienoic acid | 9Z,12Z-octadecadienoic acid | acide cis-linolÃ©ique | acide linolÃ©ique | Ã¡cido linoleico | all-cis-9,12-octadecadienoic acid | cis,cis-9,12-octadecadienoic acid | cis,cis-linoleic acid | LA | Linolic acid",OYHQOLUKZRVURQ-HZJYTTRNSA-N
PAYRUJLWNCNPSJ-UHFFFAOYSA-N,1749,HMDB0003012,93.057849229,aniline,Aniline,C6H7N,62-53-3,C00292,FDB003571,NA,NA,34-DICHLOROANILINE,6115,5889,NC1=CC=CC=C1,489,Organic compounds,Aniline and substituted anilines,Benzenoids,Benzene and substituted derivatives,Aniline and substituted anilines,Aromatic homomonocyclic compounds,0.9,3657,T3D4984,Endogenous,0.9,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,93.057849229,aniline,Aniline,C6H7N,62-53-3,HMDB03012,DB06728,C00292,34-DICHLOROANILINE,6115,5889,NC1=CC=CC=C1,Organic compounds,Aniline and substituted anilines,Benzenoids,Benzene and substituted derivatives,Aniline and substituted anilines,Aromatic homomonocyclic compounds,3572,11055,SmallMoleculeCompound,FDB003571,Aniline,TRUE,Liquid,low,"Aniline is a weak base. Aromatic amines such as aniline are, in general, much weaker bases than aliphatic amines. Aniline reacts with strong acids to form anilinium (or phenylammonium) ion (C6H5-NH3+). The sulfate forms beautiful white plates. Although aniline is weakly basic, it precipitates zinc, aluminium, and ferric salts, and, on warming, expels ammonia from its salts. The weak basicity is due to a negative inductive effect as the lone pair on the nitrogen is partially delocalised into the pi system of the benzene ring.; Aniline is an organic chemical compound, specifically a primary aromatic amine. It consists of a benzene ring attached to an amino group.  Aniline is oily and, although colorless, it can be slowly oxidized and resinified in air to form impurities which can give it a red-brown tint. Its boiling point is 184 degree centigrade and its melting point is -6 degree centegrade. It is a liquid at room temperature. Like most volatile amines, it possesses a somewhat unpleasant odour of rotten fish, and also has a burning aromatic taste; Aniline was first isolated from the destructive distillation of indigo in 1826 by Otto Unverdorben , who named it crystalline. In 1834, Friedrich Runge (Pogg. Ann., 1834, 31, p. 65; 32, p. 331) isolated from coal tar a substance that produced a beautiful blue colour on treatment with chloride of lime, which he named kyanol or cyanol. In 1841, C. J. Fritzsche showed that, by treating indigo with caustic potash, it yielded an oil, which he named aniline, from the specific name of one of the indigo-yielding plants, Indigofera anil, anil being derived from the Sanskrit n?la, dark-blue, and n?l?, the indigo plant. About the same time N. N. Zinin found that, on reducing nitrobenzene, a base was formed, which he named benzidam. August Wilhelm von Hofmann investigated these variously-prepared substances, and proved them to be identical (1855), and thenceforth they took their place as one body, under the name aniline or phenylamine.; Aniline, phenylamine or aminobenzene is an organic compound with the formula C6H7N. It is the simplest and one of the most important aromatic amines, being used as a precursor to more complex chemicals. Its main application is in the manufacture of polyurethane. Like most volatile amines, it possesses the somewhat unpleasant odour of rotten fish and also has a burning aromatic taste; it is a highly-acrid poison. It ignites readily, burning with a smoky flame.; Like phenols, aniline derivatives are highly susceptible to electrophilic substitution reactions. For example, reaction of aniline with sulfuric acid at 180 å¡C produces sulfanilic acid, NH2C6H4SO3H, which can be converted to sulfanilamide. Sulfanilamide is one of the sulfa drugs that were widely used as antibacterials in the early 20th century.; The great commercial value of aniline was due to the readiness with which it yields, directly or indirectly, dyestuffs. The discovery of mauve in 1856 by William Henry Perkin was the first of a series of an enormous range of dyestuffs, such as fuchsine, safranine and induline. In addition to its use as a precursor to dyestuffs, it is a starting-product for the manufacture of many drugs, such as paracetamol (acetaminophen, Tylenol).; it is a highly acrid poison. It ignites readily, burning with a large smoky flame. Aniline reacts with strong acids to form salts containing the anilinium (or phenylammonium) ion (C6H5-NH3+), and reacts with acyl halides (such as acetyl chloride (ethanoyl chloride), CH3COCl) to form amides. The amides formed from aniline are sometimes called anilides, for example CH3-CO-NH-C6H5 is acetanilide, for which the modern name is N-phenyl ethanamide. Like phenols, aniline derivatives are highly reactive in electrophilic substitution reactions. For example, sulfonation of aniline produces sulfanilic acid, which can be converted to sulfanilamide. Sulfanilamide is one of the sulfa drugs which were widely used as antibacterial in the early 20th century. Aniline was first isolated from the destructive distillation of indigo in 1826 by Otto Unverdorben. In 1834, Friedrich Runge isolated from coal tar a substance which produced a beautiful blue color on treatment with chloride of lime; this he named kyanol or cyanol. In 1841, C. J. Fritzsche showed that by treating indigo with caustic potash it yielded an oil, which he named aniline, from the specific name of one of the indigo-yielding plants, Indigofera anil, anil being derived from the Sanskrit, dark-blue.",62-53-3,-6 oC,NA,NA,36 mg/mL at 25 oC,0.9,NA,NA,NA,C00292,6115,NA,17296,ANL,NA,NA,NA,Aniline,NA,NA,NA,NA,NA,NA,NA,HMDB03012.pdf,application/pdf,52723,2015-02-28 18:08:17 UTC,NA,NA,2010-04-08 22:05:51 UTC,2015-10-09 22:31:25 UTC,NA,NA,HMDB03012,ANILINE,DB06728,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4.6,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,NA,0.89,1.14,-0.71,NC1=CC=CC=C1,NA,C6H7N,93.1265,"InChI=1S/C6H7N/c7-6-4-2-1-3-5-6/h1-5H,7H2",93.05784923,InChIKey=PAYRUJLWNCNPSJ-UHFFFAOYSA-N,1.80e+01 g/l,39937,aniline,BIOSPIDER,NA,NA,NA,DUKE,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Anilines,Anilines,Aromatic homomonocyclic compounds,CHEMBL538,5889,34-DICHLOROANILINE,TRUE,NA,DB06728,NA,Aniline,62-53-3,SIR7XX2F1K,Aminobenzene | Aminophen | Anilin | Anilina | Aniline oil | Anilinum | Benzenamine | Benzeneamine | Fentanyl impurity F | Huile d'aniline | Kyanol | Phenylamine | Trimethoprim specified impurity K,PAYRUJLWNCNPSJ-UHFFFAOYSA-N
PEDCQBHIVMGVHV-UHFFFAOYSA-N,85,HMDB0000131,92.047344122,"propane-1,2,3-triol",Glycerol,C3H8O3,56-81-5,C00116,FDB000756,DB04077,NA,GLYCEROL,753,733,OCC(O)CO,105,Organic compounds,Sugar alcohols,Organic oxygen compounds,Organooxygen compounds,Carbohydrates and carbohydrate conjugates,Aliphatic acyclic compounds,-1.76,3203,T3D4360,Endogenous,-1.76,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,92.047344122,"propane-1,2,3-triol",Glycerol,C3H8O3,56-81-5,HMDB00131,DB04077,C00116,GLYCEROL,753,733,OCC(O)CO,Organic compounds,Sugar alcohols,Organic oxygen compounds,Organooxygen compounds,Carbohydrates and carbohydrate conjugates,Aliphatic acyclic compounds,756,2054,SmallMoleculeCompound,FDB000756,Glycerol,TRUE,Liquid,low,"Found extensively in esterified form in animal and plant glycerides. Humectant, emollient and solvent in foodsGlycerol (or glycerin, glycerine) is a simple polyol compound. It is a colorless, odorless, viscous liquid that is widely used in pharmaceutical formulations. The glycerol backbone is central to all lipids known as triglycerides. Glycerol is sweet-tasting and of low toxicity. (Wikipedia)",56-81-5,Mp 17.8å¡,NA,NA,1000 mg/mL at 25 oC,-1.76,NA,NA,NA,C00116,753,NA,17754,GOL,NA,NA,NA,Glycerol,NA,NA,NA,NA,NA,NA,NA,HMDB00131.pdf,application/pdf,679645,2015-02-28 17:45:11 UTC,NA,2,2010-04-08 22:04:42 UTC,2015-10-09 22:31:00 UTC,NA,BGV25-K:BGV25-K,HMDB00131,GLYCEROL|GLYCERIN,DB04077,33915,1512,C00001163,Bp20 182å¡,DFC,0,NA,d1515 1.27,DFC,NA,NA,C 39.13%; H 8.76%; O 52.12%,DFC,NA,NA,n20D<vs=1>  1.4720,DFC,NA,NA,pKa1 14.4,DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,-1.93,-1.84,1.1,OCC(O)CO,15.17,C3H8O3,92.0938,"InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",92.04734412,InChIKey=PEDCQBHIVMGVHV-UHFFFAOYSA-N,1.17e+03 g/l,34964,"propane-1,2,3-triol",MANUAL,NA,NA,"Glycerol, INN",DFC,NA,rw1008461,NA,NA,Organic compounds,Organooxygen compounds,Carbohydrates and carbohydrate conjugates,Sugar alcohols,Sugar alcohols,Aliphatic acyclic compounds,CHEMBL692,733,GLYCEROL,TRUE,NA,DB09462,EXPT01027 | DB04077,Glycerin,56-81-5,PDC6A3C0OX,"1,2,3-propanetriol | 1,2,3-trihydroxypropane | Glycerin, anhydrous | Glycerin,anhydrous | Glycerine | glycÃ©rine | Glycerinum | Glycerol | glycÃ©rol | Glyzerin | Monoctanoin component D | ÃlsÃ¼Ã | Propanetriol | Trihydroxypropane",PEDCQBHIVMGVHV-UHFFFAOYSA-N
PFNFFQXMRSDOHW-UHFFFAOYSA-N,967,HMDB0001256,202.215746852,(3-aminopropyl)({4-[(3-aminopropyl)amino]butyl})amine,Spermine,C10H26N4,71-44-3,C00750,FDB003225,DB00127,NA,SPERMINE,1103,1072,NCCCNCCCCNCCCN,255,Organic compounds,Dialkylamines,Organic nitrogen compounds,Organonitrogen compounds,Amines,Aliphatic acyclic compounds,NA,3087,T3D4166,Endogenous,-0.7,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,202.215746852,(3-aminopropyl)({4-[(3-aminopropyl)amino]butyl})amine,Spermine,C10H26N4,71-44-3,HMDB01256,DB00127,C00750,SPERMINE,1103,1072,NCCCNCCCCNCCCN,Chemical entities,Dialkylamines,Organic compounds,Organic nitrogen compounds,Organonitrogen compounds,Aliphatic acyclic compounds,3226,9924,SmallMoleculeCompound,FDB003225,Spermine,TRUE,Solid,low,"Occurs as phosphate in ox pancreas, yeast and meat productsSpermine is a polyamine involved in cellular metabolism found in all eukaryotic cells. Formed from spermidine, it is found in a wide variety of organisms and tissues and is an essential growth factor in some bacteria. It is found as a polycation at physiological pH. Spermine is associated with nucleic acids and is thought to stabilize helical structure, in particular, in viruses. (Wikipedia)",71-44-3,29 oC,NA,NA,NA,NA,NA,NA,NA,C00750,1103,NA,15746,SPM,NA,NA,NA,Spermine,NA,NA,NA,NA,NA,NA,NA,HMDB01256.pdf,application/pdf,3255114,2015-02-28 17:58:48 UTC,NA,2,2010-04-08 22:05:42 UTC,2015-10-09 22:31:08 UTC,NA,CTQ89-F:CTQ89-F,HMDB01256,SPERMINE,DB00127,35875,NA,C00001432,Bp0.5 141-142å¡,DFC,4,NA,NA,NA,NA,NA,C 59.36%; H 12.95%; N 27.69%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.66,-1.45,-1.97,NCCCNCCCCNCCCN,NA,C10H26N4,202.3402,"InChI=1S/C10H26N4/c11-5-3-9-13-7-1-2-8-14-10-4-6-12/h13-14H,1-12H2",202.2157469,InChIKey=PFNFFQXMRSDOHW-UHFFFAOYSA-N,2.19e+00 g/l,32404,(3-aminopropyl)({4-[(3-aminopropyl)amino]butyl})amine,MANUAL,NA,NA,Spermine,DFC,NA,NA,NA,NA,Organic compounds,Organonitrogen compounds,Amines,Secondary amines,Dialkylamines,Aliphatic acyclic compounds,CHEMBL23194,1072,SPERMINE,TRUE,NA,DB00127,NUTR00055 | EXPT02947 | DB02564,Spermine,71-44-3,2FZ7Y3VOQX,"4,9-Diaza-1,12-dodecanediamine | 4,9-Diazadodecane-1,12-diamine | N,N'-Bis(3-aminopropyl)-1,4-butanediamine | Spermine",PFNFFQXMRSDOHW-UHFFFAOYSA-N
PKUWKAXTAVNIJR-UHFFFAOYSA-N,1124,HMDB0001460,170.01665142,diethoxy(sulfanylidene)phosphinous acid,Diethylthiophosphate,C4H11O3PS,5871-17-0,C06607,FDB022638,NA,NA,DIETHYLTHIOPHOSPHATE,655,635,CCOP(O)(=S)OCC,6256,Organic compounds,Thiophosphate diesters,Organic acids and derivatives,Organic thiophosphoric acids and derivatives,Thiophosphoric acid esters,Aliphatic acyclic compounds,NA,2984,T3D3958,Exogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,170.01665142,diethoxy(sulfanylidene)phosphinous acid,Diethylthiophosphate,C4H11O3PS,5871-17-0,HMDB01460,DB07674,C06607,DIETHYLTHIOPHOSPHATE,655,635,CCOP(O)(=S)OCC,Chemical entities,Thiophosphate diesters,Organic compounds,Organic acids and derivatives,Organic thiophosphoric acids and derivatives,Aliphatic acyclic compounds,22801,NA,SmallMoleculeCompound,FDB022638,Diethylthiophosphate,TRUE,Solid,low,Diethylthiophosphate is the most frequent metabolite of organophosphorus (OP) found in urine (PMID 15050412). Organophosphorus compounds are widely used as pesticides because of easy degradation in the environment. Acute OP intoxication results from blockage of the decomposition of synaptic acetylcholine because the pesticide covalently binds to chlolinesterase (PMID 11991535). Chronic exposure to POs  has neurological sequelae as well (PMID 8179040) and data suggests that OP exposure alters sperm chromatin condensation (PMID 15050412) [HMDB],5871-17-0,NA,NA,NA,NA,NA,NA,NA,NA,C06607,655,NA,NA,DPJ,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HMDB01460.pdf,application/pdf,137030,2015-02-28 18:02:06 UTC,NA,NA,2011-09-21 00:17:16 UTC,2015-10-09 22:31:55 UTC,NA,NA,HMDB01460,NA,DB07674,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.22,1.339303116,-1.45,[H]OP(=S)(OC([H])([H])C([H])([H])[H])OC([H])([H])C([H])([H])[H],NA,C4H11O3PS,170.167,"InChI=1S/C4H11O3PS/c1-3-6-8(5,9)7-4-2/h3-4H2,1-2H3,(H,5,9)",170.0166514,InChIKey=PKUWKAXTAVNIJR-UHFFFAOYSA-N,6.06e+00 g/l,85462,diethoxy(sulfanylidene)phosphinous acid,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organophosphorus compounds,Organothiophosphorus compounds,Organic thiophosphoric acids and derivatives,Thiophosphate diesters,Aliphatic acyclic compounds,CHEMBL1232328,635,DIETHYLTHIOPHOSPHATE,TRUE,NA,DB07674,NA,"O,O-DIETHYL HYDROGEN THIOPHOSPHATE",NA,NA,NA,PKUWKAXTAVNIJR-UHFFFAOYSA-N
PLIKAWJENQZMHA-UHFFFAOYSA-N,904,HMDB0001169,109.052763851,4-aminophenol,4-Aminophenol,C6H7NO,123-30-8,C02372,FDB022462,NA,NA,CPD-259,403,392,NC1=CC=C(O)C=C1,6051,Organic compounds,Aniline and substituted anilines,Benzenoids,Benzene and substituted derivatives,Aniline and substituted anilines,Aromatic homomonocyclic compounds,0.04,2642,T3D3600,Exogenous,0.04,Not listed by IARC.,NA,SmallMolecule,109.052763851,4-aminophenol,4-Aminophenol,C6H7NO,123-30-8,HMDB01169,NA,C02372,CPD-259,403,392,NC1=CC=C(O)C=C1,NA,NA,NA,NA,NA,NA,22625,NA,SmallMoleculeCompound,FDB022462,4-Aminophenol,TRUE,Liquid,low,"4-aminophenol is considered a minor nephrotoxic metabolite of phenacetin and acetaminophen (paracetamol) in man.4-Aminophenol can undergo autoxidations and metal-catalyzed and enzymatic oxidations in man to produce reactive oxygen species. (PMID 1713494) [HMDB]",123-30-8,NA,NA,NA,NA,NA,NA,NA,NA,C02372,403,NA,17602,4NL,NA,NA,NA,Aminophenol,NA,NA,NA,NA,NA,NA,NA,HMDB01169.pdf,application/pdf,5231586,2015-02-28 18:01:06 UTC,NA,NA,2011-09-21 00:14:26 UTC,2015-10-09 22:31:46 UTC,NA,NA,HMDB01169,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.47,0.84075454,0.04,[H]OC1=C([H])C([H])=C(N([H])[H])C([H])=C1[H],NA,C6H7NO,109.1259,"InChI=1S/C6H7NO/c7-5-1-3-6(8)4-2-5/h1-4,8H,7H2",109.0527639,InChIKey=PLIKAWJENQZMHA-UHFFFAOYSA-N,1.21e+02 g/l,86031,4-aminophenol,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenols and derivatives,Aminophenols,Aromatic homomonocyclic compounds,CHEMBL1142,392,CPD-259,TRUE,NA,DB14144,NA,p-Aminophenol,123-30-8,R7P8FRP05V,4-Aminobenzenol | 4-Aminophenol | 4-Hydroxyaniline | p-hydroxyaniline,PLIKAWJENQZMHA-UHFFFAOYSA-N
PNDPGZBMCMUPRI-UHFFFAOYSA-N,530,HMDB0000675,253.80893684,diiodane,Iodine,I2,7553-56-2,C01382,FDB003635,DB05247,NA,IODINE-MOLECULE,807,785,II,NA,Inorganic compounds,Homogeneous halogens,Homogeneous non-metal compounds,Homogeneous halogens,NA,NA,2.49,2638,T3D3596,Exogenous,2.49,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,253.80893684,diiodane,Iodine,I2,7553-56-2,HMDB00675,NA,C01382,IODINE-MOLECULE,807,785,II,Chemical entities,Homogeneous halogens,Inorganic compounds,Homogeneous non-metal compounds,Homogeneous halogens,NA,3636,11187,SmallMoleculeCompound,FDB003635,Iodine,TRUE,Solid,low,"Elemental iodine (I2) is poisonous if taken orally in larger amounts; 2?3 grams of it is a lethal dose for an adult human.; Elemental iodine is an oxidizing irritant and direct contact with skin can cause lesions, so iodine crystals should be handled with care. Solutions with high elemental iodine concentration such as tincture of iodine are capable of causing tissue damage if use for cleaning and antisepsis is prolonged.; In many ways, 129I is similar to 36Cl. It is a soluble halogen, fairly non-reactive, exists mainly as a non-sorbing anion, and is produced by cosmogenic, thermonuclear, and in-situ reactions. In hydrologic studies, 129I concentrations are usually reported as the ratio of 129I to total I (which is virtually all 127I). As is the case with 36Cl/Cl, 129I/I ratios in nature are quite small, 10?14 to 10?10 (peak thermonuclear 129I/I during the 1960s and 1970s reached about 10?7). 129I differs from 36Cl in that its halflife is longer (15.7 vs. 0.301 million years), it is highly biophilic, and occurs in multiple ionic forms (commonly, I? and IO3?) which have different chemical behaviors. This makes it fairly easy for 129I to enter the biosphere as it becomes incorporated into vegetation, soil, milk, animal tissue, etc.; Iodic acid (HIO3) and its salts are strong oxidizers. Periodic acid (HIO4) cleaves vicinal diols along the C-C bond to give aldehyde fragments. 2-Iodoxybenzoic acid and Dess-Martin periodinane are hypervalent iodine oxidants used to specifically oxidize alcohols to ketones or aldehydes. Iodine pentoxide is a strong oxidant as well.; Iodine (pronounced /?a?.?da?n/ EYE-o-dyne, /?a?.?d?n/ EYE-o-d?n, or in chemistry /?a?.?di?n/ EYE-o-deen; from Greek: ????? iodes ""violet""), is a chemical element that has the symbol I and atomic number 53. Naturally-occurring iodine is a single isotope with 74 neutrons. Chemically, iodine is the second least reactive of the halogens, and the second most electropositive halogen, trailing behind astatine in both of these categories. However, the element does not occur in the free state in nature. As with all other halogens (members of Group 17 in the periodic table), when freed from its compounds iodine forms diatomic molecules (I2).; Iodine forms many compounds. Potassium iodide is the most commercially significant iodine compound. It is a convenient source of the iodide anion; it is easier to handle than sodium iodide because it is not hygroscopic. Sodium iodide is especially useful in the Finkelstein reaction, because it is soluble in acetone, while potassium iodide is poorly so. In this reaction, an alkyl chloride is converted to an alkyl iodide. This relies on the insolubility of sodium chloride in acetone to drive the reaction:; Iodine is a common general stain used in thin-layer chromatography. It is also used in the Gram stain as a mordant, after the sample is treated with crystal violet.; Iodine is an essential trace element for life, the heaviest element commonly needed by living organisms, and the second-heaviest known to be used by any form of life (only tungsten, a component of a few bacterial enzymes, has a higher atomic number and atomic weight). Iodine's main role in animal biology is as constituents of the thyroid hormones, thyroxine (T4) and triiodothyronine (T3). These are made from addition condensation products of the amino acid tyrosine, and are stored prior to release in an iodine-containing protein called thyroglobulin. T4 and T3 contain four and three atoms of iodine per molecule, respectively. The thyroid gland actively absorbs iodide from the blood to make and release these hormones into the blood, actions which are regulated by a second hormone TSH from the pituitary. Thyroid hormones are phylogenetically very old molecules which are synthesized by most multicellular organisms, and which even have some effect on unicellular organisms.; Iodine is an essential trace element.  Chemically, iodine is the least reactive of the halogens, and the most electropositive halogen after astatine. However, iodine does not occur in the free state in nature. As with all other halogens , when freed from its compounds iodine forms diatomic molecules (I2).; Iodine and its compounds are primarily used in medicine, photography, and dyes. Iodine is required for the production of thyroid hormones, which are essential for normal brain development, and the fetus, newborn, and young child are particularly vulnerable to iodine deficiency. Physiologically, iodine exists as an ion in the body. The iodine requirement increases during pregnancy and recommended intakes are in the range of 220-250 microg/day. Monitoring iodine status during pregnancy is a challenge. New recommendations from World Health Organization suggest that a median urinary iodine concentration >250 microg/L and <500 microg/L indicates adequate iodine intake in pregnancy. Based on this range, it appears that many pregnant women in have inadequate intakes. Thyroid-stimulating hormone concentration in the newborn is a sensitive indicator of mild iodine deficiency in late pregnancy. The potential adverse effects of mild iodine deficiency during pregnancy are uncertain. Controlled trials of iodine supplementation in mildly iodine-deficient pregnant women suggest beneficial effects on maternal and newborn serum thyroglobulin and thyroid volume, but no effects on maternal and newborn total or free thyroid hormone concentrations. There are no long-term data on the effect of iodine supplementation on birth outcomes or infant development. New data from well-controlled studies indicate that iodine repletion in moderately iodine-deficient school-age children has clear benefits: it improves cognitive and motor function; Iodine under standard conditions is a shiny grey solid. It can be seen apparently sublimating at standard temperatures into a violet-pink gas that has an irritating odor. This halogen forms compounds with many elements, but is less reactive than the other members of its Group VII (halogens) and has some metallic light reflectance.; Iodine-129 (129I; half-life 15.7 million years) is a product of cosmic ray spallation on various isotopes of xenon in the atmosphere, in cosmic ray muon interaction with tellurium-130, and also uranium and plutonium fission, both in subsurface rocks and nuclear reactors. Artificial nuclear processes, in particular nuclear fuel reprocessing and atmospheric nuclear weapons tests, have now swamped the natural signal for this isotope. Nevertheless, it now serves as a groundwater tracer as indicator of nuclear waste dispersion into the natural environment. In a similar fashion, 129I was used in rainwater studies to track fission products following the Chernobyl disaster.; The most common compounds of iodine are the iodides of sodium (NaI) and potassium (KI) and the iodates (KIO3), as elemental iodine is mildly toxic to all living things. Normal iodine is an essential precursor for the manufacture of thyroid hormone.; it also increases concentrations of insulin-like growth factor 1 and insulin-like growth factor-binding protein 3, and improves somatic growth. (PMID: 17956157)",7553-56-2,113.6 oC,NA,NA,0.33 mg/mL at 25 oC,2.49,NA,NA,NA,C01382,807,NA,17606,NA,NA,NA,NA,Iodine,NA,NA,NA,NA,NA,NA,NA,HMDB00675.pdf,application/pdf,52254,2015-02-28 17:56:48 UTC,NA,NA,2010-04-08 22:05:53 UTC,2015-07-20 21:56:27 UTC,NA,NA,HMDB00675,IODINE,DB05247,37476,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CLAYTON,GD & CLAYTON,FE (1994)","HANSCH,C ET AL. (1995)",NA,NA,NA,NA,1.36,NA,II,NA,I2,253.8089,InChI=1S/I2/c1-2,253.8089368,InChIKey=PNDPGZBMCMUPRI-UHFFFAOYSA-N,NA,41002,diiodane,BIOSPIDER,NA,NA,NA,DUKE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CHEMBL1201225,785,IODINE-MOLECULE,NA,NA,DB05382,DB05247,Iodine,7553-56-2,9679TC07X4,diiodine | I2 | Jod | molecular iodine,PNDPGZBMCMUPRI-UHFFFAOYSA-N
POULHZVOKOAJMA-UHFFFAOYSA-N,496,HMDB0000638,200.177630012,dodecanoic acid,Dodecanoic acid,C12H24O2,143-07-7,C02679,FDB003010,DB03017,NA,NA,3893,3756,CCCCCCCCCCCC(O)=O,5611,Organic compounds,Medium-chain fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,4.6,3348,T3D4596,Endogenous,4.6,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,200.177630012,dodecanoic acid,Dodecanoic acid,C12H24O2,143-07-7,HMDB00638,DB03017,C02679,NA,3893,3756,CCCCCCCCCCCC(O)=O,Organic compounds,Medium-chain fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,3011,9174,SmallMoleculeCompound,FDB003010,Dodecanoic acid,TRUE,Liquid,low,"Defoamer, lubricant. Used in fruit coatings. Occurs as glyceride in coconut oil and palm kernel oil. Simple esters are flavour ingredientsLauric acid (systematically: dodecanoic acid), the saturated fatty acid with a 12 carbon atom chain, is a white, powdery solid with a faint odor of bay oil or soap. (Wikipedia)",143-07-7,Mp 44å¡,NA,NA,0.00481 mg/mL at 25 oC,4.6,NA,NA,NA,C02679,3893,NA,30805,DAO,NA,NA,NA,Dodecanoic acid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:05:37 UTC,2015-10-09 22:30:04 UTC,NA,CPX59-D:CPX59-D,HMDB00638,DODECANOIC-ACID|LAURIC-ACID,DB03017,40351,1984,C00001221,Bp0.65 141-142å¡ (lit. gives a pressure range),DFC,NA,NA,d20 0.88,DFC,NA,NA,C 71.95%; H 12.08%; O 15.97%,DFC,NA,NA,NA,NA,NA,NA,pKa 5.3 (20å¡),DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)",SANGSTER (1993),NA,NA,DFC,5.13,4.48,-4.3,CCCCCCCCCCCC(O)=O,NA,C12H24O2,200.3178,"InChI=1S/C12H24O2/c1-2-3-4-5-6-7-8-9-10-11-12(13)14/h2-11H2,1H3,(H,13,14)",200.17763,InChIKey=POULHZVOKOAJMA-UHFFFAOYSA-N,9.97e-03 g/l,37535,dodecanoic acid,MANUAL,chebi:18262,NA,"Dodecanoic acid, 9CI",DFC,143-07-7,rw1008181,NA,NA,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Medium-chain fatty acids,Aliphatic acyclic compounds,NA,3756,NA,TRUE,NA,DB03017,EXPT01112 | EXPT02006,Lauric Acid,143-07-7,1160N9NU9U,1-Undecanecarboxylic acid | ABL | C12 fatty acid | C12:0 | Coconut oil fatty acids | DAO | Dodecanoate | Dodecanoic acid | Dodecoic acid | Dodecylcarboxylate | Dodecylic acid | Duodecyclic acid | Duodecylic acid | LaurinsÃ¤ure | Laurostearic acid | N-dodecanoate | N-dodecanoic acid | Undecane-1-carboxylic acid | Vulvic acid,POULHZVOKOAJMA-UHFFFAOYSA-N
PROQIPRRNZUXQM-ZXXIGWHRSA-N,100,HMDB0000153,288.172544634,"(1S,10R,11S,13R,14R,15S)-15-methyltetracyclo[8.7.0.0\xc2\xb2,\xe2\x81\xb7.0\xc2\xb9\xc2\xb9,\xc2\xb9\xe2\x81\xb5]heptadeca-2(7),3,5-triene-5,13,14-triol",Estriol,C18H24O3,50-27-1,C05141,FDB006781,DB04573,DBMET00492,NA,5756,5553,[H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,2581,Organic compounds,Estrogens and derivatives,Lipids and lipid-like molecules,Steroids and steroid derivatives,Estrane steroids,Aromatic homopolycyclic compounds,2.45,3477,T3D4790,Endogenous,2.45,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,288.172544634,"(1S,10R,11S,13R,14R,15S)-15-methyltetracyclo[8.7.0.0\xc2\xb2,\xe2\x81\xb7.0\xc2\xb9\xc2\xb9,\xc2\xb9\xe2\x81\xb5]heptadeca-2(7),3,5-triene-5,13,14-triol",Estriol,C18H24O3,50-27-1,HMDB00153,DB04573,C05141,NA,5756,5553,[H][C@@]1(O)C[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]2(C)[C@@]1([H])O,Organic compounds,Estrogens and derivatives,Lipids and lipid-like molecules,Steroids and steroid derivatives,Estrane steroids,Aromatic homopolycyclic compounds,6782,17259,SmallMoleculeCompound,FDB006781,Estriol,TRUE,Solid,low,Estriol (also oestriol) is one of the three main estrogens produced by the human body. (Wikipedia),50-27-1,282 oC,NA,NA,NA,2.45,NA,NA,NA,C05141,5756,NA,27974,ESL,NA,NA,NA,Estriol,NA,NA,NA,NA,NA,NA,NA,HMDB00153.pdf,application/pdf,51249,2015-02-28 18:11:39 UTC,NA,2,2010-04-08 22:07:18 UTC,2015-10-09 22:30:02 UTC,NA,GQH02-E:GQH02-E,HMDB00153,ESTRIOL|ESTROL,DB04573,45207,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HANSCH,C ET AL. (1995)",NA,NA,NA,2.54,2.67,-3.38,[H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,13.62,C18H24O3,288.3814,"InChI=1S/C18H24O3/c1-18-7-6-13-12-5-3-11(19)8-10(12)2-4-14(13)15(18)9-16(20)17(18)21/h3,5,8,13-17,19-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,17+,18+/m1/s1",288.1725446,InChIKey=PROQIPRRNZUXQM-ZXXIGWHRSA-N,1.19e-01 g/l,40903,"(1S,10R,11S,13R,14R,15S)-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-triene-5,13,14-triol",MANUAL,NA,NA,NA,DUKE,NA,NA,NA,NA,Organic compounds,Lipids and lipid-like molecules,Steroids and steroid derivatives,Estrane steroids,Estrogens and derivatives,Aromatic homopolycyclic compounds,CHEMBL193482,5553,ESTRIOL,TRUE,NA,DB04573,EXPT01361 | DB05375,Estriol,50-27-1,FB33469R8E,"(16alpha,17beta)-Estra-1,3,5(10)-triene-3,16,17-triol | (16Î±,17Î²)-estra-1,3,5(10)-triene-3,16,17-triol | 1,3,5(10)-Estratriene-3,16-alpha,17beta-triol | 16-alpha-Hydroxyestradiol | 16alpha-hydroxyestradiol | 16Î±-hydroxyestradiol | 3,16alpha,17beta-Trihydroxy-delta(1,3,5)-estratriene | Deuslon-a | Estriel | Estriol | Oestriol | Trihydroxyestrin",PROQIPRRNZUXQM-ZXXIGWHRSA-N
PVNIIMVLHYAWGP-UHFFFAOYSA-N,1141,HMDB0001488,123.032028409,pyridine-3-carboxylic acid,Nicotinic acid,C6H5NO2,59-67-6,C00253,FDB001014,DB00627,NA,NIACINE,938,913,OC(=O)C1=CN=CC=C1,6272,Organic compounds,Pyridinecarboxylic acids,Organoheterocyclic compounds,Pyridines and derivatives,Pyridinecarboxylic acids and derivatives,Aromatic heteromonocyclic compounds,0.36,2284,T3D2841,Endogenous,0.36,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,123.032028409,pyridine-3-carboxylic acid,Nicotinic acid,C6H5NO2,59-67-6,HMDB01488,DB00627,C00253,NIACINE,938,913,OC(=O)C1=CN=CC=C1,Organic compounds,Pyridinecarboxylic acids,Organoheterocyclic compounds,Pyridines and derivatives,Pyridinecarboxylic acids and derivatives,Aromatic heteromonocyclic compounds,1014,2947,SmallMoleculeCompound,FDB001014,Nicotinic acid,TRUE,Solid,low,"Present in fruits and other plant materials. Nutrient supplement. Vitamin, enzyme cofactor [DFC]Niacin (also known as vitamin B3, nicotinic acid and vitamin PP) is an organic compound with the formula C6H5NO2 and, depending on the definition used, one of the forty to eighty essential human nutrients. This colorless, water-soluble solid is a derivative of pyridine, with a carboxyl group (COOH) at the 3-position. Other forms of vitamin B3 include the corresponding amide, nicotinamide (""niacinamide""), where the carboxyl group has been replaced by a carboxamide group (CONH2), as well as more complex amides and a variety of esters. The terms niacin, nicotinamide, and vitamin B3 are often used interchangeably to refer to any member of this family of compounds, since they have the same biochemical activity. [Wikipedia]",59-67-6,Mp 236å¡ (225-227å¡),NA,NA,18 mg/mL at 20 oC,0.36,NA,NA,NA,C00253,938,NA,15940,NIO,NA,NA,NA,Niacin,NA,NA,NA,NA,NA,NA,NA,HMDB01488.pdf,application/pdf,64990,2015-02-28 18:10:47 UTC,NA,2,2010-04-08 22:04:48 UTC,2015-10-09 22:29:38 UTC,NA,BPB04-S:BPB04-S,HMDB01488,NICOTINIC-ACID|NIACIN,DB00627,34401,2661,C00000208,NA,NA,NA,NA,NA,NA,NA,NA,C 58.54%; H 4.09%; N 11.38%; O 25.99%,DFC,NA,NA,NA,NA,NA,NA,pKa2 4.82 (25å¡),DFC,"YALKOWSKY,SH & HE,Y (2003)",SANGSTER (1993),NA,NA,DFC,0.29,-0.19,-0.17,OC(=O)C1=CN=CC=C1,NA,C6H5NO2,123.1094,"InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)",123.0320284,InChIKey=PVNIIMVLHYAWGP-UHFFFAOYSA-N,8.31e+01 g/l,37211,pyridine-3-carboxylic acid,MANUAL,NA,NA,3-Pyridinecarboxylic acid,DFC,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Pyridines and derivatives,Pyridinecarboxylic acids and derivatives,Pyridinecarboxylic acids,Aromatic heteromonocyclic compounds,CHEMBL573,913,NIACINE,TRUE,NA,DB00627,NUTR00042 | APRD00536,Niacin,59-67-6,2679MF687A,3-carboxypyridine | 3-Pyridinecarboxylic acid | 3-Pyridylcarboxylic acid | Acide Nicotinique | Acido nicotinico | Acidum Nicotinicum | Anti-pellagra vitamin | beta-Pyridinecarboxylic acid | M-Pyridinecarboxylic Acid | Niacin | Nicotinic Acid | Nikotinsaeure | P.P. factor | Pellagra preventive factor | PP Factor | Pyridine-beta-carboxylic acid | pyridine-Î²-carboxylic acid | Vitamin B3 | Î²-pyridinecarboxylic acid,PVNIIMVLHYAWGP-UHFFFAOYSA-N
PXQPEWDEAKTCGB-UHFFFAOYSA-N,151,HMDB0000226,156.017106626,"2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid",Orotic acid,C5H4N2O4,65-86-1,C00295,FDB012327,NA,NA,OROTATE,967,942,OC(=O)C1=CC(=O)NC(=O)N1,318,Organic compounds,Pyrimidinecarboxylic acids,Organoheterocyclic compounds,Diazines,Pyrimidines and pyrimidine derivatives,Aromatic heteromonocyclic compounds,-0.83,3171,T3D4292,Endogenous,-0.83,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,156.017106626,"2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid",Orotic acid,C5H4N2O4,65-86-1,HMDB00226,DB02262,C00295,OROTATE,967,942,OC(=O)C1=CC(O)=NC(O)=N1,Organic compounds,Pyrimidinecarboxylic acids,Organoheterocyclic compounds,Diazines,Pyrimidines and pyrimidine derivatives,Aromatic heteromonocyclic compounds,31235,NA,SmallMoleculeCompound,FDB031072,orotate,TRUE,NA,NA,NA,65-86-1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2015-05-07 20:57:19 UTC,2017-03-11 23:06:21 UTC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,OC(=O)C1=CC(=O)NC(=O)N1,NA,C5H4N2O4,156.0963,"InChI=1S/C5H4N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h1H,(H,9,10)(H2,6,7,8,11)",156.0171066,PXQPEWDEAKTCGB-UHFFFAOYSA-N,NA,NA,NA,NA,NA,NA,NA,MANUAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB02262,EXPT02447,Orotic Acid,65-86-1,61H4T033E5,NA,PXQPEWDEAKTCGB-UHFFFAOYSA-N
QBKSWRVVCFFDOT-UHFFFAOYSA-N,21355,HMDB0040723,518.194067936,"7-[8-formyl-1,6,7-trihydroxy-3-methyl-5-(propan-2-yl)naphthalen-2-yl]-2,3,8-trihydroxy-6-methyl-4-(propan-2-yl)naphthalene-1-carbaldehyde",(-)-Gossypol,C30H30O8,90141-22-3,C07667,FDB020531,NA,NA,NA,3503,3383,CC(C)C1=C2C=C(C)C(=C(O)C2=C(C=O)C(O)=C1O)C1=C(O)C2=C(C=O)C(O)=C(O)C(C(C)C)=C2C=C1C,NA,Organic compounds,Sesquiterpenoids,Lipids and lipid-like molecules,Prenol lipids,Sesquiterpenoids,Aromatic homopolycyclic compounds,NA,2473,T3D3081,Exogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,518.194067936,"7-[8-formyl-1,6,7-trihydroxy-3-methyl-5-(propan-2-yl)naphthalen-2-yl]-2,3,8-trihydroxy-6-methyl-4-(propan-2-yl)naphthalene-1-carbaldehyde",(-)-Gossypol,C30H30O8,90141-22-3,HMDB40723,NA,C07667,NA,3503,3383,CC(C)C1=C2C=C(C)C(=C(O)C2=C(C=O)C(O)=C1O)C1=C(O)C2=C(C=O)C(O)=C(O)C(C(C)C)=C2C=C1C,Chemical entities,Sesquiterpenoids,Organic compounds,Lipids and lipid-like molecules,Prenol lipids,Aromatic homopolycyclic compounds,742,2014,SmallMoleculeCompound,FDB000742,Gossypol,TRUE,NA,low,NA,303-45-7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:04:41 UTC,2015-07-20 21:33:52 UTC,NA,BGS60-C:BGS60-C,NA,GOSSYPOL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 69.49%; H 5.83%; O 24.68%,DFC,NA,NA,NA,NA,375 (e 15850) (MeOH) (Berdy),DFC,NA,NA,NA,NA,NA,NA,NA,4.49,8.02,-5.13,CC(C)C1=C(O)C(O)=C(C=O)C2=C1C=C(C)C(=C2O)C1=C(O)C2=C(C=C1C)C(C(C)C)=C(O)C(O)=C2C=O,8.29,C30H30O8,518.5544,"InChI=1S/C30H30O8/c1-11(2)19-15-7-13(5)21(27(35)23(15)17(9-31)25(33)29(19)37)22-14(6)8-16-20(12(3)4)30(38)26(34)18(10-32)24(16)28(22)36/h7-12,33-38H,1-6H3",518.1940679,InChIKey=QBKSWRVVCFFDOT-UHFFFAOYSA-N,3.85e-03 g/l,31408,"7-[8-formyl-1,6,7-trihydroxy-3-methyl-5-(propan-2-yl)naphthalen-2-yl]-2,3,8-trihydroxy-6-methyl-4-(propan-2-yl)naphthalene-1-carbaldehyde",DFC,NA,NA,Gossypol,DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB13044,NA,Gossypol,303-45-7,8DY2X8LXW4,NA,QBKSWRVVCFFDOT-UHFFFAOYSA-N
QCDWFXQBSFUVSP-UHFFFAOYSA-N,22230,HMDB0041607,138.068079562,2-phenoxyethan-1-ol,2-Phenoxyethanol,C8H10O2,122-99-6,NA,FDB021762,NA,NA,NA,31236,13848467,OCCOC1=CC=CC=C1,NA,Organic compounds,Phenol ethers,Benzenoids,Benzene and substituted derivatives,Phenol ethers,Aromatic homomonocyclic compounds,NA,2927,T3D3900,Exogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,138.068079564,NA,2-Phenoxyethanol,C8H10O2,122-99-6,HMDB41607,NA,NA,NA,31236,13848467,OCCOC1=CC=CC=C1,Organic compounds,Phenol ethers,Benzenoids,Benzene and substituted derivatives,Phenol ethers,Aromatic homomonocyclic compounds,21919,20720,SmallMoleculeCompound,FDB021762,2-Phenoxyethanol,TRUE,NA,low,Flavouring ingredient [CCD],122-99-6,Fp 11-13å¡,NA,NA,NA,NA,NA,NA,NA,NA,31236,NA,NA,268,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HMDB41607.pdf,application/pdf,48956,2015-02-28 17:44:56 UTC,NA,2,2011-03-30 21:42:02 UTC,2015-07-21 06:55:50 UTC,NA,DHQ11-H:DHQ11-H,HMDB41607,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 69.55%; H 7.29%; O 23.16%,DFC,Yellow-brown liq.,DFC,n20D<vs=1>  1.5370,DFC,NA,NA,pKa1 15.1 (25å¡),DFC,NA,NA,NA,NA,DFC,1.22,1.13,-0.76,OCCOC1=CC=CC=C1,NA,C8H10O2,138.1638,"InChI=1S/C8H10O2/c9-6-7-10-8-4-2-1-3-5-8/h1-5,9H,6-7H2",138.0680796,InChIKey=QCDWFXQBSFUVSP-UHFFFAOYSA-N,2.41e+01 g/l,42807,2-phenoxyethan-1-ol,HMDB_from_dfc,NA,NA,"2-Phenoxyethanol, 9CI",DFC,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenol ethers,Phenol ethers,Aromatic homomonocyclic compounds,CHEMBL1229846,13848467,NA,NA,NA,DB11304,NA,Phenoxyethanol,122-99-6,HIE492ZZ3T,1-Hydroxy-2-phenoxyethane | 2-Hydroxyethyl phenyl ether | 2-phenoxyethanol | 2-Phenoxyethyl alcohol | beta-Hydroxyethyl phenyl ether | Ethylene glycol monophenyl ether | Phenoxytol | Phenyl cellosolve | Phenylmonoglycol ether,QCDWFXQBSFUVSP-UHFFFAOYSA-N
QELSKZZBTMNZEB-UHFFFAOYSA-N,13534,HMDB0032574,180.07864425,propyl 4-hydroxybenzoate,Propylparaben,C10H12O3,94-13-3,NA,FDB010511,NA,NA,NA,7175,6907,CCCOC(=O)C1=CC=C(O)C=C1,NA,Organic compounds,p-Hydroxybenzoic acid alkyl esters,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Aromatic homomonocyclic compounds,3.04,3003,T3D3979,Exogenous,3.04,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,180.07864425,propyl 4-hydroxybenzoate,Propylparaben,C10H12O3,94-13-3,HMDB32574,NA,NA,NA,7175,6907,CCCOC(=O)C1=CC=C(O)C=C1,Chemical entities,p-Hydroxybenzoic acid alkyl esters,Organic compounds,Benzenoids,Benzene and substituted derivatives,Aromatic homomonocyclic compounds,10513,25914,SmallMoleculeCompound,FDB010511,Propylparaben,TRUE,NA,low,"Antimicrobial agent, preservative, flavouring agent",94-13-3,Mp 96-97å¡,NA,NA,0.5 mg/mL at 25 oC,3.04,NA,NA,NA,NA,7175,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:09:10 UTC,2015-07-20 22:33:01 UTC,NA,FBS67-S:FBS70-O,HMDB32574,NA,NA,NA,3222,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 66.65%; H 6.71%; O 26.64%,DFC,NA,NA,NA,NA,NA,NA,7.91,NA,"YALKOWSKY,SH & HE,Y (2003)","HANSCH,C ET AL. (1995)",NA,NA,DFC,3.28,2.552487808,-2.27,CCCOC(=O)C1=CC=C(O)C=C1,NA,C10H12O3,180.2005,"InChI=1S/C10H12O3/c1-2-7-13-10(12)8-3-5-9(11)6-4-8/h3-6,11H,2,7H2,1H3",180.0786443,InChIKey=QELSKZZBTMNZEB-UHFFFAOYSA-N,9.60e-01 g/l,31459,propyl 4-hydroxybenzoate,HMDB_from_dfc,NA,NA,"4-Hydroxybenzoic acid, 9CI, 8CI; Propyl ester",DFC,NA,rw1034161,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Benzoic acid esters,Aromatic homomonocyclic compounds,CHEMBL194014,6907,NA,NA,NA,DB14177,NA,Propylparaben,94-13-3,Z8IX2SC1OH,"4-Hydroxybenzoic acid propyl ester | 4-Hydroxybenzoic acid, propyl ester | n-Propyl 4-hydroxybenzoate | n-Propyl p-hydroxybenzoate | n-propyl paraben | p-Hydroxybenzoic acid propyl ester | p-Hydroxybenzoic propyl ester | p-OxybenzoesÃ¤urepropylester | Propyl p-hydroxybenzoate | Propyl paraben | Propyl parahydroxybenzoate",QELSKZZBTMNZEB-UHFFFAOYSA-N
QFOHBWFCKVYLES-UHFFFAOYSA-N,13535,HMDB0032575,194.094294314,butyl 4-hydroxybenzoate,Butylparaben,C11H14O3,94-26-8,NA,FDB010512,NA,NA,NA,7184,6916,CCCCOC(=O)C1=CC=C(O)C=C1,NA,Organic compounds,p-Hydroxybenzoic acid alkyl esters,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Aromatic homomonocyclic compounds,3.57,3004,T3D3980,Exogenous,3.57,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,194.094294314,butyl 4-hydroxybenzoate,Butylparaben,C11H14O3,94-26-8,HMDB32575,NA,NA,NA,7184,6916,CCCCOC(=O)C1=CC=C(O)C=C1,Chemical entities,p-Hydroxybenzoic acid alkyl esters,Organic compounds,Benzenoids,Benzene and substituted derivatives,Aromatic homomonocyclic compounds,10514,25915,SmallMoleculeCompound,FDB010512,Butylparaben,TRUE,NA,low,Preservative and flavouring agent,94-26-8,Mp 68-69å¡,NA,NA,0.207 mg/mL at 20 oC,3.57,NA,NA,NA,NA,7184,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:09:10 UTC,2015-07-20 22:33:01 UTC,NA,FBS67-S:FBS71-P,HMDB32575,NA,NA,NA,413,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 68.02%; H 7.26%; O 24.71%,DFC,NA,NA,NA,NA,NA,NA,8.47,NA,"YALKOWSKY,SH & HE,Y (2003)","HANSCH,C ET AL. (1995)",NA,NA,DFC,3.81,2.997056473,-2.62,CCCCOC(=O)C1=CC=C(O)C=C1,NA,C11H14O3,194.2271,"InChI=1S/C11H14O3/c1-2-3-8-14-11(13)9-4-6-10(12)7-5-9/h4-7,12H,2-3,8H2,1H3",194.0942943,InChIKey=QFOHBWFCKVYLES-UHFFFAOYSA-N,4.66e-01 g/l,32116,butyl 4-hydroxybenzoate,HMDB_from_dfc,NA,NA,"4-Hydroxybenzoic acid, 9CI, 8CI; Butyl ester",DFC,NA,rw1007641,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Benzoic acid esters,Aromatic homomonocyclic compounds,CHEMBL459008,6916,NA,NA,NA,DB14084,NA,Butylparaben,94-26-8,3QPI1U3FV8,Butyl 4-hydroxybenzoate | Butyl hydroxybenzoate | Butyl p-hydroxy benzoate | Butyl parahydroxybenzoate,QFOHBWFCKVYLES-UHFFFAOYSA-N
QGNJRVVDBSJHIZ-AQDFTDIISA-N,16020,HMDB0035185,328.240230268,"(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl acetate",Retinol acetate,C22H32O2,127-47-9,NA,FDB013829,NA,NA,NA,10245972,8421459,CC(=O)OC\C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C,NA,Organic compounds,Retinoids,Lipids and lipid-like molecules,Prenol lipids,Retinoids,Aliphatic homomonocyclic compounds,NA,3593,T3D4910,Exogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,328.240230268,"(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl acetate",Retinol acetate,C22H32O2,127-47-9,HMDB35185,NA,NA,NA,10245972,8421459,[H]\C(COC(C)=O)=C(\C)/C(/[H])=C(\[H])/C(/[H])=C(/C)C([H])=C([H])C1=C(C)CCCC1(C)C,Chemical entities,Retinoids,Organic compounds,Lipids and lipid-like molecules,Prenol lipids,Aliphatic homomonocyclic compounds,13832,36650,SmallMoleculeCompound,FDB013829,Retinol acetate,TRUE,NA,low,"Dietary supplement, permitted in infant formulas",127-47-9,Mp 57-58å¡,NA,NA,NA,NA,NA,NA,NA,NA,10245972,NA,32095,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:10:56 UTC,2015-07-20 23:02:48 UTC,NA,JHQ00-R:JHQ01-S,HMDB35185,NA,NA,NA,3861,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 80.44%; H 9.82%; O 9.74%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DFC,6.56,5.135218583,-5.14,CC(=O)OC\C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C,NA,C22H32O2,328.4883,"InChI=1S/C22H32O2/c1-17(9-7-10-18(2)14-16-24-20(4)23)12-13-21-19(3)11-8-15-22(21,5)6/h7,9-10,12-14H,8,11,15-16H2,1-6H3/b10-7+,13-12+,17-9-,18-14+",328.2402303,InChIKey=QGNJRVVDBSJHIZ-AQDFTDIISA-N,2.38e-03 g/l,32466,"(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl acetate",HMDB_from_dfc,NA,NA,"Retinol, 9CI, BAN, INN; Ac",DFC,NA,NA,NA,NA,Organic compounds,Lipids and lipid-like molecules,Prenol lipids,Retinoids,Retinoids,Aliphatic homomonocyclic compounds,NA,8421459,NA,NA,NA,DB12112,NA,Zuretinol acetate,29584-22-3,2K3YP54BYU,NA,QGNJRVVDBSJHIZ-AQDFTDIISA-N
QHKABHOOEWYVLI-UHFFFAOYSA-N,12,HMDB0000019,116.047344122,3-methyl-2-oxobutanoic acid,alpha-Ketoisovaleric acid,C5H8O3,759-05-7,C00141,FDB012250,DB04074,NA,2-KETO-ISOVALERATE,49,48,CC(C)C(=O)C(O)=O,5091,Organic compounds,Short-chain keto acids and derivatives,Organic acids and derivatives,Keto acids and derivatives,Short-chain keto acids and derivatives,Aliphatic acyclic compounds,NA,3221,T3D4425,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,116.047344122,3-methyl-2-oxobutanoic acid,Alpha-ketoisovaleric acid,C5H8O3,759-05-7,HMDB00019,DB04074,C00141,2-KETO-ISOVALERATE,49,48,CC(C)C(=O)C(O)=O,Chemical entities,Short-chain keto acids and derivatives,Organic compounds,Organic acids and derivatives,Keto acids and derivatives,Aliphatic acyclic compounds,12253,31740,SmallMoleculeCompound,FDB012250,3-Methyl-2-oxobutanoic acid,TRUE,Solid,low,"Flavouring ingredient for use in butter-type flavours. Found in banana, bread, cheeses, asparagus, beer and cocoaAlpha-ketoisovaleric acid is a branched chain organic acid which is a precursor to leucine and valine synthesis.  It is also a degradation product from valine.  The enzyme dihydroxy-acid dehydratase catalyzes the fourth step in the biosynthesis of isoleucine and valine, through the dehydration of 2, 3-dihydroxy-isovaleic acid into alpha-ketoisovaleric acid.",759-05-7,Mp 31å¡,NA,NA,NA,NA,NA,NA,NA,C00141,49,NA,16530,KIV,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HMDB00019.pdf,application/pdf,119308,2015-02-28 18:05:35 UTC,NA,NA,2010-04-08 22:10:04 UTC,2015-10-09 22:31:54 UTC,NA,HFL26-U:HFL26-U,HMDB00019,NA,DB04074,34011,2433,C00007623,Bp 170.5å¡,DFC,NA,NA,NA,NA,NA,NA,C 51.72%; H 6.94%; O 41.34%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DFC,0.49,1.31,-0.59,CC(C)C(=O)C(O)=O,NA,C5H8O3,116.1152,"InChI=1S/C5H8O3/c1-3(2)4(6)5(7)8/h3H,1-2H3,(H,7,8)",116.0473441,InChIKey=QHKABHOOEWYVLI-UHFFFAOYSA-N,3.02e+01 g/l,38952,3-methyl-2-oxobutanoic acid,DFC,NA,NA,3-Methyl-2-oxobutanoic acid,DFC,NA,rw1047091,NA,NA,Organic compounds,Organic acids and derivatives,Keto acids and derivatives,Short-chain keto acids and derivatives,Short-chain keto acids and derivatives,Aliphatic acyclic compounds,CHEMBL146554,48,2-KETO-ISOVALERATE,TRUE,NA,DB04074,EXPT01974,Alpha-ketoisovalerate,759-05-7,34P71D50E0,2-Keto-3-methylbutyric acid | 2-Ketovaline | 2-Oxo-3-methylbutanoate | 2-Oxoisopentanoate | 2-Oxoisovalerate | 3-Methyl-2-oxobutanoate | 3-Methyl-2-oxobutanoic acid | 3-Methyl-2-oxobutyric acid | alpha-Ketovaline,QHKABHOOEWYVLI-UHFFFAOYSA-N
QIGBRXMKCJKVMJ-UHFFFAOYSA-N,1626,HMDB0002434,110.036779436,"benzene-1,4-diol",Hydroquinone,C6H6O2,123-31-9,C00530,FDB000885,NA,NA,236-TRICHLOROHYDROQUINONE,785,764,OC1=CC=C(O)C=C1,6681,Organic compounds,Hydroquinones,Benzenoids,Phenols,Benzenediols,Aromatic homomonocyclic compounds,0.59,3334,T3D4577,Exogenous,0.59,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,110.036779436,"benzene-1,4-diol",Hydroquinone,C6H6O2,123-31-9,HMDB02434,NA,C00530,236-TRICHLOROHYDROQUINONE,785,764,OC1=CC=C(O)C=C1,Organic compounds,Hydroquinones,Benzenoids,Phenols,Benzenediols,Aromatic homomonocyclic compounds,885,2513,SmallMoleculeCompound,FDB000885,Hydroquinone,TRUE,Solid,low,"Hydroquinone, also benzene-1,4-diol, is an aromatic organic compound which is a type of phenol, having the chemical formula C6H4(OH)2. Its chemical structure has two hydroxyl groups bonded to a benzene ring in a para position. Hydroquinone is commonly used as a biomarker for benzene exposure.  The presence of hydroquinone in normal individuals stems mainly from direct dietary ingestion, catabolism of tyrosine and other substrates by gut bacteria, ingestion of arbutin containing foods, cigarette smoking, and the use of some over-the-counter medicines. Hydroquinone is a white granular solid at room temperature and pressure. The hydroxyl groups of hydroquinone are quite weakly acidic. Hydroquinone can lose an H+ from one of the hydroxyls to form a monophenolate ion or lose an H+ from both to form a diphenolate ion. Hydroquinone has a variety of uses principally associated with its action as a reducing agent which is soluble in water. It is a major component in most photographic developers where, with the compound Metol, it reduces silver halides to elemental silver. [HMDB]",123-31-9,NA,NA,NA,NA,NA,NA,NA,NA,C00530,785,NA,NA,HQE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HMDB02434.pdf,application/pdf,49488,2015-02-28 17:59:37 UTC,NA,NA,2010-04-08 22:04:45 UTC,2015-10-09 22:31:58 UTC,660,BLQ78-M:BLQ78-M,HMDB02434,HYDROQUINONE|P-HYDROQUINONE,NA,NA,NA,C00002656,Bp730 285å¡,DFC,NA,NA,NA,NA,NA,NA,C 65.45%; H 5.49%; O 29.06%,DFC,NA,NA,NA,NA,[neutral] lmax 250 (e 204) (CHCl3) (Berdy),DFC,NA,NA,NA,NA,NA,NA,NA,0.71,1.37,-0.06,OC1=CC=C(O)C=C1,11.55,C6H6O2,110.1106,"InChI=1S/C6H6O2/c7-5-1-2-6(8)4-3-5/h1-4,7-8H",110.0367794,InChIKey=QIGBRXMKCJKVMJ-UHFFFAOYSA-N,9.55e+01 g/l,35121,"benzene-1,4-diol",DFC,NA,NA,"1,4-Benzenediol, 9CI",DFC,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenols and derivatives,Hydroquinones,Aromatic homomonocyclic compounds,CHEMBL537,764,236-TRICHLOROHYDROQUINONE,TRUE,NA,DB09526,NA,Hydroquinone,123-31-9,XV74C1N1AE,"1,4-benzenediol | 1,4-dihydroxybenzene | 4-Hydroxyphenol | benzene-1,4-diol | p-Benzenediol | p-Hydroquinone | p-hydroxyphenol | quinol",QIGBRXMKCJKVMJ-UHFFFAOYSA-N
QIQXTHQIDYTFRH-UHFFFAOYSA-N,659,HMDB0000827,284.271530396,octadecanoic acid,Stearic acid,C18H36O2,57-11-4,C01530,FDB002941,DB03193,NA,STEARIC_ACID,5281,5091,CCCCCCCCCCCCCCCCCC(O)=O,189,Organic compounds,Long-chain fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,8.23,3442,T3D4755,Endogenous,8.23,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,284.271530396,octadecanoic acid,Stearic acid,C18H36O2,57-11-4,HMDB00827,DB03193,C01530,STEARIC_ACID,5281,5091,CCCCCCCCCCCCCCCCCC(O)=O,Organic compounds,Long-chain fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,2942,8968,SmallMoleculeCompound,FDB002941,Octadecanoic acid,TRUE,Solid,low,"Constit. of most vegetable and animal fats. Food uses include: flavour modifier, adjuvant, defoamer, lubricant, masticatory aid in chewing gum base, component of fruit coatings and clarifying agent in winesStearic acid (first syllable rhymes with either bear or gear) or 18:0 is a saturated fatty acid. It is a waxy solid, and its chemical formula is C18H36O2. Its name comes from the Greek word stÌ©ar (genitive: stÌ©atos), which means tallow. The salts and esters of stearic acid are called stearates.; Stearic acid is one of most commonly used lubricants during injection molding and pressing of ceramic powders.; Stearic acid, also called octadecanoic acid, is one of the useful types of saturated fatty acids that comes from many animal and vegetable fats and oils. It is a waxy solid, and its chemical formula is CH3(CH2)16COOH. Its name comes from the Greek word stear, which means tallow. Its IUPAC name is octadecanoic acid. -- Wikipedia",1957-11-04,Mp 69.7å¡,NA,NA,0.000597 mg/mL at 25 oC,8.23,NA,NA,NA,C01530,5281,NA,28842,STE,NA,NA,NA,Stearic acid,NA,NA,NA,NA,NA,NA,NA,HMDB00827.pdf,application/pdf,48981,2015-02-28 18:08:20 UTC,NA,NA,2010-04-08 22:05:35 UTC,2015-10-09 22:28:49 UTC,NA,CPL65-U:CPL65-U,HMDB00827,OCTADECANOIC-ACID|STEARIC-ACID,DB03193,37799,3541,C00032087,Bp5 213å¡,DFC,NA,NA,NA,NA,NA,NA,C 76.00%; H 12.75%; O 11.25%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)",SANGSTER (1993),NA,NA,DFC,8.02,7.15,-6.63,CCCCCCCCCCCCCCCCCC(O)=O,NA,C18H36O2,284.4772,"InChI=1S/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20)",284.2715304,InChIKey=QIQXTHQIDYTFRH-UHFFFAOYSA-N,6.61e-05 g/l,32930,octadecanoic acid,DFC,NA,NA,"Octadecanoic acid, 9CI",DFC,NA,rw1009271,NA,NA,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Long-chain fatty acids,Aliphatic acyclic compounds,CHEMBL46403,5091,STEARIC_ACID,TRUE,NA,DB03193,EXPT02965,Stearic acid,57-11-4,4ELV7Z65AP,1-Heptadecanecarboxylic acid | Cetylacetic acid | Fatty acids C16-18 | Isooctadecanoic acid | Isostearic acid | N-octadecanoic acidd | Octadecanoic acid | Octadecansaeure | Octadecoic acid | OLA | Stearate | Stearinsaeure,QIQXTHQIDYTFRH-UHFFFAOYSA-N
QIVBCDIJIAJPQS-VIFPVBQESA-N,739,HMDB0000929,204.089877638,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,L-Tryptophan,C11H12N2O2,73-22-3,C00078,FDB002250,DB00150,NA,TRP,6305,6066,N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O,5879,Organic compounds,Indolyl carboxylic acids and derivatives,Organoheterocyclic compounds,Indoles and derivatives,Indolyl carboxylic acids and derivatives,Aromatic heteropolycyclic compounds,-1.06,3211,T3D4369,Endogenous,-1.06,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,204.089877638,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,L-Tryptophan,C11H12N2O2,73-22-3,HMDB00929,DB00150,C00078,TRP,6305,6066,[H][C@](N)(CC1=CNC2=CC=CC=C12)C(O)=O,Chemical entities,Indolyl carboxylic acids and derivatives,Organic compounds,Organoheterocyclic compounds,Indoles and derivatives,Aromatic heteropolycyclic compounds,2250,7207,SmallMoleculeCompound,FDB002250,L-Tryptophan,TRUE,Solid,low,"Constit. of many plants. Enzymatic hydrol. prod. of most plant and animal proteins. Dietary supplement, nutrientTryptophan is one of the 20 standard amino acids, as well as an essential amino acid in the human diet. Only the L-stereoisomer of tryptophan is used in structural or enzyme proteins, but the D-stereoisomer is occasionally found in naturally produced peptides (for example, the marine venom peptide contryphan). (Wikipedia)",73-22-3,Mp ca. 282å¡ dec.,NA,NA,13.4 mg/mL at 25 oC,-1.06,NA,NA,NA,C00078,6305,NA,16828,TRP,NA,NA,NA,Tryptophan,NA,NA,NA,NA,NA,NA,NA,HMDB00929.pdf,application/pdf,49190,2015-02-28 18:07:49 UTC,NA,2,2010-04-08 22:05:18 UTC,2015-10-09 22:28:34 UTC,NA,CHP14-U:CHP19-Z,HMDB00929,L-TRYPTOPHAN|TRYPTOPHAN,DB00150,33772,3777,C00001396,NA,NA,NA,NA,NA,NA,[a]21D -5.7 (5M HCl),DFC,C 64.69%; H 5.92%; N 13.72%; O 15.67%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,-1.1,-1.22,-2.18,N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O,16.16,C11H12N2O2,204.2252,"InChI=1S/C11H12N2O2/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13H,5,12H2,(H,14,15)/t9-/m0/s1",204.0898776,InChIKey=QIVBCDIJIAJPQS-VIFPVBQESA-N,1.36e+00 g/l,34759,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,MANUAL,NA,NA,"Tryptophan, 9CI, 8CI, USAN; (S)-form",DFC,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Indoles and derivatives,Indolyl carboxylic acids and derivatives,Indolyl carboxylic acids and derivatives,Aromatic heteropolycyclic compounds,CHEMBL54976,6066,TRP,TRUE,NA,DB00150,NUTR00058 | EXPT02064,L-Tryptophan,73-22-3,8DUH1N11BX,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid | (S)-alpha-Amino-beta-(3-indolyl)-propionic acid | (S)-Tryptophan | (S)-Î±-amino-1H-indole-3-propanoic acid | L-(-)-Tryptophan | L-(â)-tryptophan | L-Î²-3-indolylalanine | Trp | Tryptophan | W,QIVBCDIJIAJPQS-VIFPVBQESA-N
QNAYBMKLOCPYGJ-REOHCLBHSA-N,105,HMDB0000161,89.047678473,(2S)-2-aminopropanoic acid,L-Alanine,C3H7NO2,56-41-7,C00041,FDB000556,DB00160,NA,L-ALPHA-ALANINE,5950,5735,C[C@H](N)C(O)=O,NA,Organic compounds,Alanine and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,-2.85,3184,T3D4320,Endogenous,-2.85,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,89.047678473,(2S)-2-aminopropanoic acid,L-Alanine,C3H7NO2,56-41-7,HMDB00161,DB00160,C01401,L-ALPHA-ALANINE,5950,5735,[H][C@@](C)(N)C(O)=O,Organic compounds,Alanine and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,556,1429,SmallMoleculeCompound,FDB000556,L-Alanine,TRUE,Solid,low,"Dietary supplement, nutrientAlanine (abbreviated as Ala or A) is an alpha-amino acid with the chemical formula CH3CH(NH2)COOH. The L-isomer is one of the 22 proteinogenic amino acids, i.e., the building blocks of proteins. Its codons are GCU, GCC, GCA, and GCG. It is classified as a nonpolar amino acid. L-Alanine is second only to leucine in rate of occurrence, accounting for 7.8% of the primary structure in a sample of 1,150 proteins. D-Alanine occurs in bacterial cell walls and in some peptide antibiotics. (Wikipedia)",56-41-7,Mp 297å¡ dec.,NA,NA,164 mg/mL at 25 oC,-2.85,NA,NA,NA,C00041,5950,NA,16977,ALA,NA,NA,NA,2-Aminopropanoic acid,NA,NA,NA,NA,NA,NA,NA,HMDB00161.pdf,application/pdf,47883,2015-02-28 18:06:06 UTC,NA,2,2010-04-08 22:04:37 UTC,2015-10-09 22:28:24 UTC,NA,BDL65-D:BDL73-E,HMDB00161,ALANINE,DB01786,33629,69,C00001332,NA,NA,NA,NA,NA,NA,"[a]D +1.8 (c, 1 in H2O)",DFC,C 40.44%; H 7.92%; N 15.72%; O 35.92%,DFC,NA,NA,NA,NA,NA,NA,pKa2 9.69 (NH2),DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)",SANGSTER (1994),NA,NA,DFC,-3.05,-2.98,0.7,C[C@H](N)C(O)=O,NA,C3H7NO2,89.0932,"InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m0/s1",89.04767847,InChIKey=QNAYBMKLOCPYGJ-REOHCLBHSA-N,4.47e+02 g/l,33023,(2S)-2-aminopropanoic acid,MANUAL,NA,NA,"Alanine, INN, USAN; (S)-form",DFC,NA,rw1044181,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",L-alpha-amino acids,Aliphatic acyclic compounds,CHEMBL279597,5735,L-ALPHA-ALANINE,TRUE,NA,DB00160,NUTR00013,L-Alanine,56-41-7,OF5P57N2ZX,(2S)-2-aminopropanoic acid | (S)-2-aminopropanoic acid | (S)-alanine | Alanine | L-2-Aminopropionic acid | L-Alanin | L-alpha-Alanine | L-Î±-alanine,QNAYBMKLOCPYGJ-REOHCLBHSA-N
QRXWMOHMRWLFEY-UHFFFAOYSA-N,9341,HMDB0015086,137.058911861,pyridine-4-carbohydrazide,Isoniazid,C6H7N3O,54-85-3,C07054,NA,DB00951,NA,NA,3767,3635,NNC(=O)C1=CC=NC=C1,NA,Organic compounds,Pyridinecarboxylic acids and derivatives,Organoheterocyclic compounds,Pyridines and derivatives,Pyridinecarboxylic acids and derivatives,Aromatic heteromonocyclic compounds,-0.8,3464,T3D4777,Exogenous,-0.7,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,137.058911861,pyridine-4-carbohydrazide,Isoniazid,C6H7N3O,54-85-3,HMDB15086,DB00951,C07054,NA,3767,3635,NNC(=O)C1=CC=NC=C1,Organic compounds,Pyridinecarboxylic acids and derivatives,Organoheterocyclic compounds,Pyridines and derivatives,Pyridinecarboxylic acids and derivatives,Aromatic heteromonocyclic compounds,29392,NA,SmallMoleculeCompound,FDB029229,Isoniazid,TRUE,NA,low,"Isoniazid (also called isonicotinyl hydrazine or INH; sold as Laniazid, Nydrazid) is an organic compound that is the first-line antituberculosis medication in prevention and treatment. First discovered in 1912 as an inhibitor of the MAO enzyme, it was first used as an antidepressant, but discontinued due to side effects. In 1951, it was later discovered that isoniazid was effective against TB. Isoniazid is never used on its own to treat active tuberculosis because resistance quickly develops.; Isoniazid is a bactericidal agent active against organisms of the genus Mycobacterium, specifically <i>M. tuberculosis</i>, <i>M. bovis</i> and <i>M. kansasii</i>. It is a highly specific agent, ineffective against other microorganisms. Isoniazid is bactericidal to rapidly-dividing mycobacteria, but is bacteriostatic if the mycobacterium is slow-growing.; Isoniazid is a prodrug and must be activated by bacterial catalase. It is activated by catalase-peroxidase enzyme KatG which couples the isonicotinic acyl with NADH to form isonicotinic acyl-NADH complex. This complex binds tightly to ketoenoylreductase known as InhA, thereby blocking the natural enoyl-AcpM substrate and the action of fatty acid synthase. This process inhibits the synthesis of mycolic acid required for the mycobacterial cell wall. A range of radicals are produced by KatG activation of Isoniazid, including nitric oxide, that has also been shown to be important in the action of another antimycobacterial prodrug PA824. [HMDB]",54-85-3,NA,NA,NA,NA,NA,NA,NA,NA,C07054,3767,NA,6030,NA,NA,NA,NA,isoniazid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2011-09-21 01:52:13 UTC,2015-07-21 06:59:39 UTC,NA,NA,HMDB12982,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.71,-0.69026201,-0.59,[H]N([H])N([H])C(=O)C1=C([H])C([H])=NC([H])=C1[H],NA,C6H7N3O,137.1393,"InChI=1S/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10)",137.0589119,InChIKey=QRXWMOHMRWLFEY-UHFFFAOYSA-N,3.49e+01 g/l,89710,pyridine-4-carbohydrazide,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB00951,APRD01055 | EXPT01940,Isoniazid,54-85-3,V83O1VOZ8L,4-pyridinecarbohydrazide | INH | Isoniazid | Isonicotinic acid hydrazide | Isonicotinic hydrazide | Isonicotinohydrazide | Isonicotinoylhydrazide | Isonicotinsaeurehydrazid | Isonicotinylhydrazine | Pyridine-4-carboxylic acid hydrazide,QRXWMOHMRWLFEY-UHFFFAOYSA-N
QSHWIQZFGQKFMA-UHFFFAOYSA-N,166,HMDB0000245,226.095356946,3-[5-(aminomethyl)-4-(carboxymethyl)-1H-pyrrol-3-yl]propanoic acid,Porphobilinogen,C10H14N2O4,487-90-1,C00931,FDB021916,NA,NA,PORPHOBILINOGEN,1021,995,NCC1=C(CC(O)=O)C(CCC(O)=O)=CN1,76,Organic compounds,Aralkylamines,Organic nitrogen compounds,Organonitrogen compounds,Amines,Aromatic heteromonocyclic compounds,NA,3158,T3D4274,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,226.095356946,3-[5-(aminomethyl)-4-(carboxymethyl)-1H-pyrrol-3-yl]propanoic acid,Porphobilinogen,C10H14N2O4,487-90-1,HMDB00245,DB02272,C00931,PORPHOBILINOGEN,1021,995,NCC1=C(CC(O)=O)C(CCC(O)=O)=CN1,Chemical entities,Aralkylamines,Organic compounds,Organic nitrogen compounds,Organonitrogen compounds,Aromatic heteromonocyclic compounds,22079,NA,SmallMoleculeCompound,FDB021916,Porphobilinogen,TRUE,Solid,low,"Porphobilinogen is a pyrrole involved in porphyrin metabolism. -- Wikipedia;  It consists of a pyrrole ring with acetyl, propionyl, and aminomethyl side chains; It is a key monopyrrolic intermediate in porphyrin, chlorophyll and vitamin B12 biosynthesis. Porphobilinogen is generated by the enzyme ALA dehydratase by combining two molecules of dALA together, and converted into hydroxymethyl bilane by the enzyme porphobilinogen deaminase.   4 molecules of porphobilinogen are condensed to form one molecule of uroporphyrinogen III, which is then converted successively to coproporphyrinogen III, protoporphyrin IX, and heme. Porphobilinogen is produced in excess and excreted in the urine in acute intermittent porphyria and several other porphyrias. [HMDB]",487-90-1,NA,NA,NA,NA,NA,NA,NA,NA,C00931,1021,NA,17381,PBG,NA,NA,NA,Porphobilinogen,NA,NA,NA,NA,NA,NA,NA,HMDB00245.pdf,application/pdf,124720,2015-02-28 17:44:18 UTC,NA,NA,2011-09-21 00:05:06 UTC,2015-10-09 22:30:22 UTC,NA,NA,HMDB00245,NA,NA,36404,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-2.4,-2.679999754,-1.92,[H]OC(=O)C([H])([H])C1=C(N([H])C([H])=C1C([H])([H])C([H])([H])C(=O)O[H])C([H])([H])N([H])[H],4.399994174,C10H14N2O4,226.2292,"InChI=1S/C10H14N2O4/c11-4-8-7(3-10(15)16)6(5-12-8)1-2-9(13)14/h5,12H,1-4,11H2,(H,13,14)(H,15,16)",226.0953569,InChIKey=QSHWIQZFGQKFMA-UHFFFAOYSA-N,2.72e+00 g/l,84087,3-[5-(aminomethyl)-4-(carboxymethyl)-1H-pyrrol-3-yl]propanoic acid,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organonitrogen compounds,Amines,Aralkylamines,Aralkylamines,Aromatic heteromonocyclic compounds,NA,995,PORPHOBILINOGEN,TRUE,NA,DB02272,EXPT02507,Porphobilinogen,487-90-1,74KHC72QXK,2-aminomethylpyrrol-3-acetic acid 4-propionic acid | 5-(Aminomethyl)-4-(carboxymethyl)-1H-pyrrole-3-propionic acid | PBG,QSHWIQZFGQKFMA-UHFFFAOYSA-N
QXKHYNVANLEOEG-UHFFFAOYSA-N,9009,HMDB0014693,216.042258738,"9-methoxy-7H-furo[3,2-g]chromen-7-one",Methoxsalen,C12H8O4,298-81-7,C01864,FDB012474,DB00553,NA,NA,4114,3971,COC1=C2OC(=O)C=CC2=CC2=C1OC=C2,NA,Organic compounds,8-methoxypsoralens,Phenylpropanoids and polyketides,Coumarins and derivatives,Furanocoumarins,Aromatic heteropolycyclic compounds,1.7,703,T3D0836,Exogenous,1.7,Methoxsalen plus UVA radiation is carcinogenic to humans (Group 1). (L135),NA,SmallMolecule,216.042258744,"9-methoxy-7H-furo[3,2-g]chromen-7-one",Methoxsalen,C12H8O4,298-81-7,HMDB14693,DB00553,C01864,8-METHOXYFURANOCOUMARIN,4114,3971,COC1=C2OC(=O)C=CC2=CC2=C1OC=C2,Chemical entities,8-methoxypsoralens,Organic compounds,Phenylpropanoids and polyketides,Coumarins and derivatives,Aromatic heteropolycyclic compounds,12477,32415,SmallMoleculeCompound,FDB012474,Xanthotoxin,TRUE,Solid,low,"Present in celery, esp. the outer leaves, and other common grocery vegetables. Implicated in photodermatitis among grocery workers. Isol. from  Aegle marmelos (bael)Methoxsalen (marketed under the trade name Oxsoralen) is a drug used to treat psoriasis, eczema, vitiligo, and some cutaneous Lymphomas in conjunction with exposing the skin to sunlight. Methoxsalen modifies the way skin cells receive the UVA radiation, allegedly clearing up the disease. The dosage comes in 10mg tablets, which are taken in the amount of 30mg 75 minutes before a PUVA light treatment. The substance is also present in bergamot oil which is used in many perfumes and aromatherapy oils.; Methoxsalen selectively inhibits the synthesis of deoxyribonucleic acid (DNA). The guanine and cytosine content correlates with the degree of Methoxsalen-induced cross-linking. At high concentrations of the drug, cellular RNA and protein synthesis are also suppressed.; Patients with high blood pressure or a history of liver problems are at risk for inflammation and irreparable damage to both liver and skin. The eyes must be protected from UVA radiation. Side effects include nausea, headaches, dizziness, and in rare cases insomnia. When Eau de Cologne was made, it became a popular perfume. It contained bergamot oil as one of its components. Ladies wearing the perfume on places where the skin was radiated by the sun, noticed that their skin turned brownish at those spots. This is due to the phototoxic effects of methoxsalen present in the bergamot oil. The methoxsalen was removed, and most modern formulations of perfumes containing bergamot are de-methoxsalenised.",298-81-7,Mp 148å¡,NA,NA,0.0476 mg/mL at 30 oC,NA,NA,NA,NA,C01864,4114,NA,NA,8MO,NA,NA,NA,Xanthotoxin,NA,NA,NA,NA,NA,NA,NA,HMDB14693.pdf,application/pdf,52048,2015-02-28 17:59:47 UTC,NA,NA,2010-04-08 22:10:11 UTC,2015-07-20 22:50:53 UTC,719,HHG12-C:HHG12-C,HMDB14693,8-METHOXY-PSORALEN|XANTHOTOXIN,DB00553,NA,NA,C00000576,NA,NA,NA,NA,NA,NA,NA,NA,C 66.67%; H 3.73%; O 29.60%,DFC,NA,NA,NA,NA,301 (e 14400) (EtOH) (Berdy),DFC,NA,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)",NA,NA,NA,DFC,2.1,1.78,-3.12,COC1=C2OC=CC2=CC2=C1OC(=O)C=C2,NA,C12H8O4,216.1895,"InChI=1S/C12H8O4/c1-14-12-10-8(4-5-15-10)6-7-2-3-9(13)16-11(7)12/h2-6H,1H3",216.0422587,InChIKey=QXKHYNVANLEOEG-UHFFFAOYSA-N,1.64e-01 g/l,35751,"9-methoxy-2H-furo[3,2-g]chromen-2-one",DFC,NA,NA,Xanthotoxin,DFC,NA,NA,NA,NA,Organic compounds,Phenylpropanoids and polyketides,Coumarins and derivatives,Furanocoumarins,8-methoxypsoralens,Aromatic heteropolycyclic compounds,CHEMBL416,3971,CPD-13042,NA,NA,DB00553,APRD00157,Methoxsalen,298-81-7,U4VJ29L7BQ,"6-Hydroxy-7-methoxy-5-benzofuranacrylic acid delta-lactone | 8-Methoxy-[furano-3'.2':6.7-coumarin] | 8-Methoxy-2',3',6,7-furocoumarin | 8-Methoxy-4',5':6,7-furocoumarin | 8-Methoxyfuranocoumarin | 8-Methoxypsoralen | 8-MP | 9-Methoxy-7H-furo[3,2-g][1]benzopyran-7-one | Ammoidin | Meladinine | Meloxine | Methoxalen | Methoxsalen | MÃ©thoxsalÃ¨ne | O-Methylxanthotoxol | Ultra mop | Xanthotoxin | Xanthotoxine | Xanthoxin | Zanthotoxin",QXKHYNVANLEOEG-UHFFFAOYSA-N
QYSXJUFSXHHAJI-YRZJJWOYSA-N,697,HMDB0000876,384.33921603,"(1S,3Z)-3-{2-[(1R,3aS,4E,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexan-1-ol",Vitamin D3,C27H44O,67-97-0,C05443,FDB012732,DB00169,NA,NA,5280795,4444353,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C)[C@H](C)CCCC(C)C,NA,Organic compounds,Vitamin D and derivatives,Lipids and lipid-like molecules,Steroids and steroid derivatives,Vitamin D and derivatives,Aliphatic homopolycyclic compounds,NA,2188,T3D2703,Endogenous,7.5,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,384.33921603,"(1S,3Z)-3-{2-[(1R,3aS,4E,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexan-1-ol",Cholecalciferol,C27H44O,67-97-0,HMDB14315,DB00169,C05443,VITAMIN_D_%7B3%7D,5280795,4444353,[H]\C(\C(\[H])=C1/CCC[C@@]2(C)[C@@]1([H])CC[C@]2([H])[C@]([H])(C)CCCC(C)C)=C1/C[C@@]([H])(O)CCC1=C,Organic compounds,Vitamin D and derivatives,Lipids and lipid-like molecules,Steroids and steroid derivatives,Vitamin D and derivatives,Aliphatic homopolycyclic compounds,21596,25794,SmallMoleculeCompound,FDB021586,Vitamin D,TRUE,NA,low,NA,1406-16-2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Vitamin_D,NA,NA,"I think this CAS number is for any form of vitamin D.This entry should represent the total vitamin D2 + D3 (UI or mg/100 g) as given in the USDA and DTU composition tables.",NA,NA,NA,NA,NA,NA,NA,NA,2,2,2010-10-13 01:18:16 UTC,2015-07-21 06:54:18 UTC,NA,NA,NA,VIT-D,NA,NA,3863,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CC(C)CCC[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,NA,C27H44O,384.6377,"InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1",384.339216,QYSXJUFSXHHAJI-YRZJJWOYSA-N,NA,NA,NA,NA,NA,NA,NA,EAFUS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB00169,NUTR00008 | APRD00506,Cholecalciferol,67-97-0,1C6V77QF41,"(+)-vitamin D3 | (1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol | (3Î²,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol | (5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol | Activated 7-dehydrocholesterol | Calciol | CC | Colecalciferol | colecalciferolum | Oleovitamin D3 | Vitamin D-3 | Vitamin D3",QYSXJUFSXHHAJI-YRZJJWOYSA-N
RAPZEAPATHNIPO-UHFFFAOYSA-N,2354,HMDB0005020,410.211804333,"3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-4H,6H,7H,8H,9H-pyrido[1,2-a]pyrimidin-4-one",Risperidone,C23H27FN4O2,106266-06-2,C06861,FDB023591,NA,NA,NA,5073,4895,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,2348,Organic compounds,Pyridopyrimidines,Organoheterocyclic compounds,Pyridopyrimidines,NA,Aromatic heteropolycyclic compounds,NA,2310,T3D2871,Exogenous,2.5,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,410.211804333,"3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-4H,6H,7H,8H,9H-pyrido[1,2-a]pyrimidin-4-one",Risperidone,C23H27FN4O2,106266-06-2,HMDB05020,DB00734,C06861,NA,5073,4895,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Organic compounds,Pyridopyrimidines,Organoheterocyclic compounds,Pyridopyrimidines,NA,Aromatic heteropolycyclic compounds,23754,NA,SmallMoleculeCompound,FDB023591,Risperidone,TRUE,Solid,low,"Risperidone is an atypical antipsychotic medication approved in 1993. It is most often used to treat delusional psychosis (including schizophrenia), but risperidone (like other atypical antipsychotics) is also used to treat some forms of bipolar disorder, psychotic depression and Tourette syndrome.Generally lower doses are used for autistic spectrum disorders than are used for schizophrenia and other forms of psychosis; Risperidone is a very strong dopamine blocker (antagonist); Risperidone is a very strong dopamine blocker (antagonist); i.e., it inhibits functioning of postsynaptic dopamine receptors.; An anxiolytic agent and a serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the benzodiazepines, but it has an efficacy comparable to diazepam; i.e., it inhibits functioning of postsynaptic dopamine receptors.; Risperidone (Belivon, Rispen, Risperdal; in the United States) is an atypical antipsychotic medication. It was approved by the United States Food and Drug Administration (FDA) in 1993. It is most often used to treat delusional psychosis (including schizophrenia), but risperidone (like other atypical antipsychotics) is also used to treat some forms of bipolar disorder, psychotic depression and Tourette syndrome; risperidone has received approval from the Food and Drug Administration (FDA) for symptomatic treatment of irritability in autistic children and adolescents.Risperidone is now the most commonly prescribed antipsychotic medication in the United States. [HMDB]",106266-06-2,NA,NA,NA,NA,NA,NA,NA,NA,C06861,5073,NA,NA,NA,NA,NA,NA,Risperidone,NA,NA,NA,NA,NA,NA,NA,HMDB05020.pdf,application/pdf,149691,2015-02-28 18:07:07 UTC,NA,NA,2011-09-21 00:32:04 UTC,2015-07-21 06:57:46 UTC,NA,NA,HMDB05020,NA,DB00734,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3.27,2.627621084,-3.38,[H]C1=C([H])C(F)=C([H])C2=C1C(=NO2)C1([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])C2=C(N=C3N(C2=O)C([H])([H])C([H])([H])C([H])([H])C3([H])[H])C([H])([H])[H])C([H])([H])C1([H])[H],NA,C23H27FN4O2,410.4845,"InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3",410.2118043,InChIKey=RAPZEAPATHNIPO-UHFFFAOYSA-N,1.71e-01 g/l,87921,"3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-4H,6H,7H,8H,9H-pyrido[1,2-a]pyrimidin-4-one",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Pyridopyrimidines,NA,Pyridopyrimidines,Aromatic heteropolycyclic compounds,CHEMBL85,4895,NA,NA,NA,DB00734,APRD00187,Risperidone,106266-06-2,L6UH7ZF8HC,risperdone | Risperidona | Risperidonum | Risperin | Rispolept | Rispolin | Sequinan,RAPZEAPATHNIPO-UHFFFAOYSA-N
REFJWTPEDVJJIY-UHFFFAOYSA-N,2550,HMDB0005794,302.042652674,"2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one",Quercetin,C15H10O7,117-39-5,C00389,FDB011904,NA,NA,CPD-520,5280343,4444051,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1,NA,Organic compounds,Flavonols,Phenylpropanoids and polyketides,Flavonoids,Flavones,Aromatic heteropolycyclic compounds,NA,3445,T3D4758,Exogenous,NA,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,302.042652674,"2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one",Quercetin,C15H10O7,117-39-5,HMDB05794,DB04216,C00389,3457-TETRAHYDROXY-3-METHOXYFLAVONE,5280343,4444051,OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C=C2)=C1,Organic compounds,Flavonols,Phenylpropanoids and polyketides,Flavonoids,Flavones,Aromatic heteropolycyclic compounds,11907,30466,SmallMoleculeCompound,FDB011904,Quercetin,TRUE,Solid,low,"Isol. from many plants, esp. fruits, such as Helichrysum, Euphorbia and Karwinskia spp. Present in the Solanaceae, Rhamnaceae, Passifloraceae and many other families. For example detected in almost all studied Umbelliferae. Nutriceutical with antiinflammatory props. and a positive influence on the blood lipid profile. Found in a wide variety of foodstuffs esp. apples, bee pollen, blackcurrants, capers, cocoa, cranberries, dock leaves, elderberries, fennel, lovage, red onions, ancho peppers, dill weed and tarragon",117-39-5,Mp 313-314å¡ dec.,NA,NA,0.06 mg/mL at 16 oC,NA,NA,NA,NA,C00389,5280343,NA,NA,QUE,NA,NA,NA,Quercetin,NA,NA,NA,NA,NA,NA,NA,HMDB05794.pdf,application/pdf,112576,2015-02-28 17:53:56 UTC,NA,2,2010-04-08 22:09:53 UTC,2015-10-09 22:32:30 UTC,291,HBR39-C:HBR39-C,HMDB05794,QUERCETIN,DB04216,NA,NA,C00004631,NA,NA,NA,NA,NA,NA,NA,NA,C 59.61%; H 3.33%; O 37.06%,DFC,NA,NA,NA,NA,375 (e 20900) (EtOH) (Berdy),DFC,NA,NA,"SEIDELL,A (1941)",NA,NA,NA,DFC,1.81,2.16,-3.06,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1,7.79,C15H10O7,302.2357,"InChI=1S/C15H10O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,16-19,21H",302.0426527,InChIKey=REFJWTPEDVJJIY-UHFFFAOYSA-N,2.61e-01 g/l,38238,"2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one",MANUAL,NA,NA,"3,3',4',5,7-Pentahydroxyflavone",DFC,NA,NA,NA,291,Organic compounds,Phenylpropanoids and polyketides,Flavonoids,Flavones,Flavonols,Aromatic heteropolycyclic compounds,CHEMBL50,4444051,3457-TETRAHYDROXY-3-METHOXYFLAVONE,TRUE,NA,DB04216,EXPT02732,Quercetin,117-39-5,9IKM0I5T1E,"3,5,7,3',4'-Pentahydroxyflavone",REFJWTPEDVJJIY-UHFFFAOYSA-N
RHMXXJGYXNZAPX-UHFFFAOYSA-N,16048,HMDB0035214,270.05282343,"1,3,8-trihydroxy-6-methyl-9,10-dihydroanthracene-9,10-dione",Emodin,C15H10O5,518-82-1,C10343,FDB013862,NA,NA,NA,3220,3107,CC1=CC2=C(C(O)=C1)C(=O)C1=C(C=C(O)C=C1O)C2=O,NA,Organic compounds,Hydroxyanthraquinones,Benzenoids,Anthracenes,Anthraquinones,Aromatic homopolycyclic compounds,NA,2789,T3D3755,Exogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,270.05282343,"1,3,8-trihydroxy-6-methyl-9,10-dihydroanthracene-9,10-dione",Emodin,C15H10O5,518-82-1,HMDB35214,DB07715,C10343,NA,3220,3107,CC1=CC2=C(C(O)=C1)C(=O)C1=C(C=C(O)C=C1O)C2=O,Chemical entities,Hydroxyanthraquinones,Organic compounds,Benzenoids,Anthracenes,Aromatic homopolycyclic compounds,13865,36719,SmallMoleculeCompound,FDB013862,Emodin,TRUE,NA,low,"Present in Cascara sagradaEmodin is a purgative resin from rhubarb, Polygonum cuspidatum, the buckthorn and Japanese Knotweed (Fallopia japonica). The term may also refer to any one of a series of principles isomeric with the emodin of rhubarb. (Wikipedia)",518-82-1,Mp 266-268å¡ (264-265å¡),NA,NA,NA,NA,NA,NA,NA,C10343,3220,NA,42223,EMO,NA,NA,NA,Emodin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:10:57 UTC,2015-07-20 23:03:02 UTC,NA,JJF10-F:JJF10-F,HMDB35214,EMODIN,DB07715,NA,NA,C00000555,NA,NA,NA,NA,NA,NA,NA,NA,C 66.67%; H 3.73%; O 29.60%,DFC,NA,NA,NA,NA,437 (e 12600) (EtOH) (Derep),DFC,NA,NA,NA,NA,NA,NA,DFC,2.66,3.821431499,-3.09,CC1=CC2=C(C(O)=C1)C(=O)C1=C(C=C(O)C=C1O)C2=O,9.437021453,C15H10O5,270.2369,"InChI=1S/C15H10O5/c1-6-2-8-12(10(17)3-6)15(20)13-9(14(8)19)4-7(16)5-11(13)18/h2-5,16-18H,1H3",270.0528234,InChIKey=RHMXXJGYXNZAPX-UHFFFAOYSA-N,2.22e-01 g/l,34499,"1,3,8-trihydroxy-6-methyl-9,10-dihydroanthracene-9,10-dione",HMDB_from_dfc,NA,NA,"1,3,8-Trihydroxy-6-methylanthraquinone, 8CI",DFC,NA,NA,NA,NA,Organic compounds,Benzenoids,Anthracenes,Anthraquinones,Hydroxyanthraquinones,Aromatic homopolycyclic compounds,CHEMBL289277,3107,NA,NA,NA,DB07715,DB12653,Emodin,518-82-1,KA46RNI6HN,"1,3,8-trihydroxy-6-methyl-9,10-anthracenedione | 1,3,8-trihydroxy-6-methyl-9,10-anthraquinone | Schuttgelb",RHMXXJGYXNZAPX-UHFFFAOYSA-N
RJKFOVLPORLFTN-LEKSSAKUSA-N,1212,HMDB0001830,314.224580204,"(1S,2R,10S,11S,14S,15S)-14-acetyl-2,15-dimethyltetracyclo[8.7.0.0\xc2\xb2,\xe2\x81\xb7.0\xc2\xb9\xc2\xb9,\xc2\xb9\xe2\x81\xb5]heptadec-6-en-5-one",Progesterone,C21H30O2,57-83-0,C00410,FDB001871,DB00396,NA,PROGESTERONE,5994,5773,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,402,Organic compounds,"Gluco/mineralocorticoids, progestogins and derivatives",Lipids and lipid-like molecules,Steroids and steroid derivatives,Pregnane steroids,Aliphatic homopolycyclic compounds,3.87,3142,T3D4244,Endogenous,3.87,"2B, possibly carcinogenic to humans. (L135)",NA,SmallMolecule,314.224580204,"(1S,2R,10S,11S,14S,15S)-14-acetyl-2,15-dimethyltetracyclo[8.7.0.0\xc2\xb2,\xe2\x81\xb7.0\xc2\xb9\xc2\xb9,\xc2\xb9\xe2\x81\xb5]heptadec-6-en-5-one",Progesterone,C21H30O2,57-83-0,HMDB01830,DB00396,C00410,CPD-272,5994,5773,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O,Organic compounds,"Gluco/mineralocorticoids, progestogins and derivatives",Lipids and lipid-like molecules,Steroids and steroid derivatives,Pregnane steroids,Aliphatic homopolycyclic compounds,1871,5905,SmallMoleculeCompound,FDB001871,Progesterone,TRUE,NA,low,"Progestational hormone secreted by corpus luteum during menstrual cycle. Also found in the gonads and haemolymph of crustaceans, e.g. Artemia, Euphosia, Homarus, Pandalus and Penaeus spp (CCD)",57-83-0,121 oC,NA,NA,0.00881 mg/mL at 25 oC,3.87,NA,NA,NA,C00410,5994,NA,17026,NA,NA,NA,NA,Progesterone,NA,NA,NA,NA,NA,NA,NA,HMDB01830.pdf,application/pdf,50016,2015-02-28 17:56:13 UTC,NA,2,2010-04-08 22:05:09 UTC,2015-10-09 22:30:41 UTC,NA,HLF54-N:HLF54-N,HMDB01830,NA,DB00396,34898,NA,C00034649,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,NA,3.58,4.15,-4.76,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,19.56,C21H30O2,314.4617,"InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1",314.2245802,InChIKey=RJKFOVLPORLFTN-LEKSSAKUSA-N,5.46e-03 g/l,40460,"(1S,2R,10S,11S,14S,15S)-14-acetyl-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one",MANUAL,NA,NA,NA,KNAPSACK,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,DB00396,APRD00700,Progesterone,57-83-0,4G7DS2Q64Y,"(S)-4-Pregnene-3,20-dione | (S)-Pregn-4-en-3,20-dione | (S)-Progesterone | 17alpha-Progesterone | 17Î±-progesterone | 4-Pregnene-3,20-dione | Agolutin | Akrolutin | Corpus Luteum Hormone | delta(4)-Pregnene-3,20-dione | GelbkÃ¶rperhormon | Luteohormone | Lutogynon | Pregn-4-ene-3,20-dione | Progesteron | Progesterona | ProgestÃ©rone | Progesterone | Progesteronum",RJKFOVLPORLFTN-LEKSSAKUSA-N
RLSSMJSEOOYNOY-UHFFFAOYSA-N,1369,HMDB0002048,108.057514878,3-methylphenol,m-Cresol,C7H8O,108-39-4,C01467,FDB008788,DB01776,NA,CPD-112,342,21105871,CC1=CC=CC(O)=C1,NA,Organic compounds,Meta cresols,Benzenoids,Phenols,Cresols,Aromatic homomonocyclic compounds,1.96,1548,T3D1842,Endogenous,1.96,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,108.057514878,3-methylphenol,m-Cresol,C7H8O,108-39-4,HMDB02048,DB01776,C01467,CPD-112,342,21105871,CC1=CC(O)=CC=C1,Chemical entities,Meta cresols,Organic compounds,Benzenoids,Phenols,Aromatic homomonocyclic compounds,8789,21852,SmallMoleculeCompound,FDB008788,3-Methylphenol,TRUE,Liquid,low,Flavouring ingredient,108-39-4,Mp 11-12å¡,NA,NA,22.7 mg/mL at 25 oC,1.96,NA,NA,NA,C01467,342,NA,17231,CRS,NA,NA,NA,m-Cresol,NA,NA,NA,NA,NA,NA,NA,HMDB02048.pdf,application/pdf,5495735,2015-02-28 18:09:24 UTC,NA,2,2010-04-08 22:08:15 UTC,2015-10-09 22:32:00 UTC,NA,DXH39-K:DXH39-K,HMDB02048,M-CRESOL,DB01776,NA,770,C00035128,Bp6 80å¡,DFC,NA,NA,d224<vs=1> 1.04,DFC,NA,NA,C 77.75%; H 7.46%; O 14.80%,DFC,NA,NA,n20D<vs=1>  1.5400,DFC,NA,NA,pKa 10.09 (25å¡),DFC,"YALKOWSKY,SH & HE,Y (2003)","HANSCH,C ET AL. (1995)",NA,NA,DFC,1.93,2.18,-0.63,CC1=CC=CC(O)=C1,NA,C7H8O,108.1378,"InChI=1S/C7H8O/c1-6-3-2-4-7(8)5-6/h2-5,8H,1H3",108.0575149,InChIKey=RLSSMJSEOOYNOY-UHFFFAOYSA-N,2.51e+01 g/l,31782,3-methylphenol,DFC,NA,NA,"3-Methylphenol, 9CI",DFC,108-39-4,rw1007701,342,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Toluenes,Nitrotoluenes,Aromatic homomonocyclic compounds,CHEMBL298312,21105871,CPD-112,TRUE,NA,DB01776,EXPT01026,M-Cresol,108-39-4,GGO4Y809LO,NA,RLSSMJSEOOYNOY-UHFFFAOYSA-N
RRAFCDWBNXTKKO-UHFFFAOYSA-N,2562,HMDB0005809,164.083729628,2-methoxy-4-(prop-2-en-1-yl)phenol,Eugenol,C10H12O2,97-53-0,C10453,FDB012171,NA,NA,NA,3314,13876103,COC1=C(O)C=CC(CC=C)=C1,4022,Organic compounds,Methoxyphenols,Benzenoids,Phenols,Methoxyphenols,Aromatic homomonocyclic compounds,NA,3562,T3D4879,Exogenous,NA,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,164.083729628,2-methoxy-4-(prop-2-en-1-yl)phenol,Eugenol,C10H12O2,97-53-0,HMDB05809,NA,C10453,NA,3314,13876103,COC1=C(O)C=CC(CC=C)=C1,Organic compounds,Methoxyphenols,Benzenoids,Phenols,Methoxyphenols,Aromatic homomonocyclic compounds,12174,31502,SmallMoleculeCompound,FDB012171,Eugenol,TRUE,Solid,low,"Very widespread occurrence in essential oils. Major component of clove oil. Also found in citrus and thyme oils. Present in apple, apricot, banana and cherry fruits. Flavouring agentEugenol (C10H12O2), is an allyl chain-substituted guaiacol. Eugenol is a member of the phenylpropanoids class of chemical compounds. It is a clear to pale yellow oily liquid extracted from certain essential oils especially from clove oil, nutmeg, cinnamon, and bay leaf[citation needed]. It is slightly soluble in water and soluble in organic solvents. It has a pleasant, spicy, clove-like aroma.; Eugenol is an allyl chain-substituted guaiacol, i.e. 2-methoxy-4-(2-propenyl)phenol. Eugenol is a member of the allylbenzene class of chemical compounds. It is a clear to pale yellow oily liquid extracted from certain essential oils especially from clove oil, nutmeg, cinnamon, and bay leaf. It is slightly soluble in water and soluble in organic solvents. It has a pleasant, spicy, clove-like odor.; Eugenol is used in perfumeries, flavorings, essential oils and in medicine as a local antiseptic and anaesthetic. It was used in the production of isoeugenol for the manufacture of vanillin, though most vanillin is now produced from petrochemicals or from by-products of paper manufacture (Wikipedia).; Eugenol is used in perfumeries, flavorings, essential oils and in medicine as a local antiseptic and anesthetic. It is a key ingredient in Indonesian kretek (clove) cigarettes. It was used in the production of isoeugenol for the manufacture of vanillin, though most vanillin is now produced from phenol or from lignin.; It is one of many compounds that is attractive to males of various species of orchid bees, who apparently gather the chemical to synthesize pheromones; it is commonly used as bait to attract and collect these bees for study.",97-53-0,Fp -9å¡,NA,NA,2.46 mg/mL at 25 oC,2.27,NA,NA,NA,C10453,3314,NA,470,EOL,NA,NA,NA,Eugenol,NA,NA,NA,NA,NA,NA,NA,HMDB05809.pdf,application/pdf,48735,2015-02-28 18:00:07 UTC,NA,NA,2010-04-08 22:10:02 UTC,2015-07-20 22:47:44 UTC,646,HDW90-Y:HDW90-Y,HMDB05809,EUGENOL,NA,NA,1326,C00000619,Bp15 128-130å¡,DFC,NA,NA,d204<vs=1> 1.07,DFC,NA,NA,C 73.15%; H 7.37%; O 19.49%,DFC,NA,NA,n20D<vs=1>  1.5400,DFC,NA,NA,pKa1 10.19 (25å¡),DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)",SANGSTER (1993),NA,NA,DFC,2.66,2.61,-2.06,COC1=CC(CC=C)=CC=C1O,NA,C10H12O2,164.2011,"InChI=1S/C10H12O2/c1-3-4-8-5-6-9(11)10(7-8)12-2/h3,5-7,11H,1,4H2,2H3",164.0837296,InChIKey=RRAFCDWBNXTKKO-UHFFFAOYSA-N,1.44e+00 g/l,33208,2-methoxy-4-(prop-2-en-1-yl)phenol,DFC,NA,NA,"2-Methoxy-4-(2-propenyl)phenol, 9CI",DFC,97-53-0,rw1004991,3314,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenols and derivatives,Methoxyphenols,Aromatic homomonocyclic compounds,CHEMBL42710,13876103,CPD-6481,NA,NA,DB09086,NA,Eugenol,97-53-0,3T8H1794QW,NA,RRAFCDWBNXTKKO-UHFFFAOYSA-N
RWCCWEUUXYIKHB-UHFFFAOYSA-N,13102,HMDB0032049,182.073164942,diphenylmethanone,Benzophenone,C13H10O,119-61-9,C06354,FDB008753,DB01878,NA,NA,3102,2991,O=C(C1=CC=CC=C1)C1=CC=CC=C1,NA,Organic compounds,Benzophenones,Benzenoids,Benzene and substituted derivatives,Benzophenones,Aromatic homomonocyclic compounds,3.18,3000,T3D3976,Exogenous,3.18,"2B, possibly carcinogenic to humans. (L135)",NA,SmallMolecule,182.073164942,diphenylmethanone,Benzophenone,C13H10O,119-61-9,HMDB32049,DB01878,C06354,NA,3102,2991,O=C(C1=CC=CC=C1)C1=CC=CC=C1,Organic compounds,Benzophenones,Benzenoids,Benzene and substituted derivatives,Benzophenones,Aromatic homomonocyclic compounds,8754,21738,SmallMoleculeCompound,FDB008753,Benzophenone,TRUE,NA,low,"Present in grapes. Flavouring agentBenzophenone is a common photosensitizer in photochemistry. It crosses from the S1 state into the triplet state with nearly 100% yield. The resulting diradical will abstract a hydrogen atom from a suitable hydrogen donor to form a ketyl radical.; Benzophenone is the organic compound with the formula (C6H5)2CO, generally abbreviated Ph2CO. Benzophenone is a widely used building block in organic chemistry, being the parent diarylketone.",119-61-9,Mp 26å¡ (labile form),NA,NA,0.137 mg/mL at 25 oC,3.18,NA,NA,NA,C06354,3102,NA,3034,BZQ,NA,NA,NA,Benzophenone,NA,NA,NA,NA,NA,NA,NA,HMDB32049.pdf,application/pdf,48529,2015-02-28 17:46:43 UTC,NA,NA,2010-04-08 22:08:14 UTC,2015-07-20 22:25:48 UTC,NA,DVQ30-G:DVQ30-G,HMDB32049,NA,DB01878,NA,306,NA,Bp10 157.6å¡,DFC,NA,NA,d184<vs=1> 1.11,DFC,NA,NA,C 85.69%; H 5.53%; O 8.78%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,3.03,3.432598853,-3.66,O=C(C1=CC=CC=C1)C1=CC=CC=C1,NA,C13H10O,182.2179,InChI=1S/C13H10O/c14-13(11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,182.0731649,InChIKey=RWCCWEUUXYIKHB-UHFFFAOYSA-N,4.01e-02 g/l,35258,diphenylmethanone,HMDB_from_dfc,NA,NA,"Benzophenone, 8CI",DFC,NA,rw1016331,3102,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Benzophenones,Benzophenones,Aromatic homomonocyclic compounds,NA,2991,NA,NA,NA,DB01878,EXPT00794,Benzophenone,119-61-9,701M4TTV9O,Benzoylbenzene | Diphenyl ketone | Diphenylmethanone | Phenyl ketone,RWCCWEUUXYIKHB-UHFFFAOYSA-N
RWSXRVCMGQZWBV-WDSKDSINSA-N,80,HMDB0000125,307.083805981,(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}butanoic acid,Glutathione,C10H17N3O6S,70-18-8,C00051,FDB001498,DB00143,DBMET00487,GLUTATHIONE,124886,111188,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O,44,Organic compounds,Peptides,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,NA,3198,T3D4352,Endogenous,-6.4,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,307.083805981,(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}butanoic acid,Glutathione,C10H17N3O6S,70-18-8,HMDB00125,DB00143,C00051,OXIDIZED-GLUTATHIONE,124886,111188,[H][C@](N)(CCC(O)=N[C@@]([H])(CS)C(O)=NCC(O)=O)C(O)=O,Chemical entities,Peptides,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Aliphatic acyclic compounds,1498,4626,SmallMoleculeCompound,FDB001498,Glutathione,TRUE,Solid,low,"Glutathione (GSH) - reduced glutathione - is a tripeptide with a gamma peptide linkage between the amine group of cysteine (which is attached by normal peptide linkage to a glycine) and the carboxyl group of the glutamate side-chain. It is an antioxidant, preventing damage to important cellular components caused by reactive oxygen species such as free radicals and peroxides. [Wikipedia]",70-18-8,195 oC,NA,NA,NA,NA,NA,NA,NA,C02471,124886,NA,16856,GSH,NA,NA,NA,Glutathione,NA,NA,NA,NA,NA,NA,NA,HMDB00125.pdf,application/pdf,47776,2015-02-28 17:51:17 UTC,NA,2,2010-04-08 22:04:59 UTC,2015-10-09 22:28:08 UTC,NA,NA,HMDB00125,GLUTATHIONE,DB00143,33669,NA,C00001518,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-2.74,-4.884693973,-2.54,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O,3.737314,C10H17N3O6S,307.323,"InChI=1S/C10H17N3O6S/c11-5(10(18)19)1-2-7(14)13-6(4-20)9(17)12-3-8(15)16/h5-6,20H,1-4,11H2,(H,12,17)(H,13,14)(H,15,16)(H,18,19)/t5-,6-/m0/s1",307.083806,InChIKey=RWSXRVCMGQZWBV-WDSKDSINSA-N,8.79e-01 g/l,39965,(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}butanoic acid,MANUAL,NA,NA,NA,KNAPSACK,NA,NA,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Gamma-glutamyl peptides,Aliphatic acyclic compounds,CHEMBL1543,111188,OXIDIZED-GLUTATHIONE,TRUE,NA,DB00143,NUTR00029 | EXPT01650,Glutathione,70-18-8,GAN16C9B8O,5-L-Glutamyl-L-cysteinylglycine | gamma-L-Glutamyl-L-cysteinyl-glycine | Glutathione | Glutathione-SH | GSH | N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine | Reduced glutathione,RWSXRVCMGQZWBV-WDSKDSINSA-N
RWZYAGGXGHYGMB-UHFFFAOYSA-N,874,HMDB0001123,137.047678473,2-aminobenzoic acid,2-Aminobenzoic acid,C7H7NO2,118-92-3,C00108,FDB000896,NA,NA,ANTHRANILATE,227,222,NC1=CC=CC=C1C(O)=O,6018,Organic compounds,Aminobenzoic acids,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Aromatic homomonocyclic compounds,1.21,3086,T3D4165,Endogenous,1.21,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,137.047678473,2-aminobenzoic acid,2-Aminobenzoic acid,C7H7NO2,118-92-3,HMDB01123,DB04166,C00108,ANTHRANILATE,227,222,NC1=CC=CC=C1C(O)=O,Organic compounds,Aminobenzoic acids,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Aromatic homomonocyclic compounds,896,2546,SmallMoleculeCompound,FDB000896,Anthranilic acid,TRUE,Solid,low,2-Aminobenzoic acid is an organic compound. It is a substrate of enzyme anthranilate hydroxylase [EC 1.14.13.35] in benzoate degradation via hydroxylation pathway (KEGG). [HMDB],118-92-3,NA,NA,NA,NA,NA,NA,NA,NA,C00108,227,NA,NA,BE2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HMDB01123.pdf,application/pdf,4525671,2015-02-28 18:02:39 UTC,NA,2,2010-04-08 22:04:45 UTC,2015-10-09 22:33:13 UTC,NA,BLS86-X:BLS86-X,HMDB01123,ANTHRANILIC-ACID,DB04166,33883,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 61.31%; H 5.14%; N 10.21%; O 23.33%,DFC,NA,NA,NA,NA,335 (e 4700) (MeOH) (Berdy),DFC,NA,NA,NA,NA,NA,NA,NA,0.78,1.45,-1.3,NC1=C(C=CC=C1)C(O)=O,19.44,C7H7NO2,137.136,"InChI=1S/C7H7NO2/c8-6-4-2-1-3-5(6)7(9)10/h1-4H,8H2,(H,9,10)",137.0476785,InChIKey=RWZYAGGXGHYGMB-UHFFFAOYSA-N,6.81e+00 g/l,31588,2-aminobenzoic acid,DFC,NA,NA,"2-Aminobenzoic acid, 9CI",DFC,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Aminobenzoic acids,Aromatic homomonocyclic compounds,CHEMBL14173,222,ANTHRANILATE,TRUE,NA,DB04166,EXPT00283 | EXPT00656 | DB04056,Anthranilic acid,118-92-3,0YS975XI6W,2-AminobenzoesÃ¤ure | 2-aminobenzoic acid | 2-carboxyaniline | o-AminobenzoesÃ¤ure | o-Aminobenzoic acid | o-carboxyaniline | Vitamin L1,RWZYAGGXGHYGMB-UHFFFAOYSA-N
RYYVLZVUVIJVGH-UHFFFAOYSA-N,1218,HMDB0001847,194.080375584,"1,3,7-trimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione",Caffeine,C8H10N4O2,58-08-2,C07481,FDB002100,DB00201,DBMET00535,NA,2519,2424,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,1455,Organic compounds,Xanthines,Organoheterocyclic compounds,Imidazopyrimidines,Purines and purine derivatives,Aromatic heteropolycyclic compounds,-0.07,2196,T3D2712,Exogenous,-0.07,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,194.080375584,"1,3,7-trimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione",Caffeine,C8H10N4O2,58-08-2,HMDB01847,DB00201,C07481,1-3-7-TRIMETHYLXANTHINE,2519,2424,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,Organic compounds,Xanthines,Organoheterocyclic compounds,Imidazopyrimidines,Purines and purine derivatives,Aromatic heteropolycyclic compounds,2100,6685,SmallMoleculeCompound,FDB002100,Caffeine,TRUE,Solid,low,"Component of coffee beans (Coffea arabica), many other Coffea spp., chocolate (Theobroma cacao), tea (Camellia thea), kolanut (Cola acuminata) and several other Cola spp. and several other plants. Used in many cola-type beverages as a flavour enhancer",1958-08-02,Mp 236å¡ (phase transition at 141å¡),NA,NA,21.6 mg/mL at 25 oC,-0.07,NA,NA,NA,C07481,2519,NA,27732,CFF,NA,NA,NA,Caffeine,NA,NA,NA,NA,NA,NA,NA,HMDB01847.pdf,application/pdf,50788,2015-02-28 17:59:12 UTC,NA,2,2010-04-08 22:05:14 UTC,2015-10-09 22:30:54 UTC,NA,CFJ89-C:CFJ89-C,HMDB01847,CAFFEINE,DB00201,NA,441,C00001492,NA,NA,NA,NA,NA,NA,NA,NA,C 49.48%; H 5.19%; N 28.85%; O 16.48%,DFC,NA,NA,NA,NA,NA,NA,10.4,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,-0.24,-0.55,-1.25,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,NA,C8H10N4O2,194.1906,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3",194.0803756,InChIKey=RYYVLZVUVIJVGH-UHFFFAOYSA-N,1.10e+01 g/l,38195,"1,3,7-trimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione",DFC,NA,NA,"Caffeine, BAN, USAN",DFC,NA,rw1014161,NA,NA,Organic compounds,Alkaloids and derivatives,NA,NA,Alkaloids and derivatives,Aromatic heteropolycyclic compounds,CHEMBL113,2424,1-3-7-TRIMETHYLXANTHINE,TRUE,NA,DB00201,APRD00673,Caffeine,58-08-2,3G6A5W338E,"1-methyltheobromine | 1,3,7-trimethyl-2,6-dioxopurine | 1,3,7-trimethylpurine-2,6-dione | 1,3,7-trimethylxanthine | 3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion | 7-methyltheophylline | Anhydrous caffeine | CafeÃ­na | CafÃ©ine | Caffeinum | Coffein | Coffeinum | Guaranine | Koffein | MateÃ­na | Methyltheobromine | teÃ­na | Thein | Theine",RYYVLZVUVIJVGH-UHFFFAOYSA-N
RZEKVGVHFLEQIL-UHFFFAOYSA-N,2349,HMDB0005014,381.075882012,4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide,Celecoxi,C17H14F3N3O2S,169590-42-5,C07589,FDB023586,NA,NA,NA,2662,2562,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,NA,Organic compounds,Phenylpyrazoles,Organoheterocyclic compounds,Azoles,Pyrazoles,Aromatic heteromonocyclic compounds,NA,3458,T3D4771,Exogenous,3.9,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,381.075882012,4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide,Celecoxi,C17H14F3N3O2S,169590-42-5,HMDB05014,DB00482,C07589,NA,2662,2562,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,Chemical entities,Phenylpyrazoles,Organic compounds,Organoheterocyclic compounds,Azoles,Aromatic heteromonocyclic compounds,23749,NA,SmallMoleculeCompound,FDB023586,Celecoxib,TRUE,Solid,low,"Celecoxib (INN) is a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis, rheumatoid arthritis, acute pain, painful menstruation and menstrual symptoms, and to reduce numbers of colon and rectum polyps in patients with familial adenomatous polyposis. It is marketed by Pfizer under the brand name Celebrex. In some countries, it is branded Celebra.; Celecoxib is a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis, rheumatoid arthritis, acute pain, painful menstruation and menstrual symptoms, and to reduce numbers of colon and rectum polyps in patients with familial adenomatous polyposis.Celecoxib is a highly selective COX-2 inhibitor and primarily inhibits this isoform of cyclooxygenase, whereas traditional NSAIDs inhibit both COX-1 and COX-2. Celecoxib is approximately 10-20 times more selective for COX-2 inhibition over COX-1. In theory, this specificity allows celecoxib and other COX-2 inhibitors to reduce inflammation (and pain) while minimizing gastrointestinal adverse drug reactions (e.g. stomach ulcers) that are common with non-selective NSAIDs. It also means that it has a reduced effect on platelet aggregation compared to traditional NSAIDs; Celecoxib is a highly selective COX-2 inhibitor and primarily inhibits this isoform of cyclooxygenase, whereas traditional NSAIDs inhibit both COX-1 and COX-2. Celecoxib is approximately 10-20 times more selective for COX-2 inhibition over COX-1. In theory, this specificity allows celecoxib and other COX-2 inhibitors to reduce inflammation (and pain) while minimizing gastrointestinal adverse drug reactions (e.g. stomach ulcers) that are common with non-selective NSAIDs. It also means that it has a reduced effect on platelet aggregation compared to traditional NSAIDs. [HMDB]",184007-95-2,NA,NA,NA,NA,NA,NA,NA,NA,C07589,2662,NA,3520,CEL,NA,NA,NA,Celecoxib,NA,NA,NA,NA,NA,NA,NA,HMDB05014.pdf,application/pdf,57619,2015-02-28 17:47:05 UTC,NA,NA,2011-09-21 00:32:00 UTC,2015-07-21 06:57:46 UTC,NA,NA,HMDB05014,NA,DB00482,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3.99,4.009441774,-4.88,[H]N([H])S(=O)(=O)C1=C([H])C([H])=C(C([H])=C1[H])N1N=C(C([H])=C1C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])[H])C(F)(F)F,NA,C17H14F3N3O2S,381.372,"InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)",381.075882,InChIKey=RZEKVGVHFLEQIL-UHFFFAOYSA-N,5.03e-03 g/l,86167,4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Azoles,Pyrazoles,Phenylpyrazoles,Aromatic heteromonocyclic compounds,CHEMBL118,2562,NA,NA,NA,DB00482,APRD00373,Celecoxib,169590-42-5,JCX84Q7J1L,Celecoxib | CÃ©lÃ©coxib | Celecoxibum | P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide,RZEKVGVHFLEQIL-UHFFFAOYSA-N
RZVAJINKPMORJF-UHFFFAOYSA-N,1229,HMDB0001859,151.063328537,N-(4-hydroxyphenyl)acetamide,Acetaminophen,C8H9NO2,103-90-2,NA,FDB022713,DB00316,DBMET00266,NA,1983,1906,CC(=O)NC1=CC=C(O)C=C1,6353,Organic compounds,1-hydroxy-2-unsubstituted benzenoids,Benzenoids,Phenols,1-hydroxy-2-unsubstituted benzenoids,Aromatic homomonocyclic compounds,0.46,2095,T3D2571,Exogenous,0.46,"3, not classifiable as to its carcinogenicity to humans. (L135)",25 g for an adult human. (A308),SmallMolecule,151.063328537,N-(4-hydroxyphenyl)acetamide,Acetaminophen,C8H9NO2,103-90-2,HMDB01859,DB00316,C06804,CPD-7669,1983,1906,CC(O)=NC1=CC=C(O)C=C1,Organic compounds,1-hydroxy-2-unsubstituted benzenoids,Benzenoids,Phenols,1-hydroxy-2-unsubstituted benzenoids,Aromatic homomonocyclic compounds,21807,35351,SmallMoleculeCompound,FDB021663,Ukonan D,TRUE,NA,low,NA,141490-48-4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2011-03-17 23:26:01 UTC,2015-07-21 06:54:48 UTC,NA,HSF47-K:HSH57-X,NA,UKONAN-D,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"[a]23D +81.7 (c, 0.1 in H2O)",DFC,NA,NA,Powder,DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CC(=O)NC1=CC=C(O)C=C1,NA,C8H9NO2,151.1626,"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)",151.0633285,RZVAJINKPMORJF-UHFFFAOYSA-N,NA,NA,NA,NA,NA,NA,Ukonans; Ukonan D,DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB00316,APRD00252,Acetaminophen,103-90-2,362O9ITL9D,4-(Acetylamino)phenol | 4-acetamidophenol | 4'-hydroxyacetanilide | Acenol | acetaminofÃ©n | Acetaminophen | acÃ©taminophÃ¨ne | APAP | N-acetyl-p-aminophenol | p-acetamidophenol | p-acetaminophenol | p-Acetylaminophenol | p-hydroxy-acetanilid | p-hydroxyacetanilide | p-hydroxyphenolacetamide | ParacÃ©tamol | Paracetamol | Paracetamolum,RZVAJINKPMORJF-UHFFFAOYSA-N
SEOVTRFCIGRIMH-UHFFFAOYSA-N,128,HMDB0000197,175.063328537,2-(1H-indol-3-yl)acetic acid,Indoleacetic acid,C10H9NO2,87-51-4,C00954,FDB000933,NA,DBMET00497,NA,802,780,OC(=O)CC1=CNC2=C1C=CC=C2,5211,Organic compounds,Indole-3-acetic acid derivatives,Organoheterocyclic compounds,Indoles and derivatives,Indolyl carboxylic acids and derivatives,Aromatic heteropolycyclic compounds,1.41,3074,T3D4152,Endogenous,1.41,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,175.063328537,2-(1H-indol-3-yl)acetic acid,Indoleacetic acid,C10H9NO2,87-51-4,HMDB00197,DB07950,C00954,NA,802,780,OC(=O)CC1=CNC2=CC=CC=C12,Organic compounds,Indole-3-acetic acid derivatives,Organoheterocyclic compounds,Indoles and derivatives,Indolyl carboxylic acids and derivatives,Aromatic heteropolycyclic compounds,933,2645,SmallMoleculeCompound,FDB000933,1H-Indole-3-acetic acid,TRUE,Solid,low,"Widely distributed in higher plantsIndole-3-acetic acid, also known as IAA, is a heterocyclic compound that is a phytohormone called auxin. This colourless solid is probably the most important plant auxin. The molecule is derived from indole, containing a carboxymethyl group (acetic acid). (Wikipedia)",87-51-4,Mp 164-165å¡,NA,NA,1.5 mg/mL at 20 oC,1.41,NA,NA,NA,C00954,802,NA,16411,IAC,NA,NA,NA,Indole-3-acetic_acid,NA,NA,NA,NA,NA,NA,NA,HMDB00197.pdf,application/pdf,3074308,2015-02-28 18:08:22 UTC,NA,2,2010-04-08 22:04:46 UTC,2015-10-09 22:27:15 UTC,NA,BNC14-M:BNC14-M,HMDB00197,INDOLE-ACETIC-ACID|BETA-INDOLACETIC-ACID|INDOLE-3-ACETIC-ACID,DB07950,1485312,NA,C00000100,NA,NA,NA,NA,NA,NA,NA,NA,C 68.56%; H 5.18%; N 8.00%; O 18.27%,DFC,NA,NA,NA,NA,289 (e 8700) (MeOH) (Berdy),DFC,pKa2 16.9 (NH),DFC,"SHIU,WY et al. (1990)","HANSCH,C ET AL. (1995)",NA,NA,DFC,1.87,1.71,-2.1,OC(=O)CC1=CNC2=C1C=CC=C2,16.19,C10H9NO2,175.184,"InChI=1S/C10H9NO2/c12-10(13)5-7-6-11-9-4-2-1-3-8(7)9/h1-4,6,11H,5H2,(H,12,13)",175.0633285,InChIKey=SEOVTRFCIGRIMH-UHFFFAOYSA-N,1.38e+00 g/l,34062,2-(1H-indol-3-yl)acetic acid,DFC,NA,NA,"1H-Indole-3-acetic acid, 9CI",DFC,NA,rw1251501,NA,NA,Organic compounds,Organoheterocyclic compounds,Indoles and derivatives,Indolyl carboxylic acids and derivatives,Indole-3-acetic acid derivatives,Aromatic heteropolycyclic compounds,CHEMBL82411,780,NA,TRUE,NA,DB07950,NA,1H-INDOL-3-YLACETIC ACID,NA,6U1S09C61L,NA,SEOVTRFCIGRIMH-UHFFFAOYSA-N
SHGAZHPCJJPHSC-YCNIQYBTSA-N,1223,HMDB0001852,300.208930142,"(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid",all-trans-Retinoic acid,C20H28O2,302-79-4,C00777,FDB022710,NA,NA,NA,444795,392618,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,2277,Organic compounds,Retinoids,Lipids and lipid-like molecules,Prenol lipids,Retinoids,Aliphatic homomonocyclic compounds,6.3,2319,T3D2884,Endogenous,6.3,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,300.20893014,"3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid",9-cis-Retinoic acid,C20H28O2,302-79-4,HMDB02369,DB00755,C00777,RETINOATE,444795,5337,[H]/C(=C(/[H])\C(\C)=C(/[H])C(O)=O)/C(/[H])=C(\C)/C(/[H])=C(\[H])C1=C(C)CCCC1(C)C,Chemical entities,Retinoids,Organic compounds,Lipids and lipid-like molecules,Prenol lipids,Aliphatic homomonocyclic compounds,22873,NA,SmallMoleculeCompound,FDB022710,Retinoic acid,TRUE,Solid,low,"Retinoic acid is the oxidized form of Vitamin A. It functions in determining position along embryonic anterior/posterior axis in chordates. It acts through Hox genes, which ultimately controls anterior/posterior patterning in early developmental stages (PMID: 17495912). It is an important regulator of gene expression during growth and development, and in neoplasms. Tretinoin, also known as retinoic acid and derived from maternal vitamin A, is essential for normal growth and embryonic development. An excess of tretinoin can be teratogenic. It is used in the treatment of psoriasis; acne vulgaris; and several other skin diseases. It has also been approved for use in promyelocytic leukemia (leukemia, promyelocytic, acute). [HMDB]",302-79-4,NA,NA,NA,NA,NA,NA,NA,NA,C00777,444795,NA,NA,REA,NA,NA,NA,Retinoic acid,NA,NA,NA,NA,NA,NA,NA,HMDB01852.pdf,application/pdf,207034,2015-02-28 17:47:10 UTC,NA,NA,2011-09-21 00:18:18 UTC,2015-10-09 22:30:58 UTC,NA,NA,HMDB01852,NA,DB00755,35948,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5.66,5.014367711,-4.8,[H]OC(=O)C(\[H])=C(\C(\[H])=C(/[H])C([H])=C(C([H])=C([H])C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])/C([H])([H])[H],NA,C20H28O2,300.4351,"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+",300.2089301,InChIKey=SHGAZHPCJJPHSC-YCNIQYBTSA-N,4.77e-03 g/l,87573,"(2E,4E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Lipids and lipid-like molecules,Prenol lipids,Retinoids,Retinoids,Aliphatic homomonocyclic compounds,CHEMBL38,392618,RETINOATE,TRUE,NA,DB00755,NUTR00051 | APRD00362,Tretinoin,302-79-4,5688UTC01R,"(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid | 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl) | Acide retinoique (french) (dsl) | AGN 100335 | All Trans Retinoic Acid | All Trans-Retinoic Acid | all-(e)-Retinoic acid | all-trans-beta-Retinoic acid | all-trans-Retinoic acid | all-trans-Tretinoin | all-trans-Vitamin a acid | all-trans-Vitamin a1 acid | ATRA | beta-Retinoic acid | Eudyna | RETINOIC acid | Retionic Acid | Ro 1-5488 | Stieva-a | trans-Retinoic acid | Tretin m | Tretinoin | Tretinoina | TrÃ©tinoÃ¯ne | Tretinoine (french) (einecs) | Tretinoinum | Vitamin A acid",SHGAZHPCJJPHSC-YCNIQYBTSA-N
SUYVUBYJARFZHO-RRKCRQDMSA-N,1173,HMDB0001532,491.000830537,"({[({[(2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid",Deoxyadenosine triphosphate,C10H16N5O12P3,1927-31-7,C00131,FDB022674,NA,NA,DATP,15993,15194,NC1=NC=NC2=C1N=CN2[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1,6303,Organic compounds,Purine 2'-deoxyribonucleoside triphosphates,"Nucleosides, nucleotides, and analogues",Purine nucleotides,Purine deoxyribonucleotides,Aromatic heteropolycyclic compounds,NA,3161,T3D4278,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,491.000830537,"({[({[(2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid",Deoxyadenosine triphosphate,C10H16N5O12P3,1927-31-7,HMDB01532,DB03222,C00131,DATP,15993,15194,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=NC2=C(N)N=CN=C12,Chemical entities,Purine 2'-deoxyribonucleoside triphosphates,Organic compounds,"Nucleosides, nucleotides, and analogues",Purine nucleotides,Aromatic heteropolycyclic compounds,22837,NA,SmallMoleculeCompound,FDB022674,dATP,TRUE,Solid,low,"Animals obtain their energy by oxidation of foods, plants do so by trapping the sunlight using chlorophyll. However, before the energy can be used, it is first transformed into a form which the organism can handle easily. This special carrier of energy is the molecule adenosine triphosphate, or ATP. The ATP molecule is composed of three components. At the centre is a sugar molecule, [[ribose] (the same sugar that forms the basis of DNA). Attached to one side of this is a base (a group consisting of linked rings of carbon and nitrogen atoms); in this case the base is adenine. The other side of the sugar is attached to a string of phosphate groups. These phosphates are the key to the activity of ATP. ATP consists of a base, in this case adenine (red), a ribose (magenta) and a phosphate chain (blue). ATP works by losing the endmost phosphate group when instructed to do so by an enzyme. This reaction releases a lot of energy, which the organism can then use to build proteins, contact muscles, etc. [HMDB]",1927-31-7,NA,NA,NA,NA,NA,NA,NA,NA,C00131,15993,NA,16284,DTP,NA,NA,NA,Deoxyadenosine triphosphate,NA,NA,NA,NA,NA,NA,NA,HMDB01532.pdf,application/pdf,51000,2015-02-28 17:53:52 UTC,NA,NA,2011-09-21 00:17:46 UTC,2015-10-09 22:29:42 UTC,NA,NA,HMDB01532,NA,NA,33969,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.66,-5.319978351,-2.11,[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O[C@]1([H])C([H])([H])OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O[H])N1C([H])=NC2=C1N=C([H])N=C2N([H])[H],2.321781665,C10H16N5O12P3,491.1816,"InChI=1S/C10H16N5O12P3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(25-7)2-24-29(20,21)27-30(22,23)26-28(17,18)19/h3-7,16H,1-2H2,(H,20,21)(H,22,23)(H2,11,12,13)(H2,17,18,19)/t5-,6+,7+/m0/s1",491.0008305,InChIKey=SUYVUBYJARFZHO-RRKCRQDMSA-N,3.83e+00 g/l,83928,"({[({[(2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,"Nucleosides, nucleotides, and analogues",Purine nucleotides,Purine deoxyribonucleotides,Purine 2'-deoxyribonucleoside triphosphates,Aromatic heteropolycyclic compounds,CHEMBL335538,15194,DATP,TRUE,NA,DB03222,EXPT01288,dATP,1927-31-7,K8KCC8SH6N,2'-Deoxyadenosine 5'-triphosphate | Deoxyadenosine 5'-triphosphate | Deoxyadenosine triphosphate,SUYVUBYJARFZHO-RRKCRQDMSA-N
SXRSQZLOMIGNAQ-UHFFFAOYSA-N,10734,HMDB0029599,100.0524295,pentanedial,Glutaral,C5H8O2,111-30-8,C12518,FDB000763,DB03266,NA,NA,3485,3365,O=CCCCC=O,NA,Organic compounds,Alpha-hydrogen aldehydes,Organic oxygen compounds,Organooxygen compounds,Carbonyl compounds,Aliphatic acyclic compounds,NA,3528,T3D4844,Exogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,100.0524295,pentanedial,Glutaral,C5H8O2,111-30-8,HMDB29599,DB03266,C12518,NA,3485,3365,O=CCCCC=O,Organic compounds,Alpha-hydrogen aldehydes,Organic oxygen compounds,Organooxygen compounds,Carbonyl compounds,Aliphatic acyclic compounds,763,2075,SmallMoleculeCompound,FDB000763,Glutaral,TRUE,Liquid,low,"Used as an antimicrobial agent in sugar mills and as a fixing agent in the immobilisation of glucose isomerase enzyme preparations for use in the manuf. of high fructose corn syrupA polymerized isomer of glutaraldehyde known as polycycloglutaracetal is a fertilizer for aquatic plants. It is claimed that it provides a bioavailable source of carbon for higher plants that is not available to algae. Though not marketed as such due to federal regulations, the biocidal effect of glutaraldehyde kills most algae at concentrations of 0.5 - 5.0 ppm. These levels are not harmful to most aquatic fauna and flora. Adverse reactions have been observed by some aquarists at these concentrations in some aquatic mosses, liverworts, and vascular plants.; Glutaraldehyde is a colorless liquid with a pungent odor used to disinfect medical and dental equipment. It is also used for industrial water treatment and as a chemical preservative.; Glutaraldehyde is an oily liquid at room temperature (density 1.06 g/mL), and miscible with water, alcohol, and benzene. It is used as a tissue fixative in electron microscopy. It is employed as an embalming fluid, is a component of leather tanning solutions, and occurs as an intermediate in the production of certain industrial chemicals. Glutaraldehyde is frequently used in biochemistry applications as an amine-reactive homobifunctional crosslinker. The oligomeric state of proteins can be examined through this application.; However, it is toxic, causing severe eye, nose, throat and lung irritation, along with headaches, drowsiness and dizziness. It is a main source of occupational asthma among health care providers.",111-30-8,Mp -14å¡,NA,NA,NA,NA,NA,NA,NA,C12518,3485,NA,NA,PTD,NA,NA,NA,Pentanedial,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:04:42 UTC,2015-07-20 21:34:12 UTC,NA,BGW32-P:BGW32-P,HMDB29599,NA,DB03266,NA,1510,NA,Bp10 71-72å¡,DFC,NA,NA,NA,NA,NA,NA,C 59.98%; H 8.05%; O 31.96%,DFC,NA,NA,n20D<vs=1>  1.4200,DFC,NA,NA,NA,NA,NA,NA,NA,NA,DFC,0.93,-0.271146807,-0.19,O=CCCCC=O,16.16858885,C5H8O2,100.1158,"InChI=1S/C5H8O2/c6-4-2-1-3-5-7/h4-5H,1-3H2",100.0524295,InChIKey=SXRSQZLOMIGNAQ-UHFFFAOYSA-N,6.40e+01 g/l,37343,pentanedial,HMDB_from_dfc,NA,NA,"Pentanedial, 9CI",DFC,NA,rw1097231,NA,NA,Organic compounds,Organooxygen compounds,Carbonyl compounds,Aldehydes,Alpha-hydrogen aldehydes,Aliphatic acyclic compounds,CHEMBL1235482,3365,CPD-9052,NA,NA,DB03266,EXPT02681,Glutaral,111-30-8,T3C89M417N,Pentanedial,SXRSQZLOMIGNAQ-UHFFFAOYSA-N
SZHOJFHSIKHZHA-UHFFFAOYSA-N,727,HMDB0000910,214.193280076,tridecanoic acid,Tridecanoic acid,C13H26O2,638-53-9,C17076,FDB010409,DB02448,NA,NA,12530,12013,CCCCCCCCCCCCC(O)=O,5866,Organic compounds,Long-chain fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,NA,3351,T3D4604,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,214.193280076,tridecanoic acid,Tridecanoic acid,C13H26O2,638-53-9,HMDB00910,DB02448,C17076,NA,12530,12013,CCCCCCCCCCCCC(O)=O,Chemical entities,Long-chain fatty acids,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Aliphatic acyclic compounds,10411,25660,SmallMoleculeCompound,FDB010409,Tridecanoic acid,TRUE,Solid,low,Tridecanoic acid is a short-chain fatty acid.,638-53-9,44.5 oC,NA,NA,0.033 mg/mL at 20 oC,NA,NA,NA,NA,C17076,12530,NA,45919,TDA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HMDB00910.pdf,application/pdf,47034,2015-02-28 18:02:35 UTC,NA,2,2010-04-08 22:09:07 UTC,2015-10-09 22:27:56 UTC,NA,NA,HMDB00910,TRIDECANOIC-ACID,DB02448,NA,3725,C00007422,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)",NA,NA,NA,NA,5.57,4.9229,-4.74,CCCCCCCCCCCCC(O)=O,NA,C13H26O2,214.3443,"InChI=1S/C13H26O2/c1-2-3-4-5-6-7-8-9-10-11-12-13(14)15/h2-12H2,1H3,(H,14,15)",214.1933,InChIKey=SZHOJFHSIKHZHA-UHFFFAOYSA-N,3.91e-03 g/l,41474,tridecanoic acid,MANUAL,NA,NA,NA,EAFUS,NA,rw1292351,NA,NA,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Long-chain fatty acids,Aliphatic acyclic compounds,CHEMBL107874,12013,NA,TRUE,NA,DB02448,EXPT03028,N-Tridecanoic Acid,638-53-9,19936LIY2V,NA,SZHOJFHSIKHZHA-UHFFFAOYSA-N
TUNFSRHWOTWDNC-UHFFFAOYSA-N,641,HMDB0000806,228.20893014,tetradecanoic acid,Myristic acid,C14H28O2,544-63-8,C06424,FDB002890,NA,NA,NA,11005,10539,CCCCCCCCCCCCCC(O)=O,196,Organic compounds,Long-chain fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,6.11,3350,T3D4599,Endogenous,6.11,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,228.20893014,tetradecanoic acid,Myristic acid,C14H28O2,544-63-8,HMDB00806,NA,C06424,NA,11005,10539,CCCCCCCCCCCCCC(O)=O,Chemical entities,Long-chain fatty acids,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Aliphatic acyclic compounds,2890,8839,SmallMoleculeCompound,FDB002890,Tetradecanoic acid,TRUE,Solid,low,"Occurs widely in vegetable glycerides. Major component of the lipids of nutmeg (Myristica moschata). Defoaming agent, lubricant used in food processingMyristic acid, also called tetradecanoic acid, is a common saturated fatty acid with the molecular formula CH3(CH2)12COOH. Besides nutmeg, myristic acid is also found in palm kernel oil, coconut oil, butter fat and is a minor component of many other animal fats. (Wikipedia)",544-63-8,Mp 54å¡,NA,NA,0.00107 mg/mL at 25 oC,6.11,NA,NA,NA,C06424,11005,NA,28875,MYR,NA,NA,NA,Myristic acid,NA,NA,NA,NA,NA,NA,NA,HMDB00806.pdf,application/pdf,48031,2015-02-28 17:45:08 UTC,NA,2,2010-04-08 22:05:34 UTC,2015-10-09 22:28:53 UTC,NA,CPB50-O:CPB50-O,HMDB00806,N-TETRADECANOIC-ACID|MYRISTIC-ACID|TETRADECANOIC-ACID,DB08231,215851,2626,C00001228,Bp16 199å¡,DFC,NA,NA,NA,NA,NA,NA,C 73.63%; H 12.36%; O 14.01%,DFC,NA,NA,NA,NA,NA,NA,4.9,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)",SANGSTER (1993),NA,NA,DFC,6.1,5.37,-5.12,CCCCCCCCCCCCCC(O)=O,NA,C14H28O2,228.3709,"InChI=1S/C14H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h2-13H2,1H3,(H,15,16)",228.2089301,InChIKey=TUNFSRHWOTWDNC-UHFFFAOYSA-N,1.72e-03 g/l,35558,tetradecanoic acid,MANUAL,NA,NA,"Tetradecanoic acid, 9CI",DFC,NA,rw1009061,NA,NA,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Long-chain fatty acids,Aliphatic acyclic compounds,CHEMBL111077,10539,NA,TRUE,NA,DB08231,NA,Myristic acid,544-63-8,0I3V7S25AW,1-tridecanecarboxylic acid | N-tetradecan-1-oic acid | N-tetradecanoic acid | Tetradecanoic acid,TUNFSRHWOTWDNC-UHFFFAOYSA-N
TWFZGCMQGLPBSX-UHFFFAOYSA-N,12826,HMDB0031769,191.069476547,"methyl N-(1H-1,3-benzodiazol-2-yl)carbamate",Carbendazim,C9H9N3O2,10605-21-7,C10897,FDB008442,NA,NA,NA,25429,23741,COC(=O)NC1=NC2=CC=CC=C2N1,NA,Organic compounds,2-benzimidazolylcarbamic acid esters,Organoheterocyclic compounds,Benzimidazoles,2-benzimidazolylcarbamic acid esters,Aromatic heteropolycyclic compounds,1.52,770,T3D0942,Exogenous,1.52,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,191.069476547,"methyl N-(1H-1,3-benzodiazol-2-yl)carbamate",Carbendazim,C9H9N3O2,10605-21-7,HMDB31769,NA,C10897,NA,25429,23741,COC(O)=NC1=NC2=CC=CC=C2N1,Chemical entities,2-benzimidazolylcarbamic acid esters,Organic compounds,Organoheterocyclic compounds,Benzimidazoles,Aromatic heteropolycyclic compounds,8443,20868,SmallMoleculeCompound,FDB008442,Carbendazim,TRUE,NA,low,Systemic agricultural and horticultural fungicide,10605-21-7,Mp 302-307å¡ dec.,NA,NA,pH4],1.52,NA,NA,NA,C10897,25429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:08:05 UTC,2015-07-20 22:22:29 UTC,NA,DKX40-T:DKX40-T,HMDB31769,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 56.54%; H 4.74%; N 21.98%; O 16.74%,DFC,NA,NA,NA,NA,NA,NA,4.2,NA,NA,"HANSCH,C ET AL. (1995)",NA,NA,DFC,1.46,1.8,-2.37,COC(=O)NC1=NC2=C(N1)C=CC=C2,13.95,C9H9N3O2,191.1867,"InChI=1S/C9H9N3O2/c1-14-9(13)12-8-10-6-4-2-3-5-7(6)11-8/h2-5H,1H3,(H2,10,11,12,13)",191.0694765,InChIKey=TWFZGCMQGLPBSX-UHFFFAOYSA-N,8.25e-01 g/l,32618,"methyl N-(1H-1,3-benzodiazol-2-yl)carbamate",DFC,NA,NA,"Carbendazim, BSI, ISO",DFC,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Benzimidazoles,NA,Benzimidazoles,Aromatic heteropolycyclic compounds,CHEMBL70971,23741,NA,NA,NA,DB13009,NA,Carbendazim,10605-21-7,H75J14AA89,NA,TWFZGCMQGLPBSX-UHFFFAOYSA-N
TZBJGXHYKVUXJN-UHFFFAOYSA-N,1796,HMDB0003217,270.052823422,"5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one",Genistein,C15H10O5,446-72-0,C06563,FDB011828,DB01645,NA,CPD-3141,5280961,4444448,OC1=CC=C(C=C1)C1=COC2=CC(O)=CC(O)=C2C1=O,3398,Organic compounds,Isoflavones,Phenylpropanoids and polyketides,Isoflavonoids,Isoflav-2-enes,Aromatic heteropolycyclic compounds,NA,2989,T3D3963,Exogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,270.05282343,"5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one",Genistein,C15H10O5,446-72-0,HMDB03217,DB01645,C06563,CPD-6641,5280961,4444448,OC1=CC=C(C=C1)C1=COC2=CC(O)=CC(O)=C2C1=O,Organic compounds,Isoflavones,Phenylpropanoids and polyketides,Isoflavonoids,Isoflav-2-enes,Aromatic heteropolycyclic compounds,11831,30117,SmallMoleculeCompound,FDB011828,Genistein,TRUE,Solid,low,"Genistein is a phenolic compound belonging to the isoflavonoid group. Isoflavonoids are found mainly in soybean. Genistein and daidzein (an other isoflavonoid) represent the major phytochemicals found in this plant. Health benefits (e.g. reduced risk for certain cancers and diseases of old age) associated to soya products consumption have been observed in East Asian populations and several epidemiological studies. This association has been linked to the action of isoflavonoids. With a chemical structure similar to the hormone 17-b-estradiol, soy isoflavones are able to interact with the estrogen receptor. They also possess numerous biological activities. (PMID: 15540649)",446-72-0,Mp 301-302å¡ dec.,NA,NA,NA,NA,NA,NA,"After deglycosylation and absorption through the small intestine, the aglycone genistein is carried via the blood to the liver where it is converted into an inactive b-glucuronide. The proportion of aglycone found in blood decreases with time owing to further conjugation: most of the absorbed genistein is found conjugated in plasma. The active form (genistein aglycone) is released by cellular glucuronidases to exerts its biological activities. (PMID: 15540649; 17516857)",C06563,5280961,NA,28088,GEN,NA,NA,NA,Genistein,NA,"# McCue P, Shetty K: Health benefits of soy isoflavonoids and strategies for enhancement: a review. Crit Rev Food Sci Nutr. 2004;44(5):361-7. ""Pubmed"":http://www.ncbi.nlm.nih.gov/pubmed/15540649# Nielsen IL, Williamson G: Review of the factors affecting bioavailability of soy isoflavones in humans. Nutr Cancer. 2007;57(1):1-10. ""Pubmed"":http://www.ncbi.nlm.nih.gov/pubmed/17516857# Jung W, Yu O, Lau SM, O'Keefe DP, Odell J, Fader G, McGonigle B: Identification and expression of isoflavone synthase, the key enzyme for biosynthesis of isoflavones in legumes. Nat Biotechnol. 2000 Feb;18(2):208-12. ""Pubmed"":http://www.ncbi.nlm.nih.gov/pubmed/10657130# Kochs G, Grisebach H: Enzymic synthesis of isoflavones. Eur J Biochem. 1986 Mar 3;155(2):311-8. ""Pubmed"":http://www.ncbi.nlm.nih.gov/pubmed/3956488",NA,NA,NA,NA,NA,HMDB03217.pdf,application/pdf,48126,2015-02-28 18:04:18 UTC,NA,2,2010-04-08 22:09:51 UTC,2015-10-09 22:33:06 UTC,396,GZR02-N:GZR02-N,HMDB03217,GENISTEIN,DB01645,NA,NA,C00002526,NA,NA,NA,NA,NA,NA,NA,NA,C 66.67%; H 3.73%; O 29.60%,DFC,NA,NA,NA,NA,[neutral] lmax 261 (e 38500) (MeOH) (Derep),DFC,7.63,NA,NA,NA,NA,NA,DFC,3.04,3.08,-3.34,OC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O,8.79,C15H10O5,270.2369,"InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)11-7-20-13-6-10(17)5-12(18)14(13)15(11)19/h1-7,16-18H",270.0528234,InChIKey=TZBJGXHYKVUXJN-UHFFFAOYSA-N,1.23e-01 g/l,28731,"5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one",DFC,NA,NA,"4',5,7-Trihydroxyisoflavone",DFC,NA,NA,NA,396,Organic compounds,Phenylpropanoids and polyketides,Isoflavonoids,Isoflav-2-enes,Isoflavones,Aromatic heteropolycyclic compounds,CHEMBL44,4444448,CPD-6641,TRUE,NA,DB01645,EXPT01582,Genistein,446-72-0,DH2M523P0H,"4',5, 7-Trihydroxyisoflavone | 5,7,4'-Trihydroxyisoflavone | Genisteol | Genisterin",TZBJGXHYKVUXJN-UHFFFAOYSA-N
UCMIRNVEIXFBKS-UHFFFAOYSA-N,40,HMDB0000056,89.047678473,3-aminopropanoic acid,beta-Alanine,C3H7NO2,107-95-9,C00099,FDB002253,DB03107,NA,B-ALANINE,239,234,NCCC(O)=O,5119,Organic compounds,Beta amino acids and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,-3.05,3195,T3D4346,Endogenous,-3.05,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,89.047678473,3-aminopropanoic acid,Beta-Alanine,C3H7NO2,107-95-9,HMDB00056,DB03107,C00099,B-ALANINE,239,234,NCCC(O)=O,Organic compounds,Beta amino acids and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,2253,7248,SmallMoleculeCompound,FDB002253,3-Aminopropanoic acid,TRUE,Solid,low,"Widely distributed in plants including algae, fungi and many higher plants. Flavouring ingredientBeta-alanine is the only naturally occurring beta-amino acid - the amino group is at the &#946;-position from the carboxylate group.  It is formed in vivo by the degradation of dihydrouracil and carnosine.  It is a component of the naturally occurring peptides carnosine and anserine and also of pantothenic acid (Vitamin B-5) which itself is a component of coenzyme A. Under normal conditions, beta-alanine is metabolized into acetic acid. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing gamma-aminobutyric acid. A rare genetic disorder, hyper-beta-alaninemia, has been reported.; Even though much weaker than glycine (and thus with a debated role as a physiological transmitter), ?-alanine is an agonist next in activity to the cognate ligant glycine itself, for strychnine-sensitive inhibitory glycine receptors (GlyRs) (the agonist order: glycine &gt;&gt; ?-alanine &gt; taurine &gt;&gt; alanine, L-serine &gt; proline).; L-Histidine, with a pKa of 6.1 is a relatively weak buffer over the physiological intramuscular pH range. However, when bound to other amino acids this increases nearer to 6.8-7.0. In particular, when bound to ?-alanine the pKa value is 6.83, making this a very efficient intramuscular buffer. Furthermore, because of the position of the beta amino group, ?-alanine dipeptides are not incorporated proteins and thus can be stored at relatively high concentrations (millimolar). Occurring at 17-25 mmol/kg (dry muscle), carnosine (?-alanyl-L-histidine) is an important intramuscular buffer, constituting 10-20% of the total buffering capacity in type I and II muscle fibres.; ?-Alanine (or beta-alanine) is a naturally occurring beta amino acid, which are amino acids in which the amino group is at the ?-position from the carboxylate group (i.e., two atoms away, see Figure 1). The IUPAC name for ?-alanine would be 3-aminopropanoic acid. Unlike its normal counterpart, L-?-alanine, ?-alanine has no chiral center.; ?-Alanine is not used in the biosynthesis of any major proteins or enzymes. It is formed in vivo by the degradation of dihydrouracil and carnosine. It is a component of the naturally occurring peptides carnosine and anserine and also of pantothenic acid (vitamin B5) which itself is a component of coenzyme A. Under normal conditions, ?-alanine is metabolized into acetic acid.",107-95-9,Mp 200å¡ (197-198å¡),NA,NA,545 mg/mL at 25 oC,-3.05,NA,NA,NA,C00099,239,NA,16958,BAL,NA,NA,NA,beta-Alanine,NA,NA,NA,NA,NA,NA,NA,HMDB00056.pdf,application/pdf,48333,2015-02-28 18:02:26 UTC,NA,NA,2010-04-08 22:05:18 UTC,2015-10-09 22:29:30 UTC,NA,CHQ52-J:CHQ52-J,HMDB00056,BETA-ALANINE,DB03107,33848,68,C00001333,NA,NA,NA,NA,NA,NA,NA,NA,C 40.44%; H 7.92%; N 15.72%; O 35.92%,DFC,NA,NA,NA,NA,NA,NA,pKa2 10.1 (30å¡),DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","TSAI,RS ET AL. (1991)",NA,NA,DFC,-3.26,-3.3,0.74,NCCC(O)=O,NA,C3H7NO2,89.0932,"InChI=1S/C3H7NO2/c4-2-1-3(5)6/h1-2,4H2,(H,5,6)",89.04767847,InChIKey=UCMIRNVEIXFBKS-UHFFFAOYSA-N,4.94e+02 g/l,35408,3-aminopropanoic acid,DFC,NA,NA,3-Aminopropanoic acid,DFC,NA,rw1002211,239,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Beta amino acids and derivatives,Aliphatic acyclic compounds,CHEMBL297569,234,B-ALANINE,TRUE,NA,DB03107,EXPT00624,Beta-Alanine,107-95-9,11P2JDE17B,NA,UCMIRNVEIXFBKS-UHFFFAOYSA-N
UEEJHVSXFDXPFK-UHFFFAOYSA-N,13257,HMDB0032231,89.084063979,2-(dimethylamino)ethan-1-ol,Dimethylethanolamine,C4H11NO,108-01-0,C04308,FDB009311,NA,NA,NA,7902,13854944,CN(C)CCO,NA,Organic compounds,"1,2-aminoalcohols",Organonitrogen compounds,Amines,Alkanolamines,Aliphatic acyclic compounds,NA,3525,T3D4841,Exogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,89.084063979,2-(dimethylamino)ethan-1-ol,Dimethylethanolamine,C4H11NO,108-01-0,HMDB32231,NA,C04308,NA,7902,13854944,CN(C)CCO,Organic compounds,"1,2-aminoalcohols",Organonitrogen compounds,Amines,Alkanolamines,Aliphatic acyclic compounds,9312,23093,SmallMoleculeCompound,FDB009311,Dimethylethanolamine,TRUE,Liquid,low,Used as a food additive [EAFUS],108-01-0,-59 oC,NA,NA,1000 mg/mL,NA,NA,NA,NA,C04308,7902,NA,52332,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:08:31 UTC,2015-07-20 22:28:04 UTC,NA,NA,HMDB32231,NA,NA,NA,979,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9.31,NA,"HANN,RWJR & JENSEN,PA (1977)",NA,NA,NA,NA,-0.46,-0.499932546,1.2,CN(C)CCO,NA,C4H11NO,89.1362,"InChI=1S/C4H11NO/c1-5(2)3-4-6/h6H,3-4H2,1-2H3",89.08406398,InChIKey=UEEJHVSXFDXPFK-UHFFFAOYSA-N,1.40e+03 g/l,39634,2-(dimethylamino)ethan-1-ol,HMDB_from_biospider,NA,NA,NA,EAFUS,NA,NA,NA,NA,Organic compounds,Organonitrogen compounds,Amines,Alkanolamines,"1,2-aminoalcohols",Aliphatic acyclic compounds,CHEMBL1135,13854944,NA,NA,NA,DB13352,NA,Deanol,108-01-0,2N6K9DRA24,2-(dimethylamino)ethanol | dimethylethanolamine | dimethylethanolamine,UEEJHVSXFDXPFK-UHFFFAOYSA-N
UGFAIRIUMAVXCW-UHFFFAOYSA-N,1046,HMDB0001361,27.99491462,NA,Carbon monoxide,CO,NA,C00237,FDB022578,NA,NA,NA,281,275,[C-]#[O+],NA,Inorganic compounds,Homogeneous other non-metal compounds,Homogeneous non-metal compounds,Homogeneous other non-metal compounds,NA,NA,0.83,161,T3D0189,Endogenous,0.83,No indication of carcinogenicity to humans (not listed by IARC).,5000 ppm over 5 minutes for an adult human. (T26),SmallMolecule,27.994914622,NA,Carbon monoxide,CO,630-08-0,HMDB01361,NA,C00237,CARBON-MONOXIDE,281,275,[C-]#[O+],Chemical entities,Homogeneous other non-metal compounds,Inorganic compounds,Homogeneous non-metal compounds,Homogeneous other non-metal compounds,NA,22741,NA,SmallMoleculeCompound,FDB022578,Carbon monoxide,TRUE,Liquid,low,"Carbon monoxide, with the chemical formula CO, is a colorless, odorless, and tasteless gas. It is the product of the incomplete combustion of carbon-containing compounds, notably in internal-combustion engines. It consists of one carbon atom covalently bonded to one oxygen atom. It is a gas at room temperature.Carbon monoxide is a significantly toxic gas and is the most common type of fatal poisoning in many countries.Exposures can lead to significant toxicity of the central nervous system and heart. Following poisoning, long-term sequelae often occur. Carbon monoxide can also have severe effects on the fetus of a pregnant woman. Despite its serious toxicity, CO is extremely useful and underpins much modern technology, being a precursor to a myriad of useful - even life-saving - products. Carbon monoxide, though thought of as a pollutant today, has always been present in the atmosphere, chiefly as a product of volcanic activity. It occurs dissolved in molten volcanic rock at high pressures in the earth's mantle. Carbon monoxide contents of volcanic gases vary from less than 0.01% to as much as 2% depending on the volcano. It also occurs naturally in bushfires. Because natural sources of carbon monoxide are so variable from year to year, it is extremely difficult to accurately measure natural emissions of the gas. (wikipedia) [HMDB]",630-08-0,NA,NA,NA,NA,NA,NA,NA,NA,C00237,281,NA,17245,CMO,NA,NA,NA,Carbon monoxide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2011-09-21 00:16:13 UTC,2015-07-21 06:57:16 UTC,NA,NA,HMDB01361,NA,NA,1749973,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.73,NA,-0.75,[C]#[O],NA,CO,28.0101,InChI=1S/CO/c1-2,27.99491462,InChIKey=UGFAIRIUMAVXCW-UHFFFAOYSA-N,5.11e+00 g/l,82068,hydroxymethyl,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Inorganic compounds,Homogeneous non-metal compounds,Homogeneous other non-metal compounds,NA,Homogeneous other non-metal compounds,Aliphatic acyclic compounds,CHEMBL1231840,275,CARBON-MONOXIDE,NA,NA,DB11588,NA,Carbon monoxide,630-08-0,7U1EE4V452,carbon(II) oxide | Carboneum oxygenisatum | CO,UGFAIRIUMAVXCW-UHFFFAOYSA-N
UGJMXCAKCUNAIE-UHFFFAOYSA-N,2350,HMDB0005015,171.125928793,2-[1-(aminomethyl)cyclohexyl]acetic acid,Gabapentin,C9H17NO2,60142-96-3,NA,FDB023587,NA,NA,CPD-16562,3446,3328,NCC1(CC(O)=O)CCCCC1,2989,Organic compounds,Gamma amino acids and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic homomonocyclic compounds,-1.1,2366,T3D2952,Exogenous,-1.1,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,171.125928793,2-[1-(aminomethyl)cyclohexyl]acetic acid,Gabapentin,C9H17NO2,60142-96-3,HMDB05015,DB00996,NA,NA,3446,3328,NCC1(CC(O)=O)CCCCC1,Organic compounds,Gamma amino acids and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic homomonocyclic compounds,23750,NA,SmallMoleculeCompound,FDB023587,Gabapentin,TRUE,Solid,low,"Gabapentin was originally developed as a chemical analogue of gamma-aminobutyric acid (GABA) to reduce the spinal reflex for the treatment of spasticity and was found to have anticonvulsant activity in various seizure models. In addition, it also displays antinociceptive activity in various animal pain models. Clinically, gabapentin is indicated as an add-on medication for the treatment of partial seizures, and neuropathic pain. It was also claimed to be beneficial in several other clinical disorders such as anxiety, bipolar disorder, and hot flashes. The possible mechanisms or targets involved in the multiple therapeutic actions of gabapentin have been actively studied. Since gabapentin was developed, several hypotheses had been proposed for its action mechanisms. They include selectively activating the heterodimeric GABA(B) receptors consisting of GABA(B1a) and GABA(B2) subunits, selectively enhancing the NMDA current at GABAergic interneurons, or blocking AMPA-receptor-mediated transmission in the spinal cord, binding to the L-alpha-amino acid transporter, activating ATP-sensitive K(+) channels, activating hyperpolarization-activated cation channels, and modulating Ca(2+) current by selectively binding to the specific binding site of [(3)H]gabapentin, the alpha(2)delta subunit of voltage-dependent Ca(2+) channels. Different mechanisms might be involved in different therapeutic actions of gabapentin. In this review, we summarized the recent progress in the findings proposed for the antinociceptive action mechanisms of gabapentin and suggest that the alpha(2)delta subunit of spinal N-type Ca(2+) channels is very likely the analgesic action target of gabapentin. (PMID: 16474201) [HMDB]",60142-96-3,NA,NA,NA,NA,NA,NA,NA,NA,NA,3446,NA,NA,GBN,NA,NA,NA,Gabapentin,NA,NA,NA,NA,NA,NA,NA,HMDB05015.pdf,application/pdf,48909,2015-02-28 17:50:49 UTC,NA,NA,2011-09-21 00:32:01 UTC,2015-10-09 22:33:08 UTC,NA,NA,HMDB05015,NA,DB00996,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-1.88,-1.273033071,-1.6,[H]OC(=O)C([H])([H])C1(C([H])([H])N([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H],NA,C9H17NO2,171.2368,"InChI=1S/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12)",171.1259288,InChIKey=UGJMXCAKCUNAIE-UHFFFAOYSA-N,4.34e+00 g/l,84588,2-[1-(aminomethyl)cyclohexyl]acetic acid,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Gamma amino acids and derivatives,Aliphatic homomonocyclic compounds,CHEMBL940,3328,CPD-16562,TRUE,NA,DB00996,APRD00015,Gabapentin,60142-96-3,6CW7F3G59X,1-(Aminomethyl)cyclohexaneacetic acid | Gabapentin GR | Gabapentina | Gabapentine | Gabapentino | Gabapentinum | Gabapetin,UGJMXCAKCUNAIE-UHFFFAOYSA-N
UHDGCWIWMRVCDJ-CCXZUQQUSA-N,9372,HMDB0015122,243.085520541,"4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one",Cytarabine,C9H13N3O5,147-94-4,C02961,FDB001979,DB00987,NA,NA,6253,6017,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,NA,Organic compounds,Pyrimidine nucleosides,"Nucleosides, nucleotides, and analogues",Pyrimidine nucleosides,NA,Aromatic heteromonocyclic compounds,-2.8,3651,T3D4978,Endogenous,-2.8,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,243.085520541,"4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one",Cytarabine,C9H13N3O5,147-94-4,HMDB15122,DB00987,C02961,NA,6253,6017,[H][C@]1(CO)O[C@@]([H])(N2C=CC(=N)N=C2O)[C@@]([H])(O)[C@]1([H])O,Organic compounds,Pyrimidine nucleosides,"Nucleosides, nucleotides, and analogues",Pyrimidine nucleosides,NA,Aromatic heteromonocyclic compounds,1216,3727,SmallMoleculeCompound,FDB001216,Arabinan,TRUE,NA,low,Arabinans devoid of other sugars have been isol. from mustard seeds. Heteroarabinans have been found in sugar beet and apples,11078-27-6,NA,NA,NA,NA,NA,NA,NA,NA,C01873,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:04:53 UTC,2015-07-20 21:38:48 UTC,NA,BWP79-H:BWP79-H,NA,ARABAN,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,[a]D -129 (H2O),DFC,C 45.46%; H 6.10%; O 48.44%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,NA,C9H13N3O5,243.2166,"InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1",243.0855205,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,NA,NA,NA,NA,NA,NA,"Arabinan, 9CI, 8CI",DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB00987,APRD00499,Cytarabine,147-94-4,04079A1RDZ,1-beta-D-Arabinofuranosylcytosine | 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone | Citarabina | Cytarabinum | Cytosine arabinoside | Cytosine-1-beta-D-arabinofuranoside | cytosine-Î²-D-arabinofuranoside,UHDGCWIWMRVCDJ-CCXZUQQUSA-N
ULGZDMOVFRHVEP-RWJQBGPGSA-N,8716,HMDB0014344,733.461241235,"4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol hydrochloride",Erythromycin,C37H67NO13,114-07-8,C01912,NA,DB00199,NA,NA,12560,12041,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,NA,Organic compounds,Catechols,Benzenoids,Phenols,Benzenediols,Aromatic homomonocyclic compounds,3.06,3451,T3D4764,Exogenous,3.06,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,733.461241235,"(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione",Erythromycin,C37H67NO13,114-07-8,HMDB14344,DB00199,C01912,NA,12560,12041,[H][C@@]1(C)C[C@]([H])(N(C)C)[C@@]([H])(O)[C@]([H])(O[C@]2([H])[C@@]([H])(C)[C@]([H])(O[C@@]3([H])C[C@@](C)(OC)[C@@]([H])(O)[C@]([H])(C)O3)[C@@]([H])(C)C(=O)O[C@]([H])(CC)[C@@](C)(O)[C@]([H])(O)[C@@]([H])(C)C(=O)[C@]([H])(C)C[C@@]2(C)O)O1,Organic compounds,Aminoglycosides,Organic oxygen compounds,Organooxygen compounds,Carbohydrates and carbohydrate conjugates,Aliphatic heteromonocyclic compounds,15816,41624,SmallMoleculeCompound,FDB015812,Gelatin,TRUE,NA,low,"Used in foods as stabiliser, surface-finishing agent and thickener. Derived from collagen",9000-70-8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Gelatin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:12:04 UTC,2015-07-20 23:22:19 UTC,NA,KJM89-D:KJM89-D,HMDB36858,NA,NA,NA,1453,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,NA,C37H67NO13,733.9268,"InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1",733.4612412,ULGZDMOVFRHVEP-RWJQBGPGSA-N,NA,NA,NA,NA,NA,NA,"Gelatin, BAN, JAN, USAN",DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB00199,APRD00953,Erythromycin,114-07-8,63937KV33D,3''-O-demethylerythromycin | Abomacetin | Eritromicina | Erythromycin A | Erythromycin C | Ã©rythromycine | Erythromycinum,ULGZDMOVFRHVEP-RWJQBGPGSA-N
UQVKZNNCIHJZLS-UHFFFAOYSA-N,21635,HMDB0041008,224.106196404,"1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-amine","1-Methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-amine",C13H12N4,105650-23-5,C16038,FDB020870,NA,NA,NA,1530,1476,CN1C(N)=NC2=NC=C(C=C12)C1=CC=CC=C1,NA,Organic compounds,Phenylpyridines,Organoheterocyclic compounds,Pyridines and derivatives,Phenylpyridines,Aromatic heteropolycyclic compounds,2.23,3337,T3D4581,Exogenous,2.23,"2B, possibly carcinogenic to humans. (L135)",NA,SmallMolecule,224.106196404,"1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-amine","1-Methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-amine",C13H12N4,105650-23-5,HMDB41008,NA,C16038,NA,1530,1476,CN1C(=N)NC2=C1C=C(C=N2)C1=CC=CC=C1,Chemical entities,Phenylpyridines,Organic compounds,Organoheterocyclic compounds,Pyridines and derivatives,Aromatic heteropolycyclic compounds,20878,56025,SmallMoleculeCompound,FDB020870,"1-Methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-amine",TRUE,NA,low,"Food-related mutagen, reported to be the most abundant heterocyclic amine found in cooked meat and fish",105650-23-5,Mp 327-328å¡,NA,NA,NA,2.23,NA,NA,NA,C16038,1530,NA,NA,PIQ,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:15:19 UTC,2015-07-21 06:48:48 UTC,NA,NDV90-H:NDV92-J,HMDB41008,NA,DB08398,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 69.62%; H 5.39%; N 24.98%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,BIOBYTE STARLIST (2009),NA,NA,DFC,2.27,2.09,-2.73,CN1C(N)=NC2=C1C=C(C=N2)C1=CC=CC=C1,NA,C13H12N4,224.2612,"InChI=1S/C13H12N4/c1-17-11-7-10(9-5-3-2-4-6-9)8-15-12(11)16-13(17)14/h2-8H,1H3,(H2,14,15,16)",224.1061964,InChIKey=UQVKZNNCIHJZLS-UHFFFAOYSA-N,4.16e-01 g/l,38112,"1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-amine",DFC,NA,NA,"2-Amino-6-phenylimidazo[4,5-b]pyridine; 1H-form, 1-Me",DFC,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Pyridines and derivatives,Phenylpyridines,Phenylpyridines,Aromatic heteropolycyclic compounds,CHEMBL1213271,1476,NA,NA,NA,DB08398,DB12735,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",105650-23-5,909C6UN66T,"2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine | PhIP",UQVKZNNCIHJZLS-UHFFFAOYSA-N
URKOMYMAXPYINW-UHFFFAOYSA-N,2355,HMDB0005021,383.166747749,"2-[2-(4-{2-thia-9-azatricyclo[9.4.0.0\xc2\xb3,\xe2\x81\xb8]pentadeca-1(15),3,5,7,9,11,13-heptaen-10-yl}piperazin-1-yl)ethoxy]ethan-1-ol",Quetiapine,C21H25N3O2S,111974-69-7,C07397,FDB023592,NA,NA,NA,5002,4827,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,NA,Organic compounds,Dibenzothiazepines,Organoheterocyclic compounds,Benzothiazepines,Dibenzothiazepines,Aromatic heteropolycyclic compounds,NA,2081,T3D2555,Exogenous,2.8,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,383.166747749,"2-[2-(4-{2-thia-9-azatricyclo[9.4.0.0\xc2\xb3,\xe2\x81\xb8]pentadeca-1(15),3,5,7,9,11,13-heptaen-10-yl}piperazin-1-yl)ethoxy]ethan-1-ol",Quetiapine,C21H25N3O2S,111974-69-7,HMDB05021,DB01224,C07397,NA,5002,4827,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Chemical entities,Dibenzothiazepines,Organic compounds,Organoheterocyclic compounds,Benzothiazepines,Aromatic heteropolycyclic compounds,23755,NA,SmallMoleculeCompound,FDB023592,Quetiapine,TRUE,Solid,low,"The most common side effect is sedation, and is prescribed specifically for this effect in patients with sleep disorders. Seroquel will put the patient into a drowsy state, and will help the patient fall asleep. It is one of the most sedating of all anti psychotic drugs, rivaling even the most sedating older antipsychotics. Many prescriptions call for the entire dose to be taken before bedtime because of its sedative effects. Although quetiapine is approved by the FDA for the treatment of schizophrenia and bipolar disorder, it is frequently prescribed for off-label purposes including insomnia or the treatment of anxiety disorders. Due to its sedative side effects, reports of quetiapine abuse (sometimes by insufflating crushed tablets) have emerged in medical literature; Quetiapine belongs to a series of neuroleptics known as ""atypical antipsychotics"", which have become increasingly popular alternatives to ""typical antipsychotics"" such as haloperidol.Quetiapine HAS approvals for the treatment of schizophrenia and acute mania in bipolar disorder. It is also used off-label to treat other disorders, such as post-traumatic stress disorder, alcoholism, obsessive compulsive disorder, anxiety disorders, hallucinations in Parkinson's disease patients using ropinirole, and as a sedative for those with sleep disorders.; The most common side effect is sedation, and is prescribed specifically for this effect in patients with sleep disorders. Seroquel will put the patient into a drowsy state, and will help the patient fall asleep. It is one of the most sedating of all anti psychotic drugs, rivaling even the most sedating older antipsychotics. Many prescriptions call for the entire dose to be taken before bedtime because of its sedative effects. Although quetiapine is approved by the FDA for the treatment of schizophrenia and bipolar disorder, it is frequently prescribed for off-label purposes including insomnia or the treatment of anxiety disorders. Due to its sedative side effects, reports of quetiapine abuse (sometimes by insufflating crushed tablets) have emerged in medical literature; for the same reason, abuse of other antipsychotics, such as chlorpromazine (Thorazine), may occur as well, but research related to the abuse of typical antipsychotics is limited.; for the same reason, abuse of other antipsychotics, such as chlorpromazine (Thorazine), may occur as well, but research related to the abuse of typical antipsychotics is limited. [HMDB]",111974-69-7,NA,NA,NA,NA,NA,NA,NA,NA,C07397,5002,NA,NA,NA,NA,NA,NA,Quetiapine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2011-09-21 00:32:05 UTC,2015-07-21 06:57:46 UTC,NA,NA,HMDB05021,NA,DB01224,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2.93,2.8079425160000002,-3.98,[H]OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])N1C([H])([H])C([H])([H])N(C2=NC3=C([H])C([H])=C([H])C([H])=C3SC3=C([H])C([H])=C([H])C([H])=C23)C([H])([H])C1([H])[H],NA,C21H25N3O2S,383.507,"InChI=1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2",383.1667477,InChIKey=URKOMYMAXPYINW-UHFFFAOYSA-N,4.03e-02 g/l,88273,"2-[2-(4-{2-thia-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,9,11,13-heptaen-10-yl}piperazin-1-yl)ethoxy]ethan-1-ol",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Benzothiazepines,Dibenzothiazepines,Dibenzothiazepines,Aromatic heteropolycyclic compounds,CHEMBL716,4827,NA,NA,NA,DB01224,APRD00675,Quetiapine,111974-69-7,BGL0JSY5SI,"2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol | Quetiapina | Quetiapine | Quetiapine fumarate | Quetiapine hemifumarate | Quetiapinum",URKOMYMAXPYINW-UHFFFAOYSA-N
VGKDLMBJGBXTGI-SJCJKPOMSA-N,2346,HMDB0005010,305.073804963,"(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine",Sertraline,C17H17Cl2N,79617-96-2,C07246,FDB023583,NA,NA,NA,68617,61881,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,2417,Organic compounds,Tametralines,Benzenoids,Tetralins,Tametralines,Aromatic homopolycyclic compounds,NA,2397,T3D2985,Exogenous,5.1,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,305.073804963,"(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine",Sertraline,C17H17Cl2N,79617-96-2,HMDB05010,DB01104,C07246,NA,68617,61881,[H][C@@]1(CC[C@@]([H])(C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12)NC,Organic compounds,Tametralines,Benzenoids,Tetralins,Tametralines,Aromatic homopolycyclic compounds,23746,NA,SmallMoleculeCompound,FDB023583,Sertraline,TRUE,Solid,low,"A selective serotonin uptake inhibitor that is used in the treatment of depression.; Sertraline hydrochloride (also labeled under numerous brand names: Zoloft, Sertralin, Lustral, Apo-Sertral, Asentra, Gladem, Serlift, Stimuloton, Xydep, Serlain, Concorz) is an orally administered antidepressant of the selective serotonin reuptake inhibitor (SSRI) type. It was first approved by the Food and Drug Administration (FDA) in 1991.; Sertraline is an odorless, white, sparingly soluble crystalline solid. The minimum effective dose is usually 50 mg per day (it can be still effective at 25 mg or 37.5 mg), but lower doses may be used in the initial weeks of treatment to acclimate the patient's body, especially the liver, to the drug and to minimize the severity of any side effects. Patients who do not experience relief of symptoms at 50 mg a day may have their dose increased, up to 200 mg a day.; Sertraline (HCl) is used medically mainly to treat the symptoms of depression and anxiety. It is also prescribed for the treatment of obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), premenstrual dysphoric disorder (PMDD), panic disorder (PD) and social phobia/social anxiety disorder.; A study has shown that sertraline is an effective treatment for impulsive aggressive behavior in personality disordered patients. [HMDB]",79617-96-2,NA,NA,NA,NA,NA,NA,NA,NA,C07246,68617,NA,NA,SRE,NA,NA,NA,Sertraline,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2011-09-21 00:31:57 UTC,2015-07-21 06:57:46 UTC,NA,NA,HMDB05010,NA,DB08567,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5.06,5.149299974,-6.32,[H]N(C([H])([H])[H])[C@]1([H])C2=C([H])C([H])=C([H])C([H])=C2[C@]([H])(C2=C([H])C(Cl)=C(Cl)C([H])=C2[H])C([H])([H])C1([H])[H],NA,C17H17Cl2N,306.23,"InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/t12-,17-/m0/s1",305.073805,InChIKey=VGKDLMBJGBXTGI-SJCJKPOMSA-N,1.45e-04 g/l,87347,"(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Benzenoids,Tetralins,Tametralines,Tametralines,Aromatic homopolycyclic compounds,CHEMBL809,61881,NA,NA,NA,DB01104,APRD00175 | DB08567,Sertraline,79617-96-2,QUC7NX6WMB,"(+)-Sertraline | (1S-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine | (1S,4S)-sertraline | cis-(+)-sertraline | Sertralina | Sertraline | Sertralinum",VGKDLMBJGBXTGI-SJCJKPOMSA-N
VHBFFQKBGNRLFZ-UHFFFAOYSA-N,1766,HMDB0003075,222.068079564,2-phenyl-4H-chromen-4-one,Flavone,C15H10O2,525-82-6,C10043,FDB006784,DB07776,NA,CPD-8485,10680,10230,O=C1C=C(OC2=CC=CC=C12)C1=CC=CC=C1,3359,Organic compounds,Flavones,Phenylpropanoids and polyketides,Flavonoids,Flavones,Aromatic heteropolycyclic compounds,3.56,3607,T3D4924,Exogenous,3.56,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,222.068079564,2-phenyl-4H-chromen-4-one,Flavone,C15H10O2,525-82-6,HMDB03075,DB07776,C10043,CPD-6641,10680,10230,O=C1C=C(OC2=CC=CC=C12)C1=CC=CC=C1,Organic compounds,Flavones,Phenylpropanoids and polyketides,Flavonoids,Flavones,Aromatic heteropolycyclic compounds,6785,17263,SmallMoleculeCompound,FDB006784,Flavones,TRUE,Solid,low,"Flavones (flavus = yellow), are a class of flavonoids based on the backbone of 2-phenylchromen-4-one (2-phenyl-1-benzopyran-4-one). (Wikipedia)",525-82-6,NA,NA,NA,NA,NA,NA,NA,NA,C15608,10680,NA,5076,FLN,NA,NA,NA,Flavones,NA,NA,NA,NA,NA,NA,NA,HMDB03075.pdf,application/pdf,48223,2015-02-28 17:59:43 UTC,NA,2,2010-04-08 22:07:18 UTC,2015-10-09 22:32:12 UTC,NA,NA,HMDB03075,FLAVONES|FLAVONE,DB07776,NA,NA,C00001040,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3.54,2.97,-4.43,O=C1C=C(OC2=C1C=CC=C2)C1=CC=CC=C1,NA,C15H10O2,222.2387,InChI=1S/C15H10O2/c16-13-10-15(11-6-2-1-3-7-11)17-14-9-5-4-8-12(13)14/h1-10H,222.0680796,InChIKey=VHBFFQKBGNRLFZ-UHFFFAOYSA-N,8.19e-03 g/l,79346,2-phenyl-4H-chromen-4-one,MANUAL,chebi:24043,NA,NA,DUKE,NA,NA,NA,NA,Organic compounds,Phenylpropanoids and polyketides,Flavonoids,Flavones,Flavones,Aromatic heteropolycyclic compounds,NA,10230,CPD-6641,TRUE,NA,DB07776,DB11139,Flavone,525-82-6,S2V45N7G3B,2-Phenyl-4-benzopyron | 2-Phenyl-4-chromone | 2-phenyl-4H-1-benzopyran-4-one | 2-phenyl-4H-benzopyran-4-one | 2-phenyl-Î³-benzopyrone | 2-Phenylbenzopyran-4-one | 2-phenylchromone | Flavon,VHBFFQKBGNRLFZ-UHFFFAOYSA-N
VKYKSIONXSXAKP-UHFFFAOYSA-N,10733,HMDB0029598,140.106196404,"1,3,5,7-tetraazatricyclo[3.3.1.1\xc2\xb3,\xe2\x81\xb7]decane",Metenamine,C6H12N4,100-97-0,NA,FDB000762,NA,NA,NA,4101,3959,C1N2CN3CN1CN(C2)C3,NA,Organic compounds,"1,3,5-triazinanes",Organoheterocyclic compounds,Triazinanes,"1,3,5-triazinanes",Aliphatic heteropolycyclic compounds,NA,3518,T3D4834,Exogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,140.106196404,"1,3,5,7-tetraazatricyclo[3.3.1.1\xc2\xb3,\xe2\x81\xb7]decane",Metenamine,C6H12N4,100-97-0,HMDB29598,NA,NA,NA,4101,3959,C1N2CN3CN1CN(C2)C3,Chemical entities,"1,3,5-triazinanes",Organic compounds,Organoheterocyclic compounds,Triazinanes,Aliphatic heteropolycyclic compounds,762,2065,SmallMoleculeCompound,FDB000762,Metenamine,TRUE,NA,low,"Antimicrobial food preservative, but limited and declining use. Acts by releasing formaldehyde in acidic conditions. Prevents ""late blowing"" of hard cheese by inhibiting growth of unwanted bacteria. Presently (2002) its European use is limited to one type of Italian cheese, Provolone",100-97-0,>250 oC,NA,NA,449 mg/mL at 12 oC,NA,NA,NA,NA,NA,4101,NA,6824,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:04:42 UTC,2015-07-20 21:34:11 UTC,NA,BGW21-L:BGW21-L,HMDB29598,NA,NA,NA,NA,NA,"Subl. 263å¡ ca., in vacuo with some dec.",DFC,NA,NA,NA,NA,NA,NA,C 51.41%; H 8.63%; N 39.97%,DFC,NA,NA,NA,NA,NA,NA,pKa 6.3 (25å¡),DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)",NA,NA,NA,NA,-1.39,0.392133857,0.74,C1N2CN3CN1CN(C2)C3,NA,C6H12N4,140.1863,InChI=1S/C6H12N4/c1-7-2-9-4-8(1)5-10(3-7)6-9/h1-6H2,140.1061964,InChIKey=VKYKSIONXSXAKP-UHFFFAOYSA-N,7.66e+02 g/l,33512,"1,3,5,7-tetraazatricyclo[3.3.1.1å_,?]decane",HMDB_from_dfc,NA,NA,"1,3,5,7-Tetraazatricyclo[3.3.1.13,7]decane, 9CI",DFC,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Triazinanes,"1,3,5-triazinanes","1,3,5-triazinanes",Aliphatic heteropolycyclic compounds,CHEMBL1201270,3959,NA,NA,NA,DB06799,DB06146,Methenamine,100-97-0,J50OIX95QV,"1,3,5,7-tetraazatricyclo[3.3.1.13,7]decane | Hexamethylenamine | Hexamethylene tetramine | Hexamethylenetetramine | Hexamethylentetramin | Hexamethylentetraminum | Hexamine | Hexaminum | HMT | HMTA | metenamina | mÃ©thÃ©namine | methenaminum",VKYKSIONXSXAKP-UHFFFAOYSA-N
VNFPBHJOKIVQEB-UHFFFAOYSA-N,1276,HMDB0001922,344.108026261,1-[(2-chlorophenyl)diphenylmethyl]-1H-imidazole,Clotrimazole,C22H17ClN2,23593-75-1,C06922,FDB022740,NA,NA,NA,2812,2710,ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,1897,Organic compounds,Triphenyl compounds,Benzenoids,Triphenyl compounds,NA,Aromatic heteromonocyclic compounds,NA,2208,T3D2729,Exogenous,6.1,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,344.108026261,1-[(2-chlorophenyl)diphenylmethyl]-1H-imidazole,Clotrimazole,C22H17ClN2,23593-75-1,HMDB01922,DB00257,C06922,NA,2812,2710,ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,Organic compounds,Triphenyl compounds,Benzenoids,Triphenyl compounds,NA,Aromatic heteromonocyclic compounds,22903,NA,SmallMoleculeCompound,FDB022740,Clotrimazole,TRUE,Solid,low,"Clotrimazole is an imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal cell membranes. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane. -- Pubchem; There is the potential for drug interactions with Clotrimazole if taken orally, as it is a potent, specific inhibitor of cytochrome P450 oxidase enzymes and so may alter the metabolism of other drugs.; Clotrimazole is an antifungal medication commonly used in the treatment of fungal infections of both humans and animals such as vaginal yeast infections and ringworm. -- Wikipedia; An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal cell membranes. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane.; Clotrimazole is a potent, specific inhibitor of cytochrome P450 oxidase enzymes. Hence, it may alter the metabolism of other drugs particularly if taken orally. -- Wikipedia; Clotrimazole is an antifungal medication commonly used in the treatment of fungal infections of both humans and animals such as vaginal yeast infections and ringworm. It also used to treat athlete's foot and jock itch. [HMDB]",23593-75-1,NA,NA,NA,NA,NA,NA,NA,NA,C06922,2812,NA,3764,CL6,NA,NA,NA,Clotrimazole,NA,NA,NA,NA,NA,NA,NA,HMDB01922.pdf,application/pdf,49183,2015-02-28 18:11:06 UTC,NA,NA,2011-09-21 00:18:53 UTC,2015-10-09 22:31:18 UTC,NA,NA,HMDB01922,NA,DB00257,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5.48,5.839451671,-5.37,[H]C1=C([H])N(C([H])=N1)C(C1=C([H])C([H])=C([H])C([H])=C1[H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C1=C([H])C([H])=C([H])C([H])=C1Cl,NA,C22H17ClN2,344.837,"InChI=1S/C22H17ClN2/c23-21-14-8-7-13-20(21)22(25-16-15-24-17-25,18-9-3-1-4-10-18)19-11-5-2-6-12-19/h1-17H",344.1080263,InChIKey=VNFPBHJOKIVQEB-UHFFFAOYSA-N,1.47e-03 g/l,88196,1-[(2-chlorophenyl)diphenylmethyl]-1H-imidazole,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Halobenzenes,Chlorobenzenes,Aromatic heteromonocyclic compounds,CHEMBL104,2710,CPD-8926,TRUE,NA,DB00257,APRD00244,Clotrimazole,23593-75-1,G07GZ97H65,"1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole | 1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole | 1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole | 1-(o-Chloro-Î±,Î±-diphenylbenzyl)imidazole | 1-(o-Chlorotrityl)imidazole | 1-(Î±-(2-Chlorophenyl)benzhydryl)imidazole | Clotrimazole | Lotrimin (tn) | Mycelex (tn)",VNFPBHJOKIVQEB-UHFFFAOYSA-N
VOXZDWNPVJITMN-ZBRFXRBCSA-N,98,HMDB0000151,272.177630012,"(1S,10R,11S,14S,15S)-15-methyltetracyclo[8.7.0.0\xc2\xb2,\xe2\x81\xb7.0\xc2\xb9\xc2\xb9,\xc2\xb9\xe2\x81\xb5]heptadeca-2(7),3,5-triene-5,14-diol",Estradiol,C18H24O2,50-28-2,C00951,FDB000362,DB00783,DBMET00491,CPD-352,5757,5554,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,263,Organic compounds,Estrogens and derivatives,Lipids and lipid-like molecules,Steroids and steroid derivatives,Estrane steroids,Aromatic homopolycyclic compounds,4.01,3378,T3D4668,Endogenous,4.01,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,272.177630012,"(1S,10R,11S,14S,15S)-15-methyltetracyclo[8.7.0.0\xc2\xb2,\xe2\x81\xb7.0\xc2\xb9\xc2\xb9,\xc2\xb9\xe2\x81\xb5]heptadeca-2(7),3,5-triene-5,14-diol",Estradiol,C18H24O2,50-28-2,NA,DB00783,C00951,NA,5757,5554,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C,Organic compounds,Estrogens and derivatives,Lipids and lipid-like molecules,Steroids and steroid derivatives,Estrane steroids,Aromatic homopolycyclic compounds,362,687,SmallMoleculeCompound,FDB000362,Estradiol,TRUE,Solid,low,"Growth promoter for livestock. Permitted in the USAEstradiol (E2 or 17?-estradiol, also oestradiol) is a sex hormone. (Wikipedia)",50-28-2,Mp 178å¡,NA,NA,0.0036 mg/mL at 27 oC,4.01,NA,NA,NA,C00951,5757,NA,16469,EST,NA,NA,NA,Estradiol,NA,NA,NA,NA,NA,NA,NA,HMDB00151.pdf,application/pdf,177148,2015-02-28 18:05:12 UTC,NA,2,2010-04-08 22:04:32 UTC,2015-10-09 22:28:47 UTC,NA,BBB24-E:BBB29-J,HMDB00151,ESTRADIOL|17-BETA-ESTRADIOL|ESTRADIOL-17-BETA,DB00783,36456,NA,NA,NA,NA,0,NA,NA,NA,[a]18D +78 (EtOH),DFC,C 79.37%; H 8.88%; O 11.75%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,3.57,3.75,-4.11,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,19.38,C18H24O2,272.382,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",272.17763,InChIKey=VOXZDWNPVJITMN-ZBRFXRBCSA-N,2.13e-02 g/l,30855,"(1S,10R,11S,14S,15S)-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-triene-5,14-diol",MANUAL,NA,NA,"Estra-1,3,5(10)-triene-3,17-diol; 17b-form",DFC,NA,NA,NA,NA,Organic compounds,Lipids and lipid-like molecules,Steroids and steroid derivatives,Estrane steroids,Estrogens and derivatives,Aromatic homopolycyclic compounds,CHEMBL135,5554,CPD-352,TRUE,NA,DB00783,APRD00311,Estradiol,50-28-2,4TI98Z838E,"(17Î²)-estra-1,3,5(10)-triene-3,17-diol | 17beta oestradiol | 17Î²-estra-1,3,5(10)-triene-3,17-diol | 17Î²-estradiol | 17Î²-oestradiol | beta-Estradiol | cis-Estradiol | Estradiol | Estradiol-17beta | Estradiolum",VOXZDWNPVJITMN-ZBRFXRBCSA-N
VYFYYTLLBUKUHU-UHFFFAOYSA-N,52,HMDB0000073,153.078978601,"4-(2-aminoethyl)benzene-1,2-diol",Dopamine,C8H11NO2,62-31-7,C03758,FDB012163,DB00988,NA,DOPAMINE,681,661,NCCC1=CC(O)=C(O)C=C1,64,Organic compounds,Catecholamines and derivatives,Benzenoids,Phenols,Benzenediols,Aromatic homomonocyclic compounds,-0.98,3177,T3D4300,Endogenous,-0.98,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,153.078978601,"4-(2-aminoethyl)benzene-1,2-diol",Dopamine,C8H11NO2,51-61-6,HMDB00073,DB00988,C03758,DOPAMINE,681,661,NCCC1=CC(O)=C(O)C=C1,Organic compounds,Catecholamines and derivatives,Benzenoids,Phenols,Benzenediols,Aromatic homomonocyclic compounds,12166,31468,SmallMoleculeCompound,FDB012163,Dopamine,TRUE,Solid,low,"Occurs in several higher plants, such as banana (Musa sapientum)As a member of the catecholamine family, dopamine is a precursor to norepinephrine (noradrenaline) and then epinephrine (adrenaline) in the biosynthetic pathways for these neurotransmitters.",51-61-6,128 oC,NA,NA,NA,-0.98,NA,NA,NA,C03758,681,NA,18243,LDP,NA,NA,NA,Dopamine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:10:01 UTC,2015-10-09 22:29:15 UTC,NA,HDV99-C:HDV99-C,HMDB00073,3-HYDROXYTYRAMINE|DOPAMINE,DB00988,42467,NA,C00001408,NA,NA,1,NA,NA,NA,NA,NA,C 62.73%; H 7.24%; N 9.14%; O 20.89%,DFC,NA,NA,NA,NA,NA,NA,8.93,NA,NA,"HANSCH,C ET AL. (1995)",NA,NA,NA,-0.4,-0.06,-1.31,NCCC1=CC=C(O)C(O)=C1,12.93,C8H11NO2,153.1784,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",153.0789786,InChIKey=VYFYYTLLBUKUHU-UHFFFAOYSA-N,7.43e+00 g/l,38933,"4-(2-aminoethyl)benzene-1,2-diol",DFC,NA,NA,"Dopamine, BAN, INN",DFC,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenols and derivatives,Catecholamines and derivatives,Aromatic homomonocyclic compounds,CHEMBL59,661,DOPAMINE,TRUE,NA,DB00988,APRD00085,Dopamine,51-61-6,VTD58H1Z2X,"2-(3,4-dihydroxyphenyl)ethylamine | 3-Hydroxytyramine | 3,4-Dihydroxyphenethylamine | 4-(2-aminoethyl)-1,2-benzenediol | 4-(2-Aminoethyl)benzene-1,2-diol | 4-(2-aminoethyl)catechol | 4-(2-aminoethyl)pyrocatechol | Dopamina | Dopamine | Dopaminum | Oxytyramine",VYFYYTLLBUKUHU-UHFFFAOYSA-N
VZCYOOQTPOCHFL-OWOJBTEDSA-N,88,HMDB0000134,116.010958616,(2E)-but-2-enedioic acid,Fumaric acid,C4H4O4,110-17-8,C00122,FDB003291,DB01677,NA,FUM,444972,10197150,OC(=O)\C=C\C(O)=O,3242,Organic compounds,Dicarboxylic acids and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,Dicarboxylic acids and derivatives,Aliphatic acyclic compounds,0.46,3139,T3D4237,Endogenous,0.46,"Not listed by IARC. Has been implicated in oncogenesis (A15088, A15092).",NA,SmallMolecule,116.010958616,(2E)-but-2-enedioic acid,Fumaric acid,C4H4O4,110-17-8,HMDB00134,DB01677,C00122,FUM,444972,10197150,[H]\C(=C(\[H])C(O)=O)C(O)=O,NA,NA,NA,NA,NA,NA,31028,NA,SmallMoleculeCompound,FDB030865,fumarate,TRUE,NA,NA,NA,110-17-8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2015-05-07 20:19:52 UTC,2017-03-11 23:05:00 UTC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,OC(=O)\C=C\C(O)=O,NA,C4H4O4,116.0722,"InChI=1S/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/b2-1+",116.0109586,VZCYOOQTPOCHFL-OWOJBTEDSA-N,NA,NA,NA,NA,NA,NA,NA,MANUAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB01677,EXPT01460 | EXPT01511,Fumaric Acid,110-17-8,88XHZ13131,"(2E)-2-butenedioic acid | (E)-2-butenedioic acid | Fumaricum acidum | FumarsÃ¤ure | trans-1,2-ethylenedicarboxylic acid | trans-but-2-enedioic acid | trans-Butenedioic acid",VZCYOOQTPOCHFL-OWOJBTEDSA-N
VZCYOOQTPOCHFL-UPHRSURJSA-N,115,HMDB0000176,116.010958616,(2E)-but-2-enedioic acid,Maleic acid,C4H4O4,110-16-7,C01384,FDB008113,NA,NA,NA,444266,392248,OC(=O)\C=C/C(O)=O,4198,Organic compounds,Dicarboxylic acids and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,Dicarboxylic acids and derivatives,Aliphatic acyclic compounds,-0.48,3486,T3D4800,Endogenous,-0.48,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,116.010958616,(2Z)-but-2-enedioic acid,Maleic acid,C4H4O4,110-16-7,HMDB00176,DB04299,C01384,NA,444266,392248,[H]\C(=C(/[H])C(O)=O)C(O)=O,Organic compounds,Dicarboxylic acids and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,Dicarboxylic acids and derivatives,Aliphatic acyclic compounds,3292,10151,SmallMoleculeCompound,FDB003291,Fumaric acid,TRUE,Solid,low,"Prod. industrially by fermentation of Rhizopus nigricans, or manuf. by catalytic or thermal isomerisation of maleic anhydride or maleic acid. Used as an antioxidant, acidulant, leavening agent and flavouring agent in foods. Present in raw lean fish. Dietary supplement. Used in powdered products since fumaric acid is less hygroscopic than other acidsA precursor to L-malate in the Krebs tricarboxylic acid cycle. It is formed by the oxidation of succinate by succinate dehydrogenase. (wikipedia)",110-17-8,Mp 300-302å¡ (sealed tube),NA,NA,7 mg/mL at 25 oC,0.46,NA,NA,NA,C00122,444972,NA,18012,FUM,NA,NA,NA,Fumaric acid,NA,NA,NA,NA,NA,NA,NA,HMDB00134.pdf,application/pdf,48549,2015-02-28 17:49:11 UTC,NA,2,2010-04-08 22:05:44 UTC,2015-10-09 22:27:15 UTC,NA,CVQ85-P:CVQ85-P,HMDB00134,FUMARIC-ACID,DB01677,33938,1403,C00001183,NA,NA,NA,NA,NA,NA,NA,NA,C 41.39%; H 3.47%; O 55.14%,DFC,NA,NA,NA,NA,NA,NA,pKa 4.54 (25å¡),DFC,US EPA (1981),"HANSCH,C ET AL. (1995)",NA,NA,DFC,0.21,-0.04,-0.68,OC(=O)\C=C/C(O)=O,5.91,C4H4O4,116.0722,"InChI=1S/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/b2-1-",116.0109586,InChIKey=VZCYOOQTPOCHFL-UPHRSURJSA-N,2.41e+01 g/l,35287,(2Z)-but-2-enedioic acid,DFC,NA,NA,"Fumaric acid, 8CI",DFC,NA,rw1024321,444972,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Dicarboxylic acids and derivatives,Dicarboxylic acids and derivatives,Aliphatic acyclic compounds,CHEMBL503160,10197150,FUM,TRUE,NA,DB04299,EXPT02106,Maleic Acid,110-16-7,91XW058U2C,NA,VZCYOOQTPOCHFL-UPHRSURJSA-N
WAEMQWOKJMHJLA-UHFFFAOYSA-N,1023,HMDB0001333,54.938049636,manganese(2+) ion,Manganese,Mn,7439-96-5,C19610,FDB003636,NA,NA,MN%2b3,27854,25916,[Mn++],NA,Inorganic compounds,Homogeneous transition metal compounds,Homogeneous metal compounds,Homogeneous transition metal compounds,NA,NA,NA,103,T3D0117,Exogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,54.936952476,manganese(2+) ion,Manganese,Mn,7439-96-5,HMDB01333,NA,C19610,MN%2b3,27854,25916,[Mn++],Chemical entities,Homogeneous transition metal compounds,Inorganic compounds,Homogeneous metal compounds,Homogeneous transition metal compounds,NA,31168,NA,SmallMoleculeCompound,FDB031005,Mn2+,TRUE,NA,NA,NA,7439-96-5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2015-05-07 20:46:59 UTC,2017-03-11 23:05:55 UTC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,[Mn++],NA,Mn,54.938045,InChI=1S/Mn/q+2,54.93804964,WAEMQWOKJMHJLA-UHFFFAOYSA-N,NA,NA,NA,NA,NA,NA,NA,MANUAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB06757,NA,Manganese,7439-96-5,H6EP7W5457,NA,WAEMQWOKJMHJLA-UHFFFAOYSA-N
WDJUZGPOPHTGOT-XUDUSOBPSA-N,9677,HMDB0015468,764.434692134,"4-[(1S,2S,5S,7R,10R,11S,14R,15R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11-hydroxy-2,15-dimethyltetracyclo[8.7.0.0\xc2\xb2,\xe2\x81\xb7.0\xc2\xb9\xc2\xb9,\xc2\xb9\xe2\x81\xb5]heptadecan-14-yl]-2,5-dihydrofuran-2-one",Digitoxin,C41H64O13,71-63-6,C06955,NA,DB01396,NA,NA,441207,389987,[H][C@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,NA,Organic compounds,Cardenolide glycosides and derivatives,Lipids and lipid-like molecules,Steroids and steroid derivatives,Steroid lactones,Aliphatic heteropolycyclic compounds,1.85,3022,T3D4021,Exogenous,1.85,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,764.434692134,"4-[(1S,2S,5S,7R,10R,11S,14R,15R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11-hydroxy-2,15-dimethyltetracyclo[8.7.0.0\xc2\xb2,\xe2\x81\xb7.0\xc2\xb9\xc2\xb9,\xc2\xb9\xe2\x81\xb5]heptadecan-14-yl]-2,5-dihydrofuran-2-one",Digitoxin,C41H64O13,71-63-6,HMDB15468,DB01396,C06955,NA,441207,389987,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@]([H])(CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@@]1([H])C[C@]([H])(O)[C@]([H])(O[C@@]2([H])C[C@]([H])(O)[C@]([H])(O[C@@]3([H])C[C@]([H])(O)[C@]([H])(O)[C@@]([H])(C)O3)[C@@]([H])(C)O2)[C@@]([H])(C)O1)C1=CC(=O)OC1,Organic compounds,Cardenolide glycosides and derivatives,Lipids and lipid-like molecules,Steroids and steroid derivatives,Steroid lactones,Aliphatic heteropolycyclic compounds,6526,16792,SmallMoleculeCompound,FDB006525,Glucokinin,TRUE,NA,low,NA,71-63-6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:07:11 UTC,2017-03-01 02:04:40 UTC,NA,NA,NA,GLUCOKININ,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,[H][C@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,NA,C41H64O13,764.9391,"InChI=1S/C41H64O13/c1-20-36(46)29(42)16-34(49-20)53-38-22(3)51-35(18-31(38)44)54-37-21(2)50-33(17-30(37)43)52-25-8-11-39(4)24(15-25)6-7-28-27(39)9-12-40(5)26(10-13-41(28,40)47)23-14-32(45)48-19-23/h14,20-22,24-31,33-38,42-44,46-47H,6-13,15-19H2,1-5H3/t20-,21-,22-,24-,25+,26-,27+,28-,29+,30+,31+,33+,34+,35+,36-,37-,38-,39+,40-,41+/m1/s1",764.4346921,WDJUZGPOPHTGOT-XUDUSOBPSA-N,NA,NA,NA,NA,NA,NA,NA,DUKE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB01396,NA,Digitoxin,71-63-6,E90NZP2L9U,Crystodigin (tn) | Digitoksin | Digitoxin | Digitoxinum | Digitoxoside,WDJUZGPOPHTGOT-XUDUSOBPSA-N
WFJIVOKAWHGMBH-UHFFFAOYSA-N,13527,HMDB0032567,194.13067982,"4-hexylbenzene-1,3-diol",Hexylresorcinol,C12H18O2,136-77-6,NA,FDB010499,NA,NA,NA,3610,21106121,CCCCCCC1=C(O)C=C(O)C=C1,NA,Organic compounds,Resorcinols,Benzenoids,Benzene and substituted derivatives,Phenols and derivatives,Aromatic homomonocyclic compounds,3.45,3539,T3D4855,Exogenous,3.45,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,194.13067982,"4-hexylbenzene-1,3-diol",Hexylresorcinol,C12H18O2,136-77-6,HMDB32567,NA,NA,NA,3610,21106121,CCCCCCC1=C(O)C=C(O)C=C1,Organic compounds,Resorcinols,Benzenoids,Benzene and substituted derivatives,Phenols and derivatives,Aromatic homomonocyclic compounds,10501,25876,SmallMoleculeCompound,FDB010499,Hexylresorcinol,TRUE,NA,low,Food additive for prevention of enzymic browning in shrimp and fruits,136-77-6,Mp 68-70å¡,NA,NA,0.5 mg/mL at 18 oC,3.45,NA,NA,NA,NA,3610,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:09:09 UTC,2015-07-20 22:32:49 UTC,NA,FBQ92-M:FBQ92-M,HMDB32567,NA,NA,NA,NA,NA,Bp6.5 178-180å¡ (lit. gives a pressure range),DFC,NA,NA,NA,NA,NA,NA,C 74.19%; H 9.34%; O 16.47%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,"YALKOWSKY,SH & HE,Y (2003)","HANSCH,C ET AL. (1995)",NA,NA,DFC,3.77,4.102379887,-2.63,CCCCCCC1=C(O)C=C(O)C=C1,10.91062095,C12H18O2,194.2701,"InChI=1S/C12H18O2/c1-2-3-4-5-6-10-7-8-11(13)9-12(10)14/h7-9,13-14H,2-6H2,1H3",194.1306798,InChIKey=WFJIVOKAWHGMBH-UHFFFAOYSA-N,4.54e-01 g/l,38141,"4-hexylbenzene-1,3-diol",HMDB_from_dfc,NA,NA,"4-Hexyl-1,3-benzenediol, 9CI",DFC,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenols and derivatives,Resorcinols,Aromatic homomonocyclic compounds,CHEMBL443605,21106121,NA,NA,NA,DB11254,NA,Hexylresorcinol,136-77-6,R9QTB5E82N,"4-hexyl-1,3-benzenediol | 4-hexylresorcinol",WFJIVOKAWHGMBH-UHFFFAOYSA-N
WHUUTDBJXJRKMK-VKHMYHEASA-N,95,HMDB0000148,147.053157781,(2S)-2-aminopentanedioic acid,L-Glutamic acid,C5H9NO4,56-86-0,C00025,FDB012535,DB00142,NA,GLT,33032,30572,N[C@@H](CCC(O)=O)C(O)=O,5174,Organic compounds,Glutamic acid and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,-3.69,3174,T3D4296,Endogenous,-3.69,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,147.053157781,(2S)-2-aminopentanedioic acid,L-Glutamic acid,C5H9NO4,56-86-0,HMDB00148,DB00142,C00025,GLT,33032,30572,[H][C@](N)(CCC(O)=O)C(O)=O,Organic compounds,Glutamic acid and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,12538,32669,SmallMoleculeCompound,FDB012535,L-Glutamic acid,TRUE,Solid,low,"Obt. from acid hydrol. of proteins. Since 1965 the industrial source of glutamic acid for MSG production has been bacterial fermentation of carbohydrate sources such as molasses and corn starch hydrolysate in the presence of  a nitrogen source such as ammonium salts or urea. Annual production approx. 350000t worldwide in 1988. Seasoning additive in food manuf. (as Na, K and NH4 salts). Dietary supplement, nutrientGlutamic acid (abbreviated as Glu or E) is one of the 20 proteinogenic amino acids. It is a non-essential amino acid. (Wikipedia)",56-86-0,"Mp 224-225 (211-213å¡, 247-249å¡)å¡ dec.",NA,NA,8.57 mg/mL at 25 oC,-3.69,NA,NA,NA,C00025,33032,NA,16015,GGL,NA,NA,NA,Glutamic_acid,NA,NA,NA,NA,NA,NA,NA,HMDB00148.pdf,application/pdf,48107,2015-02-28 17:55:59 UTC,NA,2,2010-04-08 22:10:13 UTC,2015-10-09 22:27:34 UTC,NA,HHT64-G:HHT63-F,HMDB00148,GLUTAMINIC-ACID|L-GLUTAMIC-ACID|GLUTAMIC-ACID|GLUTAMIC-ACID(FREE),DB00142,33561,1507,C00001358,NA,NA,NA,NA,NA,NA,"[a]25D +46.8 (c, 2 in 5M HCl)",DFC,C 40.82%; H 6.17%; N 9.52%; O 43.50%,DFC,NA,NA,NA,NA,NA,NA,"pKa3 9.6 (25å¡,NH2)",DFC,"BULL,HB et al. (1978)","HANSCH,C ET AL. (1995)",NA,NA,DFC,-3.54,-3.38,-0.26,N[C@@H](CCC(O)=O)C(O)=O,4.27,C5H9NO4,147.1293,"InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1",147.0531578,InChIKey=WHUUTDBJXJRKMK-VKHMYHEASA-N,8.06e+01 g/l,36005,(2S)-2-aminopentanedioic acid,MANUAL,NA,NA,Glutamic acid; (S)-form,DFC,NA,rw1025121,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",L-alpha-amino acids,Aliphatic acyclic compounds,CHEMBL575060,30572,GLT,TRUE,NA,DB00142,NUTR00027,Glutamic Acid,56-86-0,3KX376GY7L,(2S)-2-Aminopentanedioic acid | (S)-2-Aminopentanedioic acid | (S)-Glutamic acid | Glu | L-Glutamate | L-Glutamic acid | L-Glutaminic acid,WHUUTDBJXJRKMK-VKHMYHEASA-N
WLJVXDMOQOGPHL-UHFFFAOYSA-N,135,HMDB0000209,136.0524295,2-phenylacetic acid,Phenylacetic acid,C8H8O2,103-82-2,C07086,FDB010558,NA,NA,PHENYLACETATE,999,10181341,OC(=O)CC1=CC=CC=C1,129,Organic compounds,Benzene and substituted derivatives,Benzenoids,Benzene and substituted derivatives,NA,Aromatic homomonocyclic compounds,1.41,3075,T3D4153,Endogenous,1.41,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,136.0524295,2-phenylacetic acid,Phenylacetic acid,C8H8O2,103-82-2,HMDB00209,NA,C07086,PHENYLACETATE,999,10181341,OC(=O)CC1=CC=CC=C1,Organic compounds,Benzene and substituted derivatives,Benzenoids,Benzene and substituted derivatives,NA,Aromatic homomonocyclic compounds,10560,26112,SmallMoleculeCompound,FDB010558,Phenylacetic acid,TRUE,Solid,low,"Found in essential oils, e.g. neroli, rose oil, free and as esters. Also present in grapes, raspberry, strawberry, cherimoya, other fruits, cheddar cheese, Swiss cheese, wine, black tea, peated malt and other foodstuffs. Flavouring ingredientPhenyl acetate (or phenylacetate) is a carboxylic acid ester that has been found in the biofluids of patients with nephritis and/or hepatitis as well as patients with phenylketonuria (PKU). Excess phenylalanine in the body can be disposed of through a transamination process leading to the production of phenylpyruvate.  The phenylpyruvate can be further metabolized into a number of products. Decarboxylation of phenylpyruvate gives phenylacetate, while a reduction reaction gives phenyllactate.  The phenylacetate can be further conjugated with glutamine to give phenylacetyl glutamine. All of these metabolites can be detected in serum and urine of PKU patients. Phenyl acetate is also produced endogenously as the metabolite of 2-Phenylethylamine, which is mainly metabolized by monoamine oxidase to form phenyl acetate. 2-phenylethylamine is an ""endogenous amphetamine"" which may modulate central adrenergic functions, and the urinary phenyl acetate levels have been postulated as a marker for depression. (PMID: 17978765, 476920, 6857245).  Phenylacetate is also found in essential oils, e.g. neroli, rose oil, free and as esters' and in many fruits.  As a result it is used as a perfumery and flavoring ingredient.; Phenylacetic acid (abr. PAA and synonyms are: ?-toluic acid, benzeneacetic acid, alpha tolylic acid, 2-phenylacetic acid) is an organic compound containing a phenyl functional group and an acetic acid functional group. It is a white solid with a disagreeable odor. Because it is used in the illicit production of phenylacetone (used in the manufacture of meth/amphetamines), it is subject to controls in the United States.",103-82-2,Mp 77-78.5å¡,NA,NA,16.6 mg/mL at 20 oC,1.41,NA,NA,NA,C07086,999,NA,30745,PAC,NA,NA,NA,Phenylacetic_acid,NA,NA,NA,NA,NA,NA,NA,HMDB00209.pdf,application/pdf,175537,2015-02-28 17:50:21 UTC,NA,2,2010-04-08 22:09:11 UTC,2015-10-09 22:28:18 UTC,956,FDG02-B:FDG02-B,HMDB00209,PHENYLACETIC-ACID,NA,1486426,2993,C00000750,Bp0.01 65-70å¡,DFC,-1,NA,NA,NA,NA,NA,C 70.58%; H 5.92%; O 23.50%,DFC,NA,NA,NA,NA,NA,NA,pKa 4.31 (H2O),DFC,"CHIOU,CT et al. (1977)","HANSCH,C ET AL. (1995)",NA,NA,DFC,1.72,1.61,-1.58,OC(=O)CC1=CC=CC=C1,NA,C8H8O2,136.1479,"InChI=1S/C8H8O2/c9-8(10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,9,10)",136.0524295,InChIKey=WLJVXDMOQOGPHL-UHFFFAOYSA-N,3.61e+00 g/l,35275,2-phenylacetic acid,DFC,NA,NA,Phenylacetic acid,DFC,103-82-2,rw1009911,NA,956,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenylacetic acid derivatives,Phenylacetic acid derivatives,Aromatic homomonocyclic compounds,CHEMBL1044,10181341,PHENYLACETATE,TRUE,NA,DB09269,NA,Phenylacetic acid,103-82-2,ER5I1W795A,benzeneacetic acid | Î±-toluic acid | Ï-phenylacetic acid,WLJVXDMOQOGPHL-UHFFFAOYSA-N
WPYMKLBDIGXBTP-UHFFFAOYSA-N,1239,HMDB0001870,122.036779433,benzoic acid,Benzoic acid,C7H6O2,65-85-0,C00180,FDB008739,NA,NA,BENZOATE,243,238,OC(=O)C1=CC=CC=C1,1297,Organic compounds,Benzoic acids,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Aromatic homomonocyclic compounds,1.87,3472,T3D4785,Endogenous,1.87,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,122.036779436,benzoic acid,Benzoic acid,C7H6O2,65-85-0,HMDB01870,DB03793,C00180,1-O6-O-DIGALLOYL-BETA-D-GLUCOSE,243,238,OC(=O)C1=CC=CC=C1,Organic compounds,Benzoic acids,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Aromatic homomonocyclic compounds,8740,21707,SmallMoleculeCompound,FDB008739,Benzoic acid,TRUE,Solid,low,"Widespread in plants esp. in essential oils and fruits, mostly in esterified form. Also present in butter, cooked meats, pork fat, white wine, black and green tea, mushroom and Bourbon vanilla. Used in foodstuffs as antimicrobial and flavouring agent and as preservative. In practical food preservation, the Na salt of benzoic acid is the most widely used form (see <ht>MDQ71-S</ht>). The antimicrobial activity comprises a wide range of microorganisms, particularly yeasts and moulds. Undissociated benzoic acid is more effective than dissociated, thus the preservative action is more efficient in acidic foodstuffs. Typical usage levels are 500-2000 ppm",65-85-0,Mp 122å¡,NA,NA,3.4 mg/mL at 25 oC,1.87,NA,NA,NA,C00539,243,NA,NA,BEZ,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HMDB01870.pdf,application/pdf,48659,2015-02-28 17:59:50 UTC,NA,2,2010-04-08 22:08:13 UTC,2015-10-09 22:31:06 UTC,427,DVN38-Z:DVN38-Z,HMDB01870,BENZOIC-ACID,DB03793,34156,303,C00000207,Bp10 133å¡,DFC,NA,NA,NA,NA,NA,NA,C 68.85%; H 4.95%; O 26.20%,DFC,NA,NA,NA,NA,300 (E1%/1cm 46.8) (MeOH) (Berdy),DFC,4.19,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,1.72,1.63,-1.24,OC(=O)C1=CC=CC=C1,NA,C7H6O2,122.1213,"InChI=1S/C7H6O2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H,8,9)",122.0367794,InChIKey=WPYMKLBDIGXBTP-UHFFFAOYSA-N,7.08e+00 g/l,37191,benzoic acid,DFC,NA,NA,"Benzoic acid, 9CI, USAN",DFC,65-85-0,rw1033731,NA,427,Organic compounds,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Benzoic acids,Aromatic homomonocyclic compounds,CHEMBL541,238,1-O6-O-DIGALLOYL-BETA-D-GLUCOSE,TRUE,NA,DB03793,EXPT00675,Benzoic Acid,65-85-0,8SKN0B0MIM,NA,WPYMKLBDIGXBTP-UHFFFAOYSA-N
WSEQXVZVJXJVFP-FQEVSTJZSA-N,2359,HMDB0005028,324.163791509,"(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile",Escitalopram,C20H21FN2O,128196-01-0,NA,FDB023596,NA,NA,NA,146570,129277,CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,NA,Organic compounds,Phenylbutylamines,Benzenoids,Benzene and substituted derivatives,Phenylbutylamines,Aromatic heteropolycyclic compounds,NA,2416,T3D3007,Exogenous,3.5,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,324.163791509,"(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile",Escitalopram,C20H21FN2O,128196-01-0,HMDB05028,DB01175,NA,NA,146570,129277,CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,Organic compounds,Phenylbutylamines,Benzenoids,Benzene and substituted derivatives,Phenylbutylamines,Aromatic heteropolycyclic compounds,23759,NA,SmallMoleculeCompound,FDB023596,Escitalopram,TRUE,Solid,low,"A furancarbonitrile that is one of the Serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from tardive dyskinesia in preference to tricyclic antidepressants, which aggravate this condition; Escitalopram (Cipralex) is a medication developed by the Danish pharmaceutical company Lundbeck, that acts as a selective serotonin reuptake inhibitor (SSRI). It is typically used as an antidepressant to treat depression associated with mood disorders, although it also may be used in the treatment of body dysmorphic disorder and anxiety, including OCD. In the United States, the drug is marketed under the name Lexapro by Forest Laboratories, Inc; Escitalopram is a medication that acts as a selective serotonin reuptake inhibitor (SSRI). It is typically used as an antidepressant to treat depression associated with mood disorders, although it also may be used in the treatment of body dysmorphic disorder and anxiety, including OCD; Discontinuation from antidepressants, especially abruptly, has been known to cause certain withdrawal symptoms. One possible discontinuation symptom from Escitalopram is a type of spontaneous nerve pulse known as paresthesia or 'electric shock sensations', described by some patients as a feeling of small electric shocks, which may be accompanied by dizziness. These pulses may be short in duration, only milliseconds long, may affect any region of the body, and recur up to several times a minute, throughout all waking hours. They can be increased by physical activity, but are not solely linked to muscular activity. Other discontinuation symptoms include extreme sensitivity to loud sounds and bright lights, chills, hot flushes, cold sweats, reddening of the face, abdominal pain, weight gain and extreme mental fatigue. [HMDB]",128196-01-0,NA,NA,NA,NA,NA,NA,NA,NA,NA,146570,NA,NA,NA,NA,NA,NA,Escitalopram,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2011-09-21 00:32:09 UTC,2015-07-21 06:57:47 UTC,NA,NA,HMDB05028,NA,DB01175,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3.58,3.764304206,-4.74,[H]C1=C([H])C(C#N)=C([H])C2=C1[C@@](OC2([H])[H])(C1=C([H])C([H])=C(F)C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H],NA,C20H21FN2O,324.3919,"InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3/t20-/m0/s1",324.1637915,InChIKey=WSEQXVZVJXJVFP-FQEVSTJZSA-N,5.88e-03 g/l,86148,"(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenylbutylamines,Phenylbutylamines,Aromatic heteropolycyclic compounds,CHEMBL1508,129277,NA,NA,NA,DB01175,APRD00683,Escitalopram,128196-01-0,4O4S742ANY,(+)-Citalopram | (S)-Citalopram | Escitalopram | Escitalopramum | S-(+)-Citalopram | S(+)-Citalopram,WSEQXVZVJXJVFP-FQEVSTJZSA-N
WSFSSNUMVMOOMR-UHFFFAOYSA-N,1098,HMDB0001426,30.010564686,formaldehyde,Formaldehyde,CH2O,50-00-0,C00067,FDB009445,NA,DBMET00531,FORMALDEHYDE,712,692,C=O,3198,Organic compounds,Carbonyl compounds,Organic oxygen compounds,Organooxygen compounds,Carbonyl compounds,Aliphatic acyclic compounds,0.35,197,T3D0244,Exogenous,0.35,"1, carcinogenic to humans. (L135)",NA,SmallMolecule,30.010564686,formaldehyde,Formaldehyde,CH2O,50-00-0,HMDB01426,DB03843,C00067,FORMALDEHYDE,712,692,C=O,Organic compounds,Carbonyl compounds,Organic oxygen compounds,Organooxygen compounds,Carbonyl compounds,Aliphatic acyclic compounds,4859,13805,SmallMoleculeCompound,FDB004858,Aldehydes,TRUE,NA,low,"A compound RC(=O)H, in which a carbonyl group is bonded to one hydrogen atom and to one R group. (ChEBI)",50-00-0,NA,NA,NA,NA,NA,NA,NA,NA,C00071,NA,3371,17478,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:06:25 UTC,2017-02-23 19:50:35 UTC,NA,NA,NA,ALDEHYDES,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,C=O,NA,CH2O,30.026,InChI=1S/CH2O/c1-2/h1H2,30.01056469,WSFSSNUMVMOOMR-UHFFFAOYSA-N,NA,NA,NA,NA,NA,NA,NA,DUKE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB03843,EXPT01444,Formaldehyde,50-00-0,1HG84L3525,Formaldehyde solution | Formalin | Formol | Methanal | Methyl aldehyde | Methylene oxide | Oxomethane | Oxomethylene | Oxymethylene | Paraform | Paraformaldehyde,WSFSSNUMVMOOMR-UHFFFAOYSA-N
WSLDOOZREJYCGB-UHFFFAOYSA-N,10710,HMDB0029571,97.969005542,"1,2-dichloroethane","1,2-Dichloroethane",C2H4Cl2,107-06-2,C06752,FDB000726,NA,NA,NA,11,13837650,ClCCCl,NA,Organic compounds,Organochlorides,Organohalogen compounds,Organochlorides,NA,Aliphatic acyclic compounds,1.48,74,T3D0085,Exogenous,1.48,"2B, possibly carcinogenic to humans. (L135)",NA,SmallMolecule,97.969005542,"1,2-dichloroethane","1,2-Dichloroethane",C2H4Cl2,107-06-2,HMDB29571,DB03733,C06752,CPD-681,11,13837650,ClCCCl,Organic compounds,Organochlorides,Organohalogen compounds,Organochlorides,NA,Aliphatic acyclic compounds,726,1942,SmallMoleculeCompound,FDB000726,"1,2-Dichloroethane",TRUE,NA,low,"Solvent used in food processingThe chemical compound 1,2-dichloroethane, commonly known by its old name of ethylene dichloride (EDC), is a chlorinated hydrocarbon, mainly used to produce vinyl chloride monomer (VCM, chloroethene), the major precursor for PVC production. It is a colourless liquid with a chloroform-like odour. 1,2-Dichloroethane is also used generally as an intermediate for other organic chemical compounds, and as a solvent.",107-06-2,Fp -35.3å¡,NA,NA,8.6 mg/mL at 25 oC,1.48,NA,NA,NA,C06752,11,NA,NA,DCE,NA,NA,NA,"1,2-Dichloroethane",NA,NA,NA,NA,NA,NA,NA,HMDB29571.pdf,application/pdf,51199,2015-02-28 18:03:58 UTC,NA,2,2010-04-08 22:04:41 UTC,2015-07-20 21:33:38 UTC,NA,BGD76-O:BGD76-O,HMDB29571,NA,DB03733,NA,1179,NA,Bp 83-84å¡,DFC,NA,NA,d204<vs=1> 1.25,DFC,NA,NA,C 24.27%; H 4.07%; Cl 71.65%,DFC,NA,NA,n20D<vs=1>  1.4443,DFC,NA,NA,NA,NA,"HORVATH,AL et al. (1999)","HANSCH,C ET AL. (1995)",NA,NA,DFC,1.48,1.5,-1.22,ClCCCl,NA,C2H4Cl2,98.959,InChI=1S/C2H4Cl2/c3-1-2-4/h1-2H2,97.96900554,InChIKey=WSLDOOZREJYCGB-UHFFFAOYSA-N,5.94e+00 g/l,35216,"1,2-dichloroethane",DFC,NA,NA,"1,2-Dichloroethane, 9CI",DFC,NA,NA,NA,NA,Organic compounds,Organohalogen compounds,Organochlorides,NA,Organochlorides,Aliphatic acyclic compounds,CHEMBL16370,13837650,12-DICHLOROETHANE,NA,NA,DB03733,EXPT01133,Ethylene Dichloride,107-06-2,55163IJI47,NA,WSLDOOZREJYCGB-UHFFFAOYSA-N
WSMYVTOQOOLQHP-UHFFFAOYSA-N,2637,HMDB0006112,72.021129372,propanedial,Malondialdehyde,C3H4O2,542-78-9,C19440,FDB008116,DB03057,NA,NA,10964,10499,O=CCC=O,NA,Organic compounds,"1,3-dicarbonyl compounds",Organic oxygen compounds,Organooxygen compounds,Carbonyl compounds,Aliphatic acyclic compounds,NA,3103,T3D4182,Endogenous,NA,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,72.021129372,propanedial,Malondialdehyde,C3H4O2,542-78-9,HMDB06112,DB03057,C19440,NA,10964,10499,O=CCC=O,Chemical entities,"1,3-dicarbonyl compounds",Organic compounds,Organic oxygen compounds,Organooxygen compounds,Aliphatic acyclic compounds,8117,19642,SmallMoleculeCompound,FDB008116,"1,3-Propanedial",TRUE,Solid,low,"Used as an indicator of fatty acid and lipid peroxidation, and oxidative changes in foodsMDA and other ""thiobarbituric reactive substances"" (TBARS) condense with two equivalents of thiobarbituric acid to give a fluorescent red derivative that can be assayed spectrophotometrically. 1-Methyl-2-phenylindole is an alternative more selective reagent.; Malondialdehyde (MDA) is the dialdehyde of malonic acid and a biomarker of oxidative damage to lipids caused by smoking.; Oxidized lipids are able to produce MDA as a decomposition product. The mechanism is thought to involve formation of prostaglandin-like endoperoxides from polyunsaturated fatty acids with two or more double bonds. An alternative mechanism is based on successive hydroperoxide formation and &#946;-cleavage of polyunsaturated fatty acids. MDA is then directly formed by &#946;-scission of a 3-hydroperoxyaldehyde or by reaction between acrolein and hydroxyl radicals. While oxidation of polyunsaturated fatty acids is the major source of MDA in vivo, other minor sources exists such as byproducts of free radical generation by ionizing radiation and of the biosynthesis of prostaglandins. Aldehydes are generally reactive species capable of forming adducts and complexes in biological systems and MDA is no exception although the main species at physiological pH is the enolate ion which is of relative low reactivity. Consistent evidence is available for the reaction between MDA and cellular macromolecules such as proteins, RNA and DNA. MDA reacts with DNA to form adducts to deoxyguanosine and deoxyadenosine which may be mutagenic and these can be quantified in several human tissues. Oxidative stress is an imbalance between oxidants and antioxidants on a cellular or individual level. Oxidative damage is one result of such an imbalance and includes oxidative modification of cellular macromolecules, induction of cell death by apoptosis or necrosis, as well as structural tissue damage. Chemically speaking, oxidants are compounds capable of oxidizing target molecules. This can take place in three ways: abstraction of hydrogen, abstraction of electrons or addition of oxygen. All cells living under aerobic conditions are continuously exposed to a large numbers of oxidants derived from various endogenous and exogenous sources. The endogenous sources of oxidants are several and include the respiratory chain in the mitochondria, immune reactions, enzymes such as xanthine oxidase and nitric oxide synthase and transition metal mediated oxidation. Various exogenous sources of ROS also contribute directly or indirectly to the total oxidant load. These include effects of ionizing and non-ionizing radiation, air pollution and natural toxic gases such as ozone, and chemicals and toxins including oxidizing disinfectants. A poor diet containing inadequate amounts of nutrients may also indirectly result in oxidative stress by impairing cellular defense mechanisms. The cellular macromolecules, in particular lipids, proteins and DNA, are natural targets of oxidation. Oxidants are capable of initiating lipid oxidation by abstraction of an allylic proton from a polyunsaturated fatty acid. This process, by multiple stages leading to the formation of lipid hydroperoxides, is a known contributor to the development of atherosclerosis. (PMID: 17336279); Malondialdehyde is a highly reactive compound that is not typically observed in pure form. In the laboratory it can be generated in situ by hydrolysis of 1,1,3,3-tetramethoxypropane, which is commercially available. It is easily deprotonated to give the sodium salt of the enolate (m.p. 245 å¡C).; Malondialdehyde is the organic compound with the formula CH2(CHO)2. The structure of this species is more complex than this formula suggests. This reactive species occurs naturally and is a marker for oxidative stress.; Reactive oxygen species degrade polyunsaturated lipids, forming malondialdehyde. This compound is a reactive aldehyde and is one of the many reactive electrophile species that cause toxic stress in cells and form covalent protein adducts which are referred to as advanced lipoxidation end products (ALE), in analogy to advanced glycation end-products (AGE). The production of this aldehyde is used as a biomarker to measure the level of oxidative stress in an organism.",542-78-9,Mp 72-74å¡,NA,NA,NA,NA,NA,NA,NA,C19440,10964,NA,NA,MDD,NA,NA,NA,Malondialdehyde,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:07:56 UTC,2015-07-20 22:18:39 UTC,NA,DCG82-W:DCG82-W,HMDB06112,NA,DB03057,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 50.00%; H 5.59%; O 44.40%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DFC,0.1,-0.65,0.52,O=CCC=O,NA,C3H4O2,72.0627,"InChI=1S/C3H4O2/c4-2-1-3-5/h2-3H,1H2",72.02112937,InChIKey=WSMYVTOQOOLQHP-UHFFFAOYSA-N,2.41e+02 g/l,32571,propanedial,DFC,NA,NA,"1,3-Propanedial, 9CI",DFC,NA,NA,NA,NA,Organic compounds,Organooxygen compounds,Carbonyl compounds,"1,3-dicarbonyl compounds","1,3-dicarbonyl compounds",Aliphatic acyclic compounds,CHEMBL446036,10499,NA,NA,NA,DB03057,EXPT02141,Malonaldehyde,NA,4Y8F71G49Q,NA,WSMYVTOQOOLQHP-UHFFFAOYSA-N
WTDRDQBEARUVNC-LURJTMIESA-N,117,HMDB0000181,197.068807845,"(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid",L-Dopa,C9H11NO4,59-92-7,C00355,FDB000567,DB01235,NA,L-DOPA,6047,5824,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O,42,Organic compounds,Tyrosine and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aromatic homomonocyclic compounds,-2.39,2433,T3D3028,Endogenous,-2.39,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,197.068807845,"(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid",L-Dopa,C9H11NO4,59-92-7,HMDB00181,DB01235,C00355,L-DOPA,6047,5824,[H][C@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O,Chemical entities,Tyrosine and derivatives,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Aromatic homomonocyclic compounds,567,1491,SmallMoleculeCompound,FDB000567,L-DOPA,TRUE,Solid,low,"Occurs in seedlings and pods of Vicia fabaL-DOPA (L-3,4-dihydroxyphenylalanine; INN levodopa; trade names Sinemet, Parcopa, Atamet, Stalevo, Madopar, Prolopa, etc.) is a naturally-occurring dietary supplement and psychoactive drug found in certain kinds of food and herbs (e.g., Mucuna pruriens, or velvet bean), and is synthesized from the amino acid L-tyrosine in the mammalian body and brain. (Wikipedia)",59-92-7,Mp 285.5å¡ dec.,NA,NA,5 mg/mL at 20 oC,-2.39,NA,NA,NA,C00355,6047,NA,15765,DAH,NA,NA,NA,L-Dopa,NA,NA,NA,NA,NA,NA,NA,HMDB00181.pdf,application/pdf,48093,2015-02-28 18:03:55 UTC,NA,2,2010-04-08 22:04:37 UTC,2015-10-09 22:29:13 UTC,NA,HHZ68-O:BDR85-N,HMDB00181,L-DOPA|DOPA,DB01235,34719,NA,C00001357,NA,NA,NA,NA,NA,NA,"[a]20D -12.15 (c, 4 in 1N HCl)",DFC,C 54.82%; H 5.62%; N 7.10%; O 32.45%,DFC,NA,NA,NA,NA,NA,NA,2.32,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)",SANGSTER (1993),NA,NA,DFC,-2.32,-1.93,-1.78,N[C@@H](CC1=CC=C(O)C(O)=C1)C(O)=O,9.69,C9H11NO4,197.1879,"InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1",197.0688078,InChIKey=WTDRDQBEARUVNC-LURJTMIESA-N,3.30e+00 g/l,33657,"(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid",MANUAL,NA,NA,"2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid; (S)-form",DFC,NA,rw1253531,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenols and derivatives,Catecholamines and derivatives,Aromatic homomonocyclic compounds,CHEMBL1009,5824,L-DOPA,TRUE,NA,DB01235,APRD00309 | EXPT01107,Levodopa,59-92-7,46627O600J,"(â)-3-(3,4-dihydroxyphenyl)-L-alanine | (â)-dopa | 3-Hydroxy-L-tyrosine | 3,4-Dihydroxy-L-phenylalanine | Dihydroxy-L-phenylalanine | L-3,4-dihydroxyphenylalanine | L-beta-(3,4-Dihydroxyphenyl)alanine | L-DOPA | Levodopum | Î²-(3,4-dihydroxyphenyl)-L-alanine | Î²-(3,4-dihydroxyphenyl)alanine",WTDRDQBEARUVNC-LURJTMIESA-N
WWZKQHOCKIZLMA-UHFFFAOYSA-N,365,HMDB0000482,144.115029756,octanoic acid,Caprylic acid,C8H16O2,124-07-2,C06423,FDB003336,DB04519,NA,CPD-195,379,370,CCCCCCCC(O)=O,5469,Organic compounds,Medium-chain fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,3.05,3346,T3D4594,Endogenous,3.05,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,144.115029756,octanoic acid,Caprylic acid,C8H16O2,124-07-2,HMDB00482,DB04519,C06423,CPD-195,379,370,CCCCCCCC(O)=O,Chemical entities,Medium-chain fatty acids,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Aliphatic acyclic compounds,3337,10290,SmallMoleculeCompound,FDB003336,Octanoic acid,TRUE,Liquid,low,"Widespread in plant oils, free and as glycerides. Also present in apple, banana, orange juice and peel, pineapple, cognac, calamus, blue cheeses, cheddar cheese, Swiss cheese, feta cheese and other cheeses. Flavouring agent, defoamer, lubricant, binder and antimicrobial preservative in cheese wrapsCaprylic acid is the common name for the eight-carbon saturated fatty acid known by the systematic name octanoic acid. It is found naturally in the milk of various mammals, and it is a minor constituent of coconut oil and palm kernel oil. It is an oily liquid that is minimally soluble in water with a slightly unpleasant rancid-like smell. (Wikipedia)",124-07-2,Mp 16å¡,NA,NA,0.789 mg/mL at 30 oC,3.05,NA,NA,NA,C06423,379,NA,28837,OCA,NA,NA,NA,Caprylic acid,NA,NA,NA,NA,NA,NA,NA,HMDB00482.pdf,application/pdf,52260,2015-02-28 18:00:33 UTC,NA,2,2010-04-08 22:05:45 UTC,2015-10-09 22:27:17 UTC,NA,CVZ57-B:CVZ57-B,HMDB00482,OCTOIC-ACID|CAPRYLIC-ACID|OCTANOIC-ACID|N-CAPRYLIC-ACID,DB04519,48223,2753,C00001231,Bp10 124å¡,DFC,NA,NA,d204<vs=1> 0.91,DFC,NA,NA,C 66.63%; H 11.18%; O 22.19%,DFC,NA,NA,n20D<vs=1>  1.4335,DFC,NA,NA,pKa 4.89 (25å¡),DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,2.92,2.7,-2.2,CCCCCCCC(O)=O,NA,C8H16O2,144.2114,"InChI=1S/C8H16O2/c1-2-3-4-5-6-7-8(9)10/h2-7H2,1H3,(H,9,10)",144.1150298,InChIKey=WWZKQHOCKIZLMA-UHFFFAOYSA-N,9.07e-01 g/l,34714,octanoic acid,MANUAL,NA,NA,"Octanoic acid, 9CI, INN, USAN",DFC,124-07-2,rw1009091,NA,NA,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Medium-chain fatty acids,Aliphatic acyclic compounds,CHEMBL324846,370,CPD-195,TRUE,NA,DB04519,EXPT02413,Caprylic acid,124-07-2,OBL58JN025,capryloate | Caprylsaeure | Enantic acid | Kaprylsaeure | n-caprylic acid | n-octanoic acid | n-Octoic acid | n-octylic acid | neo-fat 8 | octanoate | octanoic acid | Octic acid | octoic acid | Octylic acid,WWZKQHOCKIZLMA-UHFFFAOYSA-N
WWZKQHOCKIZLMA-UHFFFAOYSA-N,42135,HMDB0062511,144.115029756,octanoic acid,octanoate radical,C8H16O2,74-81-7,NA,FDB031069,NA,NA,NA,119389,NA,CCCCCCCC(O)=O,NA,Organic compounds,Medium-chain fatty acids,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Aliphatic acyclic compounds,3.01,3346,T3D4594,Endogenous,3.05,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,144.115029756,octanoic acid,Caprylic acid,C8H16O2,124-07-2,HMDB00482,DB04519,C06423,CPD-195,379,370,CCCCCCCC(O)=O,Chemical entities,Medium-chain fatty acids,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Aliphatic acyclic compounds,3337,10290,SmallMoleculeCompound,FDB003336,Octanoic acid,TRUE,Liquid,low,"Widespread in plant oils, free and as glycerides. Also present in apple, banana, orange juice and peel, pineapple, cognac, calamus, blue cheeses, cheddar cheese, Swiss cheese, feta cheese and other cheeses. Flavouring agent, defoamer, lubricant, binder and antimicrobial preservative in cheese wrapsCaprylic acid is the common name for the eight-carbon saturated fatty acid known by the systematic name octanoic acid. It is found naturally in the milk of various mammals, and it is a minor constituent of coconut oil and palm kernel oil. It is an oily liquid that is minimally soluble in water with a slightly unpleasant rancid-like smell. (Wikipedia)",124-07-2,Mp 16å¡,NA,NA,0.789 mg/mL at 30 oC,3.05,NA,NA,NA,C06423,379,NA,28837,OCA,NA,NA,NA,Caprylic acid,NA,NA,NA,NA,NA,NA,NA,HMDB00482.pdf,application/pdf,52260,2015-02-28 18:00:33 UTC,NA,2,2010-04-08 22:05:45 UTC,2015-10-09 22:27:17 UTC,NA,CVZ57-B:CVZ57-B,HMDB00482,OCTOIC-ACID|CAPRYLIC-ACID|OCTANOIC-ACID|N-CAPRYLIC-ACID,DB04519,48223,2753,C00001231,Bp10 124å¡,DFC,NA,NA,d204<vs=1> 0.91,DFC,NA,NA,C 66.63%; H 11.18%; O 22.19%,DFC,NA,NA,n20D<vs=1>  1.4335,DFC,NA,NA,pKa 4.89 (25å¡),DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,2.92,2.7,-2.2,CCCCCCCC(O)=O,NA,C8H16O2,144.2114,"InChI=1S/C8H16O2/c1-2-3-4-5-6-7-8(9)10/h2-7H2,1H3,(H,9,10)",144.1150298,InChIKey=WWZKQHOCKIZLMA-UHFFFAOYSA-N,9.07e-01 g/l,34714,octanoic acid,MANUAL,NA,NA,"Octanoic acid, 9CI, INN, USAN",DFC,124-07-2,rw1009091,NA,NA,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Medium-chain fatty acids,Aliphatic acyclic compounds,CHEMBL324846,370,CPD-195,TRUE,NA,DB04519,EXPT02413,Caprylic acid,124-07-2,OBL58JN025,capryloate | Caprylsaeure | Enantic acid | Kaprylsaeure | n-caprylic acid | n-octanoic acid | n-Octoic acid | n-octylic acid | neo-fat 8 | octanoate | octanoic acid | Octic acid | octoic acid | Octylic acid,WWZKQHOCKIZLMA-UHFFFAOYSA-N
XBDQKXXYIPTUBI-UHFFFAOYSA-N,159,HMDB0000237,74.036779436,propanoic acid,Propionic acid,C3H6O2,79-09-4,C00163,FDB008285,DB03766,NA,PROPIONATE,1032,1005,CCC(O)=O,3215,Organic compounds,Carboxylic acids,Organic acids and derivatives,Carboxylic acids and derivatives,Carboxylic acids,Aliphatic acyclic compounds,0.33,3228,T3D4444,Endogenous,0.33,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,74.036779436,propanoic acid,Propionic acid,C3H6O2,79-09-4,HMDB00237,DB03766,C00163,PROPIONATE,1032,1005,CCC(O)=O,Organic compounds,Carboxylic acids,Organic acids and derivatives,Carboxylic acids and derivatives,Carboxylic acids,Aliphatic acyclic compounds,8286,20281,SmallMoleculeCompound,FDB008285,Propanoic acid,TRUE,Liquid,low,"Present in apples, fruit juices, beef, beer, bread, cocoa, dairy products, e.g. ripe Swiss or Jarlsberg cheese, and roasted peanuts. Flavouring ingredient. Preservative used esp. in bread and mould inhibitors",1979-09-04,Mp -21.5å¡,NA,NA,1000 mg/mL at 25 oC,0.33,NA,NA,NA,C00163,1032,NA,30768,PPI,NA,NA,NA,Propionic acid,NA,NA,NA,NA,NA,NA,NA,HMDB00237.pdf,application/pdf,50064,2015-02-28 17:51:45 UTC,NA,2,2010-04-08 22:08:00 UTC,2015-10-09 22:30:20 UTC,NA,DFP47-D:DFP47-D,HMDB00237,PROPIONIC-ACID,DB03766,34098,3182,NA,Bp10 39.7å¡,DFC,NA,NA,d1515 1,DFC,NA,NA,C 48.64%; H 8.16%; O 43.20%,DFC,NA,NA,NA,NA,NA,NA,4.88,NA,US EPA (1981),"HANSCH,C ET AL. (1995)",NA,NA,DFC,0.31,0.48,0.68,CCC(O)=O,NA,C3H6O2,74.0785,"InChI=1S/C3H6O2/c1-2-3(4)5/h2H2,1H3,(H,4,5)",74.03677944,InChIKey=XBDQKXXYIPTUBI-UHFFFAOYSA-N,3.52e+02 g/l,34731,propanoic acid,MANUAL,NA,NA,"Propanoic acid, 9CI",DFC,1979-09-04,rw1001661,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Carboxylic acids,Carboxylic acids,Aliphatic acyclic compounds,CHEMBL14021,1005,PROPIONATE,TRUE,NA,DB03766,EXPT02641,Propanoic acid,79-09-4,JHU490RVYR,Propionic acid,XBDQKXXYIPTUBI-UHFFFAOYSA-N
XEEYBQQBJWHFJM-UHFFFAOYSA-N,9727,HMDB0015531,55.934942133,\xce\xbb\xc2\xb2-iron(2+) ion,Iron,Fe,7439-89-6,C00023,NA,DB01592,NA,NA,23925,22368,[Fe],NA,Inorganic compounds,Homogeneous transition metal compounds,Homogeneous metal compounds,Homogeneous transition metal compounds,NA,NA,NA,3396,T3D4697,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,Estimates of a lethal dosage range from 180 milligrams per kilogram and upwards.,SmallMolecule,55.934942133,iron,Iron,Fe,7439-89-6,HMDB15531,DB01592,C00023,NA,23925,22368,[Fe],Chemical entities,Homogeneous transition metal compounds,Inorganic compounds,Homogeneous metal compounds,Homogeneous transition metal compounds,NA,16258,42761,SmallMoleculeCompound,FDB016251,Iron,TRUE,Solid,low,The following forms of Fe are used as nutrient supplements: carbonyl iron derived by decompn. of Fe(CO)5; electrolytic iron derived by electrodeposition; reduced iron obtained by a chem. process,15438-31-0,Mp 1535å¡,NA,NA,NA,NA,NA,NA,NA,C14818,27284,NA,18248,FE2,NA,NA,NA,Iron,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2010-04-08 22:12:19 UTC,2015-07-20 23:27:50 UTC,NA,KPN01-S:KPN01-S,HMDB00692,IRON,DB01592,33552,1815,NA,Bp 3000å¡ (2750å¡),DFC,NA,NA,NA,NA,NA,NA,Fe 100.00%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DFC,NA,-0.77,NA,[Fe],NA,Fe,55.845,InChI=1S/Fe,55.93494213,InChIKey=XEEYBQQBJWHFJM-UHFFFAOYSA-N,NA,36640,iron,DFC,NA,NA,Iron,DFC,NA,NA,NA,NA,Inorganic compounds,Homogeneous metal compounds,Homogeneous transition metal compounds,NA,Homogeneous transition metal compounds,Acyclic compounds,NA,25394,Ferric-Hydroxamate-Complexes,NA,NA,DB01592,NA,Iron,7439-89-6,E1UOL152H7,"Carbonyl iron | Eisen | Electrolytic iron | Fe | fer | Ferrum | Ferrum metallicum | Hierro | Iron powder | Iron, carbonyl | Iron, electrolytic | Iron, elemental | Iron, reduced | Reduced iron",XEEYBQQBJWHFJM-UHFFFAOYSA-N
XPFRXWCVYUEORT-UHFFFAOYSA-N,9486,HMDB0015253,178.074227574,(2-phenylacetyl)urea,Phenacemide,C9H10N2O2,63-98-9,C07428,NA,DB01121,NA,NA,4753,4589,NC(=O)NC(=O)CC1=CC=CC=C1,NA,Organic compounds,Phenylacetamides,Benzenoids,Benzene and substituted derivatives,Phenylacetamides,Aromatic homomonocyclic compounds,0.8,2402,T3D2990,Exogenous,0.87,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,178.074227574,(2-phenylacetyl)urea,Phenacemide,C9H10N2O2,63-98-9,HMDB15253,DB01121,C07428,NA,4753,4589,OC(=N)N=C(O)CC1=CC=CC=C1,Chemical entities,Phenylacetamides,Organic compounds,Benzenoids,Benzene and substituted derivatives,Aromatic homomonocyclic compounds,7357,18232,SmallMoleculeCompound,FDB007356,Fenugrin E,TRUE,NA,low,NA,63-98-9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:07:34 UTC,2017-03-01 02:05:27 UTC,NA,NA,NA,FENUGRIN-E,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NC(=O)NC(=O)CC1=CC=CC=C1,NA,C9H10N2O2,178.1879,"InChI=1S/C9H10N2O2/c10-9(13)11-8(12)6-7-4-2-1-3-5-7/h1-5H,6H2,(H3,10,11,12,13)",178.0742276,XPFRXWCVYUEORT-UHFFFAOYSA-N,NA,NA,NA,NA,NA,NA,NA,DUKE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB01121,APRD00089,Phenacemide,63-98-9,PAI7J52V09,NA,XPFRXWCVYUEORT-UHFFFAOYSA-N
XSTXAVWGXDQKEL-UHFFFAOYSA-N,10728,HMDB0029593,129.914383153,"1,1,2-trichloroethene",Trichloroethylene,C2HCl3,79-01-6,C06790,FDB000752,NA,NA,NA,6575,13837280,ClC=C(Cl)Cl,NA,Organic compounds,Vinyl chlorides,Organohalogen compounds,Vinyl halides,Vinyl chlorides,Aliphatic acyclic compounds,2.42,14,T3D0016,Exogenous,2.42,"1, carcinogenic to humans. (L135)",3 to 5 mg/kg for an adult human. (L138),SmallMolecule,129.914383153,"1,1,2-trichloroethene",Trichloroethylene,C2HCl3,1979-01-06,HMDB29593,NA,C06790,TRICHLOROETHENE,6575,13837280,ClC=C(Cl)Cl,Chemical entities,Vinyl chlorides,Organic compounds,Organohalogen compounds,Vinyl halides,Aliphatic acyclic compounds,752,2049,SmallMoleculeCompound,FDB000752,Trichloroethylene,TRUE,NA,low,"Solvent and extractive in the manuf. of foodsA spot was then ultimately chosen to receive and treat the contaminated drinking water known as the Central Groundwater Treatment Facility. Then 1989, as now, this treatment facility (CGTF) is situated on land adjacent to Pima Park and the Siemens facility documented as one of the Potentially Responsible Parties at the corner of Thomas and Pima roads. Close proximity to this park did not appear to enter into Motorola's calculations when asserting that it would save money to remove the carbon air filters in 2007. (See East Valley Tribune, October 5, 2007, ""Motorola wants to axe filters at Superfund site"" by Ari Cohn); As of 2007, 57,000 thousand pounds, or roughly 19 tons of TCE have been removed from the system of wells that once supplied drinking water to the residents of Scottsdale. One of the three drinking water wells previously owned by the City of Phoenix and ultimately sold to the City of Scottsdale, tested at 390 ppb TCE when it was closed in 1982. (see East Valley Tribune, April 6, 2007, ""Feds to Examine Superfund Site"" by John Yantis) Some Scottsdale residents who received their water bills from the City of Phoenix throughout the 1960s and 70's were understandably confused as to whether they indeed had been consuming contaminated water when information about the Superfund site was first disseminated. The City of Scottsdale recently updated their website to clarify that the contaminated wells were ""in the Scottsdale area"" and to delete all references to the levels of TCE discovered when the wells were closed as ""trace"".; One recent review of the epidemiology of kidney cancer rated cigarette smoking and obesity as more important risk factors for kidney cancer than exposure to solvents such as trichloroethylene. In contrast, the most recent overall assessment of human health risks associated with trichloroethylene states, ""[t]here is concordance between animal and human studies, which supports the conclusion that trichloroethylene is a potential kidney carcinogen"". The evidence appears to be less certain at this time regarding the relationship between humans and liver cancer observed in mice, with the NAS suggesting that low-level exposure might not represent a significant liver cancer risk in the general population.; The chemical compound trichloroethylene is a chlorinated hydrocarbon commonly used as an industrial solvent. It is a clear non-flammable liquid with a sweet smell.; The first known report of TCE in groundwater was given in 1949 by two English public chemists who described two separate instances of well contamination by industrial releases of TCE. Based on available federal and state surveys, between 9% to 34% of the drinking water supply sources tested in the U.S. may have some TCE contamination, though EPA has reported that most water supplies are in compliance with the Maximum Contaminant Level (MCL) of 5 ppb. In addition, a growing concern in recent years at sites with TCE contamination in soil or groundwater has been vapor intrusion in buildings, which has resulted in indoor air exposures, such is in a recent case in the McCook Field Neighborhood of Dayton, Ohio. Trichloroethylene has been detected in 852 Superfund sites across the United States, according to the Agency for Toxic Substances and Disease Registry (ATSDR). Under the Safe Drinking Water Act of 1974, and as amended annual water quality testing is required for all public drinking water distributors. The EPA'S current guidelines for TCE can be found here. It should be noted that the EPA's table of ""TCE Releases to Ground"" is dated 1987 to 1993, thereby omitting one of the largest Superfund Cleanup sites in the nation, the NIBW in Scottsdale, Arizona. The TCE ""released"" here occurred prior to its appearance in the municipal drinking wells in 1982.; This reaction can be catalyzed by a variety of substances. The most commonly used catalyst is a mixture of potassium chloride and aluminum chloride. However, various forms of porous carbon can also be used. This reaction produces tetrachloroethylene as a byproduct, and depending on the amount of chlorine fed to the reaction, tetrachloroethylene can even be the major product. Typically, trichloroethylene and tetrachloroethylene are collected together and then separated by distillation.; Trichloroethylene is a cleaning solvent that was used to clean military weapons during the Gulf War. There are reports associating exposure to this solvent with amyotrophic lateral sclerosis (Kasarskis EJ et al. Amyotrophic Lateral Sclerosis, 2008 Sep 16:1-7, Clinical aspects of ALS in Gulf War Veterans), and also with a neurologic syndrome resembling Parkinson's disease (Gash DM. et al. Ann Neurol. 2008 Feb;63(2):184-92. Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity).; Trichloroethylene is an effective solvent for a variety of organic materials.",1979-01-06,Mp -84.8å¡ (-86.8),NA,NA,1.28 mg/mL at 25 oC,2.42,NA,NA,NA,C06790,6575,NA,16602,NA,NA,NA,NA,Trichloroethylene,NA,NA,NA,NA,NA,NA,NA,HMDB29593.pdf,application/pdf,49568,2015-02-28 18:10:49 UTC,NA,NA,2010-04-08 22:04:42 UTC,2015-07-20 21:34:03 UTC,NA,BGT75-P:BGT75-P,HMDB29593,NA,NA,NA,3723,NA,Bp60 20å¡,DFC,NA,NA,d204<vs=1> 1.46,DFC,NA,NA,C 18.28%; H 0.77%; Cl 80.95%,DFC,NA,NA,n20D<vs=1>  1.4775,DFC,NA,NA,NA,NA,"HORVATH,AL et al. (1999)","HANSCH,C ET AL. (1995)",NA,NA,DFC,2.45,2.18,-1.83,ClC=C(Cl)Cl,NA,C2HCl3,131.388,InChI=1S/C2HCl3/c3-1-2(4)5/h1H,129.9143832,InChIKey=XSTXAVWGXDQKEL-UHFFFAOYSA-N,1.96e+00 g/l,37522,"1,1,2-trichloroethene",DFC,NA,NA,"Trichloroethylene, 8CI, INN",DFC,NA,NA,NA,NA,Organic compounds,Organohalogen compounds,Vinyl halides,Vinyl chlorides,Vinyl chlorides,Aliphatic acyclic compounds,CHEMBL279816,13837280,TRICHLOROETHENE,NA,NA,DB13323,NA,Trichloroethylene,79-01-6,290YE8AR51,"1,1-dichloro-2-chloroethylene | acetylene trichloride | ethinyl trichloride | ethylene trichloride | Narcogen | TCE | trichlor | TrichlorÃ¤then | TrichlorÃ¤thylen | trichlorÃ©thylÃ¨ne | Trichloroethene | trichloroÃ©thylÃ¨ne | trichloroethylenum | triciene",XSTXAVWGXDQKEL-UHFFFAOYSA-N
XUJNEKJLAYXESH-REOHCLBHSA-N,447,HMDB0000574,121.019749163,(2R)-2-amino-3-sulfanylpropanoic acid,L-Cysteine,C3H7NO2S,52-90-4,C00097,FDB012678,DB00151,DBMET00503,CYS,5862,5653,N[C@@H](CS)C(O)=O,5556,Organic compounds,Cysteine and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,-2.49,3077,T3D4156,Endogenous,-2.49,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,121.019749163,(2R)-2-amino-3-sulfanylpropanoic acid,L-Cysteine,C3H7NO2S,52-90-4,HMDB00574,DB00151,C00097,CYS,5862,5653,[H][C@](N)(CS)C(O)=O,Organic compounds,Cysteine and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,12681,33233,SmallMoleculeCompound,FDB012678,L-Cysteine,TRUE,Solid,low,"Detoxicant, dietary supplement, dough strengthener, yeast nutrient for leavened bakery products. Flavouring agent. Enzymic browning inhibitor",52-90-4,Mp 178å¡ dec.,NA,NA,277 mg/mL at 25 oC,-2.49,NA,NA,NA,C00097,5862,NA,17561,CYS,NA,NA,NA,L-Cysteine,NA,NA,NA,NA,NA,NA,NA,HMDB00574.pdf,application/pdf,48720,2015-02-28 17:47:56 UTC,NA,2,2010-04-08 22:10:18 UTC,2015-10-09 22:29:24 UTC,NA,HJQ86-N:HJQ81-I,HMDB00574,CYSTEINE,DB00151,33843,813,C00001351,NA,NA,NA,NA,NA,NA,[a]D +26.5 (5M HCl),DFC,C 29.74%; H 5.82%; N 11.56%; O 26.41%; S 26.47%,DFC,NA,NA,NA,NA,NA,NA,pKa3 10.46 (SH),DFC,BEILSTEIN,"HANSCH,C ET AL. (1995)",NA,NA,DFC,-2.57,-2.93,-0.72,N[C@@H](CS)C(O)=O,10.17,C3H7NO2S,121.158,"InChI=1S/C3H7NO2S/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1",121.0197492,InChIKey=XUJNEKJLAYXESH-REOHCLBHSA-N,2.31e+01 g/l,28290,(2R)-2-amino-3-sulfanylpropanoic acid,MANUAL,NA,NA,"Cysteine, INN; (R)-form",DFC,NA,rw1018061,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",L-alpha-amino acids,Aliphatic acyclic compounds,CHEMBL863,5653,CYS,TRUE,NA,DB00151,NUTR00018 | DB04443 | DB09485,L-Cysteine,52-90-4,K848JZ4886,(2R)-2-amino-3-mercaptopropanoic acid | (2R)-2-amino-3-sulfanylpropanoic acid | (R)-2-Amino-3-mercaptopropanoic acid | Cys | Cysteine | Free Cysteine | L-2-Amino-3-mercaptopropionic acid | L-Cys | L-Cystein | L-Zystein,XUJNEKJLAYXESH-REOHCLBHSA-N
XZWYZXLIPXDOLR-UHFFFAOYSA-N,1275,HMDB0001921,129.101445377,"1-carbamimidamido-N,N-dimethylmethanimidamide","1,1-Dimethylbiguanide",C4H11N5,1115-70-4,C07151,FDB022739,NA,NA,NA,4091,3949,CN(C)C(=N)NC(N)=N,6390,Organic compounds,Biguanides,Organic nitrogen compounds,Organonitrogen compounds,Guanidines,Aliphatic acyclic compounds,NA,2588,T3D3522,Exogenous,-0.5,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,129.101445377,"1-carbamimidamido-N,N-dimethylmethanimidamide","1,1-Dimethylbiguanide",C4H11N5,657-24-9,HMDB01921,DB00331,C07151,NA,4091,3949,CN(C)C(=N)NC(N)=N,Organic compounds,Biguanides,Organic nitrogen compounds,Organonitrogen compounds,Guanidines,Aliphatic acyclic compounds,22902,NA,SmallMoleculeCompound,FDB022739,"1,1-Dimethylbiguanide",TRUE,Solid,low,"1,1-Dimethylbiguanide or Metformin is a biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves  glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. Metformin is the most popular anti-diabetic drug in the United States and one of the most prescribed drugs in the country overall, with nearly 35 million prescriptions filled in 2006 for generic metformin alone. [HMDB]",657-24-9,NA,NA,NA,NA,NA,NA,NA,NA,C07151,4091,NA,NA,NA,NA,NA,NA,Glucophage,NA,NA,NA,NA,NA,NA,NA,HMDB01921.pdf,application/pdf,154627,2015-02-28 17:44:55 UTC,NA,NA,2011-09-21 00:18:52 UTC,2015-07-21 06:57:20 UTC,NA,NA,HMDB01921,NA,DB00331,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-1.83,-0.918429265,-1.97,[H]N=C(N([H])[H])N([H])C(=N[H])N(C([H])([H])[H])C([H])([H])[H],NA,C4H11N5,129.1636,"InChI=1S/C4H11N5/c1-9(2)4(7)8-3(5)6/h1-2H3,(H5,5,6,7,8)",129.1014454,InChIKey=XZWYZXLIPXDOLR-UHFFFAOYSA-N,1.38e+00 g/l,85013,"1-carbamimidamido-N,N-dimethylmethanimidamide",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organonitrogen compounds,Guanidines,Biguanides,Biguanides,Aliphatic acyclic compounds,CHEMBL1431,3949,NA,NA,NA,DB00331,APRD01099,Metformin,657-24-9,9100L32L2N,"1,1-Dimethylbiguanide | Dimethylbiguanid | Metformin | Metformina | Metformine | Metforminum",XZWYZXLIPXDOLR-UHFFFAOYSA-N
YCIMNLLNPGFGHC-UHFFFAOYSA-N,761,HMDB0000957,110.036779436,"benzene-1,2-diol",Pyrocatechol,C6H6O2,120-80-9,C00090,FDB001512,DB02232,NA,CATECHOL,289,13837760,OC1=CC=CC=C1O,282,Organic compounds,Catechols,Benzenoids,Phenols,Benzenediols,Aromatic homomonocyclic compounds,0.88,3332,T3D4575,Exogenous,0.88,"2B, possibly carcinogenic to humans. (L135)",NA,SmallMolecule,110.036779436,"benzene-1,2-diol",Pyrocatechol,C6H6O2,120-80-9,HMDB00957,DB02232,C00090,CATECHOL,289,13837760,OC1=CC=CC=C1O,Organic compounds,Catechols,Benzenoids,Phenols,Benzenediols,Aromatic homomonocyclic compounds,1512,4721,SmallMoleculeCompound,FDB001512,"1,2-Benzenediol",TRUE,Solid,low,"Constit. of var. foodstuffs esp. coffee, cocoa, bread crust, roasted malt and beer; Isol. from various plant sources and by hydrol. of tannins (CCD)",12385-08-9,105 oC,NA,NA,461 mg/mL at 25 oC,0.88,NA,NA,NA,C15571,289,NA,18135,CAQ,NA,NA,NA,Pyrocatechol,NA,NA,NA,NA,NA,NA,NA,HMDB00957.pdf,application/pdf,50427,2015-02-28 17:52:02 UTC,NA,2,2010-04-08 22:05:00 UTC,2015-10-09 22:29:08 UTC,654,HJX14-Z:HJX14-Z,HMDB00957,PYROCATECHOL|(+)-CATECHOL|CATECHOL,DB02232,NA,NA,C00002644,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9.45,NA,"YALKOWSKY,SH & HE,Y (2003)","HANSCH,C ET AL. (1995)",NA,NA,NA,0.74,1.37,-0.17,OC1=CC=CC=C1O,12.79,C6H6O2,110.1106,"InChI=1S/C6H6O2/c7-5-3-1-2-4-6(5)8/h1-4,7-8H",110.0367794,InChIKey=YCIMNLLNPGFGHC-UHFFFAOYSA-N,7.50e+01 g/l,41224,"benzene-1,2-diol",MANUAL,NA,NA,NA,KNAPSACK,NA,NA,NA,654,Organic compounds,Benzenoids,Benzene and substituted derivatives,Phenols and derivatives,Catechols,Aromatic homomonocyclic compounds,CHEMBL280998,13837760,CATECHOL,TRUE,NA,DB02232,EXPT00830,"1,2-Dihydroxybenzene",120-80-9,LF3AJ089DQ,NA,YCIMNLLNPGFGHC-UHFFFAOYSA-N
YCOXTKKNXUZSKD-UHFFFAOYSA-N,13203,HMDB0032151,122.073164942,"3,4-dimethylphenol","3,4-Dimethylphenol",C8H10O,95-65-8,NA,FDB008879,DB04052,NA,NA,7249,13839105,CC1=CC=C(O)C=C1C,NA,Organic compounds,Para cresols,Benzenoids,Phenols,Cresols,Aromatic homomonocyclic compounds,2.23,3510,T3D4826,Exogenous,2.23,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,122.073164942,"3,4-dimethylphenol","3,4-Dimethylphenol",C8H10O,95-65-8,HMDB32151,DB04052,NA,NA,7249,13839105,CC1=CC=C(O)C=C1C,Chemical entities,Para cresols,Organic compounds,Benzenoids,Phenols,Aromatic homomonocyclic compounds,8880,22162,SmallMoleculeCompound,FDB008879,"3,4-Dimethylphenol",TRUE,NA,low,Present in coffee. Flavouring ingredient,95-65-8,Mp 62-64å¡,NA,NA,4.76 mg/mL at 25 oC,2.23,NA,NA,NA,NA,7249,NA,39839,2MP,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:08:18 UTC,2015-07-20 22:26:53 UTC,NA,DZZ74-R:DZZ74-R,HMDB32151,NA,DB04052,NA,3883,NA,Bp 227å¡,DFC,NA,NA,NA,NA,NA,NA,C 78.65%; H 8.25%; O 13.10%,DFC,NA,NA,NA,NA,NA,NA,pKa1 10.36 (25å¡),DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,2.41,2.696523273,-1.35,CC1=CC=C(O)C=C1C,NA,C8H10O,122.1644,"InChI=1S/C8H10O/c1-6-3-4-8(9)5-7(6)2/h3-5,9H,1-2H3",122.0731649,InChIKey=YCOXTKKNXUZSKD-UHFFFAOYSA-N,5.45e+00 g/l,36031,"3,4-dimethylphenol",HMDB_from_dfc,NA,NA,"3,4-Dimethylphenol, 9CI",DFC,NA,rw1036991,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Toluenes,Nitrotoluenes,Aromatic homomonocyclic compounds,CHEMBL192008,13839105,CPD-10888,NA,NA,DB04052,EXPT00131,"3,4-Dimethylphenol",NA,4L479F5JU6,NA,YCOXTKKNXUZSKD-UHFFFAOYSA-N
YDGMGEXADBMOMJ-LURJTMIESA-N,1179,HMDB0001539,202.14297584,(2S)-2-amino-5-[(E)-[amino(dimethylamino)methylidene]amino]pentanoic acid,Asymmetric dimethylarginine,C8H18N4O2,30315-93-6,C03626,FDB000508,DB01686,NA,CPD-596,123831,110375,N[C@@H](CCC\N=C(/N)N(C)C)C(O)=O,6309,Organic compounds,Arginine and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,NA,3092,T3D4171,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,202.14297584,(2S)-2-amino-5-[(E)-[amino(dimethylamino)methylidene]amino]pentanoic acid,Asymmetric dimethylarginine,C8H18N4O2,30315-93-6,HMDB01539,DB01686,C03626,CPD-596,123831,110375,[H][C@](N)(CCCNC(=N)N(C)C)C(O)=O,Chemical entities,Arginine and derivatives,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Aliphatic acyclic compounds,508,1258,SmallMoleculeCompound,FDB000508,"NG,NG-Dimethyl-L-arginine",TRUE,Solid,low,Isol. from broad bean seeds (Vicia faba),30315-93-6,Mp 198-201å¡ (hydrochloride),NA,NA,NA,NA,NA,NA,NA,C03626,123831,NA,17929,DA2,NA,NA,NA,Asymmetric dimethylarginine,NA,NA,NA,NA,NA,NA,NA,HMDB01539.pdf,application/pdf,122428,2015-02-28 17:48:52 UTC,NA,2,2010-04-08 22:04:36 UTC,2015-07-20 21:31:58 UTC,NA,BCZ64-N:BCZ65-O,HMDB01539,NA,DB01686,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 47.51%; H 8.97%; N 27.70%; O 15.82%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DFC,-3.15,-3.81,-2.12,CN(C)C(=N)NCCC[C@H](N)C(O)=O,NA,C8H18N4O2,202.2541,"InChI=1S/C8H18N4O2/c1-12(2)8(10)11-5-3-4-6(9)7(13)14/h6H,3-5,9H2,1-2H3,(H2,10,11)(H,13,14)/t6-/m0/s1",202.1429758,InChIKey=YDGMGEXADBMOMJ-LURJTMIESA-N,1.52e+00 g/l,32411,NA,MANUAL,NA,NA,"NG,NG-Dimethylarginine; (S)-form",DFC,NA,NA,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",D-alpha-amino acids,Aliphatic acyclic compounds,CHEMBL457530,110375,CPD-596,NA,NA,DB01686,EXPT01101,"N,N-dimethylarginine",30315-93-6,63CV1GEK3Y,"ADMA | Asymmetric dimethylarginine | dimethyl-L-arginine | Guanidino-n,n-dimethylarginine | L-NG,NG-dimethylarginine | N(5)-((Dimethylamino)iminomethyl)-L-ornithine | N(5)-[(dimethylamino)(imino)methyl]-L-ornithine | N(g)-dimethylarginine | N(g),N(g)-dimethyl-l-arginine | N(g),N(g)-dimethylarginine | N(G1),N(G1)-Dimethylarginine | N(omega),N(omega)-dimethyl-l-arginine | NG,NG-dimethyl-l-arginine",YDGMGEXADBMOMJ-LURJTMIESA-N
YEJRWHAVMIAJKC-UHFFFAOYSA-N,424,HMDB0000549,86.036779436,oxolan-2-one,Gamma-Butyrolactone,C4H6O2,96-48-0,C01770,FDB003392,DB04699,NA,NA,7302,7029,O=C1CCCO1,5533,Organic compounds,Gamma butyrolactones,Organoheterocyclic compounds,Lactones,Gamma butyrolactones,Aliphatic heteromonocyclic compounds,-0.64,2087,T3D2562,Endogenous,-0.64,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,86.036779436,oxolan-2-one,Gamma-Butyrolactone,C4H6O2,96-48-0,HMDB00549,DB04699,C01770,CPD-10135,7302,7029,O=C1CCCO1,Organic compounds,Gamma butyrolactones,Organoheterocyclic compounds,Lactones,Gamma butyrolactones,Aliphatic heteromonocyclic compounds,3393,10490,SmallMoleculeCompound,FDB003392,gamma-Butyrolactone,TRUE,Liquid,low,"Present in morello cherry, melon, pineapple, blackberry, quince, strawberry jam, wine, soybeans, black tea, Bourbon vanilla, wheat bread, crispbread and other breads. Flavour ingredient [DFC]",96-48-0,-45,NA,NA,1000 mg/mL,-0.64,NA,NA,NA,C01770,7302,NA,42639,GBL,NA,NA,NA,4-Hydroxybutyric acid lactone,NA,NA,NA,NA,NA,NA,NA,HMDB00549.pdf,application/pdf,163093,2015-02-28 17:54:15 UTC,NA,2,2010-04-08 22:05:47 UTC,2015-10-09 22:30:51 UTC,NA,CXH55-B:CXH55-B,HMDB00549,GAMMA-BUTYROLACTONE,DB04699,NA,1728,NA,Bp12 89å¡,DFC,NA,NA,d0 1.44,DFC,NA,NA,C 55.81%; H 7.02%; O 37.17%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,"WEAST,RC (1972)","HANSCH,C ET AL. (1995)",NA,NA,NA,-0.11,0.15,0.44,O=C1CCCO1,NA,C4H6O2,86.0892,InChI=1S/C4H6O2/c5-4-2-1-3-6-4/h1-3H2,86.03677944,InChIKey=YEJRWHAVMIAJKC-UHFFFAOYSA-N,2.38e+02 g/l,37507,oxolan-2-one,DFC,NA,NA,"Dihydro-2(3H)-furanone, 9CI",DFC,96-48-0,rw1028441,NA,NA,Organic compounds,Organoheterocyclic compounds,Lactones,Gamma butyrolactones,Gamma butyrolactones,Aliphatic heteromonocyclic compounds,CHEMBL95681,7029,NA,TRUE,NA,DB04699,NA,gamma-butyrolactone,96-48-0,OL659KIY4X,"1,4-Lactone | 4-Butyrolactone | 4-Hydroxybutyric acid lactone | butyrolactone | dihydrofuran-2(3h)-one | Î³-butyrolactone",YEJRWHAVMIAJKC-UHFFFAOYSA-N
YGSDEFSMJLZEOE-UHFFFAOYSA-N,1259,HMDB0001895,138.031694053,2-hydroxybenzoic acid,Salicylic acid,C7H6O3,69-72-7,C00805,FDB000882,DB00936,NA,NA,338,331,OC(=O)C1=CC=CC=C1O,616,Organic compounds,Salicylic acids,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Aromatic homomonocyclic compounds,2.26,3502,T3D4816,Exogenous,2.26,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,138.031694058,2-hydroxybenzoic acid,Salicylic acid,C7H6O3,69-72-7,HMDB01895,DB00936,C00805,NA,338,331,OC(=O)C1=CC=CC=C1O,Organic compounds,Salicylic acids,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Aromatic homomonocyclic compounds,882,2489,SmallMoleculeCompound,FDB000882,Salicylic acid,TRUE,Solid,low,"Preservative, fungicide (superseded), prohibited in milk and wineSalicylic acid is a colorless, crystalline organic carboxylic acid. Salicylic acid is toxic if ingested in large quantities, but in small quantities is used as a food preservative and antiseptic in toothpaste. It is also the key additive in many skin-care products for the treatment of acne, psoriasis, callouses, corns, keratosis pilaris and warts. The carboxyl group (COOH) can react with alcohols, forming several useful esters. The name derives from the latin word for the willow tree (Salix), from whose bark it can be obtained.; --Wikipedia; Salicylic acid treats acne by causing skin cells to slough off more readily, preventing pores from clogging up. This effect on skin cells also makes salicylic acid an active ingredient in several shampoos meant to treat dandruff. Use of straight salicylic solution may cause hyperpigmentation on unpretreated skin for those with darker skin types (Fitzpatrick phototypes IV, V, VI), as well as with the lack of use of a broad spectrum sunblock. Subsalicylate in combination with bismuth form the popular stomach relief aid known commonly as Pepto-Bismol. When combined the two key ingredients help control diarrhea, nausea, heartburn, and even gas. It is also very mildly anti-biotic.",69-72-7,Mp 159å¡,NA,NA,2.24 mg/mL at 25 oC,2.26,NA,NA,NA,C00805,338,NA,16914,SAL,NA,NA,NA,Salicylic acid,NA,NA,NA,NA,NA,NA,NA,HMDB01895.pdf,application/pdf,50966,2015-02-28 18:01:23 UTC,NA,NA,2010-04-08 22:04:45 UTC,2015-10-09 22:31:12 UTC,428,BLP36-T:BLP36-T,HMDB01895,O-HYDROXYBENZOIC-ACID|SALICYLIC-ACID,DB00936,NA,3361,C00000206,Bp20 211å¡,DFC,NA,NA,NA,NA,NA,NA,C 60.87%; H 4.38%; O 34.75%,DFC,NA,NA,NA,NA,302 () (MeOH) (Berdy),DFC,pKa2 13.6 (25å¡),DFC,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,1.96,1.98,-1.09,OC(=O)C1=C(O)C=CC=C1,13.23,C7H6O3,138.1207,"InChI=1S/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10)",138.0316941,InChIKey=YGSDEFSMJLZEOE-UHFFFAOYSA-N,1.13e+01 g/l,30910,2-hydroxybenzoic acid,DFC,NA,NA,"2-Hydroxybenzoic acid, 9CI",DFC,NA,rw1097271,NA,428,Organic compounds,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Salicylic acids,Aromatic homomonocyclic compounds,CHEMBL424,331,NA,TRUE,NA,DB00936,APRD01605 | DB01398,Salicylic acid,69-72-7,O414PZ4LPZ,2-Carboxyphenol | 2-Hydroxybenzoic acid | O-carboxyphenol | O-hydroxybenzoic acid,YGSDEFSMJLZEOE-UHFFFAOYSA-N
YWTYJOPNNQFBPC-UHFFFAOYSA-N,20948,HMDB0040292,255.0523023,"2-chloro-5-{[2-(nitroamino)-4,5-dihydro-1H-imidazol-1-yl]methyl}pyridine",Imidacloprid,C9H10ClN5O2,105827-78-9,C11110,FDB020013,NA,NA,NA,86418,77934,[O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1,NA,Organic compounds,Nitroguanidines,Organic nitrogen compounds,Organonitrogen compounds,Guanidines,Aromatic heteromonocyclic compounds,NA,679,T3D0797,Exogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,255.052302296,"2-chloro-5-{[2-(nitroamino)-4,5-dihydro-1H-imidazol-1-yl]methyl}pyridine",Imidacloprid,C9H10ClN5O2,105827-78-9,HMDB40292,NA,C11110,NA,86418,77934,ClC1=NC=C(CN2CCN=C2NN(=O)=O)C=C1,Chemical entities,Nitroguanidines,Organic compounds,Organic nitrogen compounds,Organonitrogen compounds,Aromatic heteromonocyclic compounds,20020,52863,SmallMoleculeCompound,FDB020013,Imidacloprid,TRUE,NA,low,"InsecticideImidacloprid is a neonicotinoid, which is a class of neuro-active insecticides modeled after nicotine. A patented chemical, Imidacloprid is manufactured by Bayer Cropscience (part of Bayer AG) and sold under trade names Kohinor, Admire, Advantage, Gaucho, Merit, Confidor, Hachikusan, Premise, Prothor, and Winner. It is marketed as pest control, seed treatment, an insecticide spray, termite control, flea control, and a systemic insecticide.",138261-41-3,Mp 143-144å¡,NA,NA,NA,NA,NA,NA,NA,C11110,86418,NA,5870,IM4,NA,NA,NA,Imidacloprid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:14:44 UTC,2015-07-21 06:41:40 UTC,NA,MJN00-X:MJN00-X,HMDB40292,NA,DB07980,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 42.28%; H 3.94%; Cl 13.87%; N 27.39%; O 12.52%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DFC,0.65,0.76,-2.87,ClC1=CC=C(CN2CCN\C2=N\N(=O)=O)C=N1,NA,C9H10ClN5O2,255.661,"InChI=1S/C9H10ClN5O2/c10-8-2-1-7(5-12-8)6-14-4-3-11-9(14)13-15(16)17/h1-2,5H,3-4,6H2,(H,11,13)",255.0523023,InChIKey=YWTYJOPNNQFBPC-UHFFFAOYSA-N,3.46e-01 g/l,38223,2-chloro-5-{[(2Z)-2-(nitroimino)imidazolidin-1-yl]methyl}pyridine,DFC,NA,NA,"Imidacloprid, BSI",DFC,NA,NA,NA,NA,Organic compounds,Organonitrogen compounds,Amines,Aralkylamines,Aralkylamines,Aromatic heteromonocyclic compounds,CHEMBL406819,77934,NA,NA,NA,DB11421,DB07980,Imidacloprid,105827-78-9,3BN7M937V8,(2E)-1-[(6-chloropyridin-3-yl)methyl]-N-nitroimidazolidin-2-imine | 1-((6-chloro-3-Pyridinyl)methyl)-N-nitro-2-imidazolidinimine | 1-((6-chloro-3-Pyridyl)methyl)-N-nitro-2-imidazolidinimine | IMD,YWTYJOPNNQFBPC-UHFFFAOYSA-N
YXFVVABEGXRONW-UHFFFAOYSA-N,15083,HMDB0034168,92.062600256,toluene,Toluene,C7H8,108-88-3,C01455,FDB012454,DB01900,NA,NA,1140,1108,CC1=CC=CC=C1,NA,Organic compounds,Toluenes,Benzenoids,Benzene and substituted derivatives,Toluenes,Aromatic homomonocyclic compounds,2.73,62,T3D0071,Exogenous,2.73,"3, not classifiable as to its carcinogenicity to humans. (L135)",50 mg/kg for an adult human. (T26),SmallMolecule,92.062600256,toluene,Toluene,C7H8,108-88-3,HMDB34168,DB01900,C01455,CPD-616,1140,1108,CC1=CC=CC=C1,Organic compounds,Toluenes,Benzenoids,Benzene and substituted derivatives,Toluenes,Aromatic homomonocyclic compounds,4977,14046,SmallMoleculeCompound,FDB004976,Foluene,TRUE,NA,low,NA,108-88-3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2010-04-08 22:06:28 UTC,2017-02-23 19:50:43 UTC,NA,NA,NA,FOLUENE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CC1=CC=CC=C1,NA,C7H8,92.1384,"InChI=1S/C7H8/c1-7-5-3-2-4-6-7/h2-6H,1H3",92.06260026,YXFVVABEGXRONW-UHFFFAOYSA-N,NA,NA,NA,NA,NA,NA,NA,DUKE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB11558,DB01900 | EXPT02123,Toluene,108-88-3,3FPU23BG52,NA,YXFVVABEGXRONW-UHFFFAOYSA-N
ZAFYATHCZYHLPB-UHFFFAOYSA-N,2357,HMDB0005023,307.168462309,"N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide",Zolpidem,C19H21N3O,82626-48-0,C07219,FDB023594,NA,NA,NA,5732,5530,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,3071,Organic compounds,Phenylimidazoles,Organoheterocyclic compounds,Azoles,Imidazoles,Aromatic heteropolycyclic compounds,NA,2245,T3D2787,Exogenous,1.2,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,307.168462309,"N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide",Zolpidem,C19H21N3O,82626-48-0,HMDB05023,DB00425,C07219,NA,5732,5530,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,Chemical entities,Phenylimidazoles,Organic compounds,Organoheterocyclic compounds,Azoles,Aromatic heteropolycyclic compounds,23757,NA,SmallMoleculeCompound,FDB023594,Zolpidem,TRUE,Solid,low,"Some users take zolpidem recreationally for these side effects. However, it may be less common than benzodiazepine abuse. In the United States, recreational use may be less common than in countries where the drug is available as a less expensive generic. Zolpidem can become addictive if taken for extended periods of time, due to dependence on its ability to put one to sleep or to the euphoria it can sometimes produce. Like most addictive drugs, a tolerance in the zolpidem user develops and increases all the more quickly the longer she or he has been regularly taking it. Under the influence of the drug it is common to take more zolpidem than is necessary due to either forgetting that one has already taken a pill (elderly users are particularly at risk here), or knowingly taking more than the prescribed dosage. Users with a predilection for abuse are advised to keep additional zolpidem in a safe place that is unlikely to be remembered or accessed while intoxicated to avoid this risk. A trustworthy friend or relative is the best defense if such people are available; otherwise, a box or cupboard locked with a combination padlock is a good defense against this tendency, as the abovementioned side-effects can easily prevent a user from operating such a lock while under the drug's influence; Zolpidem is a prescription drug used for the short-term treatment of insomnia. It works quickly (usually within 15 minutes) and has a short half-life (2-3 hours). Some trade names of zolpidem are Ambien, Stilnox, Stilnoct, Hypnogen or Myslee. Its hypnotic effects are similar to those of the benzodiazepines, but it is classified as an imidazopyridine, and the anticonvulsant and muscle relaxant effects only appear at 10 and 20 times the dose required for sedation, respectively. For that reason, it has never been approved for either muscle relaxation or seizure prevention. Such drastically increased doses are more likely to induce one or more negative side effects, including hallucinations and/or amnesia. (See below.); Some users take zolpidem recreationally for these side effects. However, it may be less common than benzodiazepine abuse. In the United States, recreational use may be less common than in countries where the drug is available as a less expensive generic. Zolpidem can become addictive if taken for extended periods of time, due to dependence on its ability to put one to sleep or to the euphoria it can sometimes produce. Like most addictive drugs, a tolerance in the zolpidem user develops and increases all the more quickly the longer she or he has been regularly taking it. Under the influence of the drug it is common to take more zolpidem than is necessary due to either forgetting that one has already taken a pill (elderly users are particularly at risk here), or knowingly taking more than the prescribed dosage. Users with a predilection for abuse are advised to keep additional zolpidem in a safe place that is unlikely to be remembered or accessed while intoxicated to avoid this risk. A trustworthy friend or relative is the best defense if such people are available; Recreational zolpidem use is speculated to lead to tolerance and dependence much more quickly than prescribed use. Recreational use is rising, as demonstrated by the use of street names for the pill, such as: 'A' (which is most likely due to the imprint on the Ambien CR brand of zolpidem, which consists of a capital A along with a tilde, which looks roughly like A~, as well as for sedative and calming effects, 'A+' is a street name for Adderall, named so because of its stimulant effects) and 'zombie pills' (because of the waking sleep/sensory deprivation effect some users have reported experiencing). Another buzz term for Ambien is 'tic-tacs', referring to the shape and color of commonly abused 10mg tablets; Zolpidem is a prescription drug used for the short-term treatment of insomnia. It works quickly (usually within 15 minutes) and has a short half-life (2-3 hours). Its hypnotic effects are similar to those of the benzodiazepines, but it is actually classified as an imidazopyridine, and the anticonvulsant and muscle relaxant effects only appear at 10 and 20 times the dose required for sedation, respectively.[2] For that reason, it has never been approved for either muscle relaxation or seizure prevention. Such drastically increased doses are likely to induce one or more negative side effects, including hallucinations and/or amnesia.; Zolpidem is a prescription drug used for the short-term treatment of insomnia. It works quickly (usually within 15 minutes) and has a short half-life (2-3 hours). Some trade names of zolpidem are Ambien, Stilnox, Stilnoct, Hypnogen or Myslee. Its hypnotic effects are similar to those of the benzodiazepines, but it is actually classified as an imidazopyridine, and the anticonvulsant and muscle relaxant effects only appear at 10 and 20 times the dose required for sedation, respectively. For that reason, it has never been approved for either muscle relaxation or seizure prevention. Such drastically increased doses are more inclined to induce one or more negative side effects, including hallucinations and/or amnesia. (See below.); otherwise, a box or cupboard locked with a combination padlock is a good defense against this tendency, as the abovementioned side-effects can easily prevent a user from operating such a lock while under the drug's influence. [HMDB]",82626-48-0,NA,NA,NA,NA,NA,NA,NA,NA,C07219,5732,NA,NA,NA,NA,NA,NA,Zolpidem,NA,NA,NA,NA,NA,NA,NA,HMDB05023.pdf,application/pdf,128852,2015-02-28 18:08:51 UTC,NA,NA,2011-09-21 00:32:07 UTC,2015-07-21 06:57:47 UTC,NA,NA,HMDB05023,NA,DB00425,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3.15,3.017626821,-3.99,[H]C1=C([H])C(=C([H])N2C1=NC(=C2C([H])([H])C(=O)N(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])[H])C([H])([H])[H],NA,C19H21N3O,307.3895,"InChI=1S/C19H21N3O/c1-13-5-8-15(9-6-13)19-16(11-18(23)21(3)4)22-12-14(2)7-10-17(22)20-19/h5-10,12H,11H2,1-4H3",307.1684623,InChIKey=ZAFYATHCZYHLPB-UHFFFAOYSA-N,3.13e-02 g/l,81243,"N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organoheterocyclic compounds,Azoles,Imidazoles,Phenylimidazoles,Aromatic heteropolycyclic compounds,CHEMBL911,5530,NA,NA,NA,DB00425,APRD00095,Zolpidem,82626-48-0,7K383OQI23,"N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide | Zolpidem | Zolpidemum",ZAFYATHCZYHLPB-UHFFFAOYSA-N
ZDXPYRJPNDTMRX-VKHMYHEASA-N,499,HMDB0000641,146.069142196,(2S)-2-amino-4-carbamoylbutanoic acid,L-Glutamine,C5H10N2O3,56-85-9,C00064,FDB012164,DB00130,NA,GLN,5961,5746,N[C@@H](CCC(N)=O)C(O)=O,5614,Organic compounds,L-alpha-amino acids,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,-3.64,3183,T3D4319,Endogenous,-3.64,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,146.069142196,(2S)-2-amino-4-carbamoylbutanoic acid,L-Glutamine,C5H10N2O3,56-85-9,HMDB00641,DB00130,C00064,GLN,5961,5746,[H][C@](N)(CCC(O)=N)C(O)=O,Chemical entities,L-alpha-amino acids,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Aliphatic acyclic compounds,31128,NA,SmallMoleculeCompound,FDB030965,L-glutamine,TRUE,NA,NA,NA,56-85-9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2015-05-07 20:38:19 UTC,2017-03-11 23:05:37 UTC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,N[C@@H](CCC(N)=O)C(O)=O,NA,C5H10N2O3,146.1445,"InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1",146.0691422,ZDXPYRJPNDTMRX-VKHMYHEASA-N,NA,NA,NA,NA,NA,NA,NA,MANUAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB00130,NUTR00026,L-Glutamine,56-85-9,0RH81L854J,"(2S)-2-amino-4-carbamoylbutanoic acid | (2S)-2,5-diamino-5-oxopentanoic acid | (S)-2,5-diamino-5-oxopentanoic acid | Glutamic acid 5-amide | Glutamic acid amide | Glutamine | L-(+)-glutamine | L-2-aminoglutaramic acid | L-glutamic acid Î³-amide | L-Glutamin | L-GlutaminsÃ¤ure-5-amid | Levoglutamide | Q",ZDXPYRJPNDTMRX-VKHMYHEASA-N
ZFXYFBGIUFBOJW-UHFFFAOYSA-N,1253,HMDB0001889,180.06472552,"1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione",Theophylline,C7H8N4O2,58-55-9,C07130,FDB000453,DB00277,DBMET00221,THF-GLU-N,2153,2068,CN1C2=C(NC=N2)C(=O)N(C)C1=O,1458,Organic compounds,Xanthines,Organoheterocyclic compounds,Imidazopyrimidines,Purines and purine derivatives,Aromatic heteropolycyclic compounds,-0.02,3467,T3D4780,Exogenous,-0.02,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,180.06472552,"1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione",Theophylline,C7H8N4O2,58-55-9,HMDB01889,DB00277,C07130,THF-GLU-N,2153,2068,CN1C2=C(N=CN2)C(=O)N(C)C1=O,Chemical entities,Xanthines,Organic compounds,Organoheterocyclic compounds,Imidazopyrimidines,Aromatic heteropolycyclic compounds,453,1010,SmallMoleculeCompound,FDB000453,Theophylline,TRUE,Solid,low,"Constit. of tea leaves (Camellia thea) and matÌ© (Ilex paraguariensis)Theophylline, also known as dimethylxanthine, is a methylxanthine drug used in therapy for respiratory diseases such as COPD and asthma under a variety of brand names. As a member of the xanthine family, it bears structural and pharmacological similarity to caffeine. It is naturally found in tea and in cocoa beans. (Wikipedia)",58-55-9,Mp 264å¡,NA,NA,7.36 mg/mL at 25 oC,-0.02,NA,NA,NA,C07130,2153,NA,28177,TEP,NA,NA,NA,Theophylline,NA,NA,NA,NA,NA,NA,NA,HMDB01889.pdf,application/pdf,50427,2015-02-28 17:45:25 UTC,NA,2,2010-04-08 22:04:34 UTC,2015-10-09 22:31:10 UTC,NA,BCK73-S:BCK73-S,HMDB01889,THEOPHYLLINE|	DIMETHYLXANTHINE,DB00277,NA,NA,C00001510,NA,NA,NA,NA,NA,NA,NA,NA,C 46.67%; H 4.48%; N 31.10%; O 17.76%,DFC,NA,NA,NA,NA,NA,NA,pKa2 8.6 (25å¡),DFC,"YALKOWSKY,SH & HE,Y (2003)","HANSCH,C ET AL. (1995)",NA,NA,DFC,-0.26,-0.77,-0.9,CN1C2=C(NC=N2)C(=O)N(C)C1=O,NA,C7H8N4O2,180.164,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)",180.0647255,InChIKey=ZFXYFBGIUFBOJW-UHFFFAOYSA-N,2.29e+01 g/l,38541,"1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione",MANUAL,NA,NA,"Theophylline, BAN, JAN, USAN",DFC,NA,NA,NA,NA,Organic compounds,Alkaloids and derivatives,NA,NA,Alkaloids and derivatives,Aromatic heteropolycyclic compounds,CHEMBL190,2068,THF-GLU-N,TRUE,NA,DB00277,APRD00082 | DB09359,Theophylline,58-55-9,0I55128JYK,"1,3-dimethyl-7H-purine-2,6-dione | 1,3-dimethylxanthine | Theophyllin | Theophylline anhydrous | Theophylline, anhydrous",ZFXYFBGIUFBOJW-UHFFFAOYSA-N
ZGXJTSGNIOSYLO-UHFFFAOYSA-N,891,HMDB0001149,131.058243159,5-amino-4-oxopentanoic acid,5-Aminolevulinic acid,C5H9NO3,106-60-5,C00430,FDB022452,NA,NA,5-AMINO-LEVULINATE,137,134,NCC(=O)CCC(O)=O,6037,Organic compounds,Delta amino acids and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Aliphatic acyclic compounds,NA,3157,T3D4273,Endogenous,-1.5,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,131.058243159,5-amino-4-oxopentanoic acid,5-Aminolevulinic acid,C5H9NO3,106-60-5,HMDB01149,DB00855,C00430,5-AMINO-LEVULINATE,137,134,NCC(=O)CCC(O)=O,Chemical entities,Delta amino acids and derivatives,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Aliphatic acyclic compounds,22615,NA,SmallMoleculeCompound,FDB022452,5-Aminolevulinic acid,TRUE,Solid,low,"An intermediate in heme synthesis.  This is the first compound in the porphyrin synthesis pathway. It is produced by the enzyme ALA synthase, from glycine and succinyl CoA. This reaction is known as the Shemin pathway. Aminolevulinic acid plus blue light illumination using a blue light photodynamic therapy illuminator is indicated for the treatment of minimally to moderately thick actinic keratoses of the face or scalp. [HMDB]",106-60-5,NA,NA,NA,NA,NA,NA,NA,NA,C00430,137,NA,17549,NA,NA,NA,NA,5-Aminolevulinic acid,NA,NA,NA,NA,NA,NA,NA,HMDB01149.pdf,application/pdf,140666,2015-02-28 17:46:42 UTC,NA,2,2011-09-21 00:14:15 UTC,2015-10-09 22:31:08 UTC,NA,NA,HMDB01149,DELTA-AMINO-LEVULINIC-ACID,DB00855,34963,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-2.85,-3.252645453,0.12,[H]OC(=O)C([H])([H])C([H])([H])C(=O)C([H])([H])N([H])[H],17.16400107,C5H9NO3,131.1299,"InChI=1S/C5H9NO3/c6-3-4(7)1-2-5(8)9/h1-3,6H2,(H,8,9)",131.0582432,InChIKey=ZGXJTSGNIOSYLO-UHFFFAOYSA-N,1.73e+02 g/l,85227,5-amino-4-oxopentanoic acid,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues",Delta amino acids and derivatives,Aliphatic acyclic compounds,CHEMBL601,134,5-AMINO-LEVULINATE,TRUE,NA,DB00855,APRD00793 | DB05277,Aminolevulinic acid,106-60-5,88755TAZ87,5-ALA | 5-Aminolevulinic acid | Aminolevulinic acid | dALA | Î´-ALA | Î´-aminolevulinic acid,ZGXJTSGNIOSYLO-UHFFFAOYSA-N
ZIYVHBGGAOATLY-UHFFFAOYSA-N,130,HMDB0000202,118.02660868,2-methylpropanedioic acid,Methylmalonic acid,C4H6O4,516-05-2,C02170,FDB021905,NA,NA,NA,487,473,CC(C(O)=O)C(O)=O,3712,Organic compounds,Dicarboxylic acids and derivatives,Organic acids and derivatives,Carboxylic acids and derivatives,Dicarboxylic acids and derivatives,Aliphatic acyclic compounds,NA,3215,T3D4404,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,118.02660868,2-methylpropanedioic acid,Methylmalonic acid,C4H6O4,516-05-2,HMDB00202,DB04183,C02170,NA,487,473,CC(C(O)=O)C(O)=O,Chemical entities,Dicarboxylic acids and derivatives,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Aliphatic acyclic compounds,22068,NA,SmallMoleculeCompound,FDB021905,Methylmalonic acid,TRUE,Solid,low,A malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA. [HMDB],516-05-2,NA,NA,NA,NA,NA,NA,NA,NA,C02170,487,NA,17453,DXX,NA,NA,NA,Methylmalonic acid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2011-09-21 00:04:56 UTC,2015-10-09 22:29:58 UTC,NA,NA,HMDB00202,NA,DB04183,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.17,0.21186901,0.1,[H]OC(=O)C([H])(C(=O)O[H])C([H])([H])[H],6.256772105,C4H6O4,118.088,"InChI=1S/C4H6O4/c1-2(3(5)6)4(7)8/h2H,1H3,(H,5,6)(H,7,8)",118.0266087,InChIKey=ZIYVHBGGAOATLY-UHFFFAOYSA-N,1.49e+02 g/l,83580,2-methylpropanedioic acid,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Dicarboxylic acids and derivatives,Dicarboxylic acids and derivatives,Aliphatic acyclic compounds,CHEMBL1232416,473,NA,TRUE,NA,DB04183,EXPT01309,Methylmalonic Acid,516-05-2,8LL8S712J7,NA,ZIYVHBGGAOATLY-UHFFFAOYSA-N
ZJUKTBDSGOFHSH-WFMPWKQPSA-N,747,HMDB0000939,384.12158847,"(2S)-2-amino-4-({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}sulfanyl)butanoic acid",S-Adenosylhomocysteine,C14H20N6O5S,979-92-0,C00021,FDB022327,NA,DBMET00514,ADENOSYL-HOMO-CYS,439155,388301,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N)C(O)=O,296,Organic compounds,5'-deoxy-5'-thionucleosides,"Nucleosides, nucleotides, and analogues",5'-deoxyribonucleosides,5'-deoxy-5'-thionucleosides,Aromatic heteropolycyclic compounds,NA,3232,T3D4455,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,384.12158847,"(2S)-2-amino-4-({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}sulfanyl)butanoic acid",S-Adenosylhomocysteine,C14H20N6O5S,979-92-0,HMDB00939,DB01752,C00021,ADENOSYL-HOMO-CYS,439155,388301,[H][C@](N)(CCSC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)C(O)=O,Chemical entities,5'-deoxy-5'-thionucleosides,Organic compounds,"Nucleosides, nucleotides, and analogues",5'-deoxyribonucleosides,Aromatic heteropolycyclic compounds,22490,NA,SmallMoleculeCompound,FDB022327,S-(5'-Adenosyl)-L-homocysteine,TRUE,Solid,low,"S-Adenosylhomocysteine (AdoHcy) is the immediate precursor of all of the homocysteine produced in the body. The reaction is catalyzed by S-adenosylhomocysteine hydrolase and is reversible with the equilibrium favoring formation of AdoHcy. In vivo, the reaction is driven in the direction of homocysteine formation by the action of the enzyme adenosine deaminase, which converts the second product of the S-adenosylhomocysteine hydrolase reaction, adenosine, to inosine. Except for methyl transfer from betaine and from methylcobalamin in the methionine synthase reaction, AdoHcy is the product of all methylation reactions that involve S-adenosylmethionine (AdoMet) as the methyl donor. Methylation is significant in epigenetic regulation of protein expression via DNA and histone methylation. The inhibition of these AdoMet-mediated processes by AdoHcy is a proven mechanism for metabolic alteration. Because the conversion of AdoHcy to homocysteine is reversible, with the equilibrium favoring the formation of AdoHcy, increases in plasma homocysteine are accompanied by an elevation of AdoHcy in most cases. Disturbances in the transmethylation pathway indicated by abnormal S-adenosylmethionine, S-adenosylhomocysteine or their ratio have been reported in many neurodegenerative diseases, such as dementia, depression or Parkinson's disease. (PMID: 18065573, 17892439) [HMDB]",979-92-0,NA,NA,NA,NA,NA,NA,NA,NA,C00021,439155,NA,16680,SAH,NA,NA,NA,S-adenosyl_homocysteine,NA,NA,NA,NA,NA,NA,NA,HMDB00939.pdf,application/pdf,143008,2015-02-28 18:03:42 UTC,NA,2,2011-09-21 00:12:12 UTC,2015-10-09 22:29:07 UTC,NA,NA,HMDB00939,NA,NA,33543,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-2.37,-4.028528351,-1.97,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O,12.47228005,C14H20N6O5S,384.411,"InChI=1S/C14H20N6O5S/c15-6(14(23)24)1-2-26-3-7-9(21)10(22)13(25-7)20-5-19-8-11(16)17-4-18-12(8)20/h4-7,9-10,13,21-22H,1-3,15H2,(H,23,24)(H2,16,17,18)/t6-,7+,9+,10+,13+/m0/s1",384.1215885,InChIKey=ZJUKTBDSGOFHSH-WFMPWKQPSA-N,4.08e+00 g/l,86844,"(2S)-2-amino-4-({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}sulfanyl)butanoic acid",HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organooxygen compounds,Carbohydrates and carbohydrate conjugates,Glycosyl compounds,Glycosylamines,Aromatic heteropolycyclic compounds,CHEMBL418052,388301,ADENOSYL-HOMO-CYS,TRUE,NA,DB01752,EXPT02842,S-adenosyl-L-homocysteine,979-92-0,8K31Q2S66S,"2-S-adenosyl-L-homocysteine | Adenosyl-L-homocysteine | adenosylhomocysteine | AdoHcy | S-(5'-adenosyl)-L-homocysteine | S-[1-(adenin-9-yl)-1,5-dideoxy-Î²-D-ribofuranos-5-yl]-L-homocysteine | S-Adenosylhomocysteine",ZJUKTBDSGOFHSH-WFMPWKQPSA-N
ZJXZSIYSNXKHEA-UHFFFAOYSA-N,7755,HMDB0012228,126.008195224,ethoxyphosphonic acid,Ethylphosphate,C2H7O4P,78-40-0,NA,FDB028872,NA,NA,CPD-8978,74190,66799,CCOP(O)(O)=O,NA,Organic compounds,Monoalkyl phosphates,Organic acids and derivatives,Organic phosphoric acids and derivatives,Phosphate esters,Aliphatic acyclic compounds,0.8,3512,T3D4828,Exogenous,0.8,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,126.008195224,ethoxyphosphonic acid,Ethylphosphate,C2H7O4P,78-40-0,HMDB12228,DB03347,NA,CPD-8978,6535,6287,CCOP(O)(O)=O,Organic compounds,Monoalkyl phosphates,Organic acids and derivatives,Organic phosphoric acids and derivatives,Phosphate esters,Aliphatic acyclic compounds,29035,NA,SmallMoleculeCompound,FDB028872,Ethylphosphate,TRUE,Liquid,low,"Ethylphosphate is produced by the reaction between diethylphosphate and water, with ethanol as a byproduct. [HMDB]",1623-14-9,NA,NA,NA,NA,NA,NA,NA,NA,NA,74190,NA,45927,EFS,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2011-09-21 01:46:33 UTC,2015-07-21 06:59:33 UTC,NA,NA,HMDB12228,NA,DB03822,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.27,-0.285335145,-0.64,[H]OP(=O)(O[H])OC([H])([H])C([H])([H])[H],6.827333351,C2H7O4P,126.0483,"InChI=1S/C2H7O4P/c1-2-6-7(3,4)5/h2H2,1H3,(H2,3,4,5)",126.0081952,InChIKey=ZJXZSIYSNXKHEA-UHFFFAOYSA-N,2.90e+01 g/l,87521,ethoxyphosphonic acid,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Organophosphorus compounds,Organic phosphoric acids and derivatives,Phosphate esters,Monoalkyl phosphates,Aliphatic acyclic compounds,NA,66799,CPD-8978,NA,NA,DB03822,EXPT01327,Ethyl Dihydrogen Phosphate,NA,BMH1WT204A,NA,ZJXZSIYSNXKHEA-UHFFFAOYSA-N
ZKHQWZAMYRWXGA-KQYNXXCUSA-N,413,HMDB0000538,506.995745159,"({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid",Adenosine triphosphate,C10H16N5O13P3,56-65-5,C00002,FDB021813,NA,NA,ATP,5957,5742,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,5523,Organic compounds,Purine ribonucleoside triphosphates,"Nucleosides, nucleotides, and analogues",Purine nucleotides,Purine ribonucleotides,Aromatic heteropolycyclic compounds,NA,3160,T3D4276,Endogenous,-5.5,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,506.995745159,"({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid",Adenosine triphosphate,C10H16N5O13P3,56-65-5,HMDB00538,DB00171,C00002,ATP,5957,5742,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,Chemical entities,Purine ribonucleoside triphosphates,Organic compounds,"Nucleosides, nucleotides, and analogues",Purine nucleotides,Aromatic heteropolycyclic compounds,30846,NA,SmallMoleculeCompound,FDB030683,ATP,TRUE,NA,NA,NA,56-65-5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2015-05-07 19:47:50 UTC,2017-03-11 23:04:10 UTC,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,NA,C10H16N5O13P3,507.181,"InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",506.9957452,ZKHQWZAMYRWXGA-KQYNXXCUSA-N,NA,NA,NA,NA,NA,NA,NA,MANUAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,DB00171,NUTR00017 | EXPT00007,ATP,56-65-5,8L70Q75FXE,Adenosine 5'-triphosphate | Adenosine triphosphate | Adenosine-5'-triphosphate | ATP,ZKHQWZAMYRWXGA-KQYNXXCUSA-N
ZMXDDKWLCZADIW-UHFFFAOYSA-N,1252,HMDB0001888,73.052763851,"N,N-dimethylformamide","N,N-Dimethylformamide",C3H7NO,68-12-2,C03134,FDB004724,DB01844,NA,CPD-581,6228,5993,CN(C)C=O,NA,Organic compounds,Tertiary carboxylic acid amides,Organic acids and derivatives,Carboxylic acids and derivatives,Carboxylic acid derivatives,Aliphatic acyclic compounds,-1.01,203,T3D0252,Exogenous,-1.01,"3, not classifiable as to its carcinogenicity to humans. (L135)",10 grams for an adult human. (T36),SmallMolecule,73.052763851,"N,N-dimethylformamide","N,N-Dimethylformamide",C3H7NO,1968-12-02,HMDB01888,DB01844,C03134,CPD-581,6228,5993,CN(C)C=O,Chemical entities,Tertiary carboxylic acid amides,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Aliphatic acyclic compounds,4725,13527,SmallMoleculeCompound,FDB004724,"N,N-Dimethylformamide",TRUE,Liquid,low,"Dimethylformamide is a polar (hydrophilic) Aprotic solvent with a high boiling point. It facilitates reactions that follow polar mechanisms, such as SN2 reactions. Dimethylformamide can be synthesized from methyl formate and dimethyl amine or reaction of dimethyl amine and carbon monoxide. Dimethylformamide is not stable in the presence of strong bases like sodium hydroxide or strong acids such as hydrochloric acid or sulfuric acid and is hydrolyzed back into formic acid and dimethylamine, especially at elevated temperatures.; Dimethylformamide is the organic compound with the formula (CH3)2NC(O)H. Commonly abbreviated DMF (though this acronym is sometimes used for dimethylfuran), this colourless liquid is miscible with water and the majority of organic liquids. DMF is a common solvent for chemical reactions. Pure dimethylformamide is odorless whereas technical grade or degraded dimethylformamide often has a fishy smell due to impurity of dimethylamine. Its name is derived from the fact that it is a derivative of formamide, the amide of formic acid.; N,N-Dimethylformamide (DMF) is a clear liquid that has been widely used in industries as a solvent, an additive, or an intermediate because of its extensive miscibility with water and most common organic solvents. Its health effects include hepatotoxicity and male reproductoxicity, possibly linked with mitochondrial DNA (mtDNA) alterations including mtDNA common deletion (delta-mtDNA4977) and mtDNA copy number; during the biotransformation of DMF in the body, free radicals are formed, including hydroxyl radicals.; The world-wide consumption of DMF in 2001 was approximately 285,000 metric tonnes and most of that was used as an industrial solvent. Overexposure to DMF could result in hepatotoxicity, alcohol intolerance, possible embryotoxicity and teratogenicity in humans and animals, and decline of human sperm motility. Based on its wide application and a wide range of toxic effects, DMF has been selected as one of the four priority compounds for human field studies by the National Toxicology Program (NTP) of the US National Institute of Environmental Health Sciences (NIEHS). The current permissible exposure limit for DMF in the working environment is 10 ppm in both USA and Taiwan. The concentrations of two major DMF metabolites in urine, N-methylformamide (U-NMF) of 15 mg/L and N-acetyl-S-(N-methylcarbamoyl) cysteine (U-AMCC) of 40 mg/L, were recommended as the biological exposure indices (BEIs) by the American Conference of Governmental Industrial Hygienists for DMF exposure in workplace. (PMID: 17254560)",1968-12-02,-60.4 oC,NA,NA,1000 mg/mL at 25 oC,-1.01,NA,NA,NA,C03134,6228,NA,17741,DMF,NA,NA,NA,"N,N-Dimethylformamide",NA,NA,NA,NA,NA,NA,NA,HMDB01888.pdf,application/pdf,52578,2015-02-28 18:01:48 UTC,NA,NA,2010-04-08 22:06:22 UTC,2015-10-09 22:32:57 UTC,NA,NA,HMDB01888,"N,N-DIMETHYL-FORMAMIDE",DB01844,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.3,NA,ISHOW (NA--) @2ND,"HANSCH,C ET AL. (1995)",NA,NA,NA,-0.77,-0.63,1,CN(C)C=O,NA,C3H7NO,73.0938,"InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3",73.05276385,InChIKey=ZMXDDKWLCZADIW-UHFFFAOYSA-N,7.25e+02 g/l,41379,"N,N-dimethylformamide",BIOSPIDER,NA,NA,NA,DUKE,NA,NA,NA,NA,Organic compounds,Organic acids and derivatives,Carboxylic acids and derivatives,Carboxylic acid derivatives,Tertiary carboxylic acid amides,Aliphatic acyclic compounds,CHEMBL268291,5993,CPD-581,TRUE,NA,DB01844,EXPT01224,"N,N-dimethylformamide",68-12-2,8696NH0Y2X,"Dimethylformamide | N-Formyldimethylamine | N,N-Dimethylmethanamide",ZMXDDKWLCZADIW-UHFFFAOYSA-N
ZNQVEEAIQZEUHB-UHFFFAOYSA-N,12299,HMDB0031213,90.068079564,2-ethoxyethan-1-ol,2-Ethoxyethanol,C4H10O2,110-80-5,C14687,FDB003236,DB02249,NA,NA,8076,13836591,CCOCCO,NA,Organic compounds,Dialkyl ethers,Organic oxygen compounds,Organooxygen compounds,Ethers,Aliphatic acyclic compounds,-0.32,3625,T3D4943,Exogenous,-0.32,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,90.068079564,2-ethoxyethan-1-ol,2-Ethoxyethanol,C4H10O2,110-80-5,HMDB31213,DB02249,C14687,NA,8076,13836591,CCOCCO,Chemical entities,Dialkyl ethers,Organic compounds,Organic oxygen compounds,Organooxygen compounds,Aliphatic acyclic compounds,3237,9971,SmallMoleculeCompound,FDB003236,2-Ethoxyethanol,TRUE,NA,low,"Diluent in colour additive mixts. for marking food2-Ethoxyethanol, also known by the trademark Cellosolve or ethyl cellosolve, is a solvent used widely in commercial and industrial applications. It is a clear, colorless, nearly odorless liquid that is miscible with water, ethanol, diethyl ether, acetone, and ethyl acetate.; As with other glycol ethers, 2-ethoxyethanol has the useful property of being able to dissolve chemically diverse compounds. It will dissolve oils, resins, grease, waxes, nitrocellulose, and lacquers. This is an ideal property as a multi-purpose cleaner and therefore 2-ethoxyethanol is used in products such as varnish removers and degreasing solutions.",110-80-5,Fp -70å¡,NA,NA,1000 mg/mL,-0.32,NA,NA,NA,C14687,8076,NA,46788,ETX,NA,NA,NA,2-Ethoxyethanol,NA,NA,NA,NA,NA,NA,NA,HMDB31213.pdf,application/pdf,50235,2015-02-28 17:48:08 UTC,NA,NA,2010-04-08 22:05:42 UTC,2015-07-20 21:52:18 UTC,NA,CTW16-L:CTW16-L,HMDB31213,NA,DB02249,NA,1182,NA,Bp743 134.8å¡,DFC,NA,NA,NA,NA,NA,NA,C 53.31%; H 11.18%; O 35.51%,DFC,NA,NA,NA,NA,NA,NA,14.8,NA,DOW CHEMICAL COMPANY (1981),"HANSCH,C ET AL. (1995)",NA,NA,DFC,-0.28,-0.208744622,0.81,CCOCCO,NA,C4H10O2,90.121,"InChI=1S/C4H10O2/c1-2-6-4-3-5/h5H,2-4H2,1H3",90.06807956,InChIKey=ZNQVEEAIQZEUHB-UHFFFAOYSA-N,5.85e+02 g/l,31360,2-ethoxyethan-1-ol,HMDB_from_dfc,NA,NA,"2-Ethoxyethanol, 9CI",DFC,NA,NA,NA,NA,Organic compounds,Organooxygen compounds,Ethers,Dialkyl ethers,Dialkyl ethers,Aliphatic acyclic compounds,CHEMBL119596,13836591,NA,NA,NA,DB02249,EXPT01374,2-Ethoxyethanol,110-80-5,IDK7C2HS09,NA,ZNQVEEAIQZEUHB-UHFFFAOYSA-N
ZQBAKBUEJOMQEX-UHFFFAOYSA-N,13071,HMDB0032018,214.062994186,phenyl 2-hydroxybenzoate,Phenyl salicylate,C13H10O3,118-55-8,C14163,FDB008716,NA,NA,NA,8361,8058,OC1=CC=CC=C1C(=O)OC1=CC=CC=C1,NA,Organic compounds,Depsides and depsidones,Phenylpropanoids and polyketides,Depsides and depsidones,NA,Aromatic homomonocyclic compounds,NA,3588,T3D4905,Exogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,214.062994186,phenyl 2-hydroxybenzoate,Phenyl salicylate,C13H10O3,118-55-8,HMDB32018,NA,C14163,NA,8361,8058,OC1=CC=CC=C1C(=O)OC1=CC=CC=C1,Chemical entities,Depsides and depsidones,Organic compounds,Phenylpropanoids and polyketides,Depsides and depsidones,Aromatic homomonocyclic compounds,8717,21594,SmallMoleculeCompound,FDB008716,Phenyl salicylate,TRUE,NA,low,Used as a food additive [EAFUS],118-55-8,Mp 43å¡,NA,NA,0.15 mg/mL at 25 oC,NA,NA,NA,NA,C14163,8361,NA,413346,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HMDB32018.pdf,application/pdf,48077,2015-02-28 17:55:44 UTC,NA,NA,2010-04-08 22:08:13 UTC,2015-07-20 22:25:16 UTC,NA,BLP36-T:DSV83-C,HMDB32018,NA,NA,NA,3032,NA,Bp12 173å¡,DFC,NA,NA,NA,NA,NA,NA,C 72.89%; H 4.70%; O 22.41%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)",NA,NA,NA,DFC,3.58,3.981115907,-3,OC1=CC=CC=C1C(=O)OC1=CC=CC=C1,NA,C13H10O3,214.2167,"InChI=1S/C13H10O3/c14-12-9-5-4-8-11(12)13(15)16-10-6-2-1-3-7-10/h1-9,14H",214.0629942,InChIKey=ZQBAKBUEJOMQEX-UHFFFAOYSA-N,2.16e-01 g/l,34536,phenyl 2-hydroxybenzoate,HMDB_from_dfc,NA,NA,"2-Hydroxybenzoic acid, 9CI; Ph ester",DFC,NA,rw1040381,NA,NA,Organic compounds,Phenylpropanoids and polyketides,Depsides and depsidones,NA,Depsides and depsidones,Aromatic homomonocyclic compounds,CHEMBL1339216,8058,NA,NA,NA,DB11071,NA,Phenyl salicylate,118-55-8,28A37T47QO,NA,ZQBAKBUEJOMQEX-UHFFFAOYSA-N
ZQHYXNSQOIDNTL-UHFFFAOYSA-N,325,HMDB0000428,148.037173366,3-hydroxypentanedioic acid,3-Hydroxyglutaric acid,C5H8O5,638-18-6,NA,FDB022040,NA,NA,R-2-HYDROXYGLUTARATE,181976,158277,OC(CC(O)=O)CC(O)=O,5417,Organic compounds,Beta hydroxy acids and derivatives,Organic acids and derivatives,Hydroxy acids and derivatives,Beta hydroxy acids and derivatives,Aliphatic acyclic compounds,NA,3200,T3D4357,Endogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,148.037173366,3-hydroxypentanedioic acid,3-Hydroxyglutaric acid,C5H8O5,638-18-6,HMDB00428,DB04594,NA,R-2-HYDROXYGLUTARATE,181976,158277,OC(CC(O)=O)CC(O)=O,Chemical entities,Beta hydroxy acids and derivatives,Organic compounds,Organic acids and derivatives,Hydroxy acids and derivatives,Aliphatic acyclic compounds,22203,NA,SmallMoleculeCompound,FDB022040,3-Hydroxyglutaric acid,TRUE,Solid,low,"3-Hydroxyglutaric acid is a key metabolite in glutaryl co-enzyme A dehydrogenase deficiency, and is considered to be a potential neurotoxin. The urine level of 3-Hydroxyglutaric acid is elevated in Glutaric Aciduria Type I (glutaryl-CoA dehydrogenase deficiency) patients. (PMID 16573641) [HMDB]",638-18-6,NA,NA,NA,NA,NA,NA,NA,NA,NA,181976,NA,NA,3HG,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HMDB00428.pdf,application/pdf,2388011,2015-02-28 18:08:06 UTC,NA,NA,2011-09-21 00:07:26 UTC,2015-10-09 22:33:28 UTC,NA,NA,HMDB00428,NA,DB04594,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-1.17,-1.028817909,0.06,[H]OC(=O)C([H])([H])C([H])(O[H])C([H])([H])C(=O)O[H],4.294116867,C5H8O5,148.114,"InChI=1S/C5H8O5/c6-3(1-4(7)8)2-5(9)10/h3,6H,1-2H2,(H,7,8)(H,9,10)",148.0371734,InChIKey=ZQHYXNSQOIDNTL-UHFFFAOYSA-N,1.72e+02 g/l,83506,3-hydroxypentanedioic acid,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Lipids and lipid-like molecules,Fatty Acyls,Fatty acids and conjugates,Hydroxy fatty acids,Aliphatic acyclic compounds,CHEMBL556937,158277,R-2-HYDROXYGLUTARATE,TRUE,NA,DB04594,NA,3-hydroxyglutaric acid,638-18-6,NA,NA,ZQHYXNSQOIDNTL-UHFFFAOYSA-N
ZQSIJRDFPHDXIC-UHFFFAOYSA-N,1821,HMDB0003312,254.057908802,7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one,Daidzein,C15H10O4,486-66-8,C10208,FDB002608,NA,NA,2-HYDROXYDAIDZEIN,5281708,4445025,OC1=CC=C(C=C1)C1=COC2=C(C=CC(O)=C2)C1=O,NA,Organic compounds,Isoflavones,Phenylpropanoids and polyketides,Isoflavonoids,Isoflav-2-enes,Aromatic heteropolycyclic compounds,NA,2990,T3D3964,Exogenous,NA,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,254.057908808,7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one,Daidzein,C15H10O4,486-66-8,HMDB03312,NA,C10208,2-HYDROXYDAIDZEIN,5281708,4445025,OC1=CC=C(C=C1)C1=COC2=C(C=CC(O)=C2)C1=O,NA,NA,NA,NA,NA,NA,2608,8143,SmallMoleculeCompound,FDB002608,Daidzein,TRUE,Solid,low,"Widespread isoflavone in the Leguminosae, esp. Phaseolus spp. (broad beans, lima beans); also found in soy and soy products (tofu, miso), chick peas (Cicer arietinum) and peanuts (Arachis hypogaea). Nutriceutical with anticancer and bone protective props.Daidzein is one of several known isoflavones. Isoflavones compounds are found in a number of plants, but soybeans and soy products like tofu and textured vegetable protein are the primary food source. Up until recently, daidzein was considered to be one of the most important and most studied isoflavones, however more recently attention has shifted to isoflavone metabolites. Equol represents the main active product of daidzein metabolism, produced via specific microflora in the gut. The clinical effectiveness of soy isoflavones may be a function of the ability to biotransform soy isoflavones to the more potent estrogenic metabolite, equol, which may enhance the actions of soy isoflavones, owing to its greater affinity for estrogen receptors, unique antiandrogenic properties, and superior antioxidant activity. However, not all individuals consuming daidzein produce equol. Only approximately one-third to one-half of the population is able to metabolize daidzein to equol. This high variability in equol production is presumably attributable to interindividual differences in the composition of the intestinal microflora, which may play an important role in the mechanisms of action of isoflavones. But, the specific bacterial species in the colon involved in the production of equol are yet to be discovered. (PMID: 18045128, 17579894, Curr Med Chem. 2007;14(26):2824-30., Mol Nutr Food Res. 2007 Jul;51(7):765-81.)",486-66-8,Mp 330å¡ (323å¡),NA,NA,NA,NA,NA,NA,NA,C10208,5281708,NA,28197,NA,NA,NA,NA,Daidzein,NA,NA,NA,NA,NA,NA,NA,HMDB03312.pdf,application/pdf,48154,2015-02-28 18:10:59 UTC,NA,2,2010-04-08 22:05:27 UTC,2015-10-09 22:33:11 UTC,394,CMR01-H:CMR01-H,HMDB03312,TATOIN|DAIDZEIN,NA,NA,NA,C00009380,NA,NA,NA,NA,NA,NA,NA,NA,C 70.86%; H 3.96%; O 25.17%,DFC,NA,NA,NA,NA,[neutral] lmax 252 (e 25400) (MeOH) (Derep),DFC,NA,NA,NA,NA,NA,NA,DFC,3.3,2.730437711,-3.48,OC1=CC=C(C=C1)C1=COC2=CC(O)=CC=C2C1=O,8.964965074,C15H10O4,254.2375,"InChI=1S/C15H10O4/c16-10-3-1-9(2-4-10)13-8-19-14-7-11(17)5-6-12(14)15(13)18/h1-8,16-17H",254.0579088,InChIKey=ZQSIJRDFPHDXIC-UHFFFAOYSA-N,8.49e-02 g/l,35628,7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one,MANUAL,NA,NA,"4',7-Dihydroxyisoflavone",DFC,NA,NA,NA,394,Organic compounds,Phenylpropanoids and polyketides,Isoflavonoids,Isoflav-2-enes,Isoflavones,Aromatic heteropolycyclic compounds,CHEMBL8145,4445025,2-HYDROXYDAIDZEIN,TRUE,NA,DB13182,NA,Daidzein,486-66-8,6287WC5J2L,"4',7-dihydroxyisoflavone | 7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone | 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one | 7,4'-dihydroxyisoflavone | Daidzeol | Isoaurostatin",ZQSIJRDFPHDXIC-UHFFFAOYSA-N
ZRALSGWEFCBTJO-UHFFFAOYSA-N,1214,HMDB0001842,59.048347175,guanidine,Guanidine,CH5N3,50-01-1,C17349,FDB005416,DB00536,NA,CPD-13517,3520,3400,NC(N)=N,6342,Organic compounds,Guanidines,Organic nitrogen compounds,Organonitrogen compounds,Guanidines,Aliphatic acyclic compounds,NA,3093,T3D4172,Endogenous,-0.6,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,59.048347175,guanidine,Guanidine,CH5N3,113-00-8,HMDB01842,DB00536,C17349,CPD-593,3520,3400,NC(N)=N,Organic compounds,Guanidines,Organic nitrogen compounds,Organonitrogen compounds,Guanidines,Aliphatic acyclic compounds,5417,14836,SmallMoleculeCompound,FDB005416,Guanidine,TRUE,Solid,low,"Guanidine apparently acts by enhancing the release of acetylcholine following a nerve impulse. It also appears to slow the rates of depolarization and repolarization of muscle cell membranes.; Guanidine is a crystalline compound of strong alkalinity formed by the oxidation of guanine. It is used in the manufacture of plastics and explosives. It is found in urine as a normal product of protein metabolism. The molecule was first synthesized in 1861 by the oxidative degradation of an aromatic natural product, guanine, isolated from Peruvian guano. Despite the provocative simplicity of the molecule, the crystal structure was first described 148 years later.; Guanidine is a polyamine that can function as a strong organic base existing primarily as guanidium ions at physiological pH.  With a pKa of 12.5, guanidine is protonated, with a charge of +1 in physiological conditions.  It is found in the urine as a normal product of protein metabolism. It is also used in laboratory research as a protein denaturant. (From Martindale, the Extra Pharmacopoeia, 30th ed and Merck Index, 12th ed).  Guanidine is a crystalline compound of strong alkalinity formed by the oxidation of guanine. It is used in the manufacture of plastics and explosives.   -- Wikipedia; Guanidines are a group of organic compounds sharing a common functional group with the general structure (R1R2N)(R3R4N)C=N-R5. The central bond within this group is that of an imine; the other recognizable motif within this group is an aminal. Examples of guanidines are arginine, triazabicyclodecene and saxitoxin. other derivatives could include guanidine hydroxide, the active ingredient in some non-lye relaxers. Guanidinium salts are well known for their denaturing action on proteins. Guanidinium chloride is one of the most effective denaturants. In 6 M GndHCl all proteins with an ordered structure lose their structure, and most of them become randomly coiled, that is, they do not contain any residual structure.",113-00-8,182.3 oC,NA,NA,NA,NA,NA,NA,NA,C17349,3520,NA,24435,GAI,NA,NA,NA,Guanidine,NA,NA,NA,NA,NA,NA,NA,HMDB01842.pdf,application/pdf,144463,2015-02-28 18:01:39 UTC,NA,NA,2010-04-08 22:06:40 UTC,2015-10-09 22:30:42 UTC,NA,NA,HMDB01842,GUANIDINE,DB00536,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12.5,NA,NA,NA,NA,NA,NA,-1.92,-1.24,-0.71,NC(N)=N,NA,CH5N3,59.0705,"InChI=1S/CH5N3/c2-1(3)4/h(H5,2,3,4)",59.04834718,InChIKey=ZRALSGWEFCBTJO-UHFFFAOYSA-N,1.15e+01 g/l,40921,guanidine,BIOSPIDER,NA,NA,NA,DUKE,NA,NA,NA,NA,Organic compounds,Organonitrogen compounds,Guanidines,NA,Guanidines,Aliphatic acyclic compounds,NA,3400,CPD-593,TRUE,NA,DB00536,APRD01008 | EXPT01546,Guanidine,113-00-8,JU58VJ6Y3B,Aminomethanamidine | Gu | Guanidin | GUANIDINE | H2N-C(=NH)-NH2 | Imidourea | Iminourea,ZRALSGWEFCBTJO-UHFFFAOYSA-N
ZTHYODDOHIVTJV-UHFFFAOYSA-N,14755,HMDB0033835,212.068473494,"propyl 3,4,5-trihydroxybenzoate",Propyl gallate,C10H12O5,121-79-9,C11155,FDB012003,NA,NA,NA,4947,4778,CCCOC(=O)C1=CC(O)=C(O)C(O)=C1,NA,Organic compounds,Galloyl esters,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Aromatic homomonocyclic compounds,1.8,3534,T3D4850,Exogenous,1.8,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,212.068473494,"propyl 3,4,5-trihydroxybenzoate",Propyl gallate,C10H12O5,121-79-9,HMDB33835,NA,C11155,NA,4947,4778,CCCOC(=O)C1=CC(O)=C(O)C(O)=C1,Organic compounds,Galloyl esters,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Aromatic homomonocyclic compounds,12006,30822,SmallMoleculeCompound,FDB012003,Propyl gallate,TRUE,NA,low,"Antioxidant used in foods esp. animal fats and vegetable oils. Synergistic with other antioxidants such as Butylated hydroxyanisole <ht>DNB28-K</ht> and 2,6-Di-tert-butyl-4-methylphenol <ht>HCH42-H</ht>. Esp. effective with polyunsaturated fats. Indirect food additive arising from paper or board packaging, adhesives and food contact polymersPropyl gallate is an anti-oxidant. It protects against oxidation by hydrogen peroxide and oxygen free radicals, in a catalytic manner similar to superoxide dismutase.; Propyl gallate, or propyl 3,4,5-trihydroxybenzoate is an ester formed by the condensation of gallic acid and propanol. It is an antioxidant added to foods containing oils and fats to prevent oxidation.[citation needed] As a food additive, it is used under the E number E310.",121-79-9,Mp 150å¡ (147-148å¡),NA,NA,3.5 mg/mL at 25 oC,1.8,NA,NA,NA,C11155,4947,NA,NA,NA,NA,NA,NA,"Propyl_3,4,5-trihydroxybenzoate",NA,NA,NA,NA,NA,NA,NA,HMDB33835.pdf,application/pdf,48068,2015-02-28 18:00:54 UTC,NA,NA,2010-04-08 22:09:56 UTC,2015-07-20 22:45:49 UTC,NA,BFL35-I:HCL42-B,HMDB33835,N-PROPYL-GALLATE,NA,NA,3219,NA,NA,NA,NA,NA,NA,NA,NA,NA,C 56.60%; H 5.70%; O 37.70%,DFC,NA,NA,NA,NA,NA,NA,NA,NA,MERCK INDEX (1996),"HANSCH,C ET AL. (1995)",NA,NA,DFC,1.84,1.945357165,-2.09,CCCOC(=O)C1=CC(O)=C(O)C(O)=C1,11.28515216,C10H12O5,212.1993,"InChI=1S/C10H12O5/c1-2-3-15-10(14)6-4-7(11)9(13)8(12)5-6/h4-5,11-13H,2-3H2,1H3",212.0684735,InChIKey=ZTHYODDOHIVTJV-UHFFFAOYSA-N,1.71e+00 g/l,37825,"propyl 3,4,5-trihydroxybenzoate",HMDB_from_dfc,NA,NA,"3,4,5-Trihydroxybenzoic acid; Propyl ester",DFC,NA,rw1034121,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Benzoic acids and derivatives,Galloyl esters,Aromatic homomonocyclic compounds,CHEMBL7983,4778,CPD-6542,NA,NA,DB12450,NA,Propyl Gallate,121-79-9,8D4SNN7V92,NA,ZTHYODDOHIVTJV-UHFFFAOYSA-N
ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,944,HMDB0001218,146.036779433,2H-chromen-2-one,Coumarin,C9H6O2,91-64-5,C05851,FDB011938,DB04665,NA,COUMARIN,323,13848793,O=C1OC2=CC=CC=C2C=C1,3525,Organic compounds,Coumarins and derivatives,Phenylpropanoids and polyketides,Coumarins and derivatives,NA,Aromatic heteropolycyclic compounds,2.23,3558,T3D4875,Exogenous,2.23,"3, not classifiable as to its carcinogenicity to humans. (L135)",NA,SmallMolecule,146.036779436,2H-chromen-2-one,Coumarin,C9H6O2,91-64-5,HMDB01218,DB04665,C05851,COUMARIN,323,13848793,O=C1OC2=CC=CC=C2C=C1,Chemical entities,Coumarins and derivatives,Organic compounds,Phenylpropanoids and polyketides,Coumarins and derivatives,Aromatic heteropolycyclic compounds,11941,30569,SmallMoleculeCompound,FDB011938,2H-1-Benzopyran-2-one,TRUE,Solid,low,"Occurs in sweet clover. Banned by FDA for use in foodCoumarin is a fragrant chemical compound in the benzopyrone chemical class, found in many plants, notably in high concentration in the tonka bean (Dipteryx odorata), vanilla grass (Anthoxanthum odoratum), sweet woodruff (Galium odoratum), mullein (Verbascum spp.), sweet grass (Hierochloe odorata), cassia cinnamon (Cinnamomum aromaticum) and sweet clover (Fabaceae spp.). It has a sweet odor, readily recognised as the scent of newly-mown hay, and has been used in perfumes since 1882. Sweet woodruff, sweet grass and sweet clover in particular are named for their sweet smell, which is due to their high content of this substance. When it occurs in high concentrations in forage plants, coumarin is a somewhat bitter-tasting appetite suppressant, and is presumed to be produced by plants as a defense chemical to discourage predation. Although coumarin itself has no anticoagulant properties, it is transformed into the natural anticoagulant dicoumarol by a number of species of fungi. Coumarin is used in the pharmaceutical industry as a precursor molecule in the synthesis of a number of synthetic anticoagulant pharmaceuticals similar to dicoumarol, the notable ones being warfarin (tradenamed ""Coumadin,"" not to be confused with coumarin) and some even more potent rodenticides that work by the same anticoagulant mechanism. [Wikipedia]",91-64-5,Mp 70å¡,NA,NA,1.9 mg/mL at 20 oC,2.23,NA,NA,NA,C05851,323,NA,28794,COU,NA,NA,NA,Coumarin,NA,NA,knapsack_id:C00002460,NA,NA,NA,NA,HMDB01218.pdf,application/pdf,48757,2015-02-28 18:01:10 UTC,NA,2,2010-04-08 22:09:54 UTC,2015-07-20 22:44:59 UTC,635,HBX68-O:HBX68-O,HMDB01218,COUMARIN|COUMARINS,DB04665,46647,768,NA,Bp 291å¡,DFC,NA,NA,NA,NA,NA,NA,C 73.97%; H 4.14%; O 21.90%,DFC,NA,NA,NA,NA,307 (e 5623) (MeOH) (Berdy),DFC,NA,NA,"YALKOWSKY,SH & DANNENFELSER,RM (1992)","HANSCH,C ET AL. (1995)",NA,NA,DFC,1.72,1.78,-2.16,O=C1OC2=C(C=CC=C2)C=C1,NA,C9H6O2,146.1427,InChI=1S/C9H6O2/c10-9-6-5-7-3-1-2-4-8(7)11-9/h1-6H,146.0367794,InChIKey=ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,1.00e+00 g/l,37922,2H-chromen-2-one,DFC,NA,NA,"2H-1-Benzopyran-2-one, 9CI",DFC,91-64-5,rw1003831,NA,NA,Organic compounds,Phenylpropanoids and polyketides,Coumarins and derivatives,NA,Coumarins and derivatives,Aromatic heteropolycyclic compounds,CHEMBL6466,13848793,COUMARIN,NA,NA,DB04665,NA,Coumarin,91-64-5,A4VZ22K1WT,"1,2-benzopyrone | 2H-1-benzopyran-2-one | 2H-benzo(b)pyran-2-one | Coumarinic lactone | Cumarin",ZYGHJZDHTFUPRJ-UHFFFAOYSA-N
ZZVUWRFHKOJYTH-UHFFFAOYSA-N,1281,HMDB0001927,255.162314299,[2-(diphenylmethoxy)ethyl]dimethylamine,Diphenhydramine,C17H21NO,147-24-0,C06960,FDB022744,NA,NA,NA,3100,2989,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,2312,Organic compounds,Diphenylmethanes,Benzenoids,Benzene and substituted derivatives,Diphenylmethanes,Aromatic homomonocyclic compounds,NA,2389,T3D2976,Exogenous,3.27,No indication of carcinogenicity to humans (not listed by IARC).,NA,SmallMolecule,255.162314299,[2-(diphenylmethoxy)ethyl]dimethylamine,Diphenhydramine,C17H21NO,58-73-1,HMDB01927,DB01075,C06960,CPD-10890,3100,2989,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,Chemical entities,Diphenylmethanes,Organic compounds,Benzenoids,Benzene and substituted derivatives,Aromatic homomonocyclic compounds,22907,NA,SmallMoleculeCompound,FDB022744,Diphenhydramine,TRUE,Solid,low,"A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects. -- Pubchem; Pseudoephedrine is a phenethylamine, and an isomer of ephedrine. Pseudoephedrine is the International Nonproprietary Name (INN) of the (1S,2S)- diastereomer of ephedrine (which has 1R,2S- configuration). Other names are (+)-pseudoephedrine and D-pseudoephedrine (Reynolds, 1989). The enantiomer (-)-(1R,2R)-Pseudoephedrine has fewer side-effects, fewer central nervous system (CNS) stimulatory effects, does not reduce to d-methamphetamine, yet retains its efficacy as a decongestant.[citation needed] However, the patent holder for (-)-Pseudoephedrine (Pfizer/Warner-Lambert) has not yet sought or received government approval for its sale to the public.(US Patent 6,495,529); Treatment for urinary incontinence is an unlabeled use for these medications. Unlabeled use means doctors can use the medication to treat a condition other than that for which it was first approved by the U.S. Food and Drug Administration (FDA). These medications are approved by the FDA for the treatment of nasal congestion caused by colds or allergies. However it has also been successful in treating stress incontinence by increasing the pressure (tension) exerted by the muscles of the bladder neck and the urethra, which helps retain the urine within the bladder.; Despite being one of the oldest antihistamines on the market, it is by and large the most effective antihistamine available, either by prescription or over-the-counter, and has been shown to exceed the effectiveness of even the latest prescription drugs. Consequently, it is frequently used when an allergic reaction requires fast, effective reversal of the (often dangerous) effects of a massive histamine release. However, it is not always the drug of choice for treating allergies. Like many other first generation antihistamines, is also a potent anticholinergic agent. This leads to profound drowsiness as a very common side-effect, along with the possibilities of motor impairment (ataxia), dry mouth and throat, flushed skin, rapid or irregular heartbeat (tachycardia), blurred vision at near point due to lack of accommodation (cycloplegia), abnormal sensitivity to bright light (photophobia), pupil dilatation, urinary retention, constipation, difficulty concentrating, short-term memory loss, visual disturbances, hallucinations, confusion, erectile dysfunction, and delirium. -- Wikipedia [HMDB]",58-73-1,NA,NA,NA,NA,NA,NA,NA,NA,C06960,3100,NA,NA,2PM,NA,NA,NA,Diphenhydramine,NA,NA,NA,NA,NA,NA,NA,HMDB01927.pdf,application/pdf,3047496,2015-02-28 17:57:10 UTC,NA,NA,2011-09-21 00:18:57 UTC,2015-07-21 06:57:21 UTC,NA,NA,HMDB01927,NA,DB01075,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3.44,3.651907262,-3.53,[H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(OC([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H],NA,C17H21NO,255.3547,"InChI=1S/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3",255.1623143,InChIKey=ZZVUWRFHKOJYTH-UHFFFAOYSA-N,7.52e-02 g/l,83712,[2-(diphenylmethoxy)ethyl]dimethylamine,HMDB,NA,NA,NA,HMDB,NA,NA,NA,NA,Organic compounds,Benzenoids,Benzene and substituted derivatives,Diphenylmethanes,Diphenylmethanes,Aromatic homomonocyclic compounds,CHEMBL657,2989,CPD-10890,NA,NA,DB01075,APRD00587 | DB06975,Diphenhydramine,58-73-1,8GTS82S83M,"2-(Benzhydryloxy)-N,N-dimethylethylamine | 2-diphenylmethoxy-N,N-demthylethanamine | alpha-(2-Dimethylaminoethoxy)diphenylmethane | beta-Dimethylaminoethanol diphenylmethyl ether | beta-Dimethylaminoethyl benzhydryl ether | Difenhidramina | Diphenhydraminum | N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine | O-benzhydryldimethylaminoethanol | Î²-dimethylaminoethyl benzhydryl ether",ZZVUWRFHKOJYTH-UHFFFAOYSA-N
